data_1o7c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1o7c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.482 ' C ' ' HE2' ' T' ' 44' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.872 0.368 . . . . 0.0 111.161 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 137.01 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -69.22 150.35 47.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.507 ' HG3' ' SG ' ' T' ' 92' ' ' CYS . 11.0 mmt180 -144.21 144.86 31.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.471 ' O ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -115.88 -168.97 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.877 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.72 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -99.13 153.55 18.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -17.45 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.758 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -25.2 14.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.3 166.29 10.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.452 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.4 ttpm? -56.72 151.97 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 18.8 m-30 63.16 55.39 1.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.572 ' HA ' ' HD2' ' T' ' 87' ' ' ARG . 9.8 mttt -154.5 1.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.669 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.72 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 12.3 mt -104.08 134.88 46.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 4.6 p -105.1 148.06 27.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.117 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.801 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -35.34 -38.68 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.46 -44.13 65.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' T' ' 15' ' ' THR . 72.0 mt-10 -73.13 -48.24 37.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 110.39 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.793 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -49.83 -45.59 50.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.036 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.15 -55.7 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -42.18 -38.17 1.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.48 -49.91 49.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 46.2 m -64.0 -51.66 63.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.1 tt0 -69.83 -15.81 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -52.52 -50.94 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.51 53.75 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.25 34.15 32.33 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.235 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -103.71 -178.49 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.614 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -147.07 135.52 21.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.014 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.39 143.73 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.228 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' T' ' 52' ' ' MET . . . -83.77 142.25 30.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 33.5 p -98.84 -170.97 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.501 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.767 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 58.1 t80 -70.63 -68.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.104 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 5.2 mmtp -49.42 -37.75 26.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.764 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.437 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.2 mt-30 -67.69 -57.08 6.99 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.258 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.523 ' O ' HD12 ' T' ' 36' ' ' LEU . 1.2 tm? -58.59 -21.36 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 10.3 tt0 -70.26 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.448 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -55.25 -22.52 18.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.655 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.57 -29.33 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.478 0.656 . . . . 0.0 109.442 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.644 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 3.1 tmm_? -69.62 -35.3 75.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.641 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 3.1 mtmp? -71.73 -13.27 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.557 ' CG1' ' O ' ' T' ' 39' ' ' ALA . 1.4 pt -97.26 -16.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.491 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.403 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.92 9.17 1.14 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.421 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.655 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.4 OUTLIER -75.87 91.13 2.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.986 0.393 . . . . 0.0 110.825 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.661 ' HB2' HG21 ' T' ' 62' ' ' VAL . 2.8 t-160 -123.24 129.07 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.643 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -151.21 98.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.283 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.475 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 6.1 t -66.27 80.68 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.485 ' HA ' ' HH ' ' T' ' 12' ' ' TYR . . . 177.66 136.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.695 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.29 112.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.675 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -109.66 118.64 5.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.668 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.546 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 75.9 m95 -52.36 150.1 5.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.444 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' T' ' 31' ' ' ALA . 0.0 OUTLIER -169.85 176.17 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' T' ' 56' ' ' ARG . . . 51.0 -165.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.619 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -8.85 9.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.533 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 159.93 18.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.047 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.52 ' HG2' ' HB2' ' T' ' 53' ' ' ALA . 6.2 ptp180 -95.07 132.53 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.546 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -121.42 121.0 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.94 -168.93 14.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.568 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.2 OUTLIER -133.94 76.99 63.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.864 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.807 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_exo -59.39 122.35 11.37 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.792 2.328 . . . . 0.0 112.379 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.501 HD11 HG22 ' T' ' 61' ' ' ILE . 16.8 mm -139.87 110.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.11 -168.03 30.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.893 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.807 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 33.5 mt -75.39 125.98 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.359 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.568 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.1 mm -95.95 81.34 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.43 133.51 54.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -110.76 -6.8 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.79 174.01 25.69 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.565 HG21 ' H ' ' T' ' 81' ' ' ARG . 7.5 mt -55.56 157.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.565 ' H ' HG21 ' T' ' 80' ' ' ILE . 6.5 mtm180 -120.75 11.01 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.405 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.0 44.34 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -168.55 75.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.801 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -66.88 -5.87 14.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.038 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 77.3 p -73.67 10.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.557 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 4.4 mm-40 -75.3 177.42 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.718 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' T' ' 13' ' ' LYS . 2.8 mtm180 -131.69 113.53 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 111.315 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.661 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.5 m95 -151.87 -153.46 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.203 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -171.79 2.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.424 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.793 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.84 119.22 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.481 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.675 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 33.6 m-85 -86.77 116.2 24.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.507 ' SG ' ' HG3' ' T' ' 5' ' ' ARG . 1.3 m -93.48 155.31 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 111.205 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.501 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 1.9 t80 -153.6 99.31 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.587 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' T' ' 94' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.847 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.872 0.368 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.526 ' N ' HG21 ' T' ' 2' ' ' VAL . 24.8 p90 -151.91 -176.53 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.783 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.52 ' HE2' ' HB3' ' T' ' 89' ' ' ASP . 10.2 t-80 -109.21 157.68 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 2.1 mmt180 -156.33 148.97 23.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.491 ' C ' HD13 ' T' ' 14' ' ' LEU . 2.9 pm0 -112.54 -173.21 2.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.58 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -91.38 158.4 16.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.179 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -61.09 -20.51 62.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.657 ' HB2' ' HD2' ' T' ' 13' ' ' LYS . 32.9 m -95.28 -28.54 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.65 167.11 12.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.44 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.444 ' HD2' ' CB ' ' T' ' 48' ' ' ALA . 1.6 ttpm? -56.65 152.13 12.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 19.3 m-30 63.79 54.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.657 ' HD2' ' HB2' ' T' ' 9' ' ' SER . 53.7 mttt -152.76 5.77 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.678 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.58 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 9.2 mt -109.19 130.23 55.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.048 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.624 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.2 p -103.09 150.47 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.257 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.529 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 85.9 t80 -35.29 -43.14 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.724 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.624 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 13.8 mt-10 -68.07 -56.29 9.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.66 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -44.2 -39.04 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -70.24 -38.36 75.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -60.94 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.52 -48.11 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -66.19 -54.87 20.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.349 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -71.66 -1.58 14.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.701 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -65.1 -48.67 72.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -115.62 63.96 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.242 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.68 45.53 54.59 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.335 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.628 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -115.88 177.53 17.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.535 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -149.65 133.9 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 110.958 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 141.22 6.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.328 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -83.92 146.25 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.463 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.445 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 43.6 p -100.93 -172.29 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.917 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 69.8 t80 -70.93 -64.9 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -49.12 -39.33 28.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.536 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.445 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.5 mt-30 -65.64 -53.06 46.62 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.488 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.36 -27.23 62.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.001 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.13 -59.67 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.426 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.45 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.124 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.612 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.39 -32.94 15.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.457 0.646 . . . . 0.0 109.681 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.676 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -70.53 -33.35 71.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.871 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -66.09 -21.13 66.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.612 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.98 -23.19 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 110.391 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.578 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 141.33 16.26 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.126 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.676 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -75.91 132.41 40.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.904 0.352 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.799 ' HD1' HG11 ' T' ' 62' ' ' VAL . 2.6 t-160 -156.11 124.22 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.615 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -146.78 89.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.82 74.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.675 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.444 ' CB ' ' HD2' ' T' ' 11' ' ' LYS . . . -175.77 119.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.785 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -37.42 114.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.295 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.672 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -114.25 121.3 5.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.545 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.5 m95 -54.68 148.58 12.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.113 0.482 . . . . 0.0 111.634 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -170.94 178.81 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.636 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 50.22 -165.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.468 . . . . 0.0 111.509 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -7.86 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.413 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 160.22 18.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.811 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.7 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.5 mtp180 -92.78 134.79 34.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.512 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -129.92 111.8 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -113.89 -172.26 17.89 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.271 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -122.91 81.45 50.13 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 0.0 111.016 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.846 ' HG3' HG22 ' T' ' 75' ' ' ILE . 28.0 Cg_exo -59.77 126.2 19.84 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.686 2.258 . . . . 0.0 112.164 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.443 HG12 ' O ' ' T' ' 59' ' ' TYR . 25.3 mm -131.59 134.31 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.225 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.799 HG11 ' HD1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.798 0.332 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . 0.414 ' O ' HD12 ' T' ' 76' ' ' ILE . . . 70.44 168.69 7.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.093 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.917 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.5 mp -62.37 105.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.452 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 7.0 mm -73.96 82.29 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.09 120.12 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.443 ' HE1' HG23 ' T' ' 76' ' ' ILE . 7.9 m-85 -87.36 -35.42 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.23 169.66 12.55 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.7 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.0 mt -61.22 115.42 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -84.31 11.13 8.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.64 ' HA ' HH21 ' T' ' 84' ' ' ARG . 0.1 OUTLIER 58.25 46.24 16.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.786 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -151.74 77.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.64 HH21 ' HA ' ' T' ' 82' ' ' LEU . 0.3 OUTLIER -72.4 7.34 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.822 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.415 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -104.43 7.16 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.565 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -66.36 -173.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.93 113.07 11.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.446 . . . . 0.0 111.517 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.593 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.7 m95 -154.47 -166.69 2.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.118 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.52 ' HB3' ' HE2' ' T' ' 4' ' ' HIS . 0.4 OUTLIER -84.34 -173.55 4.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.66 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.26 118.92 10.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.397 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.672 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 39.1 m-85 -88.4 113.95 24.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.403 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.42 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 2.0 t -93.89 159.8 15.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.855 0.36 . . . . 0.0 111.05 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 14.3 t80 -145.11 134.15 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.628 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 6.9 m-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.944 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.531 ' N ' HG21 ' T' ' 2' ' ' VAL . 17.3 p90 -157.53 177.42 11.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.203 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.465 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 37.9 t-80 -97.66 160.09 14.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -157.11 147.26 20.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.3 OUTLIER -112.52 -168.43 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.681 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -102.6 155.92 17.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.14 -17.72 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 p -98.47 -25.59 14.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.53 166.94 10.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.458 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -57.41 152.03 15.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 17.7 m-30 61.41 56.28 2.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.142 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -155.12 8.53 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.573 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.681 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 6.3 mt -110.63 132.32 54.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.291 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.721 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.7 p -103.0 146.54 28.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.141 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.5 t80 -33.93 -39.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.31 -45.2 70.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' T' ' 15' ' ' THR . 73.4 mt-10 -73.8 -49.9 23.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.775 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -48.39 -41.1 27.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.989 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -50.1 22.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.931 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.71 -40.99 30.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.409 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 6.8 t -70.49 -54.31 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.452 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 63.4 m -60.77 -42.04 96.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.923 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 10.0 tt0 -81.8 -10.25 59.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 0.9 OUTLIER -54.23 -50.89 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.003 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -96.62 61.37 1.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.92 30.72 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.418 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -111.56 -169.31 18.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.502 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.494 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.15 135.26 13.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.592 0.234 . . . . 0.0 110.441 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.19 125.43 26.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.463 . . . . 0.0 110.235 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -50.21 163.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.546 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 5.9 p -111.21 -158.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.74 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 30.9 t80 -79.89 -74.19 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.2 mttt -47.19 -36.35 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.73 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.31 -53.95 30.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.39 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -55.49 -24.47 31.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.932 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 15.0 tt0 -69.0 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.266 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.404 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -59.02 -12.01 4.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.562 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.1 -29.88 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.328 0.585 . . . . 0.0 109.872 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.57 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -73.42 -33.86 65.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.139 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.3 mtmt -69.97 -17.17 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.36 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.562 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.95 -17.63 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.433 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.51 11.53 1.49 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.014 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.57 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -82.63 124.48 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.921 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.581 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.4 t-160 -148.6 126.63 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.598 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -146.94 100.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.24 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.87 ' HA ' HD13 ' T' ' 61' ' ' ILE . 5.9 t -66.83 80.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 175.99 126.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.551 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -45.13 113.17 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.279 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.4 114.96 3.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.596 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.646 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 77.6 m95 -48.68 168.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 111.757 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.785 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -161.86 173.77 14.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.504 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.93 166.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 111.52 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.559 ' HB3' HD13 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 76.84 -31.64 0.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.34 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 109.14 20.12 8.1 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.592 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HB3' HG13 ' T' ' 80' ' ' ILE . 0.4 OUTLIER -108.99 156.28 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.594 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.646 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -137.03 133.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.052 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -137.53 -172.59 12.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.312 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.642 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -133.03 102.59 13.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.5 Cg_endo -60.33 -88.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.196 . . . . 0.0 112.291 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.87 HD13 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm 71.42 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' T' ' 45' ' ' HIS . 14.8 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.28 176.9 51.66 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.799 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 2.5 mt -76.81 108.67 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 111.258 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.0 mm -79.13 82.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.975 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.42 121.65 45.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 1.6 m-85 -83.71 11.96 6.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.62 170.74 7.83 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' T' ' 56' ' ' ARG . 9.4 mt -60.33 117.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.18 19.42 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.547 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.71 35.24 20.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -129.91 53.11 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.721 ' O ' ' HB ' ' T' ' 15' ' ' THR . 21.4 mtt180 -60.95 -5.55 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.41 ' H ' ' C ' ' T' ' 83' ' ' ASN . 1.0 OUTLIER -90.64 20.74 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.76 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.544 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.4 mm-40 -83.72 -172.05 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.641 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.56 114.15 10.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.1 m95 -153.98 -164.74 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.97 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.458 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -89.56 -173.96 4.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.55 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.775 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.06 135.16 25.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.683 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 35.8 m-85 -96.88 111.91 23.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.276 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 9.1 m -90.49 137.2 32.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 111.09 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.944 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.4 OUTLIER -136.83 126.26 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.774 HG22 ' HB3' ' T' ' 31' ' ' ALA . 2.1 p . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.79 -176.99 5.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.881 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.462 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 16.4 t-80 -95.38 153.85 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.32 150.97 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.044 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 26.0 tt0 -120.02 173.19 7.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.631 ' N ' HD13 ' T' ' 14' ' ' LEU . . . -80.29 159.92 25.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.084 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -61.25 -28.54 69.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.452 ' HB2' ' HE3' ' T' ' 13' ' ' LYS . 0.9 OUTLIER -91.55 -50.05 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 176.39 174.21 42.69 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.497 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 20.1 ttpt -62.96 168.14 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.745 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 46.3 47.79 13.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.7 OUTLIER -143.41 2.34 1.26 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.785 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.631 HD13 ' N ' ' T' ' 7' ' ' ALA . 6.5 mt -104.2 139.06 39.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.487 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.637 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 19.8 p -107.8 149.67 27.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.94 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 61.9 t80 -34.07 -42.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 111.054 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.69 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.7 mt-10 -69.34 -44.66 71.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 110.032 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -56.09 -38.65 70.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.815 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.474 ' HZ1' HD22 ' T' ' 30' ' ' LEU . 7.9 tttp -76.42 -37.13 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -59.56 -38.47 81.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.084 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -53.16 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.355 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -63.89 -28.39 69.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 30.9 tt0 -99.31 -9.28 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 110.307 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -51.34 -42.6 61.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.92 59.0 0.66 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.88 33.34 20.24 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.28 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.27 -168.2 19.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.585 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.4 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.583 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -70.58 126.89 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 0.0 110.358 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.774 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -51.3 161.23 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.575 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.639 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 28.2 p -111.84 -164.94 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.883 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 32.5 t80 -74.76 -70.75 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.991 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 30.0 mttm -45.28 -41.85 9.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.667 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.71 -51.21 63.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.732 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.69 -27.33 49.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.949 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.7 tp10 -65.9 -61.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.087 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.27 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.936 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.544 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.92 -30.16 14.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.348 0.594 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.558 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 53.0 ttt-85 -73.6 -33.35 64.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.009 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 13.0 mttt -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.544 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.74 -15.73 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.415 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 131.15 12.12 2.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.091 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.47 120.0 23.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.563 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.5 t-160 -136.4 129.32 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.656 HG23 ' HE1' ' T' ' 91' ' ' TYR . 1.3 t -143.24 103.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.447 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.687 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.71 66.32 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.5 ' HA ' ' HH ' ' T' ' 12' ' ' TYR . . . -175.26 138.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.671 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -55.09 111.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.643 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -108.6 113.85 3.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.6 m95 -47.12 152.06 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.779 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.5 174.54 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.688 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 53.44 -166.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.543 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 0.34 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.537 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 151.74 16.16 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.786 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' T' ' 52' ' ' MET . 1.9 mtt180 -92.05 125.52 36.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.585 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -116.3 126.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -130.23 -169.2 12.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.318 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.492 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.1 OUTLIER -139.45 91.92 10.67 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.855 0.36 . . . . 0.0 111.143 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.887 ' HB3' HD12 ' T' ' 75' ' ' ILE . 68.4 Cg_endo -78.49 125.06 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.67 2.247 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' T' ' 47' ' ' CYS . 20.0 mm -136.82 101.21 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.01 -175.93 34.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.834 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' T' ' 60' ' ' PRO . 0.6 OUTLIER -80.31 89.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.987 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.492 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 18.3 mm -62.42 84.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.43 138.21 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 2.0 m-85 -112.82 27.72 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.499 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 68.49 168.2 4.83 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.401 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.2 mt -57.43 147.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.947 0.403 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.663 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 4.7 mmm-85 -115.14 22.52 13.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.02 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' T' ' 82' ' ' LEU . 0.2 OUTLIER 44.46 53.4 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.663 ' OD1' ' HB2' ' T' ' 81' ' ' ARG . 27.5 p-10 -165.81 61.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.631 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -58.3 -3.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.501 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -81.93 17.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.502 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 1.8 mm-40 -78.01 -172.46 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.63 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -139.04 113.38 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.283 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.745 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 16.2 m95 -153.13 -156.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.105 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -97.33 -171.23 2.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.374 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.674 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.17 137.92 29.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.221 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.664 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 32.5 m-85 -101.02 120.38 40.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.441 ' O ' HG21 ' T' ' 2' ' ' VAL . 5.7 m -96.1 147.51 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.431 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.733 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 26.5 t80 -137.6 133.95 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.589 179.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.2 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.03 -177.97 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.496 ' HE2' ' HB3' ' T' ' 89' ' ' ASP . 21.1 t-80 -101.7 161.56 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.467 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.83 144.81 23.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.598 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.8 tt0 -115.62 173.28 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.692 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.651 ' HB3' ' HG ' ' T' ' 14' ' ' LEU . . . -87.25 157.19 19.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.194 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -65.93 -21.5 66.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -91.41 -23.75 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.85 167.79 11.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.453 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 7.6 ttpt -58.59 158.15 8.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.0 m-30 57.2 55.98 5.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -153.25 2.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.651 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 6.8 mt -103.05 136.81 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.072 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.676 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.5 p -107.73 152.91 23.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.243 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 71.5 t80 -36.66 -43.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.03 -39.86 68.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.676 ' HB2' ' H ' ' T' ' 15' ' ' THR . 76.4 mt-10 -70.55 -47.69 59.08 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 109.806 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.764 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -55.89 -46.47 78.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.561 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.636 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -65.67 -39.54 91.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.142 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.89 -52.31 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 92.1 m -64.13 -48.98 73.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.541 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 42.9 tt0 -69.9 -16.4 63.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.532 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.95 -49.09 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.803 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -103.71 51.6 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.28 38.97 34.51 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.356 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -117.98 172.83 14.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.569 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -124.79 139.47 53.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.71 0.291 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -74.64 126.12 30.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.215 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.846 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -49.3 155.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.461 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.592 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 27.1 p -110.39 -164.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.735 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 27.6 t80 -74.88 -72.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.107 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -47.59 -41.59 21.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.921 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.45 -47.79 80.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' T' ' 91' ' ' TYR . 0.6 OUTLIER -54.81 -40.72 69.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 3.6 tp10 -54.26 -60.66 3.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.188 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.85 -18.48 8.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.585 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.27 -29.75 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.76 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' T' ' 62' ' ' VAL . 3.1 tmm_? -71.17 -33.62 70.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.011 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtpt -69.45 -17.03 63.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.314 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.53 -12.33 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.683 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.24 14.9 3.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.012 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -83.01 124.6 30.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 0.0 110.981 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.725 ' HD1' HG13 ' T' ' 62' ' ' VAL . 2.2 t-160 -147.15 127.25 13.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.645 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -143.75 94.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.556 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 1.3 m -61.75 83.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 170.32 125.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -46.28 113.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -110.43 121.37 5.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.633 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.4 m95 -49.68 152.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.97 0.414 . . . . 0.0 111.318 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.803 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.41 177.82 3.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.73 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.592 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 51.97 -165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.469 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 2.78 2.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.372 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.526 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 151.02 15.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.791 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.697 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 28.6 mtt180 -94.72 127.48 40.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.563 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -115.93 131.37 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.504 ' N ' ' HE3' ' T' ' 52' ' ' MET . . . -141.38 -178.28 17.45 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.393 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.95 98.3 39.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.745 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 37.9 Cg_exo -55.35 -84.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.786 2.324 . . . . 0.0 112.689 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.2 mm 73.57 102.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.948 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.725 HG13 ' HD1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.861 0.363 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . 0.557 ' HA3' ' NH2' ' T' ' 40' ' ' ARG . . . 86.21 175.39 49.78 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.735 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.3 mt -68.49 107.41 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.046 0.45 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.493 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.8 mm -81.39 83.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.479 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 3.1 t70 -109.47 132.12 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -105.15 23.01 14.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.697 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 70.05 170.97 8.75 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.37 152.29 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.05 18.65 17.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.55 ' O ' HD11 ' T' ' 82' ' ' LEU . 0.1 OUTLIER 54.76 31.66 15.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -148.92 77.44 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.66 ' O ' ' HB ' ' T' ' 15' ' ' THR . 69.2 mtt180 -65.79 2.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.483 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -102.14 12.67 36.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.511 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -65.17 -178.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -132.35 114.27 14.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 111.341 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 23.2 m95 -151.43 -136.6 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.274 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' T' ' 4' ' ' HIS . 0.7 OUTLIER -115.4 -167.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.378 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.764 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -147.6 132.53 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.276 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.713 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 31.1 m-85 -105.1 127.28 52.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.463 ' O ' HG21 ' T' ' 2' ' ' VAL . 1.2 m -100.76 159.67 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.304 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.676 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 24.2 t80 -150.67 119.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.484 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.78 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.1 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.792 0.33 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -147.23 -176.69 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.436 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 40.7 t-80 -98.93 163.95 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 154.77 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.549 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 24.7 tt0 -121.91 172.91 7.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.567 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -78.33 161.23 27.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -20.16 65.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.757 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.525 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.5 m -102.82 -47.49 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.91 172.53 39.3 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 150.25 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.692 0.282 . . . . 0.0 110.969 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.69 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 61.81 57.36 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.525 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 9.0 mttm -153.55 1.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.515 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.567 HD13 ' HA ' ' T' ' 7' ' ' ALA . 12.3 mt -104.66 139.54 39.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.7 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.6 p -108.55 151.8 25.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.553 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 67.6 t80 -36.52 -41.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 0.0 110.791 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.79 -39.03 64.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.304 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.7 ' HB2' ' H ' ' T' ' 15' ' ' THR . 82.6 mt-10 -71.02 -45.38 64.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.179 0.514 . . . . 0.0 109.958 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.83 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.56 -45.26 89.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.565 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -68.47 -26.86 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.563 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.71 -41.53 83.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.194 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.78 -51.73 47.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.259 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -63.84 -47.71 79.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.592 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 4.1 tt0 -73.55 -13.45 61.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -54.43 -48.83 71.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -102.9 50.98 0.81 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.758 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.15 39.62 50.53 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.313 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -118.17 177.41 16.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.733 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -130.12 141.83 50.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.564 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.765 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.63 125.44 29.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.068 0.461 . . . . 0.0 110.23 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.78 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -48.22 154.32 0.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.533 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -109.99 -162.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.222 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 31.6 t80 -77.23 -72.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 14.1 mttm -46.89 -38.49 10.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.732 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.28 -53.55 35.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 110.39 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.63 -23.86 44.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 12.1 tp10 -68.45 -61.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.205 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.52 -16.09 8.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.798 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.548 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.49 -29.48 15.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.491 0.662 . . . . 0.0 109.684 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.549 HH11 ' HA3' ' T' ' 74' ' ' GLY . 0.0 OUTLIER -72.61 -33.25 66.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.112 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.0 mttt -69.52 -17.88 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.286 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.548 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.39 -14.35 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.81 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.22 11.35 2.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.045 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -81.48 118.6 22.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.697 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.9 t-160 -141.55 127.2 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.649 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -145.43 102.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.28 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.778 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -72.72 80.5 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.701 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 178.55 123.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.835 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.576 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -41.73 111.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.676 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.31 114.97 3.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.667 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.619 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 71.7 m95 -48.95 156.83 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.432 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.765 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -177.61 178.33 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.896 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.595 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 50.77 -165.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -7.52 7.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.498 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.488 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 158.49 19.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.858 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.637 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.9 OUTLIER -97.53 135.66 39.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.73 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.619 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -126.61 122.42 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -170.65 13.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.576 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -124.99 82.97 60.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.961 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.619 ' HG3' HD12 ' T' ' 75' ' ' ILE . 26.7 Cg_exo -60.37 104.95 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.761 2.307 . . . . 0.0 112.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.778 HD13 ' HA ' ' T' ' 47' ' ' CYS . 29.4 mm -130.74 112.28 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.028 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.697 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.821 0.344 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . 0.549 ' HA3' HH11 ' T' ' 40' ' ' ARG . . . 90.03 -176.24 42.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.85 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.631 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -70.36 110.85 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 111.058 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.427 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.2 mm -89.36 79.86 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -101.92 122.83 44.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.01 3.36 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.09 172.44 44.37 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.468 HG12 ' C ' ' T' ' 55' ' ' GLY . 6.3 mt -65.4 119.92 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.315 . . . . 0.0 111.027 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -112.03 28.35 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.96 27.89 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' T' ' 85' ' ' SER . 22.9 m120 -114.38 51.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.612 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -70.65 4.34 2.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.409 ' H ' ' C ' ' T' ' 83' ' ' ASN . 1.3 m -106.62 6.97 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.547 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -72.15 -171.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 23.5 mtp85 -132.63 113.48 13.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.139 0.495 . . . . 0.0 111.56 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.69 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.8 m95 -153.99 -171.24 3.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.038 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -81.99 -171.21 3.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.424 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.83 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.77 136.87 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.676 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 38.8 m-85 -103.24 127.91 50.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.51 ' O ' HG21 ' T' ' 2' ' ' VAL . 0.7 OUTLIER -99.56 161.35 13.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 111.284 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.693 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 25.2 t80 -151.62 119.88 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.757 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.705 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.6 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.804 0.335 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.487 ' N ' HG21 ' T' ' 2' ' ' VAL . 27.3 p90 -145.59 -176.91 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.48 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 16.1 t-80 -113.56 155.26 25.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.434 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.2 OUTLIER -154.96 164.43 38.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.2 OUTLIER -122.82 -170.0 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -90.7 149.55 22.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -60.12 -16.47 32.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.753 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -98.77 -25.35 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 149.19 167.65 14.13 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.492 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 8.1 tttm -62.38 153.84 29.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.345 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.9 m-30 57.06 51.92 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.753 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 3.7 mttm -142.69 1.05 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 6.9 mt -104.33 146.77 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.714 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 22.3 p -114.36 153.31 30.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.012 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.694 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 72.2 t80 -37.76 -40.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.849 0.357 . . . . 0.0 110.751 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.99 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.359 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.714 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.7 mt-10 -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.173 0.511 . . . . 0.0 109.936 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.09 -46.2 85.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -67.69 -26.5 66.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.489 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -69.41 -40.98 77.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.86 -50.41 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -52.27 50.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.148 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 6.5 tt0 -71.62 -3.04 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.644 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -65.71 -45.11 83.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.574 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.81 59.61 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.047 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 55.82 21.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.262 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.482 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -138.96 166.96 25.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.784 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.47 139.07 51.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.612 0.244 . . . . 0.0 110.57 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.791 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -74.22 124.65 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.0 110.316 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -49.69 153.13 1.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.483 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 28.3 p -106.17 -164.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.977 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.87 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 53.0 t80 -75.61 -69.79 0.47 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.021 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -46.68 -42.7 16.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.17 -46.25 84.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.647 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.73 -38.01 71.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.226 0.536 . . . . 0.0 109.661 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.02 -60.68 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.428 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.555 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -54.48 -21.59 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.058 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -90.91 -28.85 17.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 0.0 109.633 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.436 ' O ' HG22 ' T' ' 62' ' ' VAL . 19.2 ttp85 -71.59 -34.21 69.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.001 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -73.24 -18.05 61.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.555 HG21 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -87.88 -7.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.92 7.07 7.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.331 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -78.17 130.64 36.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.645 ' HD1' HG13 ' T' ' 62' ' ' VAL . 2.6 t-160 -153.07 130.8 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.763 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.59 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -152.37 99.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.261 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.605 ' HA ' HD12 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.731 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 179.67 122.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.45 110.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.653 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -109.71 115.94 4.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.838 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.626 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 67.3 m95 -48.19 156.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 111.367 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.791 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.1 OUTLIER -178.28 177.37 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.055 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.04 -165.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.754 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -14.03 10.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.476 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 160.85 23.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.926 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' T' ' 52' ' ' MET . 10.7 ptp180 -99.71 136.41 39.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.538 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.626 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -127.88 119.57 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -118.68 -173.67 15.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.257 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.415 ' O ' HG12 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -120.56 82.32 33.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.826 ' HG3' HG22 ' T' ' 75' ' ' ILE . 27.7 Cg_exo -59.97 120.9 8.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.689 2.259 . . . . 0.0 112.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' T' ' 47' ' ' CYS . 10.4 mm -138.69 100.56 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.645 HG13 ' HD1' ' T' ' 45' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.899 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 168.4 44.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.87 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.0 mp -63.49 97.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.757 0.313 . . . . 0.0 111.301 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.8 80.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.444 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 3.4 t70 -105.12 123.17 47.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 2.2 m-85 -86.31 -3.16 58.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.967 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.57 169.69 40.32 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.423 HG12 ' C ' ' T' ' 55' ' ' GLY . 16.2 mt -60.67 127.83 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 111.082 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.88 16.99 21.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.99 45.75 26.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.418 HD21 ' HG2' ' T' ' 86' ' ' GLU . 18.9 t30 -163.93 77.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.694 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -69.89 -4.94 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 17.26 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.54 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -80.32 -171.81 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.599 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 2.7 ppt_? -137.53 111.75 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.094 0.473 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.646 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.2 m95 -153.71 -172.11 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.171 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -170.62 3.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.32 137.79 27.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.653 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 36.2 m-85 -103.45 121.14 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 154.17 17.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.014 0.435 . . . . 0.0 111.3 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.705 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 28.8 t80 -143.7 126.27 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.482 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 26.6 m-20 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.525 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.952 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 2.0 p90 -151.22 177.46 10.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.163 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.503 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.3 t-80 -112.86 160.74 17.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.154 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 6.0 tpp180 -158.89 159.81 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 -169.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.868 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.774 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -96.17 149.86 21.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -20.49 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.498 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -95.72 -22.74 17.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.833 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 144.47 166.97 11.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.417 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -65.02 162.74 16.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.7 m-30 53.69 38.75 29.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.4 OUTLIER -134.54 4.9 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.876 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.774 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 7.7 mt -107.51 139.04 42.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.982 0.42 . . . . 0.0 111.427 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.8 p -109.86 149.12 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.011 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.598 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -34.48 -41.16 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.786 0.326 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.39 -43.85 69.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.319 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.518 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.8 mt-10 -70.38 -46.78 63.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -49.7 -43.95 47.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.95 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -65.63 -54.45 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -50.01 -36.8 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 t -75.18 -54.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.524 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.449 ' O ' ' HA2' ' T' ' 28' ' ' GLY . 58.8 m -64.19 -30.32 71.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 24.4 tt0 -92.59 -12.14 32.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 110.104 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.567 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.4 t80 -54.33 -41.62 69.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.044 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -107.69 59.09 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.218 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.53 20.46 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.415 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -94.54 -174.3 38.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.92 136.26 14.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.14 137.17 10.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.475 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -77.54 166.94 22.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.134 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 47.0 p -117.99 -175.15 2.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 0.0 111.373 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.939 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 48.0 t80 -69.54 -68.99 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.955 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.2 mttp -45.89 -42.09 12.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.583 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.432 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.2 mt-30 -65.03 -51.04 63.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.764 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -60.17 -22.17 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.5 tt0 -73.98 -61.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.286 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.28 -13.45 7.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.2 -29.11 14.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.656 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 8.4 ttt-85 -72.73 -34.38 67.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.035 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.7 mtpt -69.67 -15.79 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.574 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.0 -19.16 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.741 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.476 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.11 11.77 1.02 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.103 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.656 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.65 115.74 20.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.526 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.4 t-160 -135.53 127.99 30.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' T' ' 45' ' ' HIS . 1.3 t -144.64 102.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.249 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.509 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 52.8 t -77.56 63.85 2.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.74 125.59 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.894 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.535 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -42.5 115.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.05 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -115.59 119.31 4.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.632 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.504 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.1 m95 -53.48 148.52 9.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.47 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.649 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -167.5 175.31 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.344 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' T' ' 56' ' ' ARG . . . 51.62 -165.99 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -2.17 4.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.441 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.9 14.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.846 ' HG3' HG13 ' T' ' 80' ' ' ILE . 6.8 mtt180 -88.41 125.94 34.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.474 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -121.88 117.81 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.73 -169.72 13.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.261 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -141.48 95.06 7.34 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 111.219 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.814 ' HB3' HD12 ' T' ' 75' ' ' ILE . 71.8 Cg_endo -81.58 131.25 7.26 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 15.2 mm -134.77 107.22 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.184 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.47 -174.78 35.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.907 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.939 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -79.88 95.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.163 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 11.6 mm -68.18 83.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -110.38 122.05 46.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.464 ' HE1' HG23 ' T' ' 76' ' ' ILE . 1.0 OUTLIER -87.69 -5.94 58.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.072 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.718 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 91.22 169.11 41.99 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.846 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.7 mt -59.36 122.4 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -102.37 13.84 33.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.949 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.48 48.93 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.32 58.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.642 ' HB2' HH11 ' T' ' 84' ' ' ARG . 0.0 OUTLIER -60.39 -9.71 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -79.69 12.59 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.47 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -79.37 -178.68 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.688 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -134.85 116.36 14.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.578 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 20.8 m95 -150.18 -134.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.339 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -115.83 -166.83 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.357 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -148.0 119.54 7.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.369 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.627 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 28.4 m-85 -87.63 103.8 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.498 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.6 m -82.26 151.84 26.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.952 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -148.91 125.75 11.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.769 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.679 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.7 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.805 0.336 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.494 ' N ' HG21 ' T' ' 2' ' ' VAL . 21.0 p90 -143.21 178.41 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.818 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.514 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 46.9 t-80 -96.1 159.05 15.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.205 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.786 ' HG2' HG12 ' T' ' 22' ' ' VAL . 0.0 OUTLIER -151.31 151.4 31.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.031 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.0 tt0 -122.91 173.09 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.556 ' N ' ' CG ' ' T' ' 6' ' ' GLU . . . -88.64 157.72 18.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.191 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.665 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -93.8 -24.82 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.38 166.86 10.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.538 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 17.4 ttpt -58.41 155.66 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 110.97 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.488 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 10.5 m-30 58.5 54.2 5.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.989 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -152.5 3.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 6.6 mt -104.32 134.9 46.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 28.0 p -105.56 150.93 24.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.736 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 78.8 t80 -34.86 -42.28 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.956 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -42.25 65.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.373 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.601 ' HB2' ' H ' ' T' ' 15' ' ' THR . 67.5 mt-10 -69.72 -46.58 65.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.017 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.851 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -52.83 -42.12 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.738 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -68.0 -34.9 77.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.605 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.96 -36.37 83.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.972 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . 0.786 HG12 ' HG2' ' T' ' 5' ' ' ARG . 3.0 t -69.16 -50.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.178 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -64.57 -54.31 34.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.029 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 44.0 tt0 -62.26 -19.26 63.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -54.06 -48.41 70.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.81 54.45 0.66 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.37 31.5 35.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.241 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.444 ' C ' ' HD1' ' T' ' 29' ' ' HIS . . . -100.95 167.56 19.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.646 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -133.91 138.14 45.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.004 0.431 . . . . 0.0 111.412 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.87 139.17 22.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.871 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -81.17 166.27 20.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.452 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 38.9 p -120.82 -175.01 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.0 111.684 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.838 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 36.0 t80 -68.32 -70.34 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.757 ' HA ' ' HG3' ' T' ' 37' ' ' GLU . 3.0 mttp -46.69 -40.99 14.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.865 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.452 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.5 mt-30 -63.65 -47.13 82.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.743 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -30.81 61.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.384 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.757 ' HG3' ' HA ' ' T' ' 34' ' ' LYS . 0.0 OUTLIER -66.51 -60.86 2.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.451 0.643 . . . . 0.0 110.118 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.44 -18.52 2.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.546 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.17 -30.72 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.398 0.618 . . . . 0.0 109.678 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.413 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.1 OUTLIER -72.65 -32.95 66.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.044 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.4 mtmp? -69.69 -18.21 63.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.546 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.61 -10.95 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.41 14.03 4.57 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.514 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.2 t80 -82.15 125.66 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.643 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.5 t-160 -147.61 126.1 12.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.635 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -145.66 101.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.222 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.829 ' HA ' HD13 ' T' ' 61' ' ' ILE . 4.4 t -72.15 78.99 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . -179.62 116.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.602 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -38.61 117.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.072 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.638 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -116.27 122.73 5.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.692 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.5 m95 -53.99 146.56 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -164.64 178.41 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.471 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' T' ' 56' ' ' ARG . . . 51.04 -166.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.475 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.77 3.88 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.448 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 151.04 13.7 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.856 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.844 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 11.4 mtt180 -91.47 127.09 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.496 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -117.55 125.38 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.02 -175.67 14.16 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.602 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -134.7 103.68 11.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.3 Cg_exo -58.5 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.623 2.216 . . . . 0.0 112.199 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.829 HD13 ' HA ' ' T' ' 47' ' ' CYS . 30.0 mm 75.42 108.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.903 0.383 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.47 176.21 49.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.838 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -68.47 112.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 111.021 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.566 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.6 mm -87.23 88.7 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.117 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -112.87 112.89 24.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.473 ' HE1' ' CE2' ' T' ' 59' ' ' TYR . 3.2 m-85 -79.38 4.35 15.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.844 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 76.65 170.11 31.32 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.676 HG21 ' H ' ' T' ' 82' ' ' LEU . 11.9 mt -48.21 142.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 3.9 mmm-85 -108.26 16.09 23.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.676 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.75 35.37 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -169.07 86.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.736 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -70.42 -1.15 9.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -76.87 15.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.511 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.5 mm-40 -75.11 -173.57 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -138.22 113.7 9.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 111.1 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 15.7 m95 -151.22 -137.79 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.507 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.538 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -116.01 -165.35 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.449 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.851 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -147.34 126.89 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 111.559 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.638 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 29.9 m-85 -97.47 107.59 20.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.413 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 t -84.89 154.93 21.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.825 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 13.9 t80 -144.02 123.05 12.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.999 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.322 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.87 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.5 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.826 0.346 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.457 ' N ' HG21 ' T' ' 2' ' ' VAL . 31.0 p90 -156.98 -176.52 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.497 ' HE2' ' HB3' ' T' ' 89' ' ' ASP . 9.8 t-80 -101.38 159.33 15.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.049 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 8.1 mmt180 -153.04 148.49 27.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.566 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.7 tt0 -116.4 173.34 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' T' ' 6' ' ' GLU . . . -86.43 156.07 20.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -20.7 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.442 ' HB3' ' NZ ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -93.88 -28.01 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.8 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 147.65 168.27 13.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.345 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.441 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 4.1 ttpm? -63.68 165.23 8.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 16.2 m-30 50.8 43.95 28.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 3.8 mttt -138.63 -2.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 8.4 mt -102.18 139.56 37.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.336 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.616 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 2.8 p -110.46 151.58 27.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.108 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.517 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 79.5 t80 -34.01 -42.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.99 68.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.223 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.616 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.0 mt-10 -68.63 -45.27 72.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.823 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -52.93 -40.4 63.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.896 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -70.11 -34.89 73.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -64.53 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.53 -50.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.21 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.68 -53.26 50.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.4 tt0 -63.8 -21.07 66.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.413 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.4 OUTLIER -51.38 -49.81 60.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.844 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -106.03 53.47 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.58 42.23 43.66 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.231 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -115.07 165.86 12.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.728 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.555 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.46 139.45 51.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.891 0.377 . . . . 0.0 111.312 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.45 149.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.983 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -90.7 149.28 22.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.401 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.632 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 62.8 p -105.93 -175.57 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.915 0.388 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.926 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 51.8 t80 -67.29 -68.57 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.042 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -48.29 -42.86 32.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.947 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.12 -50.19 69.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -60.45 -31.69 70.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.336 0.588 . . . . 0.0 109.646 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' T' ' 41' ' ' LYS . 8.8 tt0 -65.28 -58.39 6.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.236 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.14 -23.91 6.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.786 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -87.51 -30.53 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.516 0.674 . . . . 0.0 109.78 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.75 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.4 OUTLIER -70.45 -33.71 71.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.093 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' T' ' 37' ' ' GLU . 11.4 mttm -67.48 -19.22 65.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.197 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.626 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.1 -21.83 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.556 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 139.7 15.19 0.56 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.211 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.75 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -70.75 137.64 49.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.737 0.303 . . . . 0.0 110.683 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.566 ' NE2' HD11 ' T' ' 61' ' ' ILE . 3.2 t-160 -161.09 124.45 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.651 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -146.67 103.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.733 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.48 72.79 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' T' ' 12' ' ' TYR . . . -178.72 139.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -56.28 116.64 3.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.688 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -113.39 121.39 5.48 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.725 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 77.0 m95 -55.16 144.44 24.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.503 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -163.26 176.06 10.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.664 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.539 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.95 -165.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.584 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -6.41 9.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.563 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.11 16.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.954 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.611 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.7 ptp180 -93.69 130.36 39.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.712 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.5 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -118.01 121.26 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.967 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.21 -169.07 13.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.289 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.683 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -143.77 93.02 6.28 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.128 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.856 ' HB3' HD12 ' T' ' 75' ' ' ILE . 73.5 Cg_endo -80.93 130.54 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.739 2.293 . . . . 0.0 112.259 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' T' ' 47' ' ' CYS . 22.6 mm -142.98 107.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' T' ' 45' ' ' HIS . 2.7 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.913 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.838 0.352 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.34 179.36 52.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.966 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.926 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -74.85 98.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.05 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.683 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 8.8 mm -70.21 85.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.94 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.491 ' HE1' ' HE2' ' T' ' 59' ' ' TYR . 2.5 m-85 -111.6 22.05 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.38 170.86 7.5 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.608 HG23 ' H ' ' T' ' 82' ' ' LEU . 8.2 mt -53.94 152.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.433 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -130.63 16.24 5.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.608 ' H ' HG23 ' T' ' 80' ' ' ILE . 4.3 mm? 56.28 27.26 11.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.89 57.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.572 ' O ' ' HB ' ' T' ' 15' ' ' THR . 11.4 mtm180 -66.45 -1.67 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 9.6 t -97.47 6.19 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.574 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -68.21 -176.47 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.33 113.35 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.438 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.7 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 12.7 m95 -152.87 -155.99 0.66 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.204 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.497 ' HB3' ' HE2' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -96.12 -169.76 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.227 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.823 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.9 121.87 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 0.0 111.437 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.688 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 34.4 m-85 -90.26 107.47 19.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.419 ' O ' HG21 ' T' ' 2' ' ' VAL . 8.0 m -82.29 164.58 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.337 . . . . 0.0 111.023 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.761 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 7.9 t80 -153.04 118.1 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.437 179.536 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.864 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.427 ' N ' HG21 ' T' ' 2' ' ' VAL . 5.9 p90 -145.5 -179.97 7.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.517 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 9.1 t-80 -112.31 161.91 16.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.517 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 10.9 mmt180 -155.9 161.53 40.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.672 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -126.29 -174.31 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' T' ' 14' ' ' LEU . . . -86.36 153.61 21.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -58.77 -20.77 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.806 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -27.58 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.44 167.74 12.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.519 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.578 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 1.6 ttpt -55.37 153.52 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.2 m-30 55.37 69.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.1 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -158.74 -7.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.689 HD12 ' HB1' ' T' ' 90' ' ' ALA . 1.1 pp -111.94 161.62 16.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.106 0.479 . . . . 0.0 111.27 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.774 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 3.4 p -114.58 -166.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.554 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.1 t80 -67.5 -41.39 84.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.34 -38.63 74.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.541 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.774 ' HB2' ' H ' ' T' ' 15' ' ' THR . 53.7 mt-10 -71.76 -43.3 66.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.194 0.521 . . . . 0.0 110.182 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -54.03 -41.78 68.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.986 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -55.93 10.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.118 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.5 -36.65 3.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.285 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.54 -56.04 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.442 ' O ' ' HA2' ' T' ' 28' ' ' GLY . 82.9 m -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 18.5 tt0 -88.21 -12.72 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 109.614 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.2 t80 -57.31 -39.5 75.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.86 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -113.4 56.64 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.163 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.63 34.75 28.74 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.584 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.96 171.1 14.23 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.427 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.593 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.18 143.56 46.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.284 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -52.74 136.52 33.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.292 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.645 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -77.87 153.51 32.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 35.4 p -106.5 -172.29 2.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 111.673 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.92 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 65.3 t80 -71.63 -67.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.07 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -46.56 -40.89 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.429 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 93.9 mt-30 -64.75 -49.38 71.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.529 HD22 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -59.19 -23.66 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.071 0.462 . . . . 0.0 110.118 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 2.9 tp10 -74.04 -62.08 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.98 -13.73 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.995 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -95.06 -29.99 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.362 0.601 . . . . 0.0 109.671 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.753 ' HG2' HG22 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -71.6 -33.04 68.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.954 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.5 OUTLIER -69.76 -16.67 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.374 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.05 -14.98 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.599 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.409 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.21 17.58 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.988 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -80.15 112.63 17.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 111.006 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.886 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.3 t-160 -135.13 124.11 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.553 ' HB ' ' HH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -143.71 89.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.804 ' HA ' HD12 ' T' ' 61' ' ' ILE . 13.9 t -63.87 85.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.576 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . 172.57 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.871 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -38.29 113.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.65 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.84 126.39 7.64 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.554 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 75.0 m95 -58.03 149.73 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.92 0.39 . . . . 0.0 111.426 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -169.44 179.27 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.591 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 50.08 -166.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -7.22 5.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.382 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 157.58 20.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.624 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.766 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.1 mtm180 -94.68 130.61 41.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.908 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.552 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -120.8 121.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.8 -173.75 13.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.443 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.624 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -132.63 101.82 14.11 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.77 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.9 Cg_endo -61.01 -81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.804 2.336 . . . . 0.0 112.517 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' T' ' 47' ' ' CYS . 8.2 mm 75.04 106.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.886 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.82 167.56 43.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.92 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.2 mp -64.1 100.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.387 . . . . 0.0 111.42 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.624 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 10.7 mm -69.68 87.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -108.45 120.12 41.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.424 ' HE1' ' HE2' ' T' ' 59' ' ' TYR . 12.9 m-85 -91.06 -11.33 39.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' T' ' 56' ' ' ARG . . . 103.66 173.76 25.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.766 HG13 ' HG3' ' T' ' 56' ' ' ARG . 19.4 mt -61.41 122.71 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -91.71 9.54 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.522 ' O ' HD11 ' T' ' 82' ' ' LEU . 0.0 OUTLIER 59.58 38.81 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.4 OUTLIER -145.13 75.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.435 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.7 mpt_? -74.61 16.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.927 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.45 ' H ' ' C ' ' T' ' 83' ' ' ASN . 5.5 m -114.33 6.75 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.532 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -63.67 -171.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.73 113.61 11.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.675 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 7.8 m95 -153.55 -147.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.578 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -106.78 -171.23 1.85 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.36 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -141.3 121.53 13.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.644 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.65 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 23.4 m-85 -90.59 110.37 21.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.419 ' O ' HG21 ' T' ' 2' ' ' VAL . 86.4 m -86.47 167.97 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.188 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.864 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 2.5 t80 -158.46 124.34 4.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.552 179.772 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.764 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 2.3 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.762 0.315 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -147.93 178.35 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.999 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -92.07 155.56 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' T' ' 5' ' ' ARG . 2.6 tpp85 -149.02 153.88 38.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.1 tt0 -125.77 173.91 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.594 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.593 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -82.65 151.68 26.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -62.33 -18.29 61.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.667 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 17.0 m -98.84 -27.74 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 151.09 167.51 14.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.43 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 14.3 tttt -60.23 153.89 21.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.691 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.8 m-30 57.37 49.61 12.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.667 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 4.2 mttm -142.28 1.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' T' ' 7' ' ' ALA . 9.4 mt -105.82 134.14 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.258 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.655 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.4 p -104.0 151.62 22.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.138 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.541 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.8 t80 -34.25 -44.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.99 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.655 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 15.0 mt-10 -66.38 -54.9 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.274 0.559 . . . . 0.0 109.842 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.769 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -43.51 -43.51 5.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.946 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -67.17 -37.75 84.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.69 -34.58 77.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.5 t -69.64 -53.2 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.285 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -64.31 -52.61 57.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.2 tt0 -62.52 -21.05 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.38 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -52.2 -48.86 64.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.694 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -106.0 52.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.42 38.1 56.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.235 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.84 169.82 13.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.763 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.61 140.01 44.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.952 0.405 . . . . 0.0 111.236 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.03 139.02 18.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.376 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -83.81 152.23 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.685 HG23 ' HB2' ' T' ' 53' ' ' ALA . 37.7 p -107.54 -171.38 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.557 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.756 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 55.3 t80 -70.85 -67.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.029 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.1 OUTLIER -46.79 -40.55 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.564 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.16 -54.24 27.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.279 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -58.63 -19.86 42.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.774 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.503 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 2.5 tp10 -72.34 -62.19 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.16 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.82 -15.66 9.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.757 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.553 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.22 -29.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.463 0.649 . . . . 0.0 109.753 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.695 ' HG3' HG21 ' T' ' 62' ' ' VAL . 9.8 ttt-85 -73.03 -33.47 65.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.187 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.503 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 45.5 mttt -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.427 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.553 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -86.34 -17.27 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.441 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 15.1 1.9 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.021 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.535 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.49 94.65 7.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.979 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.518 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.7 t-160 -115.17 125.99 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.736 HG13 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -147.89 100.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.57 ' HA ' HD12 ' T' ' 61' ' ' ILE . 40.5 t -75.79 65.83 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.481 ' HB2' ' OD1' ' T' ' 89' ' ' ASP . . . -161.91 118.61 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -39.87 121.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -123.39 121.24 4.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.731 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 84.1 m95 -54.18 162.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.798 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -155.63 174.39 15.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.392 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.685 ' HB2' HG23 ' T' ' 32' ' ' THR . . . -53.53 160.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.286 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mtpp 78.66 -30.66 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.508 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.507 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 112.44 23.93 5.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.531 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.678 ' HG3' HG13 ' T' ' 80' ' ' ILE . 19.1 mtt180 -100.18 160.22 14.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.932 0.396 . . . . 0.0 110.809 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.42 ' O ' HG21 ' T' ' 57' ' ' VAL . 0.2 OUTLIER -149.1 107.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -108.82 -167.65 20.79 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.291 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.551 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -137.44 85.07 21.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.125 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.836 ' HB3' HG12 ' T' ' 75' ' ' ILE . 23.1 Cg_exo -62.76 129.04 24.9 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.887 2.391 . . . . 0.0 112.238 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' T' ' 47' ' ' CYS . 8.5 mm -141.39 116.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.232 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.695 HG21 ' HG3' ' T' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.802 0.334 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.34 -168.21 51.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.89 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.836 HG12 ' HB3' ' T' ' 60' ' ' PRO . 12.7 mt -76.06 124.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.897 0.379 . . . . 0.0 111.212 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.551 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.8 mm -93.29 81.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.8 120.99 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 1.5 m-85 -86.33 -74.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.41 169.79 36.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.232 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.678 HG13 ' HG3' ' T' ' 56' ' ' ARG . 51.8 mt -57.7 108.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.041 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 81' ' ' ARG . 7.4 mmt85 -87.09 15.46 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.413 ' HA ' HD21 ' T' ' 82' ' ' LEU . 0.2 OUTLIER 53.77 27.95 7.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 62.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.994 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.593 ' O ' ' HB ' ' T' ' 15' ' ' THR . 3.2 mpt_? -69.99 -0.92 8.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.81 3.24 47.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.674 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.567 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -64.79 -170.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.653 ' HD3' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -135.79 112.44 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.123 0.487 . . . . 0.0 111.648 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.691 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 5.2 m95 -155.44 -177.13 6.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.837 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -77.65 -173.24 2.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.769 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -140.38 133.56 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.736 ' HE1' HG13 ' T' ' 46' ' ' VAL . 42.1 m-85 -97.82 117.04 31.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.428 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.68 154.29 18.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.0 110.836 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.764 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 8.1 t80 -149.41 114.05 5.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.764 179.747 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.898 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.854 0.359 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.451 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 26.7 p90 -162.17 173.5 14.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 111.705 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.743 ' HD1' ' HH ' ' T' ' 91' ' ' TYR . 4.7 t60 -93.27 150.43 20.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 4.2 tpp85 -152.25 154.83 36.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.9 OUTLIER -116.13 -169.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.61 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -90.64 152.3 20.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -52.86 -24.35 8.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.726 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -93.27 -47.74 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 177.98 44.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.545 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -65.42 146.75 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.852 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.545 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 7.9 m-30 63.67 61.83 0.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.053 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -155.89 6.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.61 HD13 ' HA ' ' T' ' 7' ' ' ALA . 6.0 mt -109.03 138.69 44.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.4 p -107.67 148.05 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 83.0 t80 -34.99 -39.53 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.93 61.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.373 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.523 ' HB2' ' H ' ' T' ' 15' ' ' THR . 77.8 mt-10 -71.36 -46.3 60.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.226 0.536 . . . . 0.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.811 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.39 -37.11 72.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -75.56 -32.21 60.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.023 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.5 -45.64 75.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.361 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.83 -50.31 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 56.6 m -64.44 -45.25 88.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.7 tt0 -78.57 -6.94 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -59.07 -50.76 72.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.842 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.55 58.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.175 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.54 34.08 13.32 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.458 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.46 -172.42 18.2 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.2 134.17 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 0.258 . . . . 0.0 110.472 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -67.08 124.34 22.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -52.42 165.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.74 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 13.0 p -115.73 -158.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.78 ' HB2' ' HE2' ' T' ' 52' ' ' MET . 34.2 t80 -80.41 -71.64 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.978 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.9 mttt -47.42 -37.35 11.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.79 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -67.21 -54.96 16.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.261 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.92 -21.14 27.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.754 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.1 tp10 -69.82 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.268 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.531 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -55.54 -19.87 11.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.787 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.516 ' O ' ' CG1' ' T' ' 42' ' ' ILE . . . -91.29 -29.11 17.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 109.613 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.557 ' HE ' HG12 ' T' ' 62' ' ' VAL . 4.2 ttt180 -70.61 -34.31 71.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.001 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 27.2 mtmt -73.52 -17.49 61.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.219 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.531 HG21 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -88.35 -6.94 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.73 5.9 8.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.25 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.0 OUTLIER -76.0 117.36 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.699 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.4 t-160 -140.14 125.82 19.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.68 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -153.21 101.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.959 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.09 85.75 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.335 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' T' ' 4' ' ' HIS . . . -177.38 115.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.521 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -39.21 108.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.767 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -107.84 122.48 6.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.668 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.609 ' HA ' ' HB ' ' T' ' 57' ' ' VAL . 71.2 m95 -52.68 171.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.78 ' HE2' ' HB2' ' T' ' 33' ' ' TYR . 0.0 OUTLIER -166.58 162.13 16.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.512 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -45.17 159.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.631 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.639 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.8 -24.79 0.21 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.425 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 109.39 22.82 6.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.504 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' T' ' 52' ' ' MET . 37.6 mtm180 -94.91 165.82 12.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -163.12 108.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -116.64 -171.01 15.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.224 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.537 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.89 82.72 55.3 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.1 Cg_exo -59.89 119.98 7.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.765 2.31 . . . . 0.0 112.3 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.495 HD11 HG22 ' T' ' 61' ' ' ILE . 14.5 mm -138.9 132.56 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.699 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . 0.441 ' HA3' ' CZ ' ' T' ' 40' ' ' ARG . . . 72.73 -175.09 44.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.799 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.627 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 5.4 mt -73.38 117.46 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.5 mm -88.98 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.509 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 5.3 t70 -110.13 135.17 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.77 25.28 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.1 -178.49 26.2 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.615 HG13 ' HG3' ' T' ' 56' ' ' ARG . 50.8 mt -61.85 119.83 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.71 6.92 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.54 33.09 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.82 78.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.677 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtt85 -62.86 -8.62 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 17.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.42 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 1.7 mm-40 -79.46 -176.21 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.85 115.8 14.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.054 0.454 . . . . 0.0 111.274 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.488 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 28.4 m95 -150.7 -135.05 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.083 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.14 -171.83 2.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.35 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.811 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.79 130.16 17.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.767 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.13 109.63 22.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.253 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.8 131.78 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.114 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.898 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.1 OUTLIER -131.04 113.98 14.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.541 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' T' ' 31' ' ' ALA . 1.6 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.721 0.296 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.3 OUTLIER -147.74 160.26 42.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.085 0.469 . . . . 0.0 111.271 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.595 ' CG ' HG12 ' T' ' 46' ' ' VAL . 10.1 t-80 -106.13 158.57 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.099 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -164.26 166.0 21.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.041 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.804 ' HG2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -123.18 -167.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.971 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -170.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.93 -34.15 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.1 t -177.29 19.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.27 160.74 23.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.804 ' HA ' ' HG2' ' T' ' 6' ' ' GLU . 1.2 tttt -98.43 158.47 15.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 111.503 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.687 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 23.7 m-85 42.46 60.2 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.494 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' T' ' 12' ' ' TYR . 1.7 mmtm -149.7 10.1 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.512 HD13 ' C ' ' T' ' 6' ' ' GLU . 17.8 mt -106.29 125.24 50.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.0 OUTLIER -99.57 145.42 27.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.008 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.567 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.6 t80 -33.56 -41.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.98 70.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' T' ' 15' ' ' THR . 83.8 mt-10 -72.96 -52.2 15.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.006 0.432 . . . . 0.0 110.195 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.805 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -45.82 -49.59 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.926 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -65.78 -56.99 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.0 -42.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.425 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.23 -50.37 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.4 m -63.71 -48.17 78.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 16.9 tt0 -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.736 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.8 OUTLIER -55.72 -51.77 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.899 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.28 58.24 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.152 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.8 27.54 9.75 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.525 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -107.88 -169.9 21.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.514 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.81 133.3 11.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.444 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.863 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -64.02 123.52 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 110.381 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -50.98 162.77 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.348 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.64 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 23.8 p -108.5 -164.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.748 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 20.5 t80 -75.02 -73.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.167 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mttt -48.06 -37.68 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -67.12 -55.11 15.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.549 HD13 ' HG3' ' T' ' 60' ' ' PRO . 1.7 tm? -58.07 -22.77 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.8 tt0 -70.18 -61.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.241 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -13.52 10.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.709 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -93.88 -28.5 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.484 0.659 . . . . 0.0 109.731 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.643 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 5.6 tmm_? -69.7 -32.7 71.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.863 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -68.67 -15.22 63.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.611 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -93.47 -17.28 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.459 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 135.72 12.17 1.21 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.866 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.643 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -79.49 100.74 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.1 t-160 -129.69 131.28 46.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.168 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.595 HG12 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.82 98.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.852 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -64.7 81.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.509 ' HB2' ' CE1' ' T' ' 12' ' ' TYR . . . 174.45 137.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.67 105.33 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.781 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.621 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -102.98 116.77 5.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.661 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.574 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 76.3 m95 -48.22 155.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.863 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.77 -179.61 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.593 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.64 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 49.93 -165.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.115 0.483 . . . . 0.0 111.488 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.52 0.35 4.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.471 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.507 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 155.48 14.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.672 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 5.3 mtp180 -93.37 135.98 34.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.881 0.372 . . . . 0.0 110.996 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.574 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -124.38 134.22 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.765 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.421 ' N ' HG21 ' T' ' 57' ' ' VAL . . . -145.13 -174.61 17.53 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.466 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.514 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -131.11 102.39 15.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.8 Cg_endo -61.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' T' ' 47' ' ' CYS . 25.9 mm 74.06 105.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.631 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.01 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.12 172.62 47.22 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.913 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.748 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.6 mt -67.34 104.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.5 mm -80.16 85.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.23 132.3 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.01 4.58 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.997 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.661 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 81.04 173.52 47.69 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.626 HG13 ' HG3' ' T' ' 56' ' ' ARG . 13.7 mt -59.38 115.8 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -87.97 21.31 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.574 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.78 36.89 25.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.68 67.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.585 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.9 OUTLIER -65.41 -4.59 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.7 t -91.52 12.82 19.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.504 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.3 mm-40 -68.56 -175.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.724 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 8.3 mtt180 -135.46 115.05 12.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.687 ' HA ' ' HD1' ' T' ' 12' ' ' TYR . 21.0 m95 -151.89 -132.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.234 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.53 ' HB3' ' OE1' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -121.04 -172.88 2.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.329 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.805 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.3 135.13 23.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.193 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.687 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 41.1 m-85 -97.91 107.52 20.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.066 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.41 ' HB3' ' CE2' ' T' ' 3' ' ' TYR . 5.2 m -87.31 137.23 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.919 0.39 . . . . 0.0 111.077 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' T' ' 93' ' ' TYR . 1.3 t80 -140.91 135.51 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.73 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.8 179.882 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.941 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.469 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 25.5 p90 -155.39 170.34 22.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 111.638 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.721 ' HD1' ' HH ' ' T' ' 91' ' ' TYR . 4.2 t60 -90.97 153.71 19.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.962 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.454 ' N ' ' CD2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -155.78 148.32 23.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.012 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.429 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.8 OUTLIER -114.08 -168.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.49 153.54 18.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.21 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' T' ' 8' ' ' ARG . 4.0 mmt180 -61.13 -19.35 61.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -94.46 -24.53 17.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.69 167.41 11.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.547 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 8.3 ttpt -60.07 158.85 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.434 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 8.6 m-30 53.45 61.56 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.102 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -156.33 2.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.687 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.429 HD13 ' C ' ' T' ' 6' ' ' GLU . 6.5 mt -105.21 127.58 52.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.453 ' O ' ' N ' ' T' ' 18' ' ' GLU . 1.1 p -99.49 149.94 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.607 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 92.0 t80 -36.18 -41.04 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -42.95 69.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' T' ' 15' ' ' THR . 85.1 mt-10 -74.15 -53.9 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.999 0.428 . . . . 0.0 110.301 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.732 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -44.96 -51.49 9.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.99 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -63.92 -55.7 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.644 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.48 -39.03 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.23 -51.73 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.219 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.25 -50.61 67.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.474 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 31.3 tt0 -67.07 -16.48 64.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.429 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.03 -47.87 77.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.754 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.19 53.89 0.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.53 41.78 42.37 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.426 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -121.95 168.22 14.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.432 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.22 137.49 51.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.773 0.321 . . . . 0.0 110.622 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.715 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -73.81 122.0 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.762 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -49.76 158.79 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.43 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 11.5 p -110.69 -159.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.29 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.825 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 25.7 t80 -77.02 -72.97 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.052 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 1.9 mttp -46.92 -37.23 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.556 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.45 -51.77 57.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.529 HD13 ' HG2' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -56.66 -23.89 44.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 110.058 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 8.4 tt0 -72.15 -61.94 1.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.461 ' HA ' ' HE3' ' T' ' 41' ' ' LYS . . . -56.02 -16.23 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.553 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.7 -29.64 15.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.396 0.617 . . . . 0.0 109.718 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -72.17 -33.1 67.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.925 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.8 OUTLIER -69.66 -16.98 63.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.553 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.61 -12.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.93 13.01 3.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.973 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.52 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.0 OUTLIER -79.9 126.48 31.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.8 t-160 -150.21 126.39 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.681 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -151.5 102.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.787 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.94 86.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.332 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 177.31 119.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.004 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.01 118.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.744 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -115.39 123.14 5.83 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.803 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.607 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.6 m95 -53.03 171.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.107 0.479 . . . . 0.0 111.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.715 ' HA ' HD13 ' T' ' 30' ' ' LEU . 3.4 ptp -168.9 173.11 7.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.49 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.33 159.6 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.652 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.555 ' HB3' HD12 ' T' ' 80' ' ' ILE . 1.5 mmtp 67.23 16.28 10.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.254 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.579 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 64.07 33.28 86.82 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.515 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.681 ' HD3' ' HA3' ' T' ' 79' ' ' GLY . 4.7 mtt180 -101.12 157.35 16.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.804 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.4 OUTLIER -154.09 115.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.126 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.97 -168.44 12.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.3 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.563 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -135.58 103.24 10.27 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 24.6 Cg_exo -61.01 -93.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.706 2.27 . . . . 0.0 112.017 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.787 HD13 ' HA ' ' T' ' 47' ' ' CYS . 40.0 mm 75.24 110.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.797 0.332 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.47 175.96 41.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.938 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.825 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -75.04 95.44 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 111.01 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 18.9 mm -68.06 81.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -108.1 120.42 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.805 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 1.9 m-85 -84.83 13.99 5.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' T' ' 56' ' ' ARG . . . 72.86 179.17 35.61 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.179 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.557 HG13 ' HG3' ' T' ' 56' ' ' ARG . 40.6 mt -62.05 119.81 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -95.85 14.26 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 53.73 34.32 18.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.432 ' HB3' ' CG ' ' T' ' 86' ' ' GLU . 0.5 OUTLIER -137.65 67.13 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.989 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -63.94 -3.18 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.409 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -101.03 8.17 43.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 1.8 mm-40 -60.59 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.1 113.05 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 111.305 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 27.9 m95 -151.62 -133.52 0.05 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.547 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -121.91 -170.84 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.732 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.86 130.69 17.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.744 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.82 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.316 . . . . 0.0 110.457 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.8 130.24 34.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 110.952 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.941 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -130.44 121.55 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.925 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 179.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.87 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.465 ' N ' HG21 ' T' ' 2' ' ' VAL . 18.0 p90 -144.62 -179.94 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.501 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 20.3 t-80 -92.88 154.72 18.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.181 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' T' ' 5' ' ' ARG . 0.4 OUTLIER -147.33 147.98 30.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.986 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.636 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.5 tt0 -120.14 173.36 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.636 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -75.4 168.52 19.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -21.88 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -47.99 4.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.17 176.57 45.39 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.559 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.549 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.2 ttpm? -59.08 151.72 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.5 m-30 52.34 75.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -158.04 -5.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -115.01 164.93 13.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.07 0.462 . . . . 0.0 111.275 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.83 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 6.6 p -116.56 -166.19 1.13 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.347 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.588 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.9 t80 -66.44 -40.45 89.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.062 0.458 . . . . 0.0 109.767 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.75 65.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.72 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.83 ' HB2' ' H ' ' T' ' 15' ' ' THR . 54.6 mt-10 -69.16 -42.83 75.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.278 0.561 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.804 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.42 -40.81 83.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.925 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -31.41 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -63.93 -46.58 84.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.26 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.84 -48.02 83.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 55.4 m -64.63 -51.19 63.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.771 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -70.88 -11.98 61.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.81 -50.03 73.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.841 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -104.2 57.4 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.27 38.37 26.18 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.247 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.62 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -106.66 178.33 22.32 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.655 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -144.52 133.37 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 141.63 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.406 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -85.99 143.37 28.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.527 HG23 ' HB2' ' T' ' 53' ' ' ALA . 32.2 p -98.35 -170.68 2.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 111.576 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.744 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 37.9 t80 -70.98 -70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.884 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 12.0 mttt -45.62 -38.38 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.494 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.437 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 84.5 mt-30 -66.62 -55.45 15.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.063 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' T' ' 31' ' ' ALA . 0.2 OUTLIER -57.78 -19.86 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.696 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.7 tt0 -74.74 -62.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.254 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.645 ' HA ' ' HD2' ' T' ' 41' ' ' LYS . . . -55.68 -15.44 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.576 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.91 -28.45 15.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.621 . . . . 0.0 109.656 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.72 ' HG3' HG23 ' T' ' 62' ' ' VAL . 50.8 ttp85 -72.33 -36.13 68.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.215 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -67.3 -19.36 65.46 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.636 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.576 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -85.79 -16.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.441 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.32 14.18 2.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.965 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.516 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.09 117.63 22.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.828 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.556 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.9 t-160 -138.42 128.36 25.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.692 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -148.43 102.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.642 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.35 67.24 1.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.593 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . -165.06 121.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.18 112.7 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.172 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.715 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.18 121.89 5.95 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.778 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 80.6 m95 -57.0 165.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.139 0.495 . . . . 0.0 111.831 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -159.15 165.34 33.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.324 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' T' ' 32' ' ' THR . . . -48.16 158.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.5 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 79.53 -25.22 0.19 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.501 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 109.35 20.74 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.507 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.701 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 0.2 OUTLIER -94.4 160.94 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.902 0.382 . . . . 0.0 111.006 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -158.22 109.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.17 -168.25 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.315 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -132.84 86.38 43.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 111.144 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.826 ' HB3' HG12 ' T' ' 75' ' ' ILE . 32.9 Cg_endo -67.0 118.42 5.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.666 2.244 . . . . 0.0 111.955 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' T' ' 47' ' ' CYS . 31.6 mm -134.17 119.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.72 HG23 ' HG3' ' T' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.828 0.347 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.31 -171.0 54.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.866 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.826 HG12 ' HB3' ' T' ' 60' ' ' PRO . 10.0 mt -82.63 121.78 36.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.504 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.6 mm -95.1 82.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.44 114.18 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 3.4 m-85 -78.91 -27.25 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.701 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 115.35 169.9 16.01 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.471 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.5 mt -53.48 105.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.293 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -90.34 20.29 4.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.956 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' T' ' 82' ' ' LEU . 0.5 OUTLIER 49.45 39.99 17.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.872 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -126.37 53.84 1.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtm180 -68.13 10.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.549 ' H ' ' C ' ' T' ' 83' ' ' ASN . 68.0 m -115.66 8.72 15.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.632 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.556 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -74.43 -170.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.55 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.407 ' HG3' ' C ' ' T' ' 86' ' ' GLU . 0.0 OUTLIER -136.53 115.95 12.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 111.592 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.762 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 4.4 m95 -154.44 -155.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.106 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.549 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -100.12 -172.39 2.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.184 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.804 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.01 131.18 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.74 0.305 . . . . 0.0 111.452 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.715 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 40.4 m-85 -96.02 113.91 25.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.123 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -89.68 153.18 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.311 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.797 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 11.2 t80 -141.37 133.02 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.62 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 4.4 m-20 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.634 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.512 HG11 ' O ' ' T' ' 92' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.69 0.281 . . . . 0.0 111.317 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -142.75 151.02 40.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.488 . . . . 0.0 111.378 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.445 ' O ' ' HG2' ' T' ' 5' ' ' ARG . 15.0 t-80 -90.88 145.16 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' T' ' 4' ' ' HIS . 5.1 mmm180 -153.82 151.08 29.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.215 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.531 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.6 OUTLIER -113.37 -169.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.434 ' CB ' ' HG ' ' T' ' 14' ' ' LEU . . . -83.44 151.38 25.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . 0.406 HH12 HH22 ' T' ' 5' ' ' ARG . 6.6 mmt-85 -54.07 -26.39 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -91.72 -49.66 6.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.69 47.77 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.45 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 3.2 ttpm? -68.56 162.03 26.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.794 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.6 m-30 52.07 44.12 29.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.72 5.95 2.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.531 HD13 ' C ' ' T' ' 6' ' ' GLU . 11.7 mt -108.98 142.67 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.076 0.465 . . . . 0.0 111.514 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.572 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.2 p -114.7 152.13 32.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.947 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.648 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.0 t80 -38.41 -39.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.82 -40.48 72.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.482 ' HB2' ' H ' ' T' ' 15' ' ' THR . 84.3 mt-10 -75.24 -51.48 13.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.703 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -48.18 -48.96 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.057 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -64.91 -52.84 54.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.21 -36.59 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.309 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 7.1 t -70.74 -54.84 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.81 -47.63 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 37.7 tt0 -70.66 -17.43 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.602 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.2 -48.22 68.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.75 54.21 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.943 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.15 42.95 24.88 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.261 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -123.28 174.63 16.56 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -127.75 141.52 51.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.633 0.254 . . . . 0.0 110.605 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -76.64 125.18 28.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.451 . . . . 0.0 110.071 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -48.2 152.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.714 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.554 ' HA ' ' CB ' ' T' ' 52' ' ' MET . 9.7 p -109.72 -157.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.638 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 22.9 t80 -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.166 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.6 mttm -47.76 -35.96 10.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.442 ' CD ' HG22 ' T' ' 32' ' ' THR . 92.5 mt-30 -67.33 -56.1 11.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.359 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.64 HD11 ' O ' ' T' ' 36' ' ' LEU . 1.6 tm? -56.45 -24.01 42.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 14.1 tp10 -66.49 -62.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.75 -13.99 12.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.619 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.06 -28.2 15.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.448 0.642 . . . . 0.0 109.613 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.551 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -71.06 -32.92 69.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.896 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -67.14 -17.83 65.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.187 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.619 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.82 -18.52 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.494 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 133.89 15.78 1.17 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.865 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -83.46 79.69 9.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.991 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.6 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.5 t-160 -111.93 128.39 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.691 ' O ' HG21 ' T' ' 46' ' ' VAL . 2.0 m -147.02 111.65 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.081 0.467 . . . . 0.0 110.991 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.561 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.1 OUTLIER -76.12 77.41 2.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.926 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.81 126.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.25 121.29 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.692 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -117.36 120.77 4.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.4 m95 -53.93 166.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.427 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.579 ' HG3' ' HG3' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -162.32 171.36 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.528 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.32 166.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.381 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.405 ' HB3' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 77.02 -28.8 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.554 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 106.68 18.74 10.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.65 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.756 ' HB3' HG13 ' T' ' 80' ' ' ILE . 3.5 ptp85 -105.34 158.76 16.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 110.547 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.3 OUTLIER -146.25 122.01 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -117.9 -168.41 14.45 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -131.01 88.08 46.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 111.038 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.949 ' HB3' HG12 ' T' ' 75' ' ' ILE . 56.3 Cg_endo -73.55 123.3 8.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.822 2.348 . . . . 0.0 112.193 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.561 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.6 mm -136.32 97.66 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.573 HG11 ' HD1' ' T' ' 45' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.95 -169.51 54.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.766 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.949 HG12 ' HB3' ' T' ' 60' ' ' PRO . 22.6 mt -80.45 122.09 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.484 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.2 mm -96.18 80.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.876 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.495 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 4.1 t70 -110.64 131.12 55.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 1.8 m-85 -100.33 25.22 7.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.982 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.16 178.58 8.75 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.756 HG13 ' HB3' ' T' ' 56' ' ' ARG . 3.6 mt -65.17 126.67 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 111.194 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -106.62 19.64 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.789 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.12 32.23 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 m120 -124.8 54.95 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.572 ' O ' ' HB ' ' T' ' 15' ' ' THR . 1.4 mtt85 -65.21 -1.93 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 85' ' ' SER . . . . . 0.4 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -100.97 11.51 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.453 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.0 mm-40 -72.96 -171.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -137.01 115.97 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.387 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.579 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.2 m95 -150.75 -138.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.141 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -112.24 -170.71 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.08 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.703 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.5 126.56 15.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.415 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.737 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 30.5 m-85 -97.36 126.81 42.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.898 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . 0.512 ' O ' HG11 ' T' ' 2' ' ' VAL . 0.1 OUTLIER -100.23 162.84 12.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.872 0.368 . . . . 0.0 110.932 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' T' ' 29' ' ' HIS . 21.2 t80 -156.11 118.8 4.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.797 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.698 179.735 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.904 ' HB ' ' HD1' ' T' ' 93' ' ' TYR . 2.3 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.651 ' N ' HG21 ' T' ' 2' ' ' VAL . 26.4 p90 -160.32 178.98 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.993 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.406 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.1 t-80 -89.11 155.88 19.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.3 OUTLIER -148.81 152.02 35.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.629 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.6 tt0 -122.53 172.79 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.629 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -80.23 158.76 26.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -61.27 -26.99 68.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.624 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.9 t -91.81 -50.53 5.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.39 172.8 43.17 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.9 ttpt -66.22 161.94 21.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.737 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.2 m-30 55.7 53.89 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.624 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 8.3 mtmt -154.68 3.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.562 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 8.0 mt -102.43 132.41 48.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 30.3 p -103.47 148.85 25.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.538 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.666 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 84.2 t80 -35.66 -38.1 0.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.46 -44.97 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.457 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' T' ' 15' ' ' THR . 64.2 mt-10 -73.05 -47.69 42.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.17 0.51 . . . . 0.0 110.348 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.833 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -50.98 -45.3 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.077 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.91 -47.13 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.58 -47.59 19.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -68.19 -53.27 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 87.7 m -59.89 -38.39 82.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.759 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.1 tt0 -90.08 -2.64 58.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.41 -48.13 82.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.546 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.95 60.59 2.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.24 22.41 10.14 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.509 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.96 -158.27 12.56 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 3.7 p80 -155.04 -178.46 7.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.756 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -103.29 124.95 49.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.642 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -46.02 157.57 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.543 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -111.29 -162.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.886 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 50.0 t80 -75.25 -68.17 0.58 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.945 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 2.2 mtpm? -47.21 -45.28 23.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . 0.533 ' NE2' HG22 ' T' ' 32' ' ' THR . 49.1 mt-30 -62.28 -49.35 76.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.881 0.372 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -54.92 -29.44 56.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.106 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.0 tt0 -65.05 -61.84 1.91 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -12.1 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.558 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.73 -29.86 14.58 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.423 0.63 . . . . 0.0 109.892 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.69 ' HE ' HG11 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -72.98 -33.99 66.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.07 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.9 mttt -69.85 -17.49 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.408 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.558 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.5 -17.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.454 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.8 11.51 1.43 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.591 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.7 129.63 34.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.567 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 3.3 t-160 -146.24 125.56 13.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.619 HG23 ' HE1' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -142.99 98.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.122 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.72 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.47 -0.13 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' T' ' 46' ' ' VAL . . . -102.64 141.77 34.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.686 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -58.79 114.23 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -109.87 117.43 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.707 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.62 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 72.3 m95 -52.38 166.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 111.435 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 3.9 ptp -164.55 173.24 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.484 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.11 167.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.424 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.13 -28.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.266 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.518 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 104.8 18.6 12.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.571 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.8 ptt180 -105.03 158.67 16.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.701 0.286 . . . . 0.0 110.581 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.62 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -142.07 122.86 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.72 -168.43 12.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.686 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -145.51 90.84 5.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.162 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 58.4 Cg_endo -74.9 134.95 18.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.659 2.24 . . . . 0.0 112.179 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm -126.67 145.13 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.69 HG11 ' HE ' ' T' ' 40' ' ' ARG . 4.1 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.087 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.67 -169.91 33.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.057 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.886 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -72.79 101.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.655 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.3 mm -72.05 81.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.07 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.72 137.32 49.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.727 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 0.8 OUTLIER -105.05 28.44 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.59 171.28 3.36 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.425 HD12 ' O ' ' T' ' 54' ' ' LYS . 13.8 mt -69.84 119.01 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.9 15.4 2.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.516 ' O ' HD11 ' T' ' 82' ' ' LEU . 0.1 OUTLIER 53.09 43.66 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.76 82.26 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.24 -1.15 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.0 13.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.553 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.8 mm-40 -76.84 -177.15 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.7 OUTLIER -134.55 113.29 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.503 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.638 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.7 m95 -153.32 -160.34 1.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.168 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -170.91 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.833 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -141.04 128.62 21.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.665 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 23.4 m-85 -91.07 107.86 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.92 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.28 149.32 23.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 111.213 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.904 ' HD1' ' HB ' ' T' ' 2' ' ' VAL . 61.8 t80 -136.47 132.1 34.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' T' ' 94' ' ' ASN . 3.6 m120 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.947 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . 0.563 ' N ' HG21 ' T' ' 2' ' ' VAL . 12.5 p90 -156.41 176.21 13.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.021 0.439 . . . . 0.0 111.405 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.58 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 39.3 t-80 -98.65 163.79 12.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.447 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.88 146.38 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.464 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.4 OUTLIER -109.23 -168.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 110.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.536 ' HB3' ' HG ' ' T' ' 14' ' ' LEU . . . -95.48 150.67 20.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.08 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -25.66 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -92.13 -48.94 6.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' T' ' 7' ' ' ALA . . . 170.66 172.7 37.23 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . 0.62 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 1.4 tttt -58.97 151.02 22.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.62 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 9.3 m-30 61.77 58.67 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.04 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -155.17 5.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.634 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 5.7 mt -109.0 133.1 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.289 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.4 p -104.8 149.32 25.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.286 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.583 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 78.3 t80 -35.44 -40.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.982 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.15 -45.25 67.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' T' ' 15' ' ' THR . 74.5 mt-10 -72.48 -47.62 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.751 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -50.03 -45.44 52.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -71.08 -50.77 30.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -48.7 -38.69 22.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.24 -53.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.487 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 66.4 m -64.34 -27.18 68.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 23.5 tt0 -98.9 -9.03 24.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.155 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.5 t80 -53.73 -42.96 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.081 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.71 60.23 0.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.268 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.79 26.2 10.52 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.538 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -106.57 -169.29 22.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.561 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -155.71 134.05 11.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.418 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.87 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -65.04 125.34 24.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.079 0.466 . . . . 0.0 110.387 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -53.02 161.4 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 26.3 p -109.34 -164.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.207 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.632 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 28.4 t80 -74.91 -72.59 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.143 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mtpt -48.23 -40.21 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.913 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.95 -51.19 63.17 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.563 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 6.5 tp10 -54.71 -60.37 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.232 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.51 14.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.862 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.591 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -90.62 -27.93 18.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 109.723 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.2 OUTLIER -72.23 -33.27 67.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.053 179.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.563 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 8.4 mttp -68.99 -17.78 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.396 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.591 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.46 -15.9 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.424 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.22 14.9 2.13 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.068 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.58 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -81.95 99.25 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.666 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.7 t-160 -121.73 119.78 32.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.618 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -141.3 94.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.569 ' O ' ' HB1' ' T' ' 48' ' ' ALA . 6.5 t -64.37 89.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 171.91 127.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.556 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -46.46 101.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -101.66 111.11 4.0 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.676 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.588 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 74.2 m95 -44.65 157.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.983 0.42 . . . . 0.0 111.294 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.87 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -174.83 178.13 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' T' ' 56' ' ' ARG . . . 50.14 -166.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.12 0.4 3.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.305 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.433 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 156.81 13.15 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.739 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.829 ' HG3' HG13 ' T' ' 80' ' ' ILE . 4.4 mtt-85 -90.45 130.76 36.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.588 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -125.08 129.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.961 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -135.17 -175.74 14.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.329 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.556 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.43 78.93 14.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.756 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD12 ' T' ' 75' ' ' ILE . 21.7 Cg_exo -63.12 124.59 14.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.758 2.305 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.547 HG21 ' N ' ' T' ' 62' ' ' VAL . 38.6 mm -130.51 153.3 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 15.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.347 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.62 179.55 50.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.872 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.632 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.7 mt -73.42 111.56 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.3 mm -91.05 80.15 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . 0.411 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 2.4 t70 -103.29 129.18 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -94.41 15.84 16.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . 0.714 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 71.22 169.6 9.81 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.829 HG13 ' HG3' ' T' ' 56' ' ' ARG . 10.6 mt -59.36 112.68 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.983 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' T' ' 81' ' ' ARG . 2.2 mmp_? -91.57 21.05 4.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.474 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 51.66 50.82 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.61 66.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.647 ' O ' ' HB ' ' T' ' 15' ' ' THR . 19.3 mtm105 -66.67 -3.58 6.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m -98.19 18.62 15.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.476 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.3 mm-40 -74.87 -171.25 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.5 114.48 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.516 ' CA ' ' HA ' ' T' ' 12' ' ' TYR . 22.8 m95 -151.68 -134.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.378 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.419 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -121.64 -172.12 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.379 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.751 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.15 137.23 25.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.648 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 28.9 m-85 -101.67 107.65 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -85.85 133.83 33.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 111.327 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.947 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.9 OUTLIER -132.57 124.55 28.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.676 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' T' T ' 2' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.3 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.93 169.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 4' ' ' HIS . . . . . 0.499 ' HB2' HG12 ' T' ' 46' ' ' VAL . 9.7 t-80 -96.76 145.7 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.764 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 5' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -152.47 166.4 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 6' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.6 OUTLIER -123.3 -170.15 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.66 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 7' ' ' ALA . . . . . 0.514 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -86.31 150.69 24.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -19.26 61.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 9' ' ' SER . . . . . 0.446 ' HB3' ' CE ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -97.33 -25.89 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 152.51 168.12 16.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -61.85 153.89 27.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.702 0.287 . . . . 0.0 110.855 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 12' ' ' TYR . . . . . 0.741 ' HB3' ' HD2' ' T' ' 87' ' ' ARG . 10.2 m-30 55.52 51.55 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 1.0 OUTLIER -142.28 2.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.636 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 14' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' T' ' 7' ' ' ALA . 8.8 mt -105.78 141.23 37.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 15' ' ' THR . . . . . 0.588 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 49.4 p -110.51 149.71 29.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 16' ' ' TYR . . . . . 0.56 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 81.4 t80 -34.91 -40.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.07 61.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.409 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 18' ' ' GLU . . . . . 0.588 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.0 mt-10 -68.61 -44.04 75.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 109.966 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 19' ' ' ALA . . . . . 0.69 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.06 -39.22 74.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.972 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 20' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' T' ' 24' ' ' GLU . 10.5 tttm -75.51 -38.22 59.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.106 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 21' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -56.06 -50.01 72.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.81 -53.76 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.42 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 23' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 88.3 m -63.31 -26.96 69.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 24' ' ' GLU . . . . . 0.772 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 22.3 tt0 -103.39 1.59 32.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.232 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 25' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -63.71 -43.33 96.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.203 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -100.53 61.26 1.02 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.39 19.97 6.68 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.619 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 28' ' ' GLY . . . . . 0.772 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.26 -159.97 13.9 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 29' ' ' HIS . . . . . 0.614 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 5.7 p80 -152.88 -177.56 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.996 0.427 . . . . 0.0 110.657 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 30' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -101.6 124.06 46.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.6 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 31' ' ' ALA . . . . . 0.906 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -44.92 154.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.571 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 32' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 6.9 p -108.31 -158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 33' ' ' TYR . . . . . 0.904 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 35.2 t80 -80.99 -73.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.112 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 34' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 20.8 mtmt -44.83 -36.85 3.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.82 -53.1 36.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 36' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -57.89 -21.13 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.138 0.494 . . . . 0.0 109.984 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 37' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 9.3 tt0 -72.63 -61.97 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 38' ' ' ALA . . . . . 0.527 ' HA ' ' HE2' ' T' ' 41' ' ' LYS . . . -58.43 -15.58 11.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 39' ' ' ALA . . . . . 0.636 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.02 -29.73 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.537 0.684 . . . . 0.0 109.578 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 40' ' ' ARG . . . . . 0.65 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -69.06 -32.56 72.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.863 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 41' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' T' ' 38' ' ' ALA . 28.7 mtmt -66.61 -17.85 65.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 42' ' ' ILE . . . . . 0.636 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -92.1 -22.47 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 43' ' ' GLY . . . . . 0.568 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 138.61 17.88 0.56 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.96 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 44' ' ' PHE . . . . . 0.65 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.5 OUTLIER -74.75 86.76 2.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.778 0.323 . . . . 0.0 110.876 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 45' ' ' HIS . . . . . 0.619 ' NE2' HD11 ' T' ' 61' ' ' ILE . 3.5 t-160 -115.36 122.84 47.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.97 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 46' ' ' VAL . . . . . 0.706 ' O ' HG21 ' T' ' 46' ' ' VAL . 0.7 OUTLIER -148.54 112.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 47' ' ' CYS . . . . . 0.687 ' HA ' HD13 ' T' ' 61' ' ' ILE . 1.8 t -82.76 74.38 9.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 48' ' ' ALA . . . . . 0.534 ' HB2' ' OD1' ' T' ' 89' ' ' ASP . . . -176.54 123.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 49' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -42.85 116.68 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 50' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -116.17 117.42 3.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 51' ' ' TRP . . . . . 0.555 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 75.3 m95 -50.66 166.47 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 52' ' ' MET . . . . . 0.596 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 2.0 ptp -162.18 168.61 22.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.362 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 53' ' ' ALA . . . . . 0.645 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.67 165.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.541 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 54' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mmtp 78.76 -33.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.375 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 55' ' ' GLY . . . . . 0.56 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 111.45 17.22 8.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.695 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 56' ' ' ARG . . . . . 0.596 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.8 OUTLIER -105.23 157.25 17.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.579 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 57' ' ' VAL . . . . . 0.555 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -139.39 125.75 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.312 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.23 -168.01 12.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.149 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 59' ' ' TYR . . . . . 0.546 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -144.59 98.32 4.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 60' ' ' PRO . . . . . 0.734 ' HB3' HD12 ' T' ' 75' ' ' ILE . 78.5 Cg_endo -83.41 129.45 5.08 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.814 2.343 . . . . 0.0 112.183 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 61' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' T' ' 47' ' ' CYS . 16.4 mm -141.13 111.61 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.5 -173.1 33.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 75' ' ' ILE . . . . . 0.904 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -79.78 98.39 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 76' ' ' ILE . . . . . 0.458 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 16.0 mm -70.9 79.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.69 117.62 34.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.874 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 78' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 0.6 OUTLIER -81.14 11.86 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.64 169.41 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 80' ' ' ILE . . . . . 0.621 HD12 ' HB3' ' T' ' 54' ' ' LYS . 8.8 mt -52.87 136.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.027 0.441 . . . . 0.0 111.251 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.31 17.08 14.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.018 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 82' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' T' ' 82' ' ' LEU . 0.2 OUTLIER 49.54 50.27 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.33 55.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 84' ' ' ARG . . . . . 0.53 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -56.09 -12.52 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.4 15.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 86' ' ' GLU . . . . . 0.548 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.7 mm-40 -78.82 -171.68 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 87' ' ' ARG . . . . . 0.741 ' HD2' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -136.18 113.2 10.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 88' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 3.4 m95 -156.26 179.49 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.056 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 89' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -73.83 -170.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.323 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' T' T ' 90' ' ' ALA . . . . . 0.69 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.08 132.23 19.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.598 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 91' ' ' TYR . . . . . 0.672 ' HE1' HG12 ' T' ' 46' ' ' VAL . 45.5 m-85 -94.08 115.57 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.63 151.67 21.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 111.331 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' T' T ' 93' ' ' TYR . . . . . 0.654 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 12.0 t80 -148.3 118.88 7.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 179.43 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' T' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.482 ' C ' ' HE2' ' T' ' 44' ' ' PHE . 0.9 OUTLIER -109.98 134.85 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.504 ' HH ' ' HB3' ' T' ' 97' ' ' ALA . 0.0 OUTLIER -147.76 137.01 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -69.22 150.35 47.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.507 ' HG3' ' SG ' ' T' ' 92' ' ' CYS . 11.0 mmt180 -144.21 144.86 31.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.471 ' O ' HD13 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -115.88 -168.97 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.877 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.72 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -99.13 153.55 18.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -17.45 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.758 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -25.2 14.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.3 166.29 10.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.452 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.4 ttpm? -56.72 151.97 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 18.8 m-30 63.16 55.39 1.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.572 ' HA ' ' HD2' ' T' ' 87' ' ' ARG . 9.8 mttt -154.5 1.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.669 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.72 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 12.3 mt -104.08 134.88 46.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 4.6 p -105.1 148.06 27.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.117 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.801 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -35.34 -38.68 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.46 -44.13 65.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' T' ' 15' ' ' THR . 72.0 mt-10 -73.13 -48.24 37.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 110.39 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.793 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -49.83 -45.59 50.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.036 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.15 -55.7 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -42.18 -38.17 1.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.48 -49.91 49.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 46.2 m -64.0 -51.66 63.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.1 tt0 -69.83 -15.81 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -52.52 -50.94 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.51 53.75 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.25 34.15 32.33 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.235 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -103.71 -178.49 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.614 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -147.07 135.52 21.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.014 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.39 143.73 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.228 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' T' ' 52' ' ' MET . . . -83.77 142.25 30.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 33.5 p -98.84 -170.97 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.501 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.767 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 58.1 t80 -70.63 -68.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.104 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 5.2 mmtp -49.42 -37.75 26.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.764 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.437 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.2 mt-30 -67.69 -57.08 6.99 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.258 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.523 ' O ' HD12 ' T' ' 36' ' ' LEU . 1.2 tm? -58.59 -21.36 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 10.3 tt0 -70.26 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.448 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -55.25 -22.52 18.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.655 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.57 -29.33 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.478 0.656 . . . . 0.0 109.442 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.644 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 3.1 tmm_? -69.62 -35.3 75.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.641 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 3.1 mtmp? -71.73 -13.27 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.557 ' CG1' ' O ' ' T' ' 39' ' ' ALA . 1.4 pt -97.26 -16.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.491 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.403 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.92 9.17 1.14 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.421 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.655 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.4 OUTLIER -75.87 91.13 2.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.986 0.393 . . . . 0.0 110.825 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.661 ' HB2' HG21 ' T' ' 62' ' ' VAL . 2.8 t-160 -123.24 129.07 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.643 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -151.21 98.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.283 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.475 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 6.1 t -66.27 80.68 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.485 ' HA ' ' HH ' ' T' ' 12' ' ' TYR . . . 177.66 136.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.695 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.613 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.29 112.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.675 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -109.66 118.64 5.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.668 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.546 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 75.9 m95 -52.36 150.1 5.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.444 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.532 ' HB3' ' O ' ' T' ' 31' ' ' ALA . 0.0 OUTLIER -169.85 176.17 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' T' ' 56' ' ' ARG . . . 51.0 -165.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.619 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -8.85 9.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.533 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 159.93 18.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.047 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.52 ' HG2' ' HB2' ' T' ' 53' ' ' ALA . 6.2 ptp180 -95.07 132.53 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.546 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -121.42 121.0 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.94 -168.93 14.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.568 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.2 OUTLIER -133.94 76.99 63.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.864 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.807 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_exo -59.39 122.35 11.37 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.792 2.328 . . . . 0.0 112.379 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.501 HD11 HG22 ' T' ' 61' ' ' ILE . 16.8 mm -139.87 110.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -88.87 -14.88 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -126.73 98.14 31.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.597 ' HB3' ' HA3' ' T' ' 71' ' ' GLY . 70.7 Cg_exo -48.73 105.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.555 2.17 . . . . 0.0 112.368 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.16 161.92 53.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.76 -39.8 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.933 2.422 . . . . 0.0 111.954 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.19 -22.43 7.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.819 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -83.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' T' ' 71' ' ' GLY . . . -85.2 -1.82 88.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.903 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 64.75 2.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 111.12 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' T' ' 64' ' ' PRO . . . 110.46 44.62 0.97 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.819 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.778 ' HD2' HG13 ' T' ' 76' ' ' ILE . 8.5 mmtm -87.14 157.18 19.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.772 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 130.64 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.11 -168.03 30.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.893 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.807 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 33.5 mt -75.39 125.98 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.359 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.778 HG13 ' HD2' ' T' ' 72' ' ' LYS . 5.1 mm -95.95 81.34 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.43 133.51 54.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -110.76 -6.8 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.79 174.01 25.69 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.565 HG21 ' H ' ' T' ' 81' ' ' ARG . 7.5 mt -55.56 157.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.565 ' H ' HG21 ' T' ' 80' ' ' ILE . 6.5 mtm180 -120.75 11.01 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.405 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.0 44.34 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -168.55 75.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.801 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -66.88 -5.87 14.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.038 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 77.3 p -73.67 10.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.557 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 4.4 mm-40 -75.3 177.42 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.718 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' T' ' 13' ' ' LYS . 2.8 mtm180 -131.69 113.53 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 111.315 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.661 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.5 m95 -151.87 -153.46 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.203 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -171.79 2.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.424 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.793 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.84 119.22 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.481 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.675 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 33.6 m-85 -86.77 116.2 24.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.507 ' SG ' ' HG3' ' T' ' 5' ' ' ARG . 1.3 m -93.48 155.31 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 111.205 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.501 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 1.9 t80 -153.6 99.31 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.587 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.777 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 0.7 OUTLIER -126.14 135.91 27.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.495 ' HD3' ' NE2' ' T' ' 29' ' ' HIS . 52.2 Cg_exo -51.63 -33.29 48.21 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.427 2.084 . . . . 0.0 111.848 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -131.31 -27.34 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.966 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 37.07 58.24 1.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.307 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.449 ' H1 ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.847 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.4 p -89.09 147.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.872 0.368 . . . . 0.0 111.269 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.526 ' N ' HG21 ' T' ' 2' ' ' VAL . 24.8 p90 -151.91 -176.53 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.783 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.52 ' HE2' ' HB3' ' T' ' 89' ' ' ASP . 10.2 t-80 -109.21 157.68 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 2.1 mmt180 -156.33 148.97 23.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.491 ' C ' HD13 ' T' ' 14' ' ' LEU . 2.9 pm0 -112.54 -173.21 2.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.58 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -91.38 158.4 16.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.179 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -61.09 -20.51 62.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.657 ' HB2' ' HD2' ' T' ' 13' ' ' LYS . 32.9 m -95.28 -28.54 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.65 167.11 12.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.44 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.444 ' HD2' ' CB ' ' T' ' 48' ' ' ALA . 1.6 ttpm? -56.65 152.13 12.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 19.3 m-30 63.79 54.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.657 ' HD2' ' HB2' ' T' ' 9' ' ' SER . 53.7 mttt -152.76 5.77 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.678 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.58 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 9.2 mt -109.19 130.23 55.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.048 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.624 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.2 p -103.09 150.47 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.257 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.529 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 85.9 t80 -35.29 -43.14 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.724 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.624 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 13.8 mt-10 -68.07 -56.29 9.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.66 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -44.2 -39.04 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -70.24 -38.36 75.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -60.94 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.52 -48.11 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -66.19 -54.87 20.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.349 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -71.66 -1.58 14.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.701 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -65.1 -48.67 72.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -115.62 63.96 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.242 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.68 45.53 54.59 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.335 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.628 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -115.88 177.53 17.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.535 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.628 ' HE2' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -149.65 133.9 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 110.958 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 141.22 6.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.328 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -83.92 146.25 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.463 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.445 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 43.6 p -100.93 -172.29 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.917 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 69.8 t80 -70.93 -64.9 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -49.12 -39.33 28.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.536 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.445 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.5 mt-30 -65.64 -53.06 46.62 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.488 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.36 -27.23 62.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.001 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.13 -59.67 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.426 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.45 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.124 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.612 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.39 -32.94 15.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.457 0.646 . . . . 0.0 109.681 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.676 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -70.53 -33.35 71.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.871 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -66.09 -21.13 66.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.612 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.98 -23.19 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 110.391 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.578 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 141.33 16.26 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.126 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.676 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -75.91 132.41 40.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.904 0.352 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.799 ' HD1' HG11 ' T' ' 62' ' ' VAL . 2.6 t-160 -156.11 124.22 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.615 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -146.78 89.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.82 74.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.675 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.444 ' CB ' ' HD2' ' T' ' 11' ' ' LYS . . . -175.77 119.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.785 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -37.42 114.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.295 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.672 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -114.25 121.3 5.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.545 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.5 m95 -54.68 148.58 12.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.113 0.482 . . . . 0.0 111.634 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -170.94 178.81 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.636 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 50.22 -165.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.468 . . . . 0.0 111.509 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -7.86 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.413 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 160.22 18.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.811 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.7 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.5 mtp180 -92.78 134.79 34.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.512 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -129.92 111.8 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -113.89 -172.26 17.89 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.271 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -122.91 81.45 50.13 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 0.0 111.016 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.846 ' HG3' HG22 ' T' ' 75' ' ' ILE . 28.0 Cg_exo -59.77 126.2 19.84 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.686 2.258 . . . . 0.0 112.164 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.443 HG12 ' O ' ' T' ' 59' ' ' TYR . 25.3 mm -131.59 134.31 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.225 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.799 HG11 ' HD1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER -102.53 -38.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -126.03 105.94 25.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.733 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.484 ' HB3' ' HA3' ' T' ' 71' ' ' GLY . 73.8 Cg_exo -46.69 129.61 14.34 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.829 2.353 . . . . 0.0 112.519 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.28 -171.68 16.78 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.455 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 56.9 Cg_endo -71.02 -86.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.76 2.306 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.2 OUTLIER -82.78 10.33 7.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.079 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.46 23.03 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.839 ' HA2' ' HD2' ' T' ' 72' ' ' LYS . . . 112.02 36.67 1.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.933 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 t80 44.12 44.02 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.019 0.437 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' T' ' 64' ' ' PRO . . . 68.79 71.23 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.709 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.839 ' HD2' ' HA2' ' T' ' 69' ' ' GLY . 6.0 mttp -88.05 155.1 19.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.87 132.09 54.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.218 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . 0.414 ' O ' HD12 ' T' ' 76' ' ' ILE . . . 70.44 168.69 7.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.093 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.917 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.5 mp -62.37 105.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.733 HG13 ' HD3' ' T' ' 72' ' ' LYS . 7.0 mm -73.96 82.29 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.09 120.12 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.443 ' HE1' HG23 ' T' ' 76' ' ' ILE . 7.9 m-85 -87.36 -35.42 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.23 169.66 12.55 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.7 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.0 mt -61.22 115.42 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -84.31 11.13 8.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.64 ' HA ' HH21 ' T' ' 84' ' ' ARG . 0.1 OUTLIER 58.25 46.24 16.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.786 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -151.74 77.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.64 HH21 ' HA ' ' T' ' 82' ' ' LEU . 0.3 OUTLIER -72.4 7.34 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.822 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.415 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.1 OUTLIER -104.43 7.16 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.565 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -66.36 -173.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.93 113.07 11.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.446 . . . . 0.0 111.517 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.593 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.7 m95 -154.47 -166.69 2.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.118 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.52 ' HB3' ' HE2' ' T' ' 4' ' ' HIS . 0.4 OUTLIER -84.34 -173.55 4.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.66 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.26 118.92 10.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.397 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.672 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 39.1 m-85 -88.4 113.95 24.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.403 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.42 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 2.0 t -93.89 159.8 15.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.855 0.36 . . . . 0.0 111.05 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 14.3 t80 -145.11 134.15 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.628 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 6.9 m-20 -152.76 141.33 13.99 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.628 ' HD3' ' HE2' ' T' ' 29' ' ' HIS . 60.8 Cg_exo -50.34 -33.26 36.45 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.481 2.121 . . . . 0.0 111.847 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' T' ' 97' ' ' ALA . 11.9 m-70 -119.49 -34.29 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.574 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 33.59 64.66 0.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.325 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.9 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.944 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.55 148.87 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.531 ' N ' HG21 ' T' ' 2' ' ' VAL . 17.3 p90 -157.53 177.42 11.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.203 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.465 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 37.9 t-80 -97.66 160.09 14.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -157.11 147.26 20.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.3 OUTLIER -112.52 -168.43 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.681 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -102.6 155.92 17.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.14 -17.72 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 p -98.47 -25.59 14.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.53 166.94 10.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.458 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -57.41 152.03 15.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 17.7 m-30 61.41 56.28 2.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.142 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -155.12 8.53 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.573 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.681 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 6.3 mt -110.63 132.32 54.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.291 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.721 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.7 p -103.0 146.54 28.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.141 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.5 t80 -33.93 -39.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.31 -45.2 70.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' T' ' 15' ' ' THR . 73.4 mt-10 -73.8 -49.9 23.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.775 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -48.39 -41.1 27.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.989 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -50.1 22.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.931 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.71 -40.99 30.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.409 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 6.8 t -70.49 -54.31 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.452 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 63.4 m -60.77 -42.04 96.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.923 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 10.0 tt0 -81.8 -10.25 59.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 0.9 OUTLIER -54.23 -50.89 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.003 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -96.62 61.37 1.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.92 30.72 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.418 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -111.56 -169.31 18.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.502 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.494 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.15 135.26 13.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.592 0.234 . . . . 0.0 110.441 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.19 125.43 26.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.463 . . . . 0.0 110.235 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -50.21 163.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.546 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 5.9 p -111.21 -158.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.74 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 30.9 t80 -79.89 -74.19 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.2 mttt -47.19 -36.35 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.73 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.31 -53.95 30.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.39 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -55.49 -24.47 31.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.932 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 15.0 tt0 -69.0 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.266 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.404 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -59.02 -12.01 4.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.562 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.1 -29.88 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.328 0.585 . . . . 0.0 109.872 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.57 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -73.42 -33.86 65.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.139 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.3 mtmt -69.97 -17.17 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.36 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.562 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.95 -17.63 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.433 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.51 11.53 1.49 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.014 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.57 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -82.63 124.48 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.921 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.581 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.4 t-160 -148.6 126.63 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.598 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -146.94 100.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.24 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.87 ' HA ' HD13 ' T' ' 61' ' ' ILE . 5.9 t -66.83 80.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 175.99 126.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.551 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -45.13 113.17 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.279 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.4 114.96 3.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.596 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.646 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 77.6 m95 -48.68 168.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 111.757 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.785 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -161.86 173.77 14.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.504 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.93 166.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 111.52 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.559 ' HB3' HD13 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 76.84 -31.64 0.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.34 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 109.14 20.12 8.1 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.592 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HB3' HG13 ' T' ' 80' ' ' ILE . 0.4 OUTLIER -108.99 156.28 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.594 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.646 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -137.03 133.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.052 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -137.53 -172.59 12.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.312 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.642 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -133.03 102.59 13.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.5 Cg_endo -60.33 -88.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.196 . . . . 0.0 112.291 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.87 HD13 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm 71.42 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.581 HG22 ' HB2' ' T' ' 45' ' ' HIS . 14.8 t -60.45 -70.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -101.69 155.02 36.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.86 144.12 36.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.643 2.229 . . . . 0.0 112.353 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.589 ' H ' ' H ' ' T' ' 71' ' ' GLY . . . -97.26 140.85 15.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.461 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 46.1 Cg_endo -68.83 -78.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -99.8 -1.95 36.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -19.47 65.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.47 36.14 2.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.936 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 58.44 95.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.814 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.802 ' HA2' HG23 ' T' ' 61' ' ' ILE . . . -74.91 4.51 37.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.657 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.26 -165.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.015 0.436 . . . . 0.0 111.58 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.06 56.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.169 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.28 176.9 51.66 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.799 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 2.5 mt -76.81 108.67 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 111.258 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.0 mm -79.13 82.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.975 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.42 121.65 45.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 1.6 m-85 -83.71 11.96 6.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.62 170.74 7.83 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.661 HG13 ' HB3' ' T' ' 56' ' ' ARG . 9.4 mt -60.33 117.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.18 19.42 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.547 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.71 35.24 20.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -129.91 53.11 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.721 ' O ' ' HB ' ' T' ' 15' ' ' THR . 21.4 mtt180 -60.95 -5.55 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.41 ' H ' ' C ' ' T' ' 83' ' ' ASN . 1.0 OUTLIER -90.64 20.74 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.76 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.544 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.4 mm-40 -83.72 -172.05 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.641 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.56 114.15 10.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.1 m95 -153.98 -164.74 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.97 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.458 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.3 OUTLIER -89.56 -173.96 4.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.55 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.775 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.06 135.16 25.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.683 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 35.8 m-85 -96.88 111.91 23.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.276 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 9.1 m -90.49 137.2 32.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 111.09 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.944 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.4 OUTLIER -136.83 126.26 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.623 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 4.0 m-20 -133.24 151.05 76.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.16 -33.64 21.89 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.476 2.117 . . . . 0.0 111.92 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' T' ' 97' ' ' ALA . 21.2 t-160 -123.2 -32.18 3.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 31.45 68.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.334 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.938 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.774 HG22 ' HB3' ' T' ' 31' ' ' ALA . 2.1 p -101.96 146.29 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.79 -176.99 5.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.881 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.462 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 16.4 t-80 -95.38 153.85 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.32 150.97 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.044 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 26.0 tt0 -120.02 173.19 7.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.631 ' N ' HD13 ' T' ' 14' ' ' LEU . . . -80.29 159.92 25.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.084 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -61.25 -28.54 69.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.452 ' HB2' ' HE3' ' T' ' 13' ' ' LYS . 0.9 OUTLIER -91.55 -50.05 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 176.39 174.21 42.69 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.497 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 20.1 ttpt -62.96 168.14 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.745 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 46.3 47.79 13.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.7 OUTLIER -143.41 2.34 1.26 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.785 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.631 HD13 ' N ' ' T' ' 7' ' ' ALA . 6.5 mt -104.2 139.06 39.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.487 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.637 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 19.8 p -107.8 149.67 27.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.94 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 61.9 t80 -34.07 -42.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 111.054 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.69 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.7 mt-10 -69.34 -44.66 71.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 110.032 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -56.09 -38.65 70.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.815 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.474 ' HZ1' HD22 ' T' ' 30' ' ' LEU . 7.9 tttp -76.42 -37.13 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -59.56 -38.47 81.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.084 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -53.16 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.355 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -63.89 -28.39 69.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 30.9 tt0 -99.31 -9.28 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 110.307 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -51.34 -42.6 61.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.92 59.0 0.66 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.88 33.34 20.24 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.28 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.27 -168.2 19.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.585 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.4 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.583 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -70.58 126.89 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 0.0 110.358 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.774 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -51.3 161.23 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.575 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.639 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 28.2 p -111.84 -164.94 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.883 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 32.5 t80 -74.76 -70.75 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.991 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 30.0 mttm -45.28 -41.85 9.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.667 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.71 -51.21 63.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.732 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.69 -27.33 49.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.949 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.7 tp10 -65.9 -61.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.087 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.27 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.936 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.544 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.92 -30.16 14.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.348 0.594 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.558 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 53.0 ttt-85 -73.6 -33.35 64.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.009 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 13.0 mttt -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.544 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.74 -15.73 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.415 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 131.15 12.12 2.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.091 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.47 120.0 23.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.563 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.5 t-160 -136.4 129.32 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.656 HG23 ' HE1' ' T' ' 91' ' ' TYR . 1.3 t -143.24 103.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.447 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.687 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.71 66.32 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.5 ' HA ' ' HH ' ' T' ' 12' ' ' TYR . . . -175.26 138.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.671 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -55.09 111.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.643 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -108.6 113.85 3.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.6 m95 -47.12 152.06 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.779 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.5 174.54 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.688 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 53.44 -166.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.543 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 0.34 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.537 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 151.74 16.16 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.786 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' T' ' 52' ' ' MET . 1.9 mtt180 -92.05 125.52 36.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.585 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -116.3 126.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -130.23 -169.2 12.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.318 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.492 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.1 OUTLIER -139.45 91.92 10.67 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.855 0.36 . . . . 0.0 111.143 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.887 ' HB3' HD12 ' T' ' 75' ' ' ILE . 68.4 Cg_endo -78.49 125.06 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.67 2.247 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' T' ' 47' ' ' CYS . 20.0 mm -136.82 101.21 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -73.64 -17.94 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.03 91.13 48.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.697 ' HB3' ' HA3' ' T' ' 71' ' ' GLY . 50.2 Cg_exo -51.87 128.96 28.45 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.59 -171.84 16.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.414 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 43.4 Cg_endo -68.31 -78.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.763 2.308 . . . . 0.0 112.322 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.445 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -100.76 -21.38 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.956 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.81 -82.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.916 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' T' ' 72' ' ' LYS . . . -80.87 -9.92 85.71 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.894 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.8 32.07 21.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' T' ' 64' ' ' PRO . . . 64.79 24.0 69.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.681 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' T' ' 76' ' ' ILE . 29.5 mttm -89.38 151.59 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.26 131.28 53.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.01 -175.93 34.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.834 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.887 HD12 ' HB3' ' T' ' 60' ' ' PRO . 0.6 OUTLIER -80.31 89.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.987 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' T' ' 72' ' ' LYS . 18.3 mm -62.42 84.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.43 138.21 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 2.0 m-85 -112.82 27.72 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.499 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 68.49 168.2 4.83 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.401 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.2 mt -57.43 147.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.947 0.403 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.663 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 4.7 mmm-85 -115.14 22.52 13.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.02 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' T' ' 82' ' ' LEU . 0.2 OUTLIER 44.46 53.4 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.663 ' OD1' ' HB2' ' T' ' 81' ' ' ARG . 27.5 p-10 -165.81 61.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.631 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -58.3 -3.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.501 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -81.93 17.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.502 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 1.8 mm-40 -78.01 -172.46 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.63 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -139.04 113.38 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.283 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.745 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 16.2 m95 -153.13 -156.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.105 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -97.33 -171.23 2.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.374 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.674 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.17 137.92 29.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.221 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.664 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 32.5 m-85 -101.02 120.38 40.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.441 ' O ' HG21 ' T' ' 2' ' ' VAL . 5.7 m -96.1 147.51 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.431 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.733 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 26.5 t80 -137.6 133.95 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.755 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 12.7 m-20 -154.74 137.46 10.17 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.589 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.56 -32.75 28.53 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.496 2.131 . . . . 0.0 111.698 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' T' ' 97' ' ' ALA . 4.0 m-70 -118.35 -34.14 4.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.618 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.755 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 30.36 69.4 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.335 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.416 ' H3 ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.2 p -88.64 138.35 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.126 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.03 -177.97 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.496 ' HE2' ' HB3' ' T' ' 89' ' ' ASP . 21.1 t-80 -101.7 161.56 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.467 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.83 144.81 23.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.598 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.8 tt0 -115.62 173.28 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.692 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.651 ' HB3' ' HG ' ' T' ' 14' ' ' LEU . . . -87.25 157.19 19.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.194 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -65.93 -21.5 66.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -91.41 -23.75 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.85 167.79 11.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.453 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 7.6 ttpt -58.59 158.15 8.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.0 m-30 57.2 55.98 5.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -153.25 2.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.651 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 6.8 mt -103.05 136.81 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.072 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.676 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.5 p -107.73 152.91 23.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.243 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 71.5 t80 -36.66 -43.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.03 -39.86 68.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.676 ' HB2' ' H ' ' T' ' 15' ' ' THR . 76.4 mt-10 -70.55 -47.69 59.08 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 109.806 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.764 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -55.89 -46.47 78.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.561 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.636 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -65.67 -39.54 91.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.142 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.89 -52.31 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 92.1 m -64.13 -48.98 73.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.541 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 42.9 tt0 -69.9 -16.4 63.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.532 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.95 -49.09 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.803 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -103.71 51.6 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.28 38.97 34.51 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.356 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -117.98 172.83 14.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.569 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -124.79 139.47 53.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.71 0.291 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -74.64 126.12 30.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.215 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.846 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -49.3 155.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.461 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.592 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 27.1 p -110.39 -164.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.735 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 27.6 t80 -74.88 -72.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.107 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -47.59 -41.59 21.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.921 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.45 -47.79 80.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' T' ' 91' ' ' TYR . 0.6 OUTLIER -54.81 -40.72 69.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 3.6 tp10 -54.26 -60.66 3.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.188 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.85 -18.48 8.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.585 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.27 -29.75 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.76 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' T' ' 62' ' ' VAL . 3.1 tmm_? -71.17 -33.62 70.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.011 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtpt -69.45 -17.03 63.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.314 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.53 -12.33 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.683 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.24 14.9 3.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.012 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.463 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -83.01 124.6 30.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 0.0 110.981 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.725 ' HD1' HG13 ' T' ' 62' ' ' VAL . 2.2 t-160 -147.15 127.25 13.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.645 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -143.75 94.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.556 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 1.3 m -61.75 83.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 170.32 125.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -46.28 113.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -110.43 121.37 5.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.633 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.4 m95 -49.68 152.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.97 0.414 . . . . 0.0 111.318 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.803 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.41 177.82 3.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.73 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.592 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 51.97 -165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.469 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 2.78 2.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.372 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.526 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 151.02 15.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.791 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.697 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 28.6 mtt180 -94.72 127.48 40.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.563 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -115.93 131.37 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.504 ' N ' ' HE3' ' T' ' 52' ' ' MET . . . -141.38 -178.28 17.45 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.393 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.95 98.3 39.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.745 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 37.9 Cg_exo -55.35 -84.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.786 2.324 . . . . 0.0 112.689 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.2 mm 73.57 102.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.948 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.725 HG13 ' HD1' ' T' ' 45' ' ' HIS . 0.3 OUTLIER -76.06 -41.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.644 ' H ' ' HD1' ' T' ' 45' ' ' HIS . 6.9 ptpt -124.43 95.48 43.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.71 141.97 42.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.589 2.193 . . . . 0.0 112.294 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.47 -117.73 2.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.272 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.476 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 73.7 Cg_endo -83.89 -79.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.476 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -104.27 -19.82 13.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.84 -34.21 72.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.31 -14.03 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.837 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 59.4 29.52 19.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.97 17.89 72.12 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.734 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.715 ' HD3' HG13 ' T' ' 76' ' ' ILE . 17.6 mttt -89.67 151.01 22.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.39 129.23 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . 0.557 ' HA3' ' NH2' ' T' ' 40' ' ' ARG . . . 86.21 175.39 49.78 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.735 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.3 mt -68.49 107.41 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.046 0.45 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.715 HG13 ' HD3' ' T' ' 72' ' ' LYS . 9.8 mm -81.39 83.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.479 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 3.1 t70 -109.47 132.12 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -105.15 23.01 14.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.697 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 70.05 170.97 8.75 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.37 152.29 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.282 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.05 18.65 17.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.55 ' O ' HD11 ' T' ' 82' ' ' LEU . 0.1 OUTLIER 54.76 31.66 15.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -148.92 77.44 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.66 ' O ' ' HB ' ' T' ' 15' ' ' THR . 69.2 mtt180 -65.79 2.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.483 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -102.14 12.67 36.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.511 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -65.17 -178.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -132.35 114.27 14.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 111.341 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 23.2 m95 -151.43 -136.6 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.274 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' T' ' 4' ' ' HIS . 0.7 OUTLIER -115.4 -167.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.378 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.764 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -147.6 132.53 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.276 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.713 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 31.1 m-85 -105.1 127.28 52.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.463 ' O ' HG21 ' T' ' 2' ' ' VAL . 1.2 m -100.76 159.67 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.304 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.676 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 24.2 t80 -150.67 119.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.871 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 2.8 m120 -139.03 133.73 16.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.484 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.28 -33.52 28.75 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.507 2.138 . . . . 0.0 111.905 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.495 ' O ' ' C ' ' T' ' 97' ' ' ALA . 2.2 p80 -115.25 -31.75 5.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.711 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.871 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 25.74 74.51 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.47 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.78 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.1 p -86.61 142.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.151 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -147.23 -176.69 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.436 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 40.7 t-80 -98.93 163.95 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 154.77 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.549 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 24.7 tt0 -121.91 172.91 7.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.567 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -78.33 161.23 27.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -20.16 65.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.757 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.525 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.5 m -102.82 -47.49 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.91 172.53 39.3 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 150.25 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.692 0.282 . . . . 0.0 110.969 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.69 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 61.81 57.36 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.525 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 9.0 mttm -153.55 1.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.515 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.567 HD13 ' HA ' ' T' ' 7' ' ' ALA . 12.3 mt -104.66 139.54 39.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.7 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.6 p -108.55 151.8 25.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.553 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 67.6 t80 -36.52 -41.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 0.0 110.791 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.79 -39.03 64.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.304 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.7 ' HB2' ' H ' ' T' ' 15' ' ' THR . 82.6 mt-10 -71.02 -45.38 64.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.179 0.514 . . . . 0.0 109.958 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.83 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.56 -45.26 89.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.565 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -68.47 -26.86 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.563 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.71 -41.53 83.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.194 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.78 -51.73 47.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.259 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -63.84 -47.71 79.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.592 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 4.1 tt0 -73.55 -13.45 61.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -54.43 -48.83 71.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -102.9 50.98 0.81 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.758 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.15 39.62 50.53 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.313 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -118.17 177.41 16.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.733 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -130.12 141.83 50.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.564 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.765 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.63 125.44 29.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.068 0.461 . . . . 0.0 110.23 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.78 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -48.22 154.32 0.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.533 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -109.99 -162.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.222 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 31.6 t80 -77.23 -72.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 14.1 mttm -46.89 -38.49 10.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.732 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.28 -53.55 35.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 110.39 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.63 -23.86 44.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 12.1 tp10 -68.45 -61.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.205 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.52 -16.09 8.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.798 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.548 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.49 -29.48 15.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.491 0.662 . . . . 0.0 109.684 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.549 HH11 ' HA3' ' T' ' 74' ' ' GLY . 0.0 OUTLIER -72.61 -33.25 66.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.112 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.0 mttt -69.52 -17.88 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.286 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.548 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.39 -14.35 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.81 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.22 11.35 2.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.045 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -81.48 118.6 22.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.697 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.9 t-160 -141.55 127.2 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.649 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -145.43 102.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.28 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.778 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -72.72 80.5 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.701 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 178.55 123.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.835 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.576 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -41.73 111.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.676 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.31 114.97 3.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.667 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.619 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 71.7 m95 -48.95 156.83 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.432 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.765 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -177.61 178.33 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.896 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.595 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 50.77 -165.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -7.52 7.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.498 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.488 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 158.49 19.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.858 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.637 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.9 OUTLIER -97.53 135.66 39.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.73 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.619 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -126.61 122.42 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -170.65 13.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.576 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -124.99 82.97 60.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.961 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.619 ' HG3' HD12 ' T' ' 75' ' ' ILE . 26.7 Cg_exo -60.37 104.95 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.761 2.307 . . . . 0.0 112.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.778 HD13 ' HA ' ' T' ' 47' ' ' CYS . 29.4 mm -130.74 112.28 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.028 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.697 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER -70.01 -16.69 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.897 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.519 ' H ' HG21 ' T' ' 61' ' ' ILE . 0.2 OUTLIER -104.6 164.04 16.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.893 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.47 -8.42 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.564 2.176 . . . . 0.0 112.402 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.439 ' HA2' ' HA2' ' T' ' 69' ' ' GLY . . . 79.89 135.99 1.42 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.39 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.58 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 98.6 Cg_endo -92.1 -67.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.073 2.516 . . . . 0.0 112.226 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.58 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -122.25 -22.91 5.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 10.3 41.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.439 ' HA2' ' HA2' ' T' ' 65' ' ' GLY . . . -124.49 -38.41 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.008 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 64.06 41.87 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.55 17.82 78.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.74 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.577 ' HD2' HG13 ' T' ' 76' ' ' ILE . 9.9 mttm -92.53 154.8 18.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.98 131.96 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . 0.549 ' HA3' HH11 ' T' ' 40' ' ' ARG . . . 90.03 -176.24 42.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.85 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.631 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -70.36 110.85 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 111.058 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' T' ' 72' ' ' LYS . 5.2 mm -89.36 79.86 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -101.92 122.83 44.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.01 3.36 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.09 172.44 44.37 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.468 HG12 ' C ' ' T' ' 55' ' ' GLY . 6.3 mt -65.4 119.92 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.315 . . . . 0.0 111.027 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -112.03 28.35 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.96 27.89 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' T' ' 85' ' ' SER . 22.9 m120 -114.38 51.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.612 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -70.65 4.34 2.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.409 ' H ' ' C ' ' T' ' 83' ' ' ASN . 1.3 m -106.62 6.97 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.547 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -72.15 -171.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 23.5 mtp85 -132.63 113.48 13.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.139 0.495 . . . . 0.0 111.56 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.69 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.8 m95 -153.99 -171.24 3.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.038 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -81.99 -171.21 3.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.424 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.83 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.77 136.87 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.676 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 38.8 m-85 -103.24 127.91 50.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.51 ' O ' HG21 ' T' ' 2' ' ' VAL . 0.7 OUTLIER -99.56 161.35 13.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 111.284 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.693 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 25.2 t80 -151.62 119.88 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.757 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.819 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 27.6 m-20 -143.43 147.07 38.41 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.58 -51.13 9.82 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.54 2.16 . . . . 0.0 111.498 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.488 ' O ' ' C ' ' T' ' 97' ' ' ALA . 18.9 p-80 -101.48 -28.45 12.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.58 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.819 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 27.11 66.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.371 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.895 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.705 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.6 p -92.32 141.91 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 111.273 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.487 ' N ' HG21 ' T' ' 2' ' ' VAL . 27.3 p90 -145.59 -176.91 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.48 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 16.1 t-80 -113.56 155.26 25.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.434 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.2 OUTLIER -154.96 164.43 38.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.2 OUTLIER -122.82 -170.0 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -90.7 149.55 22.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -60.12 -16.47 32.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.753 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -98.77 -25.35 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 149.19 167.65 14.13 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.492 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 8.1 tttm -62.38 153.84 29.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.345 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.9 m-30 57.06 51.92 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.753 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 3.7 mttm -142.69 1.05 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 6.9 mt -104.33 146.77 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.714 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 22.3 p -114.36 153.31 30.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.012 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.694 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 72.2 t80 -37.76 -40.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.849 0.357 . . . . 0.0 110.751 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.99 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.359 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.714 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.7 mt-10 -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.173 0.511 . . . . 0.0 109.936 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.09 -46.2 85.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -67.69 -26.5 66.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.489 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -69.41 -40.98 77.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.86 -50.41 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -52.27 50.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.148 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 6.5 tt0 -71.62 -3.04 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.644 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -65.71 -45.11 83.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.574 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.81 59.61 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.047 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 55.82 21.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.262 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.482 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -138.96 166.96 25.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.784 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.47 139.07 51.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.612 0.244 . . . . 0.0 110.57 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.791 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -74.22 124.65 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.0 110.316 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -49.69 153.13 1.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.483 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 28.3 p -106.17 -164.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.977 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.87 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 53.0 t80 -75.61 -69.79 0.47 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.021 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -46.68 -42.7 16.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.17 -46.25 84.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.647 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.73 -38.01 71.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.226 0.536 . . . . 0.0 109.661 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.02 -60.68 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.428 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.555 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -54.48 -21.59 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.058 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -90.91 -28.85 17.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 0.0 109.633 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.436 ' O ' HG22 ' T' ' 62' ' ' VAL . 19.2 ttp85 -71.59 -34.21 69.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.001 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -73.24 -18.05 61.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.555 HG21 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -87.88 -7.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.92 7.07 7.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.331 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -78.17 130.64 36.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.645 ' HD1' HG13 ' T' ' 62' ' ' VAL . 2.6 t-160 -153.07 130.8 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.763 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.59 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -152.37 99.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.261 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.605 ' HA ' HD12 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.731 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 179.67 122.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -41.45 110.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.653 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -109.71 115.94 4.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.838 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.626 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 67.3 m95 -48.19 156.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 111.367 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.791 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.1 OUTLIER -178.28 177.37 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.055 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.04 -165.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.754 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -14.03 10.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.476 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 160.85 23.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.926 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.616 ' O ' ' HG3' ' T' ' 52' ' ' MET . 10.7 ptp180 -99.71 136.41 39.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.538 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.626 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -127.88 119.57 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -118.68 -173.67 15.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.257 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.415 ' O ' HG12 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -120.56 82.32 33.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.826 ' HG3' HG22 ' T' ' 75' ' ' ILE . 27.7 Cg_exo -59.97 120.9 8.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.689 2.259 . . . . 0.0 112.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' T' ' 47' ' ' CYS . 10.4 mm -138.69 100.56 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.645 HG13 ' HD1' ' T' ' 45' ' ' HIS . 0.4 OUTLIER -71.52 -41.85 72.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.477 ' H ' ' ND1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -113.36 96.86 41.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 9.9 Cg_endo -53.0 144.03 47.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.774 2.316 . . . . 0.0 112.285 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.04 15.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.312 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 39.3 Cg_endo -68.15 -77.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 0.0 112.181 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.427 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -97.41 -12.69 22.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.755 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 48.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.47 -31.21 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 62.71 32.53 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 111.013 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.92 16.77 70.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.675 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.903 ' HD3' HG13 ' T' ' 76' ' ' ILE . 15.7 mttp -95.09 149.87 20.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.805 0.336 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.12 128.55 53.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 168.4 44.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.87 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.0 mp -63.49 97.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.757 0.313 . . . . 0.0 111.301 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.903 HG13 ' HD3' ' T' ' 72' ' ' LYS . 16.1 mm -70.8 80.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.444 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 3.4 t70 -105.12 123.17 47.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 2.2 m-85 -86.31 -3.16 58.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.967 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.57 169.69 40.32 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.423 HG12 ' C ' ' T' ' 55' ' ' GLY . 16.2 mt -60.67 127.83 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 111.082 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.88 16.99 21.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.99 45.75 26.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.418 HD21 ' HG2' ' T' ' 86' ' ' GLU . 18.9 t30 -163.93 77.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.694 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -69.89 -4.94 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 17.26 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.54 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -80.32 -171.81 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.599 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 2.7 ppt_? -137.53 111.75 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.094 0.473 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.646 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.2 m95 -153.71 -172.11 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.171 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -170.62 3.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.32 137.79 27.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.653 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 36.2 m-85 -103.45 121.14 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 154.17 17.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.014 0.435 . . . . 0.0 111.3 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.705 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 28.8 t80 -143.7 126.27 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.787 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 26.6 m-20 -149.56 134.04 9.16 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.525 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -50.28 -32.43 33.03 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 111.705 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' T' ' 97' ' ' ALA . 37.1 t60 -116.3 -34.74 4.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.566 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.787 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 30.13 71.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.362 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.939 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.952 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -83.01 146.44 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 2.0 p90 -151.22 177.46 10.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.163 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.503 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.3 t-80 -112.86 160.74 17.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.154 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 6.0 tpp180 -158.89 159.81 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 -169.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.868 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.774 ' HB1' ' HG ' ' T' ' 14' ' ' LEU . . . -96.17 149.86 21.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -20.49 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.498 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -95.72 -22.74 17.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.833 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 144.47 166.97 11.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.417 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -65.02 162.74 16.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.7 m-30 53.69 38.75 29.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.4 OUTLIER -134.54 4.9 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.876 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.774 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 7.7 mt -107.51 139.04 42.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.982 0.42 . . . . 0.0 111.427 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.8 p -109.86 149.12 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.011 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.598 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -34.48 -41.16 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.786 0.326 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.39 -43.85 69.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.319 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.518 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.8 mt-10 -70.38 -46.78 63.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -49.7 -43.95 47.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.95 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -65.63 -54.45 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -50.01 -36.8 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 t -75.18 -54.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.524 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.449 ' O ' ' HA2' ' T' ' 28' ' ' GLY . 58.8 m -64.19 -30.32 71.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 24.4 tt0 -92.59 -12.14 32.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 110.104 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.567 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.4 t80 -54.33 -41.62 69.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.044 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -107.69 59.09 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.218 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.53 20.46 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.415 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -94.54 -174.3 38.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.92 136.26 14.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.14 137.17 10.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.475 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -77.54 166.94 22.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.134 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 47.0 p -117.99 -175.15 2.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 0.0 111.373 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.939 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 48.0 t80 -69.54 -68.99 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.955 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.2 mttp -45.89 -42.09 12.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.583 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.432 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.2 mt-30 -65.03 -51.04 63.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.764 HD13 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -60.17 -22.17 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.5 tt0 -73.98 -61.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.286 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.28 -13.45 7.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.2 -29.11 14.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.656 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 8.4 ttt-85 -72.73 -34.38 67.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.035 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.7 mtpt -69.67 -15.79 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.574 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.0 -19.16 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.741 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.476 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.11 11.77 1.02 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.103 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.656 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.65 115.74 20.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.566 ' HD1' ' HG2' ' T' ' 63' ' ' LYS . 2.4 t-160 -135.53 127.99 30.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' T' ' 45' ' ' HIS . 1.3 t -144.64 102.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.249 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.509 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 52.8 t -77.56 63.85 2.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.74 125.59 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.894 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.535 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -42.5 115.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.05 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -115.59 119.31 4.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.632 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.504 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.1 m95 -53.48 148.52 9.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.47 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.649 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -167.5 175.31 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.344 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' T' ' 56' ' ' ARG . . . 51.62 -165.99 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -2.17 4.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.441 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.9 14.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.846 ' HG3' HG13 ' T' ' 80' ' ' ILE . 6.8 mtt180 -88.41 125.94 34.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.474 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -121.88 117.81 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.73 -169.72 13.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.261 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -141.48 95.06 7.34 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 111.219 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.814 ' HB3' HD12 ' T' ' 75' ' ' ILE . 71.8 Cg_endo -81.58 131.25 7.26 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 15.2 mm -134.77 107.22 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.184 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.01 -45.7 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.566 ' HG2' ' HD1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -118.59 94.27 47.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 140.73 90.96 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.571 2.181 . . . . 0.0 112.305 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.3 -135.3 5.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 73.2 Cg_endo -85.77 -80.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.855 2.37 . . . . 0.0 112.447 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.445 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -104.73 -16.3 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.783 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.77 74.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.44 -22.48 8.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . 0.419 ' HB3' ' HG3' ' T' ' 72' ' ' LYS . 3.1 t80 61.06 22.5 12.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.59 14.58 75.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.703 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.895 ' HD3' HG13 ' T' ' 76' ' ' ILE . 27.5 mttm -83.58 150.83 25.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.97 129.08 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.47 -174.78 35.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.907 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.939 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -79.88 95.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.163 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.895 HG13 ' HD3' ' T' ' 72' ' ' LYS . 11.6 mm -68.18 83.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -110.38 122.05 46.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.464 ' HE1' HG23 ' T' ' 76' ' ' ILE . 1.0 OUTLIER -87.69 -5.94 58.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.072 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.718 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 91.22 169.11 41.99 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.846 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.7 mt -59.36 122.4 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -102.37 13.84 33.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.949 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.48 48.93 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.32 58.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.642 ' HB2' HH11 ' T' ' 84' ' ' ARG . 0.0 OUTLIER -60.39 -9.71 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -79.69 12.59 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.47 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -79.37 -178.68 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.688 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -134.85 116.36 14.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.578 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 20.8 m95 -150.18 -134.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.339 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -115.83 -166.83 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.357 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -148.0 119.54 7.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.369 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.627 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 28.4 m-85 -87.63 103.8 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.498 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.6 m -82.26 151.84 26.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.952 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -148.91 125.75 11.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.769 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.713 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 2.7 m120 -137.03 162.03 58.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.679 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 15.7 Cg_endo -57.8 -52.9 5.15 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.621 2.214 . . . . 0.0 111.622 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.508 ' O ' ' C ' ' T' ' 97' ' ' ALA . 18.1 p80 -102.31 -29.46 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.531 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.713 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 23.83 66.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.425 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.571 ' H1 ' ' HB2' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.7 p -92.5 143.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.805 0.336 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.494 ' N ' HG21 ' T' ' 2' ' ' VAL . 21.0 p90 -143.21 178.41 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.818 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.514 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 46.9 t-80 -96.1 159.05 15.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.205 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.786 ' HG2' HG12 ' T' ' 22' ' ' VAL . 0.0 OUTLIER -151.31 151.4 31.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.031 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.0 tt0 -122.91 173.09 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.556 ' N ' ' CG ' ' T' ' 6' ' ' GLU . . . -88.64 157.72 18.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.191 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.665 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -93.8 -24.82 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.38 166.86 10.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.538 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 17.4 ttpt -58.41 155.66 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 110.97 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.488 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 10.5 m-30 58.5 54.2 5.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.989 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -152.5 3.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 6.6 mt -104.32 134.9 46.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 28.0 p -105.56 150.93 24.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.736 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 78.8 t80 -34.86 -42.28 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.956 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -42.25 65.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.373 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.601 ' HB2' ' H ' ' T' ' 15' ' ' THR . 67.5 mt-10 -69.72 -46.58 65.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.017 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.851 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -52.83 -42.12 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.738 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -68.0 -34.9 77.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.605 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.96 -36.37 83.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.972 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . 0.786 HG12 ' HG2' ' T' ' 5' ' ' ARG . 3.0 t -69.16 -50.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.178 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -64.57 -54.31 34.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.029 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 44.0 tt0 -62.26 -19.26 63.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -54.06 -48.41 70.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.81 54.45 0.66 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.37 31.5 35.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.241 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.444 ' C ' ' HD1' ' T' ' 29' ' ' HIS . . . -100.95 167.56 19.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.646 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.564 ' NE2' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -133.91 138.14 45.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.004 0.431 . . . . 0.0 111.412 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.87 139.17 22.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.871 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -81.17 166.27 20.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.452 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 38.9 p -120.82 -175.01 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.0 111.684 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.838 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 36.0 t80 -68.32 -70.34 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.757 ' HA ' ' HG3' ' T' ' 37' ' ' GLU . 3.0 mttp -46.69 -40.99 14.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.865 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.452 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.5 mt-30 -63.65 -47.13 82.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.743 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -30.81 61.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.384 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.757 ' HG3' ' HA ' ' T' ' 34' ' ' LYS . 0.0 OUTLIER -66.51 -60.86 2.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.451 0.643 . . . . 0.0 110.118 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.44 -18.52 2.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.546 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.17 -30.72 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.398 0.618 . . . . 0.0 109.678 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.413 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.1 OUTLIER -72.65 -32.95 66.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.044 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.4 mtmp? -69.69 -18.21 63.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.546 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.61 -10.95 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.41 14.03 4.57 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.514 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.2 t80 -82.15 125.66 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.643 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.5 t-160 -147.61 126.1 12.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.635 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -145.66 101.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.222 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.829 ' HA ' HD13 ' T' ' 61' ' ' ILE . 4.4 t -72.15 78.99 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . -179.62 116.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.602 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -38.61 117.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.072 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.638 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -116.27 122.73 5.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.692 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.5 m95 -53.99 146.56 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -164.64 178.41 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.471 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' T' ' 56' ' ' ARG . . . 51.04 -166.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.475 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.77 3.88 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.448 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 151.04 13.7 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.856 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.844 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 11.4 mtt180 -91.47 127.09 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.496 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -117.55 125.38 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.02 -175.67 14.16 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.602 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -134.7 103.68 11.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.3 Cg_exo -58.5 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.623 2.216 . . . . 0.0 112.199 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.829 HD13 ' HA ' ' T' ' 47' ' ' CYS . 30.0 mm 75.42 108.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER -81.23 -38.41 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -113.68 96.9 42.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.92 139.68 91.21 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.535 2.156 . . . . 0.0 112.243 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.54 -151.47 10.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.398 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.719 ' HG2' ' ND2' ' T' ' 67' ' ' ASN . 74.1 Cg_endo -87.79 -64.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.996 2.464 . . . . 0.0 111.982 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.719 ' ND2' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -104.72 -22.53 13.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.771 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -80.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.48 -6.04 83.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.926 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.12 27.69 17.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.019 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.35 12.49 63.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.677 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.97 ' HD3' HG13 ' T' ' 76' ' ' ILE . 21.6 mttp -81.72 159.5 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.761 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.25 130.5 52.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.47 176.21 49.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.838 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -68.47 112.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 111.021 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.97 HG13 ' HD3' ' T' ' 72' ' ' LYS . 6.6 mm -87.23 88.7 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.117 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -112.87 112.89 24.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.473 ' HE1' ' CE2' ' T' ' 59' ' ' TYR . 3.2 m-85 -79.38 4.35 15.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.844 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 76.65 170.11 31.32 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.676 HG21 ' H ' ' T' ' 82' ' ' LEU . 11.9 mt -48.21 142.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 3.9 mmm-85 -108.26 16.09 23.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.676 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.75 35.37 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -169.07 86.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.736 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -70.42 -1.15 9.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -76.87 15.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.511 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.5 mm-40 -75.11 -173.57 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -138.22 113.7 9.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 111.1 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 15.7 m95 -151.22 -137.79 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.507 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.538 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -116.01 -165.35 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.449 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.851 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -147.34 126.89 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 111.559 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.638 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 29.9 m-85 -97.47 107.59 20.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.413 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 4.5 t -84.89 154.93 21.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.825 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 13.9 t80 -144.02 123.05 12.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.999 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.704 ' HB2' ' HB3' ' T' ' 97' ' ' ALA . 5.3 m120 -139.11 141.2 28.97 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.322 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.564 ' HD3' ' NE2' ' T' ' 29' ' ' HIS . 73.7 Cg_exo -49.22 -33.22 27.35 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.36 2.04 . . . . 0.0 111.87 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' T' ' 97' ' ' ALA . 81.7 t60 -119.6 -33.26 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.543 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' T' ' 94' ' ' ASN . . . 31.83 75.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.416 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.873 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' T' ' 94' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.87 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.5 p -96.95 148.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.0 111.516 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.457 ' N ' HG21 ' T' ' 2' ' ' VAL . 31.0 p90 -156.98 -176.52 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.497 ' HE2' ' HB3' ' T' ' 89' ' ' ASP . 9.8 t-80 -101.38 159.33 15.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.049 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 8.1 mmt180 -153.04 148.49 27.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.566 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.7 tt0 -116.4 173.34 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' T' ' 6' ' ' GLU . . . -86.43 156.07 20.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -20.7 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.442 ' HB3' ' NZ ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -93.88 -28.01 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.8 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 147.65 168.27 13.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.345 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.441 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 4.1 ttpm? -63.68 165.23 8.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 16.2 m-30 50.8 43.95 28.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 3.8 mttt -138.63 -2.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 8.4 mt -102.18 139.56 37.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.336 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.616 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 2.8 p -110.46 151.58 27.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.108 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.517 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 79.5 t80 -34.01 -42.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.99 68.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.223 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.616 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.0 mt-10 -68.63 -45.27 72.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.823 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -52.93 -40.4 63.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.896 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -70.11 -34.89 73.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.715 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -64.53 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.53 -50.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.21 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.68 -53.26 50.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.4 tt0 -63.8 -21.07 66.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.413 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.4 OUTLIER -51.38 -49.81 60.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.844 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -106.03 53.47 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.58 42.23 43.66 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.231 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -115.07 165.86 12.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.728 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.555 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.46 139.45 51.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.891 0.377 . . . . 0.0 111.312 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.45 149.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.983 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -90.7 149.28 22.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.401 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.632 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 62.8 p -105.93 -175.57 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.915 0.388 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.926 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 51.8 t80 -67.29 -68.57 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.042 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -48.29 -42.86 32.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.947 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.12 -50.19 69.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -60.45 -31.69 70.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.336 0.588 . . . . 0.0 109.646 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' T' ' 41' ' ' LYS . 8.8 tt0 -65.28 -58.39 6.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.236 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.14 -23.91 6.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.786 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -87.51 -30.53 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.516 0.674 . . . . 0.0 109.78 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.75 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.4 OUTLIER -70.45 -33.71 71.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.093 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' T' ' 37' ' ' GLU . 11.4 mttm -67.48 -19.22 65.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.197 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.626 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.1 -21.83 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.556 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 139.7 15.19 0.56 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.211 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.75 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -70.75 137.64 49.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.737 0.303 . . . . 0.0 110.683 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.566 ' NE2' HD11 ' T' ' 61' ' ' ILE . 3.2 t-160 -161.09 124.45 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.651 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -146.67 103.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.733 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.48 72.79 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' T' ' 12' ' ' TYR . . . -178.72 139.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -56.28 116.64 3.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.688 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -113.39 121.39 5.48 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.725 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 77.0 m95 -55.16 144.44 24.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.503 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -163.26 176.06 10.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.664 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.539 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.95 -165.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.584 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -6.41 9.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.563 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.11 16.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.954 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.611 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.7 ptp180 -93.69 130.36 39.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.712 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.5 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -118.01 121.26 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.967 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.21 -169.07 13.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.289 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.683 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -143.77 93.02 6.28 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.128 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.856 ' HB3' HD12 ' T' ' 75' ' ' ILE . 73.5 Cg_endo -80.93 130.54 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.739 2.293 . . . . 0.0 112.259 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' T' ' 47' ' ' CYS . 22.6 mm -142.98 107.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' T' ' 45' ' ' HIS . 2.7 m -67.75 -39.72 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.57 95.02 11.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.835 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' T' ' 62' ' ' VAL . 54.1 Cg_exo -50.04 104.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.576 2.184 . . . . 0.0 112.523 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.57 161.43 52.65 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.226 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.41 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 94.5 Cg_endo -83.06 -49.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.848 2.365 . . . . 0.0 111.804 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.41 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -101.98 -16.83 16.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.822 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.487 ' HB3' ' H ' ' T' ' 69' ' ' GLY . 0.7 OUTLIER -83.99 -89.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.126 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' T' ' 68' ' ' CYS . . . -75.11 0.25 59.35 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.05 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 66.45 -2.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' T' ' 69' ' ' GLY . . . 106.12 29.31 4.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.779 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.664 ' HD2' HD13 ' T' ' 76' ' ' ILE . 15.9 mmtm -81.28 153.74 26.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.874 0.369 . . . . 0.0 110.959 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 131.06 53.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.174 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.34 179.36 52.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.966 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.926 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -74.85 98.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.05 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.683 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 8.8 mm -70.21 85.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.94 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.491 ' HE1' ' HE2' ' T' ' 59' ' ' TYR . 2.5 m-85 -111.6 22.05 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.38 170.86 7.5 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.608 HG23 ' H ' ' T' ' 82' ' ' LEU . 8.2 mt -53.94 152.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.433 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -130.63 16.24 5.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.608 ' H ' HG23 ' T' ' 80' ' ' ILE . 4.3 mm? 56.28 27.26 11.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.89 57.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.572 ' O ' ' HB ' ' T' ' 15' ' ' THR . 11.4 mtm180 -66.45 -1.67 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 9.6 t -97.47 6.19 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.574 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -68.21 -176.47 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.33 113.35 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.438 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.7 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 12.7 m95 -152.87 -155.99 0.66 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.204 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.497 ' HB3' ' HE2' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -96.12 -169.76 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.227 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.823 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.9 121.87 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 0.0 111.437 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.688 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 34.4 m-85 -90.26 107.47 19.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.419 ' O ' HG21 ' T' ' 2' ' ' VAL . 8.0 m -82.29 164.58 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.337 . . . . 0.0 111.023 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.761 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 7.9 t80 -153.04 118.1 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.736 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 2.8 m-20 -134.85 142.08 40.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.437 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 53.3 Cg_exo -51.25 -33.91 46.95 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.488 2.125 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' T' ' 97' ' ' ALA . 30.5 m80 -117.81 -35.3 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.532 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.736 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 33.77 70.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.902 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.864 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.5 OUTLIER -78.97 143.72 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' T' ' 97' ' ' ALA . 5.9 p90 -145.5 -179.97 7.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.517 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 9.1 t-80 -112.31 161.91 16.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.517 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 10.9 mmt180 -155.9 161.53 40.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.672 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -126.29 -174.31 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' T' ' 14' ' ' LEU . . . -86.36 153.61 21.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -58.77 -20.77 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.806 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -27.58 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.44 167.74 12.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.519 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.578 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 1.6 ttpt -55.37 153.52 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.2 m-30 55.37 69.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.1 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -158.74 -7.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.689 HD12 ' HB1' ' T' ' 90' ' ' ALA . 1.1 pp -111.94 161.62 16.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.106 0.479 . . . . 0.0 111.27 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.774 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 3.4 p -114.58 -166.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.554 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.1 t80 -67.5 -41.39 84.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.34 -38.63 74.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.541 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.774 ' HB2' ' H ' ' T' ' 15' ' ' THR . 53.7 mt-10 -71.76 -43.3 66.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.194 0.521 . . . . 0.0 110.182 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -54.03 -41.78 68.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.986 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -55.93 10.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.118 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.599 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.5 -36.65 3.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.285 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.54 -56.04 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.442 ' O ' ' HA2' ' T' ' 28' ' ' GLY . 82.9 m -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 18.5 tt0 -88.21 -12.72 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 109.614 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.2 t80 -57.31 -39.5 75.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.86 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -113.4 56.64 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.163 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.63 34.75 28.74 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.584 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.96 171.1 14.23 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.427 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.593 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.18 143.56 46.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.284 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -52.74 136.52 33.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.292 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.645 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -77.87 153.51 32.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 35.4 p -106.5 -172.29 2.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 111.673 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.92 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 65.3 t80 -71.63 -67.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.07 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -46.56 -40.89 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.429 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 93.9 mt-30 -64.75 -49.38 71.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.529 HD22 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -59.19 -23.66 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.071 0.462 . . . . 0.0 110.118 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 2.9 tp10 -74.04 -62.08 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.98 -13.73 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.995 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -95.06 -29.99 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.362 0.601 . . . . 0.0 109.671 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.753 ' HG2' HG22 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -71.6 -33.04 68.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.954 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.5 OUTLIER -69.76 -16.67 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.374 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.05 -14.98 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.599 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.409 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.21 17.58 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.988 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -80.15 112.63 17.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 111.006 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.886 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.3 t-160 -135.13 124.11 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.553 ' HB ' ' HH ' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -143.71 89.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.804 ' HA ' HD12 ' T' ' 61' ' ' ILE . 13.9 t -63.87 85.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.576 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . 172.57 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.871 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -38.29 113.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.65 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.84 126.39 7.64 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.554 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 75.0 m95 -58.03 149.73 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.92 0.39 . . . . 0.0 111.426 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -169.44 179.27 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.591 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . 50.08 -166.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -7.22 5.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.382 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 157.58 20.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.624 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.766 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.1 mtm180 -94.68 130.61 41.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.908 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.552 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -120.8 121.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.8 -173.75 13.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.443 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.624 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -132.63 101.82 14.11 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.77 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.9 Cg_endo -61.01 -81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.804 2.336 . . . . 0.0 112.517 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' T' ' 47' ' ' CYS . 8.2 mm 75.04 106.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.886 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -77.41 -32.47 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.473 ' H ' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -122.36 97.34 45.19 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.847 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.37 101.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.93 -168.21 34.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.322 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.49 -89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 112.297 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -13.88 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.11 52.06 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 160.76 -25.34 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.997 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 t80 49.08 33.43 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.46 40.99 98.43 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.708 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.595 ' HD3' HG13 ' T' ' 76' ' ' ILE . 33.5 mttt -103.69 150.13 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.62 130.1 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.209 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.82 167.56 43.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.92 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.2 mp -64.1 100.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.387 . . . . 0.0 111.42 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.624 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 10.7 mm -69.68 87.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -108.45 120.12 41.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.424 ' HE1' ' HE2' ' T' ' 59' ' ' TYR . 12.9 m-85 -91.06 -11.33 39.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' T' ' 56' ' ' ARG . . . 103.66 173.76 25.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.766 HG13 ' HG3' ' T' ' 56' ' ' ARG . 19.4 mt -61.41 122.71 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -91.71 9.54 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.522 ' O ' HD11 ' T' ' 82' ' ' LEU . 0.0 OUTLIER 59.58 38.81 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.4 OUTLIER -145.13 75.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.435 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.7 mpt_? -74.61 16.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.927 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.45 ' H ' ' C ' ' T' ' 83' ' ' ASN . 5.5 m -114.33 6.75 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.532 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -63.67 -171.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.73 113.61 11.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.675 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 7.8 m95 -153.55 -147.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.578 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -106.78 -171.23 1.85 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.36 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -141.3 121.53 13.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.644 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.65 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 23.4 m-85 -90.59 110.37 21.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.419 ' O ' HG21 ' T' ' 2' ' ' VAL . 86.4 m -86.47 167.97 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.188 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.864 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 2.5 t80 -158.46 124.34 4.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' T' ' 97' ' ' ALA . 4.8 m120 -139.73 143.58 35.55 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.552 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 76.7 Cg_exo -49.18 -33.41 27.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.52 2.147 . . . . 0.0 112.035 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -125.13 -30.55 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.638 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' T' ' 94' ' ' ASN . . . 37.67 75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.764 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 2.3 p -97.82 139.68 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 111.202 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -147.93 178.35 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.999 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -92.07 155.56 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' T' ' 5' ' ' ARG . 2.6 tpp85 -149.02 153.88 38.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.1 tt0 -125.77 173.91 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.594 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.593 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -82.65 151.68 26.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -62.33 -18.29 61.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.667 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 17.0 m -98.84 -27.74 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 151.09 167.51 14.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.43 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 14.3 tttt -60.23 153.89 21.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.691 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.8 m-30 57.37 49.61 12.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.667 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 4.2 mttm -142.28 1.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' T' ' 7' ' ' ALA . 9.4 mt -105.82 134.14 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.258 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.655 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.4 p -104.0 151.62 22.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.138 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.541 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.8 t80 -34.25 -44.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.99 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.655 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 15.0 mt-10 -66.38 -54.9 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.274 0.559 . . . . 0.0 109.842 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.769 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -43.51 -43.51 5.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.946 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -67.17 -37.75 84.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.69 -34.58 77.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.5 t -69.64 -53.2 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.285 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -64.31 -52.61 57.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.2 tt0 -62.52 -21.05 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.38 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -52.2 -48.86 64.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.694 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -106.0 52.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.42 38.1 56.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.235 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.84 169.82 13.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.763 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.61 140.01 44.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.952 0.405 . . . . 0.0 111.236 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.03 139.02 18.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.376 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -83.81 152.23 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.685 HG23 ' HB2' ' T' ' 53' ' ' ALA . 37.7 p -107.54 -171.38 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.557 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.756 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 55.3 t80 -70.85 -67.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.029 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.1 OUTLIER -46.79 -40.55 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.564 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.16 -54.24 27.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.279 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -58.63 -19.86 42.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.774 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.503 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 2.5 tp10 -72.34 -62.19 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.16 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.82 -15.66 9.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.757 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.553 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.22 -29.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.463 0.649 . . . . 0.0 109.753 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.695 ' HG3' HG21 ' T' ' 62' ' ' VAL . 9.8 ttt-85 -73.03 -33.47 65.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.187 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.503 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 45.5 mttt -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.427 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.553 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -86.34 -17.27 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.441 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 15.1 1.9 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.021 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.535 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.49 94.65 7.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.979 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.518 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.7 t-160 -115.17 125.99 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.736 HG13 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -147.89 100.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.57 ' HA ' HD12 ' T' ' 61' ' ' ILE . 40.5 t -75.79 65.83 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.481 ' HB2' ' OD1' ' T' ' 89' ' ' ASP . . . -161.91 118.61 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -39.87 121.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -123.39 121.24 4.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.731 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.541 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 84.1 m95 -54.18 162.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.798 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -155.63 174.39 15.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.392 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.685 ' HB2' HG23 ' T' ' 32' ' ' THR . . . -53.53 160.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.286 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mtpp 78.66 -30.66 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.508 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.507 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 112.44 23.93 5.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.531 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.678 ' HG3' HG13 ' T' ' 80' ' ' ILE . 19.1 mtt180 -100.18 160.22 14.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.932 0.396 . . . . 0.0 110.809 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.42 ' O ' HG21 ' T' ' 57' ' ' VAL . 0.2 OUTLIER -149.1 107.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -108.82 -167.65 20.79 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.291 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.551 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -137.44 85.07 21.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.125 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.836 ' HB3' HG12 ' T' ' 75' ' ' ILE . 23.1 Cg_exo -62.76 129.04 24.9 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.887 2.391 . . . . 0.0 112.238 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' T' ' 47' ' ' CYS . 8.5 mm -141.39 116.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.232 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.695 HG21 ' HG3' ' T' ' 40' ' ' ARG . 0.2 OUTLIER -90.07 -16.03 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 2.8 tttp -140.99 93.9 8.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.522 ' HB2' ' HA3' ' T' ' 71' ' ' GLY . 17.8 Cg_endo -61.31 129.44 28.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.643 2.229 . . . . 0.0 112.401 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . 0.402 ' H ' ' HA2' ' T' ' 69' ' ' GLY . . . -110.65 -145.7 10.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.424 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.419 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 41.6 Cg_endo -67.7 -81.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.747 2.298 . . . . 0.0 112.317 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -107.18 -26.02 11.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.59 -45.0 94.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.797 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' T' ' 65' ' ' GLY . . . -94.92 -25.38 14.87 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 58.81 26.03 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' T' ' 64' ' ' PRO . . . 64.06 16.8 60.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.549 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.518 ' HB3' HD13 ' T' ' 76' ' ' ILE . 4.0 mmmt -76.16 164.63 25.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 130.69 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.34 -168.21 51.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.89 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.836 HG12 ' HB3' ' T' ' 60' ' ' PRO . 12.7 mt -76.06 124.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.897 0.379 . . . . 0.0 111.212 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.551 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.8 mm -93.29 81.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.8 120.99 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 1.5 m-85 -86.33 -74.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.41 169.79 36.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.232 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.678 HG13 ' HG3' ' T' ' 56' ' ' ARG . 51.8 mt -57.7 108.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.041 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 81' ' ' ARG . 7.4 mmt85 -87.09 15.46 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.413 ' HA ' HD21 ' T' ' 82' ' ' LEU . 0.2 OUTLIER 53.77 27.95 7.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.97 62.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.994 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.593 ' O ' ' HB ' ' T' ' 15' ' ' THR . 3.2 mpt_? -69.99 -0.92 8.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.81 3.24 47.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.674 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.567 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -64.79 -170.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.653 ' HD3' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -135.79 112.44 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.123 0.487 . . . . 0.0 111.648 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.691 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 5.2 m95 -155.44 -177.13 6.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.837 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -77.65 -173.24 2.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.769 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -140.38 133.56 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.736 ' HE1' HG13 ' T' ' 46' ' ' VAL . 42.1 m-85 -97.82 117.04 31.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.428 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -92.68 154.29 18.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.0 110.836 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.764 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 8.1 t80 -149.41 114.05 5.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.742 ' HB2' ' CB ' ' T' ' 97' ' ' ALA . 2.0 m-20 -129.72 166.57 25.04 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.764 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.733 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 57.0 Cg_endo -73.31 -53.59 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.627 2.218 . . . . 0.0 111.595 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -100.94 25.97 7.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.742 ' CB ' ' HB2' ' T' ' 94' ' ' ASN . . . -72.47 51.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.271 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' T' ' 94' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.898 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p -79.53 148.27 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 111.315 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.451 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 26.7 p90 -162.17 173.5 14.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 111.705 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.743 ' HD1' ' HH ' ' T' ' 91' ' ' TYR . 4.7 t60 -93.27 150.43 20.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 4.2 tpp85 -152.25 154.83 36.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.9 OUTLIER -116.13 -169.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.61 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -90.64 152.3 20.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -52.86 -24.35 8.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.726 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -93.27 -47.74 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 177.98 44.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.545 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -65.42 146.75 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.852 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.545 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 7.9 m-30 63.67 61.83 0.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.053 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -155.89 6.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.61 HD13 ' HA ' ' T' ' 7' ' ' ALA . 6.0 mt -109.03 138.69 44.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.4 p -107.67 148.05 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.624 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 83.0 t80 -34.99 -39.53 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.93 61.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.373 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.523 ' HB2' ' H ' ' T' ' 15' ' ' THR . 77.8 mt-10 -71.36 -46.3 60.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.226 0.536 . . . . 0.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.811 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.39 -37.11 72.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -75.56 -32.21 60.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.023 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.5 -45.64 75.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.361 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.83 -50.31 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 56.6 m -64.44 -45.25 88.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.7 tt0 -78.57 -6.94 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -59.07 -50.76 72.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.842 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.55 58.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.175 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.54 34.08 13.32 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.458 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.46 -172.42 18.2 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.2 134.17 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 0.258 . . . . 0.0 110.472 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -67.08 124.34 22.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -52.42 165.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.74 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 13.0 p -115.73 -158.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.78 ' HB2' ' HE2' ' T' ' 52' ' ' MET . 34.2 t80 -80.41 -71.64 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.978 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.9 mttt -47.42 -37.35 11.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.79 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -67.21 -54.96 16.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.261 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.92 -21.14 27.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.754 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.1 tp10 -69.82 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.268 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.531 ' O ' HG21 ' T' ' 42' ' ' ILE . . . -55.54 -19.87 11.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.787 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.516 ' O ' ' CG1' ' T' ' 42' ' ' ILE . . . -91.29 -29.11 17.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 109.613 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.557 ' HE ' HG12 ' T' ' 62' ' ' VAL . 4.2 ttt180 -70.61 -34.31 71.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.001 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 27.2 mtmt -73.52 -17.49 61.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.219 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.531 HG21 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -88.35 -6.94 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.73 5.9 8.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.25 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.0 OUTLIER -76.0 117.36 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.699 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.4 t-160 -140.14 125.82 19.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.68 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -153.21 101.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.959 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.09 85.75 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.335 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' T' ' 4' ' ' HIS . . . -177.38 115.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.521 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -39.21 108.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.767 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -107.84 122.48 6.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.668 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.609 ' HA ' ' HB ' ' T' ' 57' ' ' VAL . 71.2 m95 -52.68 171.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.78 ' HE2' ' HB2' ' T' ' 33' ' ' TYR . 0.0 OUTLIER -166.58 162.13 16.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.512 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -45.17 159.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.631 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.639 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.8 -24.79 0.21 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.425 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 109.39 22.82 6.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.504 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' T' ' 52' ' ' MET . 37.6 mtm180 -94.91 165.82 12.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -163.12 108.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -116.64 -171.01 15.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.224 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.537 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.89 82.72 55.3 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.1 Cg_exo -59.89 119.98 7.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.765 2.31 . . . . 0.0 112.3 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.495 HD11 HG22 ' T' ' 61' ' ' ILE . 14.5 mm -138.9 132.56 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.699 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -110.09 -29.05 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -123.76 83.76 54.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.592 ' HA ' ' HA2' ' T' ' 69' ' ' GLY . 20.8 Cg_endo -62.63 137.52 64.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.597 2.198 . . . . 0.0 112.191 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.69 -130.89 2.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.442 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.429 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 40.8 Cg_endo -67.61 -80.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.278 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.429 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -109.22 -23.5 11.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.19 44.93 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' T' ' 64' ' ' PRO . . . 169.7 -44.13 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.943 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 58.88 29.76 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.938 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' T' ' 64' ' ' PRO . . . 66.81 25.1 73.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.457 ' HD3' HG13 ' T' ' 76' ' ' ILE . 11.8 mttp -91.12 152.5 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.21 130.47 53.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . 0.441 ' HA3' ' CZ ' ' T' ' 40' ' ' ARG . . . 72.73 -175.09 44.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.799 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.627 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 5.4 mt -73.38 117.46 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.5 mm -88.98 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.509 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 5.3 t70 -110.13 135.17 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.77 25.28 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.1 -178.49 26.2 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.615 HG13 ' HG3' ' T' ' 56' ' ' ARG . 50.8 mt -61.85 119.83 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.71 6.92 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.54 33.09 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.82 78.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.677 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtt85 -62.86 -8.62 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 17.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.42 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 1.7 mm-40 -79.46 -176.21 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.85 115.8 14.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.054 0.454 . . . . 0.0 111.274 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.488 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 28.4 m95 -150.7 -135.05 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.083 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.14 -171.83 2.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.35 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.811 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.79 130.16 17.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.767 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.13 109.63 22.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.253 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.8 131.78 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.114 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.898 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.1 OUTLIER -131.04 113.98 14.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.615 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 4.2 m-20 -131.82 158.75 74.57 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.541 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -54.92 -51.41 10.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.574 2.183 . . . . 0.0 111.493 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.484 ' O ' ' C ' ' T' ' 97' ' ' ALA . 10.4 t-160 -104.55 -27.74 11.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 27.54 70.9 0.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.438 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.743 ' H1 ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' T' ' 31' ' ' ALA . 1.6 t -111.35 138.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.227 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.546 ' HE1' ' HB1' ' T' ' 97' ' ' ALA . 0.3 OUTLIER -147.74 160.26 42.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.085 0.469 . . . . 0.0 111.271 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.595 ' CG ' HG12 ' T' ' 46' ' ' VAL . 10.1 t-80 -106.13 158.57 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.099 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -164.26 166.0 21.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.041 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.804 ' HG2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -123.18 -167.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.971 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -170.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.93 -34.15 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.1 t -177.29 19.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.27 160.74 23.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.804 ' HA ' ' HG2' ' T' ' 6' ' ' GLU . 1.2 tttt -98.43 158.47 15.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 111.503 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.687 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 23.7 m-85 42.46 60.2 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.494 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' T' ' 12' ' ' TYR . 1.7 mmtm -149.7 10.1 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.512 HD13 ' C ' ' T' ' 6' ' ' GLU . 17.8 mt -106.29 125.24 50.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.0 OUTLIER -99.57 145.42 27.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.008 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.567 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.6 t80 -33.56 -41.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.98 70.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' T' ' 15' ' ' THR . 83.8 mt-10 -72.96 -52.2 15.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.006 0.432 . . . . 0.0 110.195 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.805 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -45.82 -49.59 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.926 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -65.78 -56.99 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.0 -42.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.425 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.23 -50.37 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.4 m -63.71 -48.17 78.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 16.9 tt0 -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.736 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.8 OUTLIER -55.72 -51.77 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.899 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.28 58.24 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.152 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.8 27.54 9.75 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.525 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -107.88 -169.9 21.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.514 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.81 133.3 11.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.444 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.863 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -64.02 123.52 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 110.381 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -50.98 162.77 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.348 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.64 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 23.8 p -108.5 -164.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.748 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 20.5 t80 -75.02 -73.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.167 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mttt -48.06 -37.68 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -67.12 -55.11 15.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.549 HD13 ' HG3' ' T' ' 60' ' ' PRO . 1.7 tm? -58.07 -22.77 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.8 tt0 -70.18 -61.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.241 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -13.52 10.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.709 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -93.88 -28.5 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.484 0.659 . . . . 0.0 109.731 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.643 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 5.6 tmm_? -69.7 -32.7 71.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.863 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -68.67 -15.22 63.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.611 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -93.47 -17.28 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.459 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 135.72 12.17 1.21 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.866 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.643 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -79.49 100.74 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.1 t-160 -129.69 131.28 46.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.168 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.595 HG12 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.82 98.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.852 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -64.7 81.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.509 ' HB2' ' CE1' ' T' ' 12' ' ' TYR . . . 174.45 137.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.67 105.33 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.781 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.621 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -102.98 116.77 5.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.661 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.574 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 76.3 m95 -48.22 155.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.863 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.77 -179.61 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.593 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.64 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 49.93 -165.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.115 0.483 . . . . 0.0 111.488 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.52 0.35 4.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.471 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.507 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 155.48 14.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.672 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 5.3 mtp180 -93.37 135.98 34.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.881 0.372 . . . . 0.0 110.996 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.574 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -124.38 134.22 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.765 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.421 ' N ' HG21 ' T' ' 57' ' ' VAL . . . -145.13 -174.61 17.53 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.466 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.514 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -131.11 102.39 15.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.8 Cg_endo -61.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' T' ' 47' ' ' CYS . 25.9 mm 74.06 105.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.631 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.2 OUTLIER -81.68 -29.77 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.01 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -116.97 85.19 17.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.15 154.62 32.94 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.653 2.236 . . . . 0.0 112.274 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.48 -139.72 3.08 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.405 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.504 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 71.1 Cg_endo -79.85 -74.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.666 2.244 . . . . 0.0 112.416 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.504 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -103.72 -11.77 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.9 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 42.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' T' ' 72' ' ' LYS . . . 144.57 -9.93 1.9 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.922 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 60.6 28.69 18.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 111.001 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.72 70.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.793 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.886 ' HD3' HG13 ' T' ' 76' ' ' ILE . 14.4 mttp -82.85 158.05 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.62 132.38 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.262 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.12 172.62 47.22 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.913 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.748 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.6 mt -67.34 104.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.886 HG13 ' HD3' ' T' ' 72' ' ' LYS . 9.5 mm -80.16 85.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.23 132.3 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.01 4.58 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.997 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.661 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 81.04 173.52 47.69 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.626 HG13 ' HG3' ' T' ' 56' ' ' ARG . 13.7 mt -59.38 115.8 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -87.97 21.31 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.574 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.78 36.89 25.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.68 67.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.585 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.9 OUTLIER -65.41 -4.59 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.7 t -91.52 12.82 19.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.504 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.3 mm-40 -68.56 -175.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.724 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 8.3 mtt180 -135.46 115.05 12.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.687 ' HA ' ' HD1' ' T' ' 12' ' ' TYR . 21.0 m95 -151.89 -132.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.234 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.53 ' HB3' ' OE1' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -121.04 -172.88 2.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.329 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.805 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.3 135.13 23.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.193 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.687 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 41.1 m-85 -97.91 107.52 20.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.066 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.41 ' HB3' ' CE2' ' T' ' 3' ' ' TYR . 5.2 m -87.31 137.23 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.919 0.39 . . . . 0.0 111.077 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' T' ' 93' ' ' TYR . 1.3 t80 -140.91 135.51 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.73 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -132.74 153.42 81.06 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.93 -32.8 13.28 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.485 2.123 . . . . 0.0 111.803 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' T' ' 97' ' ' ALA . 7.9 m-70 -121.35 -32.06 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.315 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.743 ' HB3' ' H1 ' ' T' ' 1' ' ' GLY . . . 31.92 62.5 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.373 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 41.2 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.87 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.941 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.5 p -90.69 138.72 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.239 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.469 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 25.5 p90 -155.39 170.34 22.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 111.638 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.721 ' HD1' ' HH ' ' T' ' 91' ' ' TYR . 4.2 t60 -90.97 153.71 19.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.962 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.454 ' N ' ' CD2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -155.78 148.32 23.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.012 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.429 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.8 OUTLIER -114.08 -168.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.49 153.54 18.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.21 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' T' ' 8' ' ' ARG . 4.0 mmt180 -61.13 -19.35 61.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -94.46 -24.53 17.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.69 167.41 11.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.547 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 8.3 ttpt -60.07 158.85 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.434 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 8.6 m-30 53.45 61.56 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.102 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -156.33 2.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.687 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.429 HD13 ' C ' ' T' ' 6' ' ' GLU . 6.5 mt -105.21 127.58 52.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.453 ' O ' ' N ' ' T' ' 18' ' ' GLU . 1.1 p -99.49 149.94 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.607 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 92.0 t80 -36.18 -41.04 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -42.95 69.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' T' ' 15' ' ' THR . 85.1 mt-10 -74.15 -53.9 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.999 0.428 . . . . 0.0 110.301 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.732 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -44.96 -51.49 9.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.99 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -63.92 -55.7 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.644 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.48 -39.03 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.23 -51.73 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.219 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.25 -50.61 67.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.474 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 31.3 tt0 -67.07 -16.48 64.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.429 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.03 -47.87 77.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.754 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.19 53.89 0.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.53 41.78 42.37 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.426 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -121.95 168.22 14.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.432 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.22 137.49 51.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.773 0.321 . . . . 0.0 110.622 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.715 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -73.81 122.0 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.762 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -49.76 158.79 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.43 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 11.5 p -110.69 -159.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.29 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.825 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 25.7 t80 -77.02 -72.97 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.052 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 1.9 mttp -46.92 -37.23 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.556 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.45 -51.77 57.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.529 HD13 ' HG2' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -56.66 -23.89 44.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 110.058 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 8.4 tt0 -72.15 -61.94 1.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.461 ' HA ' ' HE3' ' T' ' 41' ' ' LYS . . . -56.02 -16.23 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.553 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.7 -29.64 15.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.396 0.617 . . . . 0.0 109.718 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -72.17 -33.1 67.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.925 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.8 OUTLIER -69.66 -16.98 63.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.553 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.61 -12.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.93 13.01 3.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.973 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.52 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.0 OUTLIER -79.9 126.48 31.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' T' ' 62' ' ' VAL . 2.8 t-160 -150.21 126.39 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.681 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -151.5 102.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.787 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.94 86.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.332 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 177.31 119.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.004 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.01 118.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.744 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -115.39 123.14 5.83 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.803 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.607 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.6 m95 -53.03 171.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.107 0.479 . . . . 0.0 111.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.715 ' HA ' HD13 ' T' ' 30' ' ' LEU . 3.4 ptp -168.9 173.11 7.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.49 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.33 159.6 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.652 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.555 ' HB3' HD12 ' T' ' 80' ' ' ILE . 1.5 mmtp 67.23 16.28 10.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.254 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.579 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 64.07 33.28 86.82 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.515 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.681 ' HD3' ' HA3' ' T' ' 79' ' ' GLY . 4.7 mtt180 -101.12 157.35 16.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.804 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.4 OUTLIER -154.09 115.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.126 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.97 -168.44 12.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.3 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.563 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -135.58 103.24 10.27 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 24.6 Cg_exo -61.01 -93.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.706 2.27 . . . . 0.0 112.017 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.787 HD13 ' HA ' ' T' ' 47' ' ' CYS . 40.0 mm 75.24 110.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -82.23 -38.18 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.9 OUTLIER -110.87 106.58 57.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.728 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.531 ' HB2' ' HA3' ' T' ' 71' ' ' GLY . 20.3 Cg_endo -62.5 123.21 12.0 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.618 2.212 . . . . 0.0 112.282 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.78 -174.0 13.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.369 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.85 -60.16 0.1 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.603 2.202 . . . . 0.0 112.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -3.18 13.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 38.31 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.47 -24.37 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.98 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 61.11 24.32 14.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' T' ' 64' ' ' PRO . . . 65.89 15.51 62.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.614 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.9 ' HD3' HG13 ' T' ' 76' ' ' ILE . 3.7 mttp -88.77 151.91 22.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.85 128.55 54.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.47 175.96 41.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.938 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.825 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -75.04 95.44 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 111.01 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.9 HG13 ' HD3' ' T' ' 72' ' ' LYS . 18.9 mm -68.06 81.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -108.1 120.42 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.805 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 1.9 m-85 -84.83 13.99 5.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' T' ' 56' ' ' ARG . . . 72.86 179.17 35.61 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.179 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.557 HG13 ' HG3' ' T' ' 56' ' ' ARG . 40.6 mt -62.05 119.81 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -95.85 14.26 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 53.73 34.32 18.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.432 ' HB3' ' CG ' ' T' ' 86' ' ' GLU . 0.5 OUTLIER -137.65 67.13 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.989 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -63.94 -3.18 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.409 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -101.03 8.17 43.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 1.8 mm-40 -60.59 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.1 113.05 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 111.305 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 27.9 m95 -151.62 -133.52 0.05 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.547 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -121.91 -170.84 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.732 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.86 130.69 17.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.744 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.82 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.316 . . . . 0.0 110.457 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.8 130.24 34.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 110.952 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.941 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -130.44 121.55 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.925 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.615 ' HB2' ' HB3' ' T' ' 97' ' ' ALA . 6.6 m-20 -128.86 150.06 74.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.469 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 72.3 Cg_exo -47.84 -33.36 19.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.515 2.143 . . . . 0.0 111.831 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' T' ' 97' ' ' ALA . 36.2 m80 -122.55 -32.24 3.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.285 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' T' ' 94' ' ' ASN . . . 30.22 77.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.401 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.894 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . 0.42 ' H1 ' ' HB2' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.87 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.7 p -87.55 142.67 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.465 ' N ' HG21 ' T' ' 2' ' ' VAL . 18.0 p90 -144.62 -179.94 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.501 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 20.3 t-80 -92.88 154.72 18.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.181 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' T' ' 5' ' ' ARG . 0.4 OUTLIER -147.33 147.98 30.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.986 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.636 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.5 tt0 -120.14 173.36 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.636 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -75.4 168.52 19.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -21.88 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -47.99 4.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.17 176.57 45.39 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.559 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.549 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.2 ttpm? -59.08 151.72 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.5 m-30 52.34 75.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -158.04 -5.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' T' ' 88' ' ' TRP . 0.7 OUTLIER -115.01 164.93 13.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.07 0.462 . . . . 0.0 111.275 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.83 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 6.6 p -116.56 -166.19 1.13 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.347 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.588 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.9 t80 -66.44 -40.45 89.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.062 0.458 . . . . 0.0 109.767 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.75 65.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.72 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.83 ' HB2' ' H ' ' T' ' 15' ' ' THR . 54.6 mt-10 -69.16 -42.83 75.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.278 0.561 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.804 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.42 -40.81 83.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.925 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -31.41 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -63.93 -46.58 84.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.26 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.84 -48.02 83.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 55.4 m -64.63 -51.19 63.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.771 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -70.88 -11.98 61.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.81 -50.03 73.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.841 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -104.2 57.4 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.27 38.37 26.18 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.247 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.62 ' HA3' ' OD1' ' T' ' 94' ' ' ASN . . . -106.66 178.33 22.32 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.655 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.648 ' HE2' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -144.52 133.37 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 141.63 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.406 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -85.99 143.37 28.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.527 HG23 ' HB2' ' T' ' 53' ' ' ALA . 32.2 p -98.35 -170.68 2.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 111.576 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.744 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 37.9 t80 -70.98 -70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.884 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 12.0 mttt -45.62 -38.38 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.494 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.437 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 84.5 mt-30 -66.62 -55.45 15.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.063 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' T' ' 31' ' ' ALA . 0.2 OUTLIER -57.78 -19.86 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.696 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.7 tt0 -74.74 -62.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.254 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.645 ' HA ' ' HD2' ' T' ' 41' ' ' LYS . . . -55.68 -15.44 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.576 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.91 -28.45 15.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.621 . . . . 0.0 109.656 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.72 ' HG3' HG23 ' T' ' 62' ' ' VAL . 50.8 ttp85 -72.33 -36.13 68.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.215 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -67.3 -19.36 65.46 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.636 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.576 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -85.79 -16.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.441 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.32 14.18 2.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.965 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.516 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.09 117.63 22.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.828 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.56 ' HE1' ' O ' ' T' ' 63' ' ' LYS . 2.9 t-160 -138.42 128.36 25.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.692 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -148.43 102.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.642 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.35 67.24 1.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.593 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . -165.06 121.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.18 112.7 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.172 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.715 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -111.18 121.89 5.95 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.778 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 80.6 m95 -57.0 165.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.139 0.495 . . . . 0.0 111.831 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' T' ' 31' ' ' ALA . 1.0 OUTLIER -159.15 165.34 33.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.324 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' T' ' 32' ' ' THR . . . -48.16 158.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.5 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 79.53 -25.22 0.19 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.501 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 109.35 20.74 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.507 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.701 ' HG2' ' HA3' ' T' ' 79' ' ' GLY . 0.2 OUTLIER -94.4 160.94 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.902 0.382 . . . . 0.0 111.006 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -158.22 109.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.17 -168.25 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.315 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -132.84 86.38 43.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 111.144 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.826 ' HB3' HG12 ' T' ' 75' ' ' ILE . 32.9 Cg_endo -67.0 118.42 5.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.666 2.244 . . . . 0.0 111.955 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' T' ' 47' ' ' CYS . 31.6 mm -134.17 119.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.72 HG23 ' HG3' ' T' ' 40' ' ' ARG . 0.0 OUTLIER -97.69 -24.61 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.56 ' O ' ' HE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -123.58 93.04 48.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.52 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.691 2.261 . . . . 0.0 112.552 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.33 159.01 29.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.381 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.499 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 57.0 Cg_endo -71.12 -76.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.744 2.296 . . . . 0.0 112.584 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.499 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -86.38 -6.24 58.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.228 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.17 42.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' T' ' 70' ' ' PHE . . . 168.74 -38.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.927 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' T' ' 69' ' ' GLY . 0.9 OUTLIER 172.1 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.89 42.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -81.33 178.9 8.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.09 131.31 53.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.31 -171.0 54.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.866 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.826 HG12 ' HB3' ' T' ' 60' ' ' PRO . 10.0 mt -82.63 121.78 36.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.504 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.6 mm -95.1 82.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.44 114.18 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 3.4 m-85 -78.91 -27.25 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.701 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 115.35 169.9 16.01 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.471 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.5 mt -53.48 105.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.293 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -90.34 20.29 4.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.956 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' T' ' 82' ' ' LEU . 0.5 OUTLIER 49.45 39.99 17.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.872 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -126.37 53.84 1.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtm180 -68.13 10.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.549 ' H ' ' C ' ' T' ' 83' ' ' ASN . 68.0 m -115.66 8.72 15.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.632 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.556 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -74.43 -170.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.55 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.407 ' HG3' ' C ' ' T' ' 86' ' ' GLU . 0.0 OUTLIER -136.53 115.95 12.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 111.592 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.762 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 4.4 m95 -154.44 -155.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.106 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.549 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -100.12 -172.39 2.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.184 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.804 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -143.01 131.18 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.74 0.305 . . . . 0.0 111.452 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.715 ' CE2' ' HA2' ' T' ' 50' ' ' GLY . 40.4 m-85 -96.02 113.91 25.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.123 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -89.68 153.18 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.311 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.797 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 11.2 t80 -141.37 133.02 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.651 ' HB2' ' HB3' ' T' ' 97' ' ' ALA . 4.4 m-20 -153.27 141.18 13.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.634 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.648 ' HD3' ' HE2' ' T' ' 29' ' ' HIS . 55.7 Cg_exo -50.8 -33.34 40.46 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.484 2.122 . . . . 0.0 111.858 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' T' ' 97' ' ' ALA . 6.6 m-70 -119.42 -34.77 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.532 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.651 ' HB3' ' HB2' ' T' ' 94' ' ' ASN . . . 32.89 57.82 0.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.397 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.512 HG11 ' O ' ' T' ' 92' ' ' CYS . 0.8 OUTLIER -105.04 137.44 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.69 0.281 . . . . 0.0 111.317 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -142.75 151.02 40.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.488 . . . . 0.0 111.378 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.445 ' O ' ' HG2' ' T' ' 5' ' ' ARG . 15.0 t-80 -90.88 145.16 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' T' ' 4' ' ' HIS . 5.1 mmm180 -153.82 151.08 29.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.215 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.531 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.6 OUTLIER -113.37 -169.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.434 ' CB ' ' HG ' ' T' ' 14' ' ' LEU . . . -83.44 151.38 25.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . 0.406 HH12 HH22 ' T' ' 5' ' ' ARG . 6.6 mmt-85 -54.07 -26.39 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -91.72 -49.66 6.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.69 47.77 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.45 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 3.2 ttpm? -68.56 162.03 26.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.794 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.6 m-30 52.07 44.12 29.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.72 5.95 2.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.531 HD13 ' C ' ' T' ' 6' ' ' GLU . 11.7 mt -108.98 142.67 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.076 0.465 . . . . 0.0 111.514 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.572 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.2 p -114.7 152.13 32.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.947 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.648 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.0 t80 -38.41 -39.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.82 -40.48 72.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.482 ' HB2' ' H ' ' T' ' 15' ' ' THR . 84.3 mt-10 -75.24 -51.48 13.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.703 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -48.18 -48.96 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.057 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -64.91 -52.84 54.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.21 -36.59 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.309 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 7.1 t -70.74 -54.84 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.81 -47.63 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 37.7 tt0 -70.66 -17.43 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.602 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.2 -48.22 68.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.75 54.21 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.943 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.15 42.95 24.88 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.261 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -123.28 174.63 16.56 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' ND1' ' N ' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -127.75 141.52 51.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.633 0.254 . . . . 0.0 110.605 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -76.64 125.18 28.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.451 . . . . 0.0 110.071 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -48.2 152.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.714 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.554 ' HA ' ' CB ' ' T' ' 52' ' ' MET . 9.7 p -109.72 -157.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.638 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 22.9 t80 -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.166 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.6 mttm -47.76 -35.96 10.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.442 ' CD ' HG22 ' T' ' 32' ' ' THR . 92.5 mt-30 -67.33 -56.1 11.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.359 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.64 HD11 ' O ' ' T' ' 36' ' ' LEU . 1.6 tm? -56.45 -24.01 42.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 14.1 tp10 -66.49 -62.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.75 -13.99 12.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.619 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.06 -28.2 15.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.448 0.642 . . . . 0.0 109.613 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.551 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -71.06 -32.92 69.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.896 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -67.14 -17.83 65.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.187 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.619 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.82 -18.52 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.494 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 133.89 15.78 1.17 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.865 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -83.46 79.69 9.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.991 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.6 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.5 t-160 -111.93 128.39 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.691 ' O ' HG21 ' T' ' 46' ' ' VAL . 2.0 m -147.02 111.65 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.081 0.467 . . . . 0.0 110.991 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.561 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 0.1 OUTLIER -76.12 77.41 2.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.926 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.81 126.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.25 121.29 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.692 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -117.36 120.77 4.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.4 m95 -53.93 166.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.427 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.579 ' HG3' ' HG3' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -162.32 171.36 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.528 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.32 166.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.381 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.405 ' HB3' HD12 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 77.02 -28.8 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.554 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 106.68 18.74 10.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.65 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.756 ' HB3' HG13 ' T' ' 80' ' ' ILE . 3.5 ptp85 -105.34 158.76 16.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 110.547 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.3 OUTLIER -146.25 122.01 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -117.9 -168.41 14.45 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -131.01 88.08 46.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 111.038 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.949 ' HB3' HG12 ' T' ' 75' ' ' ILE . 56.3 Cg_endo -73.55 123.3 8.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.822 2.348 . . . . 0.0 112.193 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.561 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.6 mm -136.32 97.66 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.573 HG11 ' HD1' ' T' ' 45' ' ' HIS . 0.6 OUTLIER -62.82 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . 0.527 ' O ' ' HE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -115.27 92.26 31.3 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' T' ' 72' ' ' LYS . 78.3 Cg_exo -45.38 121.96 4.27 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.63 2.22 . . . . 0.0 112.435 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.59 166.23 21.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.506 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 57.8 Cg_endo -71.69 -78.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.669 2.246 . . . . 0.0 112.395 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.506 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -76.52 -0.36 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -7.32 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.37 55.59 2.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.94 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' T' ' 72' ' ' LYS . 10.8 t80 39.6 76.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.97 6.65 6.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.621 ' HB3' HD13 ' T' ' 76' ' ' ILE . 0.0 OUTLIER 41.53 -164.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.401 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 128.07 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.914 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.95 -169.51 54.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.766 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.949 HG12 ' HB3' ' T' ' 60' ' ' PRO . 22.6 mt -80.45 122.09 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' T' ' 72' ' ' LYS . 5.2 mm -96.18 80.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.876 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.495 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 4.1 t70 -110.64 131.12 55.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 1.8 m-85 -100.33 25.22 7.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.982 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.16 178.58 8.75 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.756 HG13 ' HB3' ' T' ' 56' ' ' ARG . 3.6 mt -65.17 126.67 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 111.194 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -106.62 19.64 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.789 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.12 32.23 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' T' ' 85' ' ' SER . 1.1 m120 -124.8 54.95 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.572 ' O ' ' HB ' ' T' ' 15' ' ' THR . 1.4 mtt85 -65.21 -1.93 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 85' ' ' SER . . . . . 0.4 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.6 OUTLIER -100.97 11.51 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.453 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.0 mm-40 -72.96 -171.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -137.01 115.97 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.387 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.579 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.2 m95 -150.75 -138.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.141 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -112.24 -170.71 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.08 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.703 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.5 126.56 15.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.415 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.737 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 30.5 m-85 -97.36 126.81 42.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.898 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . 0.512 ' O ' HG11 ' T' ' 2' ' ' VAL . 0.1 OUTLIER -100.23 162.84 12.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.872 0.368 . . . . 0.0 110.932 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' T' ' 29' ' ' HIS . 21.2 t80 -156.11 118.8 4.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.797 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.824 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 3.0 m120 -139.34 146.79 50.14 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.698 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.1 -52.08 8.07 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.552 2.168 . . . . 0.0 111.617 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.527 ' O ' ' C ' ' T' ' 97' ' ' ALA . 14.2 m-70 -97.26 -27.52 14.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.305 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 23.09 71.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.461 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 tttt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.877 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.904 ' HB ' ' HD1' ' T' ' 93' ' ' TYR . 2.3 p -102.48 152.52 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.651 ' N ' HG21 ' T' ' 2' ' ' VAL . 26.4 p90 -160.32 178.98 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.993 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.406 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.1 t-80 -89.11 155.88 19.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.3 OUTLIER -148.81 152.02 35.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.629 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.6 tt0 -122.53 172.79 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.629 ' N ' ' HG2' ' T' ' 6' ' ' GLU . . . -80.23 158.76 26.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -61.27 -26.99 68.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.624 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.9 t -91.81 -50.53 5.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.39 172.8 43.17 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.421 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.9 ttpt -66.22 161.94 21.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.737 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.2 m-30 55.7 53.89 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.624 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 8.3 mtmt -154.68 3.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.562 ' HG ' ' HB1' ' T' ' 7' ' ' ALA . 8.0 mt -102.43 132.41 48.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 30.3 p -103.47 148.85 25.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.538 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.666 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 84.2 t80 -35.66 -38.1 0.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.46 -44.97 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.457 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' T' ' 15' ' ' THR . 64.2 mt-10 -73.05 -47.69 42.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.17 0.51 . . . . 0.0 110.348 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.833 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -50.98 -45.3 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.077 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.91 -47.13 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.58 -47.59 19.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -68.19 -53.27 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 87.7 m -59.89 -38.39 82.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.759 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.1 tt0 -90.08 -2.64 58.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.41 -48.13 82.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.546 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.95 60.59 2.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.24 22.41 10.14 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.509 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.759 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.96 -158.27 12.56 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 3.7 p80 -155.04 -178.46 7.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.756 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -103.29 124.95 49.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.642 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.665 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -46.02 157.57 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.543 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -111.29 -162.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.886 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 50.0 t80 -75.25 -68.17 0.58 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.945 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 2.2 mtpm? -47.21 -45.28 23.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . 0.533 ' NE2' HG22 ' T' ' 32' ' ' THR . 49.1 mt-30 -62.28 -49.35 76.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.881 0.372 . . . . 0.0 110.517 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -54.92 -29.44 56.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.106 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.0 tt0 -65.05 -61.84 1.91 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.58 -12.1 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.558 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.73 -29.86 14.58 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.423 0.63 . . . . 0.0 109.892 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.69 ' HE ' HG11 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -72.98 -33.99 66.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.07 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.9 mttt -69.85 -17.49 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.408 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.558 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.5 -17.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.454 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.8 11.51 1.43 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.591 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.7 129.63 34.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.567 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 3.3 t-160 -146.24 125.56 13.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.619 HG23 ' HE1' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -142.99 98.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.122 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.72 ' HA ' HD13 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.47 -0.13 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' T' ' 46' ' ' VAL . . . -102.64 141.77 34.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.686 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -58.79 114.23 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -109.87 117.43 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.707 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.62 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 72.3 m95 -52.38 166.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 111.435 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 3.9 ptp -164.55 173.24 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.484 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' T' ' 55' ' ' GLY . . . -51.11 167.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.424 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.13 -28.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.266 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.518 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 104.8 18.6 12.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.571 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.8 ptt180 -105.03 158.67 16.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.701 0.286 . . . . 0.0 110.581 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.62 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -142.07 122.86 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.72 -168.43 12.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.686 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -145.51 90.84 5.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.162 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 58.4 Cg_endo -74.9 134.95 18.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.659 2.24 . . . . 0.0 112.179 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm -126.67 145.13 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.69 HG11 ' HE ' ' T' ' 40' ' ' ARG . 4.1 m -98.08 -44.57 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.087 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 94.12 46.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.37 131.1 27.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.499 2.133 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.71 -133.69 3.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.419 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 52.3 Cg_endo -69.75 -83.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 0.0 112.379 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -92.6 -17.69 24.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.859 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -4.71 57.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.18 64.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.955 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -46.95 -29.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.815 0.341 . . . . 0.0 111.023 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.2 23.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.696 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.684 ' HB3' HD13 ' T' ' 76' ' ' ILE . 7.8 mttt -92.17 149.94 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 128.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.67 -169.91 33.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.057 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.886 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -72.79 101.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.684 HD13 ' HB3' ' T' ' 72' ' ' LYS . 9.3 mm -72.05 81.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.07 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.72 137.32 49.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.727 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 0.8 OUTLIER -105.05 28.44 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.59 171.28 3.36 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.425 HD12 ' O ' ' T' ' 54' ' ' LYS . 13.8 mt -69.84 119.01 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.9 15.4 2.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.516 ' O ' HD11 ' T' ' 82' ' ' LEU . 0.1 OUTLIER 53.09 43.66 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.76 82.26 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.24 -1.15 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.0 13.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.553 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.8 mm-40 -76.84 -177.15 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.7 OUTLIER -134.55 113.29 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.503 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.638 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.7 m95 -153.32 -160.34 1.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.168 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -170.91 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.833 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -141.04 128.62 21.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.665 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 23.4 m-85 -91.07 107.86 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.92 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.28 149.32 23.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 111.213 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.904 ' HD1' ' HB ' ' T' ' 2' ' ' VAL . 61.8 t80 -136.47 132.1 34.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' T' ' 97' ' ' ALA . 3.6 m120 -116.91 81.21 11.9 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . 0.738 ' HB3' ' HE2' ' T' ' 93' ' ' TYR . 64.4 Cg_endo -75.79 -56.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.469 2.112 . . . . 0.0 110.116 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.475 ' H ' ' HG2' ' T' ' 95' ' ' PRO . 20.0 t-160 -126.06 10.14 7.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.958 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.518 ' HB3' ' ND2' ' T' ' 94' ' ' ASN . . . -77.72 54.49 1.24 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.224 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.947 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -86.57 147.07 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . 0.563 ' N ' HG21 ' T' ' 2' ' ' VAL . 12.5 p90 -156.41 176.21 13.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.021 0.439 . . . . 0.0 111.405 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.58 ' N ' ' HZ ' ' T' ' 44' ' ' PHE . 39.3 t-80 -98.65 163.79 12.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.447 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.88 146.38 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.464 ' C ' HD13 ' T' ' 14' ' ' LEU . 0.4 OUTLIER -109.23 -168.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 110.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.536 ' HB3' ' HG ' ' T' ' 14' ' ' LEU . . . -95.48 150.67 20.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.08 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -25.66 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -92.13 -48.94 6.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' T' ' 7' ' ' ALA . . . 170.66 172.7 37.23 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . 0.62 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 1.4 tttt -58.97 151.02 22.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.62 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 9.3 m-30 61.77 58.67 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.04 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -155.17 5.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.634 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' T' ' 7' ' ' ALA . 5.7 mt -109.0 133.1 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.289 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.4 p -104.8 149.32 25.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.286 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.583 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 78.3 t80 -35.44 -40.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.982 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.15 -45.25 67.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' T' ' 15' ' ' THR . 74.5 mt-10 -72.48 -47.62 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.751 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -50.03 -45.44 52.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -71.08 -50.77 30.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -48.7 -38.69 22.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.24 -53.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.487 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 66.4 m -64.34 -27.18 68.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 23.5 tt0 -98.9 -9.03 24.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.155 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.5 t80 -53.73 -42.96 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.081 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.71 60.23 0.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.268 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.79 26.2 10.52 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.538 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -106.57 -169.29 22.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.561 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -155.71 134.05 11.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.418 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.87 HD13 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -65.04 125.34 24.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.079 0.466 . . . . 0.0 110.387 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' T' ' 91' ' ' TYR . . . -53.02 161.4 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 26.3 p -109.34 -164.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.207 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.632 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 28.4 t80 -74.91 -72.59 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.143 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mtpt -48.23 -40.21 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.913 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.95 -51.19 63.17 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.563 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 6.5 tp10 -54.71 -60.37 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.232 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.51 14.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.862 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.591 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -90.62 -27.93 18.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 109.723 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.2 OUTLIER -72.23 -33.27 67.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.053 179.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.563 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 8.4 mttp -68.99 -17.78 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.396 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.591 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.46 -15.9 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.424 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.22 14.9 2.13 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.068 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.58 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -81.95 99.25 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.666 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.7 t-160 -121.73 119.78 32.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.618 HG22 ' HE1' ' T' ' 91' ' ' TYR . 0.0 OUTLIER -141.3 94.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.569 ' O ' ' HB1' ' T' ' 48' ' ' ALA . 6.5 t -64.37 89.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' T' ' 47' ' ' CYS . . . 171.91 127.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.556 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -46.46 101.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -101.66 111.11 4.0 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.676 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.588 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 74.2 m95 -44.65 157.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.983 0.42 . . . . 0.0 111.294 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.87 ' HA ' HD13 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -174.83 178.13 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' T' ' 56' ' ' ARG . . . 50.14 -166.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.12 0.4 3.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.305 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.433 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 156.81 13.15 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.739 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.829 ' HG3' HG13 ' T' ' 80' ' ' ILE . 4.4 mtt-85 -90.45 130.76 36.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.588 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -125.08 129.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.961 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' T' ' 77' ' ' ASP . . . -135.17 -175.74 14.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.329 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.556 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.43 78.93 14.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.756 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD12 ' T' ' 75' ' ' ILE . 21.7 Cg_exo -63.12 124.59 14.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.758 2.305 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.547 HG21 ' N ' ' T' ' 62' ' ' VAL . 38.6 mm -130.51 153.3 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 15.5 t -102.93 -64.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.347 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.05 155.63 45.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.056 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.08 -169.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.588 2.192 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.49 81.34 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.289 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.821 ' HG3' ' HA ' ' T' ' 70' ' ' PHE . 72.8 Cg_endo -85.82 -27.61 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.952 2.434 . . . . 0.0 112.379 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 44.43 16.23 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.398 0.618 . . . . 0.0 109.858 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . 0.562 ' H ' ' C ' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -113.85 -41.17 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.102 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.6 14.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . 0.821 ' HA ' ' HG3' ' T' ' 66' ' ' PRO . 0.6 OUTLIER 73.65 81.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . 0.422 ' O ' HG13 ' T' ' 61' ' ' ILE . . . -91.3 17.27 56.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.604 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.05 -166.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.04 0.447 . . . . 0.0 111.558 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.23 124.96 46.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.093 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.62 179.55 50.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.872 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.632 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.7 mt -73.42 111.56 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.537 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.3 mm -91.05 80.15 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . 0.411 ' HB2' ' HA2' ' T' ' 58' ' ' GLY . 2.4 t70 -103.29 129.18 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -94.41 15.84 16.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . 0.714 ' HA3' ' HG2' ' T' ' 56' ' ' ARG . . . 71.22 169.6 9.81 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.829 HG13 ' HG3' ' T' ' 56' ' ' ARG . 10.6 mt -59.36 112.68 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.983 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' T' ' 81' ' ' ARG . 2.2 mmp_? -91.57 21.05 4.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.474 ' H ' HG21 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 51.66 50.82 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.61 66.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.647 ' O ' ' HB ' ' T' ' 15' ' ' THR . 19.3 mtm105 -66.67 -3.58 6.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m -98.19 18.62 15.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.476 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.3 mm-40 -74.87 -171.25 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.5 114.48 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.516 ' CA ' ' HA ' ' T' ' 12' ' ' TYR . 22.8 m95 -151.68 -134.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.378 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.419 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -121.64 -172.12 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.379 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.751 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -145.15 137.23 25.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.648 ' HB3' ' HB1' ' T' ' 31' ' ' ALA . 28.9 m-85 -101.67 107.65 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -85.85 133.83 33.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 111.327 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.947 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.9 OUTLIER -132.57 124.55 28.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.511 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 4.9 m120 -134.14 148.5 68.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.75 -33.28 18.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.512 2.141 . . . . 0.0 111.849 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.456 ' O ' ' C ' ' T' ' 97' ' ' ALA . 28.1 m-70 -122.77 -32.03 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.439 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 30.66 71.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.338 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.863 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' T' T ' 2' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' T' ' 31' ' ' ALA . 1.3 p -86.07 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.93 169.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 4' ' ' HIS . . . . . 0.499 ' HB2' HG12 ' T' ' 46' ' ' VAL . 9.7 t-80 -96.76 145.7 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.764 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 5' ' ' ARG . . . . . 0.463 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -152.47 166.4 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 6' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.6 OUTLIER -123.3 -170.15 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.66 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 7' ' ' ALA . . . . . 0.514 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -86.31 150.69 24.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -19.26 61.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 9' ' ' SER . . . . . 0.446 ' HB3' ' CE ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -97.33 -25.89 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 10' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 152.51 168.12 16.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -61.85 153.89 27.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.702 0.287 . . . . 0.0 110.855 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 12' ' ' TYR . . . . . 0.741 ' HB3' ' HD2' ' T' ' 87' ' ' ARG . 10.2 m-30 55.52 51.55 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 1.0 OUTLIER -142.28 2.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.636 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 14' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' T' ' 7' ' ' ALA . 8.8 mt -105.78 141.23 37.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 15' ' ' THR . . . . . 0.588 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 49.4 p -110.51 149.71 29.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 16' ' ' TYR . . . . . 0.56 ' CD1' ' HA3' ' T' ' 55' ' ' GLY . 81.4 t80 -34.91 -40.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.07 61.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.409 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 18' ' ' GLU . . . . . 0.588 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.0 mt-10 -68.61 -44.04 75.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 109.966 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 19' ' ' ALA . . . . . 0.69 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.06 -39.22 74.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.972 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 20' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' T' ' 24' ' ' GLU . 10.5 tttm -75.51 -38.22 59.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.106 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 21' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -56.06 -50.01 72.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.81 -53.76 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.42 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 23' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 88.3 m -63.31 -26.96 69.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 24' ' ' GLU . . . . . 0.772 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 22.3 tt0 -103.39 1.59 32.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.232 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 25' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -63.71 -43.33 96.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.203 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -100.53 61.26 1.02 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.39 19.97 6.68 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.619 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 28' ' ' GLY . . . . . 0.772 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.26 -159.97 13.9 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 29' ' ' HIS . . . . . 0.614 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 5.7 p80 -152.88 -177.56 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.996 0.427 . . . . 0.0 110.657 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 30' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -101.6 124.06 46.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.6 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 31' ' ' ALA . . . . . 0.906 ' HB3' HG22 ' T' ' 2' ' ' VAL . . . -44.92 154.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.571 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 32' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 6.9 p -108.31 -158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 33' ' ' TYR . . . . . 0.904 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 35.2 t80 -80.99 -73.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.112 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 34' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 20.8 mtmt -44.83 -36.85 3.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.82 -53.1 36.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 36' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -57.89 -21.13 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.138 0.494 . . . . 0.0 109.984 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 37' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 9.3 tt0 -72.63 -61.97 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 38' ' ' ALA . . . . . 0.527 ' HA ' ' HE2' ' T' ' 41' ' ' LYS . . . -58.43 -15.58 11.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 39' ' ' ALA . . . . . 0.636 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.02 -29.73 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.537 0.684 . . . . 0.0 109.578 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 40' ' ' ARG . . . . . 0.65 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -69.06 -32.56 72.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.863 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 41' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' T' ' 38' ' ' ALA . 28.7 mtmt -66.61 -17.85 65.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 42' ' ' ILE . . . . . 0.636 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -92.1 -22.47 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 43' ' ' GLY . . . . . 0.568 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 138.61 17.88 0.56 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.96 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 44' ' ' PHE . . . . . 0.65 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.5 OUTLIER -74.75 86.76 2.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.778 0.323 . . . . 0.0 110.876 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 45' ' ' HIS . . . . . 0.619 ' NE2' HD11 ' T' ' 61' ' ' ILE . 3.5 t-160 -115.36 122.84 47.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.97 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 46' ' ' VAL . . . . . 0.706 ' O ' HG21 ' T' ' 46' ' ' VAL . 0.7 OUTLIER -148.54 112.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 47' ' ' CYS . . . . . 0.687 ' HA ' HD13 ' T' ' 61' ' ' ILE . 1.8 t -82.76 74.38 9.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 48' ' ' ALA . . . . . 0.534 ' HB2' ' OD1' ' T' ' 89' ' ' ASP . . . -176.54 123.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 49' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -42.85 116.68 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 50' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' T' ' 91' ' ' TYR . . . -116.17 117.42 3.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 51' ' ' TRP . . . . . 0.555 ' CZ3' HG13 ' T' ' 57' ' ' VAL . 75.3 m95 -50.66 166.47 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 52' ' ' MET . . . . . 0.596 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 2.0 ptp -162.18 168.61 22.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.362 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 53' ' ' ALA . . . . . 0.645 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.67 165.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.541 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 54' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mmtp 78.76 -33.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.375 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 55' ' ' GLY . . . . . 0.56 ' HA3' ' CD1' ' T' ' 16' ' ' TYR . . . 111.45 17.22 8.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.695 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 56' ' ' ARG . . . . . 0.596 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.8 OUTLIER -105.23 157.25 17.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.579 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 57' ' ' VAL . . . . . 0.555 HG13 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -139.39 125.75 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.312 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.23 -168.01 12.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.149 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 59' ' ' TYR . . . . . 0.546 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -144.59 98.32 4.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 60' ' ' PRO . . . . . 0.734 ' HB3' HD12 ' T' ' 75' ' ' ILE . 78.5 Cg_endo -83.41 129.45 5.08 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.814 2.343 . . . . 0.0 112.183 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 61' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' T' ' 47' ' ' CYS . 16.4 mm -141.13 111.61 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 m -66.48 -41.39 88.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -114.54 88.06 15.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.56 148.16 92.59 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.622 2.215 . . . . 0.0 112.27 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.89 -137.67 3.95 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 66' ' ' PRO . . . . . 0.424 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 39.7 Cg_endo -67.4 -77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.264 . . . . 0.0 112.392 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 67' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -105.57 -3.93 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -23.62 66.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' T' ' 72' ' ' LYS . . . -169.28 -5.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.963 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 62.36 33.65 16.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.964 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.99 22.72 65.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.672 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 72' ' ' LYS . . . . . 0.725 ' HD3' HG13 ' T' ' 76' ' ' ILE . 23.7 mttp -85.46 155.12 21.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 132.78 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.5 -173.1 33.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 75' ' ' ILE . . . . . 0.904 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -79.78 98.39 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 76' ' ' ILE . . . . . 0.725 HG13 ' HD3' ' T' ' 72' ' ' LYS . 16.0 mm -70.9 79.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.69 117.62 34.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.874 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 78' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 0.6 OUTLIER -81.14 11.86 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.64 169.41 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 80' ' ' ILE . . . . . 0.621 HD12 ' HB3' ' T' ' 54' ' ' LYS . 8.8 mt -52.87 136.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.027 0.441 . . . . 0.0 111.251 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.31 17.08 14.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.018 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 82' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' T' ' 82' ' ' LEU . 0.2 OUTLIER 49.54 50.27 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.33 55.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 84' ' ' ARG . . . . . 0.53 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -56.09 -12.52 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.4 15.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 86' ' ' GLU . . . . . 0.548 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.7 mm-40 -78.82 -171.68 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 87' ' ' ARG . . . . . 0.741 ' HD2' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -136.18 113.2 10.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 88' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 3.4 m95 -156.26 179.49 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.056 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 89' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -73.83 -170.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.323 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' T' T ' 90' ' ' ALA . . . . . 0.69 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.08 132.23 19.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.598 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 91' ' ' TYR . . . . . 0.672 ' HE1' HG12 ' T' ' 46' ' ' VAL . 45.5 m-85 -94.08 115.57 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.63 151.67 21.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 111.331 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 93' ' ' TYR . . . . . 0.654 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 12.0 t80 -148.3 118.88 7.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 94' ' ' ASN . . . . . 0.707 ' HB2' ' HB1' ' T' ' 97' ' ' ALA . 59.3 m-20 -132.34 141.38 41.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.93 -32.76 23.91 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.505 2.137 . . . . 0.0 111.738 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' T' T ' 96' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' T' ' 97' ' ' ALA . 15.1 m-70 -121.75 -32.75 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 97' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' T' ' 94' ' ' ASN . . . 31.12 53.38 0.18 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.354 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.64 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.872 0.368 . . . . 0.0 111.161 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 137.01 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.734 ' CG ' HG11 ' T' ' 46' ' ' VAL . 17.6 t-80 -69.22 150.35 47.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.518 ' HG3' ' SG ' ' T' ' 92' ' ' CYS . 11.0 mmt180 -144.21 144.86 31.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.402 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -115.88 -168.97 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.877 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.13 153.55 18.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -17.45 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.758 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -101.22 -25.2 14.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 142.3 166.29 10.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.465 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.4 ttpm? -56.72 151.97 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 18.8 m-30 63.16 55.39 1.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.589 ' HA ' ' HD2' ' T' ' 87' ' ' ARG . 9.8 mttt -154.5 1.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.669 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.08 134.88 46.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 4.6 p -105.1 148.06 27.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.117 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -35.34 -38.68 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.46 -44.13 65.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' T' ' 15' ' ' THR . 72.0 mt-10 -73.13 -48.24 37.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 110.39 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.608 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.83 -45.59 50.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.036 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.15 -55.7 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -42.18 -38.17 1.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.48 -49.91 49.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 46.2 m -64.0 -51.66 63.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.1 tt0 -69.83 -15.81 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -52.52 -50.94 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.51 53.75 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.25 34.15 32.33 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.235 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -103.71 -178.49 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.614 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -147.07 135.52 21.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.014 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.39 143.73 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.228 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.77 142.25 30.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.421 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 33.5 p -98.84 -170.97 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.501 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.776 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 58.1 t80 -70.63 -68.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.104 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 5.2 mmtp -49.42 -37.75 26.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.764 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.2 mt-30 -67.69 -57.08 6.99 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.258 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.643 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.2 tm? -58.59 -21.36 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 10.3 tt0 -70.26 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.581 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.25 -22.52 18.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.57 -29.33 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.478 0.656 . . . . 0.0 109.442 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.657 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 3.1 tmm_? -69.62 -35.3 75.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.641 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 3.1 mtmp? -71.73 -13.27 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.581 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.4 pt -97.26 -16.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.491 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.417 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.92 9.17 1.14 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.421 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.679 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.4 OUTLIER -75.87 91.13 2.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.986 0.393 . . . . 0.0 110.825 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HB2' HG23 ' T' ' 62' ' ' VAL . 1.5 t-80 -123.24 129.07 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.734 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.21 98.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.283 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.703 ' HA ' HD11 ' T' ' 61' ' ' ILE . 6.1 t -66.27 80.68 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.435 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.66 136.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.695 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.29 112.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.66 118.64 5.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.668 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.531 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.9 m95 -52.36 150.1 5.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.444 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.827 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.85 176.17 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.643 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.0 -165.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.619 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -8.85 9.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.533 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 159.93 18.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.047 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.643 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 6.2 ptp180 -95.07 132.53 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.616 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -121.42 121.0 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.94 -168.93 14.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.2 OUTLIER -133.94 76.99 63.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.864 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_exo -59.39 122.35 11.37 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.792 2.328 . . . . 0.0 112.379 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.703 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.8 mm -139.87 110.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.11 -168.03 30.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.893 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 33.5 mt -75.39 125.98 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.359 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.592 HG22 ' CE1' ' T' ' 78' ' ' TYR . 5.1 mm -95.95 81.34 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.43 133.51 54.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' T' ' 76' ' ' ILE . 16.8 m-85 -110.76 -6.8 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.79 174.01 25.69 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.8 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.5 mt -55.56 157.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.405 ' N ' HG22 ' T' ' 80' ' ' ILE . 6.5 mtm180 -120.75 11.01 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.8 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.0 44.34 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -168.55 75.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.821 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -66.88 -5.87 14.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.038 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 77.3 p -73.67 10.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.575 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 4.4 mm-40 -75.3 177.42 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.718 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.589 ' HD2' ' HA ' ' T' ' 13' ' ' LYS . 2.8 mtm180 -131.69 113.53 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 111.315 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.672 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.5 m95 -151.87 -153.46 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.203 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.435 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.82 -171.79 2.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.424 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.84 119.22 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.481 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.837 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 33.6 m-85 -86.77 116.2 24.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' T' ' 5' ' ' ARG . 1.3 m -93.48 155.31 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 111.205 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.9 t80 -153.6 99.31 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.587 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' T' ' 94' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.855 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.872 0.368 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 24.8 p90 -151.91 -176.53 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.783 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.821 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.2 t-80 -109.21 157.68 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 2.1 mmt180 -156.33 148.97 23.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' T' ' 6' ' ' GLU . 2.9 pm0 -112.54 -173.21 2.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.772 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -91.38 158.4 16.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.179 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -61.09 -20.51 62.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' T' ' 13' ' ' LYS . 32.9 m -95.28 -28.54 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.65 167.11 12.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.44 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.454 ' HD2' ' CB ' ' T' ' 48' ' ' ALA . 1.6 ttpm? -56.65 152.13 12.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 19.3 m-30 63.79 54.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' T' ' 9' ' ' SER . 53.7 mttt -152.76 5.77 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.678 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.2 mt -109.19 130.23 55.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.048 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.641 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.2 p -103.09 150.47 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.257 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.528 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 85.9 t80 -35.29 -43.14 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.724 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.641 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 13.8 mt-10 -68.07 -56.29 9.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -44.2 -39.04 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -70.24 -38.36 75.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -60.94 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.52 -48.11 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -66.19 -54.87 20.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.349 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -71.66 -1.58 14.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.701 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -65.1 -48.67 72.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -115.62 63.96 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.242 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.68 45.53 54.59 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.335 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.643 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -115.88 177.53 17.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.535 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -149.65 133.9 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 110.958 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.03 141.22 6.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.328 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.92 146.25 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.463 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 43.6 p -100.93 -172.29 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.92 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 69.8 t80 -70.93 -64.9 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -49.12 -39.33 28.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.536 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.435 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.5 mt-30 -65.64 -53.06 46.62 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.488 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.36 -27.23 62.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.001 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.13 -59.67 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.426 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.422 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.37 -19.45 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.633 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.39 -32.94 15.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.457 0.646 . . . . 0.0 109.681 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.853 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -70.53 -33.35 71.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.871 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -66.09 -21.13 66.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.98 -23.19 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 110.391 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.591 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 141.33 16.26 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.126 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.683 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -75.91 132.41 40.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.904 0.352 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.538 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.6 t-160 -156.11 124.22 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.821 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.78 89.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.82 74.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.675 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.454 ' CB ' ' HD2' ' T' ' 11' ' ' LYS . . . -175.77 119.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.785 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -37.42 114.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.295 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -114.25 121.3 5.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.545 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.528 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.5 m95 -54.68 148.58 12.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.113 0.482 . . . . 0.0 111.634 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.808 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.94 178.81 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.636 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.22 -165.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.468 . . . . 0.0 111.509 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -7.86 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 160.22 18.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.811 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.5 mtp180 -92.78 134.79 34.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -129.92 111.8 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -113.89 -172.26 17.89 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.271 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -122.91 81.45 50.13 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 0.0 111.016 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.0 Cg_exo -59.77 126.2 19.84 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.686 2.258 . . . . 0.0 112.164 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.497 HG23 ' CE1' ' T' ' 45' ' ' HIS . 25.3 mm -131.59 134.31 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.225 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.853 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.798 0.332 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.44 168.69 7.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.093 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.92 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.5 mp -62.37 105.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.461 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 7.0 mm -73.96 82.29 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.09 120.12 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.417 ' CE1' HG22 ' T' ' 76' ' ' ILE . 7.9 m-85 -87.36 -35.42 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.23 169.66 12.55 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.724 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.0 mt -61.22 115.42 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.0 mmt85 -84.31 11.13 8.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.688 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.25 46.24 16.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.786 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.74 77.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.665 HH21 ' HA ' ' T' ' 82' ' ' LEU . 0.3 OUTLIER -72.4 7.34 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.822 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.43 7.16 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.585 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -66.36 -173.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.93 113.07 11.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.446 . . . . 0.0 111.517 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.597 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.7 m95 -154.47 -166.69 2.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.118 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.451 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -84.34 -173.55 4.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.448 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.26 118.92 10.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.397 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.717 ' CD1' HD21 ' T' ' 36' ' ' LEU . 39.1 m-85 -88.4 113.95 24.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.403 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.431 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 2.0 t -93.89 159.8 15.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.855 0.36 . . . . 0.0 111.05 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.855 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 14.3 t80 -145.11 134.15 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.643 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 6.9 m-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.952 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -157.53 177.42 11.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.203 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.79 ' CG ' HG11 ' T' ' 46' ' ' VAL . 37.9 t-80 -97.66 160.09 14.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.501 ' HE ' ' HB2' ' T' ' 5' ' ' ARG . 0.0 OUTLIER -157.11 147.26 20.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.3 OUTLIER -112.52 -168.43 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.731 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -102.6 155.92 17.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.14 -17.72 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 p -98.47 -25.59 14.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.53 166.94 10.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.1 ttpm? -57.41 152.03 15.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 17.7 m-30 61.41 56.28 2.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.142 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -155.12 8.53 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.573 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.731 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.3 mt -110.63 132.32 54.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.291 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.728 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.7 p -103.0 146.54 28.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.141 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.608 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.5 t80 -33.93 -39.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.31 -45.2 70.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' T' ' 15' ' ' THR . 73.4 mt-10 -73.8 -49.9 23.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.39 -41.1 27.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.989 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -50.1 22.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.931 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.71 -40.99 30.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.409 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 6.8 t -70.49 -54.31 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.452 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 63.4 m -60.77 -42.04 96.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.923 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 10.0 tt0 -81.8 -10.25 59.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 0.9 OUTLIER -54.23 -50.89 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.003 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -96.62 61.37 1.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.92 30.72 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.418 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -111.56 -169.31 18.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.502 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.15 135.26 13.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.592 0.234 . . . . 0.0 110.441 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.19 125.43 26.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.463 . . . . 0.0 110.235 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.21 163.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.546 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 5.9 p -111.21 -158.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.752 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 30.9 t80 -79.89 -74.19 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.2 mttt -47.19 -36.35 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.73 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.31 -53.95 30.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.39 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.49 -24.47 31.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.932 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 15.0 tt0 -69.0 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.266 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.486 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.02 -12.01 4.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.585 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.1 -29.88 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.328 0.585 . . . . 0.0 109.872 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -73.42 -33.86 65.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.139 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.3 mtmt -69.97 -17.17 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.36 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.95 -17.63 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.443 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.51 11.53 1.49 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.014 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -82.63 124.48 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.921 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.636 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.9 t-80 -148.6 126.63 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.79 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -146.94 100.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.24 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.834 ' HA ' HD11 ' T' ' 61' ' ' ILE . 5.9 t -66.83 80.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.578 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 175.99 126.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -45.13 113.17 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.279 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.4 114.96 3.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.596 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.608 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 77.6 m95 -48.68 168.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 111.757 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.844 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -161.86 173.77 14.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.504 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.93 166.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 111.52 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 76.84 -31.64 0.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.34 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.58 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.14 20.12 8.1 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.592 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.702 ' HB3' HG13 ' T' ' 80' ' ' ILE . 0.4 OUTLIER -108.99 156.28 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.594 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -137.03 133.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.052 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -137.53 -172.59 12.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.312 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.654 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -133.03 102.59 13.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.849 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.5 Cg_endo -60.33 -88.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.196 . . . . 0.0 112.291 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.834 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm 71.42 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' T' ' 45' ' ' HIS . 14.8 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.28 176.9 51.66 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.849 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 2.5 mt -76.81 108.67 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 111.258 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.0 mm -79.13 82.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.975 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.1 t70 -110.42 121.65 45.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 1.6 m-85 -83.71 11.96 6.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 69.62 170.74 7.83 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' T' ' 54' ' ' LYS . 9.4 mt -60.33 117.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.18 19.42 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.533 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.71 35.24 20.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.91 53.11 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.728 ' O ' ' HB ' ' T' ' 15' ' ' THR . 21.4 mtt180 -60.95 -5.55 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.64 20.74 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.76 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.56 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.4 mm-40 -83.72 -172.05 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.641 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.56 114.15 10.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.1 m95 -153.98 -164.74 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.97 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.578 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -89.56 -173.96 4.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.55 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.06 135.16 25.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 35.8 m-85 -96.88 111.91 23.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.276 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 9.1 m -90.49 137.2 32.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 111.09 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.952 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.4 OUTLIER -136.83 126.26 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 2.1 p . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.79 -176.99 5.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.881 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.569 ' CD2' HG11 ' T' ' 46' ' ' VAL . 16.4 t-80 -95.38 153.85 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.32 150.97 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.044 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.588 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 26.0 tt0 -120.02 173.19 7.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.735 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.29 159.92 25.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.084 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -61.25 -28.54 69.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' T' ' 13' ' ' LYS . 0.9 OUTLIER -91.55 -50.05 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 176.39 174.21 42.69 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.497 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 20.1 ttpt -62.96 168.14 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 46.3 47.79 13.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.7 OUTLIER -143.41 2.34 1.26 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.785 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.735 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -104.2 139.06 39.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.487 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.672 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 19.8 p -107.8 149.67 27.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.94 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 61.9 t80 -34.07 -42.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 111.054 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.69 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.672 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.7 mt-10 -69.34 -44.66 71.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 110.032 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -56.09 -38.65 70.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.815 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -76.42 -37.13 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -59.56 -38.47 81.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.084 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -53.16 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.355 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -63.89 -28.39 69.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 30.9 tt0 -99.31 -9.28 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 110.307 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -51.34 -42.6 61.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.92 59.0 0.66 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.88 33.34 20.24 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.28 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.27 -168.2 19.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.585 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.67 136.4 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.583 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -70.58 126.89 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 0.0 110.358 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -51.3 161.23 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.575 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.639 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 28.2 p -111.84 -164.94 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.893 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 32.5 t80 -74.76 -70.75 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.991 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 30.0 mttm -45.28 -41.85 9.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.667 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.71 -51.21 63.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.673 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.69 -27.33 49.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.949 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.7 tp10 -65.9 -61.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.087 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.478 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -58.88 -13.27 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.936 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.568 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.92 -30.16 14.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.348 0.594 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 53.0 ttt-85 -73.6 -33.35 64.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.009 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 13.0 mttt -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.568 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.74 -15.73 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.422 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 131.15 12.12 2.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.091 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.47 120.0 23.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.772 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.1 t-80 -136.4 129.32 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.716 HG21 ' HE1' ' T' ' 91' ' ' TYR . 1.3 t -143.24 103.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.447 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.729 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.71 66.32 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -175.26 138.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.671 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -55.09 111.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -108.6 113.85 3.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.6 m95 -47.12 152.06 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' T' ' 50' ' ' GLY . 0.0 OUTLIER -171.5 174.54 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.688 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 53.44 -166.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.543 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 0.34 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.537 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.74 16.16 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.786 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' T' ' 52' ' ' MET . 1.9 mtt180 -92.05 125.52 36.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -116.3 126.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -130.23 -169.2 12.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.318 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.1 OUTLIER -139.45 91.92 10.67 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.855 0.36 . . . . 0.0 111.143 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' T' ' 75' ' ' ILE . 68.4 Cg_endo -78.49 125.06 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.67 2.247 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' T' ' 45' ' ' HIS . 20.0 mm -136.82 101.21 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.01 -175.93 34.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.834 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.893 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -80.31 89.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.987 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.567 HG22 ' CE1' ' T' ' 78' ' ' TYR . 18.3 mm -62.42 84.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.43 138.21 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.0 m-85 -112.82 27.72 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 68.49 168.2 4.83 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.652 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mt -57.43 147.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.947 0.403 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.676 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 4.7 mmm-85 -115.14 22.52 13.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.02 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.652 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 44.46 53.4 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' T' ' 81' ' ' ARG . 27.5 p-10 -165.81 61.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -58.3 -3.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.467 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -81.93 17.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.571 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -78.01 -172.46 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.63 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -139.04 113.38 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.283 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.748 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 16.2 m95 -153.13 -156.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.105 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -97.33 -171.23 2.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.374 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.17 137.92 29.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.221 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 32.5 m-85 -101.02 120.38 40.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 5.7 m -96.1 147.51 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.431 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 26.5 t80 -137.6 133.95 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.589 179.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.687 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.03 -177.97 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.729 ' CG ' HG11 ' T' ' 46' ' ' VAL . 21.1 t-80 -101.7 161.56 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.467 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.83 144.81 23.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.616 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.8 tt0 -115.62 173.28 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.692 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.799 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -87.25 157.19 19.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.194 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -65.93 -21.5 66.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -91.41 -23.75 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.85 167.79 11.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.463 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 7.6 ttpt -58.59 158.15 8.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.482 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 11.0 m-30 57.2 55.98 5.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -153.25 2.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.8 mt -103.05 136.81 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.072 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.713 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.5 p -107.73 152.91 23.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.243 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 71.5 t80 -36.66 -43.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.03 -39.86 68.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.713 ' HB2' ' H ' ' T' ' 15' ' ' THR . 76.4 mt-10 -70.55 -47.69 59.08 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 109.806 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.464 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -55.89 -46.47 78.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.561 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.636 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -65.67 -39.54 91.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.142 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.8 t -67.89 -52.31 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 92.1 m -64.13 -48.98 73.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.541 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 42.9 tt0 -69.9 -16.4 63.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.532 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.95 -49.09 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.803 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -103.71 51.6 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.28 38.97 34.51 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.356 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -117.98 172.83 14.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.569 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -124.79 139.47 53.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.71 0.291 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -74.64 126.12 30.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.215 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.3 155.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.461 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 27.1 p -110.39 -164.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 27.6 t80 -74.88 -72.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.107 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -47.59 -41.59 21.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.921 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.45 -47.79 80.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.6 OUTLIER -54.81 -40.72 69.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 3.6 tp10 -54.26 -60.66 3.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.188 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.85 -18.48 8.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.607 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.27 -29.75 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.76 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.886 ' HG2' HG23 ' T' ' 62' ' ' VAL . 3.1 tmm_? -71.17 -33.62 70.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.011 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtpt -69.45 -17.03 63.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.314 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.607 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.53 -12.33 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.683 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.24 14.9 3.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.012 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -83.01 124.6 30.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 0.0 110.981 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.536 ' ND1' HG12 ' T' ' 62' ' ' VAL . 2.2 t-160 -147.15 127.25 13.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.75 94.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.564 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 1.3 m -61.75 83.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 170.32 125.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -46.28 113.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -110.43 121.37 5.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.633 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.4 m95 -49.68 152.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.97 0.414 . . . . 0.0 111.318 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.664 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.41 177.82 3.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.73 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.97 -165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.469 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 2.78 2.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.372 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.02 15.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.791 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 28.6 mtt180 -94.72 127.48 40.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.428 HG12 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -115.93 131.37 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -141.38 -178.28 17.45 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.393 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.497 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.95 98.3 39.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.745 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 37.9 Cg_exo -55.35 -84.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.786 2.324 . . . . 0.0 112.689 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.2 mm 73.57 102.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.948 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.886 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.861 0.363 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' T' T ' 74' ' ' GLY . . . . . 0.577 ' HA2' ' NH2' ' T' ' 40' ' ' ARG . . . 86.21 175.39 49.78 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.749 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.3 mt -68.49 107.41 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.046 0.45 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' T' ' 78' ' ' TYR . 9.8 mm -81.39 83.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.1 t70 -109.47 132.12 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.604 ' CE1' HG22 ' T' ' 76' ' ' ILE . 10.6 m-85 -105.15 23.01 14.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.69 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 70.05 170.97 8.75 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.729 HG22 ' H ' ' T' ' 82' ' ' LEU . 9.6 mt -51.37 152.29 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.282 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.05 18.65 17.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.729 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 54.76 31.66 15.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -148.92 77.44 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' T' ' 15' ' ' THR . 69.2 mtt180 -65.79 2.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.438 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -102.14 12.67 36.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.537 ' O ' HG22 ' T' ' 15' ' ' THR . 2.4 mm-40 -65.17 -178.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -132.35 114.27 14.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 111.341 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 23.2 m95 -151.43 -136.6 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.274 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.463 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.7 OUTLIER -115.4 -167.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.378 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.464 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.6 132.53 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.276 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.904 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 31.1 m-85 -105.1 127.28 52.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.561 ' O ' HG23 ' T' ' 2' ' ' VAL . 1.2 m -100.76 159.67 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.304 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.687 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 24.2 t80 -150.67 119.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.484 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.705 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.1 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.792 0.33 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -147.23 -176.69 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.771 ' CG ' HG11 ' T' ' 46' ' ' VAL . 40.7 t-80 -98.93 163.95 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 154.77 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.549 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 24.7 tt0 -121.91 172.91 7.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -78.33 161.23 27.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -20.16 65.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.757 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.539 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.5 m -102.82 -47.49 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 173.91 172.53 39.3 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 150.25 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.692 0.282 . . . . 0.0 110.969 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 61.81 57.36 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 9.0 mttm -153.55 1.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.515 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.66 139.54 39.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.737 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.6 p -108.55 151.8 25.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 67.6 t80 -36.52 -41.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 0.0 110.791 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.79 -39.03 64.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.304 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' T' ' 15' ' ' THR . 82.6 mt-10 -71.02 -45.38 64.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.179 0.514 . . . . 0.0 109.958 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -58.56 -45.26 89.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.565 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 30.3 tttt -68.47 -26.86 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.563 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.71 -41.53 83.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.194 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.78 -51.73 47.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.259 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -63.84 -47.71 79.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.592 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 4.1 tt0 -73.55 -13.45 61.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -54.43 -48.83 71.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -102.9 50.98 0.81 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.758 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.15 39.62 50.53 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.313 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -118.17 177.41 16.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.733 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -130.12 141.83 50.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.564 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.63 125.44 29.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.068 0.461 . . . . 0.0 110.23 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.947 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.22 154.32 0.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.533 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -109.99 -162.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.222 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.637 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 31.6 t80 -77.23 -72.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 14.1 mttm -46.89 -38.49 10.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.732 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.28 -53.55 35.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 110.39 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.63 -23.86 44.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 12.1 tp10 -68.45 -61.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.205 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.409 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.52 -16.09 8.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.798 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.49 -29.48 15.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.491 0.662 . . . . 0.0 109.684 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.58 HH11 ' HA2' ' T' ' 74' ' ' GLY . 0.0 OUTLIER -72.61 -33.25 66.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.112 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.0 mttt -69.52 -17.88 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.286 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.567 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.39 -14.35 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.81 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.406 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 11.35 2.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -81.48 118.6 22.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.75 ' CE1' HG23 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -141.55 127.2 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.771 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -145.43 102.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.28 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.807 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -72.72 80.5 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.701 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 178.55 123.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.835 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -41.73 111.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.31 114.97 3.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.667 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 71.7 m95 -48.95 156.83 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.432 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.686 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -177.61 178.33 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.896 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.671 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 50.77 -165.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -7.52 7.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.498 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 158.49 19.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.858 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.671 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 0.9 OUTLIER -97.53 135.66 39.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.73 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -126.61 122.42 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -170.65 13.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -124.99 82.97 60.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.961 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' T' ' 75' ' ' ILE . 26.7 Cg_exo -60.37 104.95 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.761 2.307 . . . . 0.0 112.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.4 mm -130.74 112.28 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.028 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.821 0.344 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 74' ' ' GLY . . . . . 0.58 ' HA2' HH11 ' T' ' 40' ' ' ARG . . . 90.03 -176.24 42.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.85 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.637 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -70.36 110.85 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 111.058 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.2 mm -89.36 79.86 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -101.92 122.83 44.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.41 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.1 m-85 -84.01 3.36 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.011 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.09 172.44 44.37 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.488 HG12 ' C ' ' T' ' 55' ' ' GLY . 6.3 mt -65.4 119.92 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.315 . . . . 0.0 111.027 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -112.03 28.35 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.424 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 52.96 27.89 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -114.38 51.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.618 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -70.65 4.34 2.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -106.62 6.97 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.562 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -72.15 -171.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 23.5 mtp85 -132.63 113.48 13.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.139 0.495 . . . . 0.0 111.56 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.8 m95 -153.99 -171.24 3.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.038 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.596 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -81.99 -171.21 3.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.424 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.77 136.87 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.947 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 38.8 m-85 -103.24 127.91 50.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.583 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.7 OUTLIER -99.56 161.35 13.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 111.284 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.705 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 25.2 t80 -151.62 119.88 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.757 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.715 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.6 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.804 0.335 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -145.59 -176.91 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.797 ' CG ' HG11 ' T' ' 46' ' ' VAL . 16.1 t-80 -113.56 155.26 25.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.96 164.43 38.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 -170.0 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -90.7 149.55 22.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -60.12 -16.47 32.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.774 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -98.77 -25.35 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 149.19 167.65 14.13 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.492 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 8.1 tttm -62.38 153.84 29.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.345 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.9 m-30 57.06 51.92 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.774 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 3.7 mttm -142.69 1.05 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.9 mt -104.33 146.77 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.755 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 22.3 p -114.36 153.31 30.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.012 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 72.2 t80 -37.76 -40.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.849 0.357 . . . . 0.0 110.751 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.99 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.359 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.755 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.7 mt-10 -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.173 0.511 . . . . 0.0 109.936 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.09 -46.2 85.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -67.69 -26.5 66.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.489 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -69.41 -40.98 77.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.86 -50.41 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -52.27 50.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.148 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 6.5 tt0 -71.62 -3.04 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.644 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -65.71 -45.11 83.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.574 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.81 59.61 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.047 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 55.82 21.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.262 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -138.96 166.96 25.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.784 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.47 139.07 51.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.612 0.244 . . . . 0.0 110.57 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -74.22 124.65 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.0 110.316 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.69 153.13 1.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.483 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 28.3 p -106.17 -164.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.977 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.88 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 53.0 t80 -75.61 -69.79 0.47 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.021 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -46.68 -42.7 16.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.17 -46.25 84.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.647 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.73 -38.01 71.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.226 0.536 . . . . 0.0 109.661 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 12.0 tt0 -57.02 -60.68 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.428 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.67 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.48 -21.59 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.058 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -90.91 -28.85 17.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 0.0 109.633 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' T' ' 62' ' ' VAL . 19.2 ttp85 -71.59 -34.21 69.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.001 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtmp? -73.24 -18.05 61.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.221 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.67 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -87.88 -7.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.92 7.07 7.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.331 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -78.17 130.64 36.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.702 ' HD1' HG12 ' T' ' 62' ' ' VAL . 2.6 t-160 -153.07 130.8 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.763 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.797 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.37 99.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.261 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.587 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.731 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 179.67 122.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -41.45 110.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.71 115.94 4.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.838 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.3 m95 -48.19 156.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 111.367 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.725 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.1 OUTLIER -178.28 177.37 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.055 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.04 -165.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.754 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -14.03 10.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.476 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 160.85 23.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.926 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 10.7 ptp180 -99.71 136.41 39.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.538 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.584 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -127.88 119.57 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -118.68 -173.67 15.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.257 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.434 ' O ' HG12 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -120.56 82.32 33.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.7 Cg_exo -59.97 120.9 8.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.689 2.259 . . . . 0.0 112.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' T' ' 47' ' ' CYS . 10.4 mm -138.69 100.56 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.702 HG12 ' HD1' ' T' ' 45' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.899 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 168.4 44.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.88 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.0 mp -63.49 97.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.757 0.313 . . . . 0.0 111.301 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.8 80.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.464 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.4 t70 -105.12 123.17 47.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 2.2 m-85 -86.31 -3.16 58.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.967 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.57 169.69 40.32 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.745 HG22 ' H ' ' T' ' 82' ' ' LEU . 16.2 mt -60.67 127.83 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 111.082 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.88 16.99 21.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.745 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.99 45.75 26.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.897 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -163.93 77.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -69.89 -4.94 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 17.26 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.582 ' O ' HG22 ' T' ' 15' ' ' THR . 2.6 mm-40 -80.32 -171.81 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.599 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.645 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 2.7 ppt_? -137.53 111.75 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.094 0.473 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.65 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.2 m95 -153.71 -172.11 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.171 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.543 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -82.54 -170.62 3.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.32 137.79 27.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.799 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 36.2 m-85 -103.45 121.14 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.523 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.1 OUTLIER -96.13 154.17 17.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.014 0.435 . . . . 0.0 111.3 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.715 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 28.8 t80 -143.7 126.27 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.503 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 26.6 m-20 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.525 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.962 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 2.0 p90 -151.22 177.46 10.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.163 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.603 ' CG ' HG11 ' T' ' 46' ' ' VAL . 8.3 t-80 -112.86 160.74 17.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.154 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 6.0 tpp180 -158.89 159.81 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 -169.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.868 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -96.17 149.86 21.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -20.49 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.485 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -95.72 -22.74 17.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.833 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 144.47 166.97 11.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -65.02 162.74 16.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.7 m-30 53.69 38.75 29.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.4 OUTLIER -134.54 4.9 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.876 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 7.7 mt -107.51 139.04 42.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.982 0.42 . . . . 0.0 111.427 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.8 p -109.86 149.12 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.011 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -34.48 -41.16 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.786 0.326 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.39 -43.85 69.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.319 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.8 mt-10 -70.38 -46.78 63.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.7 -43.95 47.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.95 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -65.63 -54.45 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -50.01 -36.8 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 t -75.18 -54.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.524 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' T' ' 28' ' ' GLY . 58.8 m -64.19 -30.32 71.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 24.4 tt0 -92.59 -12.14 32.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 110.104 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.4 t80 -54.33 -41.62 69.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.044 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -107.69 59.09 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.218 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.53 20.46 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.415 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -94.54 -174.3 38.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.92 136.26 14.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -48.14 137.17 10.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.475 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.54 166.94 22.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.134 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 47.0 p -117.99 -175.15 2.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 0.0 111.373 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.95 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 48.0 t80 -69.54 -68.99 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.955 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.2 mttp -45.89 -42.09 12.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.583 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.2 mt-30 -65.03 -51.04 63.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -60.17 -22.17 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.5 tt0 -73.98 -61.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.286 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.44 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.28 -13.45 7.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.826 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.598 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.2 -29.11 14.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 8.4 ttt-85 -72.73 -34.38 67.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.035 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.7 mtpt -69.67 -15.79 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.598 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.0 -19.16 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.741 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.48 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.11 11.77 1.02 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.103 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.65 115.74 20.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.691 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.1 t-80 -135.53 127.99 30.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.603 HG11 ' CG ' ' T' ' 4' ' ' HIS . 1.3 t -144.64 102.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.249 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.674 ' HA ' HD11 ' T' ' 61' ' ' ILE . 52.8 t -77.56 63.85 2.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.74 125.59 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.894 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.523 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -42.5 115.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.05 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.59 119.31 4.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.632 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.1 m95 -53.48 148.52 9.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.47 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.763 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -167.5 175.31 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.344 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.62 -165.99 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -2.17 4.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.441 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.9 14.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.868 ' HG3' HG13 ' T' ' 80' ' ' ILE . 6.8 mtt180 -88.41 125.94 34.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.88 117.81 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.73 -169.72 13.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.261 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -141.48 95.06 7.34 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 111.219 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HB3' HD13 ' T' ' 75' ' ' ILE . 71.8 Cg_endo -81.58 131.25 7.26 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.691 HG23 ' CE1' ' T' ' 45' ' ' HIS . 15.2 mm -134.77 107.22 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.184 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.47 -174.78 35.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.907 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.95 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -79.88 95.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.163 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.53 HG22 ' CE1' ' T' ' 78' ' ' TYR . 11.6 mm -68.18 83.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -110.38 122.05 46.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.53 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.0 OUTLIER -87.69 -5.94 58.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.072 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.715 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 91.22 169.11 41.99 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.868 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.7 mt -59.36 122.4 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -102.37 13.84 33.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.949 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.6 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.48 48.93 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.32 58.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.656 HH11 ' HB2' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -60.39 -9.71 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -79.69 12.59 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.487 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -79.37 -178.68 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.688 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -134.85 116.36 14.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.585 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 20.8 m95 -150.18 -134.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.339 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -115.83 -166.83 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.357 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -148.0 119.54 7.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.369 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 28.4 m-85 -87.63 103.8 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.498 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.6 m -82.26 151.84 26.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.962 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -148.91 125.75 11.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.769 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.679 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.831 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.7 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.805 0.336 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 21.0 p90 -143.21 178.41 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.818 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.855 ' CG ' HG11 ' T' ' 46' ' ' VAL . 46.9 t-80 -96.1 159.05 15.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.205 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.827 ' HG2' HG11 ' T' ' 22' ' ' VAL . 0.0 OUTLIER -151.31 151.4 31.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.031 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.0 tt0 -122.91 173.09 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -88.64 157.72 18.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.191 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.665 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -93.8 -24.82 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.38 166.86 10.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.55 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 17.4 ttpt -58.41 155.66 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 110.97 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.497 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 10.5 m-30 58.5 54.2 5.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.989 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -152.5 3.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.828 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -104.32 134.9 46.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 28.0 p -105.56 150.93 24.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 78.8 t80 -34.86 -42.28 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.956 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -42.25 65.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.373 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' T' ' 15' ' ' THR . 67.5 mt-10 -69.72 -46.58 65.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.017 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.83 -42.12 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.738 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -68.0 -34.9 77.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.605 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.96 -36.37 83.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.972 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.827 HG11 ' HG2' ' T' ' 5' ' ' ARG . 3.0 t -69.16 -50.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.178 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -64.57 -54.31 34.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.029 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 44.0 tt0 -62.26 -19.26 63.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -54.06 -48.41 70.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.81 54.45 0.66 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.37 31.5 35.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.241 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -100.95 167.56 19.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.646 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.556 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -133.91 138.14 45.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.004 0.431 . . . . 0.0 111.412 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.672 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.87 139.17 22.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -81.17 166.27 20.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.438 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 38.9 p -120.82 -175.01 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.0 111.684 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.846 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 36.0 t80 -68.32 -70.34 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.781 ' HA ' ' HG3' ' T' ' 37' ' ' GLU . 3.0 mttp -46.69 -40.99 14.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.865 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.5 mt-30 -63.65 -47.13 82.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.743 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -55.72 -30.81 61.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.384 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.781 ' HG3' ' HA ' ' T' ' 34' ' ' LYS . 0.0 OUTLIER -66.51 -60.86 2.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.451 0.643 . . . . 0.0 110.118 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.474 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -53.44 -18.52 2.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.913 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.569 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.17 -30.72 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.398 0.618 . . . . 0.0 109.678 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' T' ' 62' ' ' VAL . 0.1 OUTLIER -72.65 -32.95 66.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.044 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.4 mtmp? -69.69 -18.21 63.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.569 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.61 -10.95 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.41 14.03 4.57 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.515 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.2 t80 -82.15 125.66 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.59 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.5 t-160 -147.61 126.1 12.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.855 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -145.66 101.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.222 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.891 ' HA ' HD11 ' T' ' 61' ' ' ILE . 4.4 t -72.15 78.99 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.62 116.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.594 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -38.61 117.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.072 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.27 122.73 5.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.692 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.5 m95 -53.99 146.56 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.672 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -164.64 178.41 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.471 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.04 -166.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.475 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.77 3.88 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.448 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.04 13.7 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.856 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.842 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 11.4 mtt180 -91.47 127.09 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.55 125.38 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.02 -175.67 14.16 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.594 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -134.7 103.68 11.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.815 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.3 Cg_exo -58.5 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.623 2.216 . . . . 0.0 112.199 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' T' ' 47' ' ' CYS . 30.0 mm 75.42 108.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.903 0.383 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.47 176.21 49.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.846 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -68.47 112.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 111.021 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.573 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.6 mm -87.23 88.7 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.117 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -112.87 112.89 24.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.556 ' CE1' HG22 ' T' ' 76' ' ' ILE . 3.2 m-85 -79.38 4.35 15.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.842 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 76.65 170.11 31.32 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.803 HG22 ' H ' ' T' ' 82' ' ' LEU . 11.9 mt -48.21 142.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 3.9 mmm-85 -108.26 16.09 23.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.803 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.75 35.37 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -169.07 86.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -70.42 -1.15 9.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -76.87 15.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.564 ' O ' HG22 ' T' ' 15' ' ' THR . 3.5 mm-40 -75.11 -173.57 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -138.22 113.7 9.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 111.1 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.529 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 15.7 m95 -151.22 -137.79 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.507 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.55 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -116.01 -165.35 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.449 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.34 126.89 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 111.559 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 29.9 m-85 -97.47 107.59 20.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.51 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.5 t -84.89 154.93 21.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.831 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 13.9 t80 -144.02 123.05 12.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.999 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.322 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.771 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.826 0.346 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -156.98 -176.52 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.71 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.8 t-80 -101.38 159.33 15.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.049 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 8.1 mmt180 -153.04 148.49 27.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.7 tt0 -116.4 173.34 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.859 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.43 156.07 20.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -20.7 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.444 ' HB3' ' NZ ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -93.88 -28.01 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.8 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 147.65 168.27 13.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.345 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.446 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 4.1 ttpm? -63.68 165.23 8.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 16.2 m-30 50.8 43.95 28.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 3.8 mttt -138.63 -2.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.859 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.4 mt -102.18 139.56 37.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.336 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.649 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 2.8 p -110.46 151.58 27.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.108 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.53 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 79.5 t80 -34.01 -42.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.99 68.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.223 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.0 mt-10 -68.63 -45.27 72.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.93 -40.4 63.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.896 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 15.1 tttt -70.11 -34.89 73.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -64.53 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.53 -50.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.21 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.68 -53.26 50.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.4 tt0 -63.8 -21.07 66.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.413 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.4 OUTLIER -51.38 -49.81 60.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.844 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -106.03 53.47 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.58 42.23 43.66 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.231 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -115.07 165.86 12.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.728 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.555 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.46 139.45 51.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.891 0.377 . . . . 0.0 111.312 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.45 149.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.983 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -90.7 149.28 22.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.401 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 62.8 p -105.93 -175.57 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.915 0.388 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.944 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 51.8 t80 -67.29 -68.57 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.042 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -48.29 -42.86 32.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.947 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.12 -50.19 69.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.809 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -60.45 -31.69 70.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.336 0.588 . . . . 0.0 109.646 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' HG2' ' HE2' ' T' ' 41' ' ' LYS . 8.8 tt0 -65.28 -58.39 6.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.236 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.4 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -52.14 -23.91 6.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.648 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -87.51 -30.53 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.516 0.674 . . . . 0.0 109.78 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.771 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.4 OUTLIER -70.45 -33.71 71.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.093 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HE2' ' HG2' ' T' ' 37' ' ' GLU . 11.4 mttm -67.48 -19.22 65.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.197 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.648 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.1 -21.83 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.567 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 139.7 15.19 0.56 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.211 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.771 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -70.75 137.64 49.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.737 0.303 . . . . 0.0 110.683 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.2 t-160 -161.09 124.45 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.67 103.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.846 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.48 72.79 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -178.72 139.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -56.28 116.64 3.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -113.39 121.39 5.48 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.725 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 77.0 m95 -55.16 144.44 24.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.503 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -163.26 176.06 10.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.664 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.95 -165.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.584 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -6.41 9.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.563 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.11 16.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.954 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.7 ptp180 -93.69 130.36 39.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.712 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.495 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.01 121.26 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.967 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.21 -169.07 13.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.289 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.691 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -143.77 93.02 6.28 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.128 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.795 ' HB3' HD13 ' T' ' 75' ' ' ILE . 73.5 Cg_endo -80.93 130.54 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.739 2.293 . . . . 0.0 112.259 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.846 HD11 ' HA ' ' T' ' 47' ' ' CYS . 22.6 mm -142.98 107.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.7 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.913 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.838 0.352 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.34 179.36 52.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.966 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -74.85 98.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.05 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.691 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 8.8 mm -70.21 85.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.94 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.584 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.5 m-85 -111.6 22.05 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.38 170.86 7.5 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.749 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.2 mt -53.94 152.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.433 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.1 mmm180 -130.63 16.24 5.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.749 ' H ' HG22 ' T' ' 80' ' ' ILE . 4.3 mm? 56.28 27.26 11.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.89 57.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.576 ' O ' ' HB ' ' T' ' 15' ' ' THR . 11.4 mtm180 -66.45 -1.67 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 9.6 t -97.47 6.19 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.59 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -68.21 -176.47 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.33 113.35 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.438 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.711 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 12.7 m95 -152.87 -155.99 0.66 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.204 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.12 -169.76 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.227 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.453 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.9 121.87 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 0.0 111.437 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.809 ' CD1' HD21 ' T' ' 36' ' ' LEU . 34.4 m-85 -90.26 107.47 19.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.496 ' O ' HG23 ' T' ' 2' ' ' VAL . 8.0 m -82.29 164.58 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.337 . . . . 0.0 111.023 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.771 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 7.9 t80 -153.04 118.1 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.437 179.536 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.876 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -145.5 -179.97 7.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.774 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.1 t-80 -112.31 161.91 16.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.517 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 10.9 mmt180 -155.9 161.53 40.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.672 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -126.29 -174.31 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.615 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -86.36 153.61 21.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 8' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -58.77 -20.77 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.806 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -27.58 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.44 167.74 12.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.519 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.574 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 1.6 ttpt -55.37 153.52 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.2 m-30 55.37 69.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.1 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -158.74 -7.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.778 HD11 ' C ' ' T' ' 89' ' ' ASP . 1.1 pp -111.94 161.62 16.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.106 0.479 . . . . 0.0 111.27 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.804 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 3.4 p -114.58 -166.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.1 t80 -67.5 -41.39 84.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.34 -38.63 74.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.541 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.804 ' HB2' ' H ' ' T' ' 15' ' ' THR . 53.7 mt-10 -71.76 -43.3 66.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.194 0.521 . . . . 0.0 110.182 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.403 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -54.03 -41.78 68.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.986 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -55.93 10.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.118 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.5 -36.65 3.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.285 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.54 -56.04 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.437 ' O ' ' CA ' ' T' ' 28' ' ' GLY . 82.9 m -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 18.5 tt0 -88.21 -12.72 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 109.614 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.2 t80 -57.31 -39.5 75.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.86 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -113.4 56.64 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.163 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.63 34.75 28.74 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.584 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.96 171.1 14.23 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.427 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.593 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.18 143.56 46.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.284 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.818 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -52.74 136.52 33.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.292 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.87 153.51 32.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 35.4 p -106.5 -172.29 2.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 111.673 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.928 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 65.3 t80 -71.63 -67.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.07 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -46.56 -40.89 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.413 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 93.9 mt-30 -64.75 -49.38 71.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.668 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -59.19 -23.66 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.071 0.462 . . . . 0.0 110.118 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 2.9 tp10 -74.04 -62.08 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.98 -13.73 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.995 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -95.06 -29.99 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.362 0.601 . . . . 0.0 109.671 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.827 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -71.6 -33.04 68.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.954 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.5 OUTLIER -69.76 -16.67 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.374 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.05 -14.98 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.599 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.416 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.21 17.58 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.988 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.615 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -80.15 112.63 17.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 111.006 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.887 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.3 t-160 -135.13 124.11 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.71 89.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.511 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 13.9 t -63.87 85.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.581 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . 172.57 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.871 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -38.29 113.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.656 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.84 126.39 7.64 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.563 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 75.0 m95 -58.03 149.73 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.92 0.39 . . . . 0.0 111.426 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.818 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.44 179.27 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.591 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.08 -166.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.437 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -7.22 5.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.382 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 157.58 20.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.624 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.807 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.1 mtm180 -94.68 130.61 41.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.908 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.449 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -120.8 121.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.8 -173.75 13.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.443 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -132.63 101.82 14.11 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.77 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.9 Cg_endo -61.01 -81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.804 2.336 . . . . 0.0 112.517 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 8.2 mm 75.04 106.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.887 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.82 167.56 43.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.928 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.2 mp -64.1 100.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.387 . . . . 0.0 111.42 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.635 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 10.7 mm -69.68 87.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -108.45 120.12 41.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.531 ' CE1' HG22 ' T' ' 76' ' ' ILE . 12.9 m-85 -91.06 -11.33 39.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 103.66 173.76 25.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.807 HG13 ' HG3' ' T' ' 56' ' ' ARG . 19.4 mt -61.41 122.71 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -91.71 9.54 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.764 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 59.58 38.81 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.4 OUTLIER -145.13 75.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.7 mpt_? -74.61 16.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.927 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.447 ' H ' ' C ' ' T' ' 83' ' ' ASN . 5.5 m -114.33 6.75 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.789 ' O ' HG22 ' T' ' 15' ' ' THR . 2.9 mm-40 -63.67 -171.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.73 113.61 11.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.685 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 7.8 m95 -153.55 -147.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.778 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.5 OUTLIER -106.78 -171.23 1.85 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.36 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' T' ' 14' ' ' LEU . . . -141.3 121.53 13.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.644 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.668 ' CD1' HD21 ' T' ' 36' ' ' LEU . 23.4 m-85 -90.59 110.37 21.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.443 ' O ' HG23 ' T' ' 2' ' ' VAL . 86.4 m -86.47 167.97 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.188 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.876 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 2.5 t80 -158.46 124.34 4.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.552 179.772 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.775 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 2.3 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.762 0.315 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -147.93 178.35 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.999 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 3.9 t60 -92.07 155.56 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' T' ' 5' ' ' ARG . 2.6 tpp85 -149.02 153.88 38.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.612 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.1 tt0 -125.77 173.91 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.594 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -82.65 151.68 26.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -62.33 -18.29 61.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.693 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 17.0 m -98.84 -27.74 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.654 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 151.09 167.51 14.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.43 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.508 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 14.3 tttt -60.23 153.89 21.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.8 m-30 57.37 49.61 12.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.693 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 4.2 mttm -142.28 1.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.693 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.4 mt -105.82 134.14 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.258 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.668 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.4 p -104.0 151.62 22.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.138 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.536 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.8 t80 -34.25 -44.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.99 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.668 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 15.0 mt-10 -66.38 -54.9 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.274 0.559 . . . . 0.0 109.842 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -43.51 -43.51 5.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.946 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -67.17 -37.75 84.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.69 -34.58 77.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.5 t -69.64 -53.2 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.285 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -64.31 -52.61 57.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.2 tt0 -62.52 -21.05 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.38 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -52.2 -48.86 64.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.694 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -106.0 52.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.42 38.1 56.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.235 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.84 169.82 13.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.763 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.559 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.61 140.01 44.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.952 0.405 . . . . 0.0 111.236 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.891 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.03 139.02 18.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.376 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.81 152.23 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 37.7 p -107.54 -171.38 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.557 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.762 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 55.3 t80 -70.85 -67.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.029 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.1 OUTLIER -46.79 -40.55 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.564 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.16 -54.24 27.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.279 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -58.63 -19.86 42.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.774 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 2.5 tp10 -72.34 -62.19 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.16 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.445 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.82 -15.66 9.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.757 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.573 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.22 -29.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.463 0.649 . . . . 0.0 109.753 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.748 ' HG3' HG22 ' T' ' 62' ' ' VAL . 9.8 ttt-85 -73.03 -33.47 65.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.187 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.545 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 45.5 mttt -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.427 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.573 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -86.34 -17.27 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 15.1 1.9 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.021 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.49 94.65 7.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.979 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.597 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.6 t-80 -115.17 125.99 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.745 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -147.89 100.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' HD11 ' T' ' 61' ' ' ILE . 40.5 t -75.79 65.83 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.6 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -161.91 118.61 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -39.87 121.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -123.39 121.24 4.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.731 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.536 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 84.1 m95 -54.18 162.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.798 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.891 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -155.63 174.39 15.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.392 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -53.53 160.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.286 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mtpp 78.66 -30.66 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.508 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 112.44 23.93 5.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.531 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.706 ' HG3' HG13 ' T' ' 80' ' ' ILE . 19.1 mtt180 -100.18 160.22 14.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.932 0.396 . . . . 0.0 110.809 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -149.1 107.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -108.82 -167.65 20.79 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.291 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.567 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -137.44 85.07 21.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.125 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.822 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 23.1 Cg_exo -62.76 129.04 24.9 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.887 2.391 . . . . 0.0 112.238 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.645 HD11 ' HA ' ' T' ' 47' ' ' CYS . 8.5 mm -141.39 116.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.232 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' T' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.802 0.334 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 74' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' T' ' 40' ' ' ARG . . . 71.34 -168.21 51.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.822 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 12.7 mt -76.06 124.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.897 0.379 . . . . 0.0 111.212 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.8 mm -93.29 81.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.8 120.99 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.47 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.5 m-85 -86.33 -74.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.41 169.79 36.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.232 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.706 HG13 ' HG3' ' T' ' 56' ' ' ARG . 51.8 mt -57.7 108.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.041 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 81' ' ' ARG . 7.4 mmt85 -87.09 15.46 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.545 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.77 27.95 7.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -121.97 62.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.994 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' T' ' 15' ' ' THR . 3.2 mpt_? -69.99 -0.92 8.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.81 3.24 47.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.674 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.586 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -64.79 -170.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -135.79 112.44 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.123 0.487 . . . . 0.0 111.648 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 5.2 m95 -155.44 -177.13 6.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.837 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -77.65 -173.24 2.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -140.38 133.56 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 42.1 m-85 -97.82 117.04 31.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.428 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.446 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.7 t -92.68 154.29 18.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.0 110.836 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 8.1 t80 -149.41 114.05 5.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.764 179.747 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.91 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.854 0.359 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.459 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 26.7 p90 -162.17 173.5 14.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 111.705 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.645 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.7 t60 -93.27 150.43 20.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 4.2 tpp85 -152.25 154.83 36.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.9 OUTLIER -116.13 -169.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -90.64 152.3 20.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 8' ' ' ARG . . . . . 0.405 HH22 HH12 ' T' ' 5' ' ' ARG . 3.6 mmp_? -52.86 -24.35 8.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.726 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -93.27 -47.74 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 174.75 177.98 44.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -65.42 146.75 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.852 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.544 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 7.9 m-30 63.67 61.83 0.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.053 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -155.89 6.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.0 mt -109.03 138.69 44.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.4 p -107.67 148.05 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 83.0 t80 -34.99 -39.53 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.93 61.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.373 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.583 ' OE1' HG23 ' T' ' 15' ' ' THR . 77.8 mt-10 -71.36 -46.3 60.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.226 0.536 . . . . 0.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.576 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -57.39 -37.11 72.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -75.56 -32.21 60.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.023 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.5 -45.64 75.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.361 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 2.9 t -66.83 -50.31 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.306 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 56.6 m -64.44 -45.25 88.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.7 tt0 -78.57 -6.94 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -59.07 -50.76 72.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.842 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.55 58.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.175 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.54 34.08 13.32 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.458 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.46 -172.42 18.2 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.2 134.17 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 0.258 . . . . 0.0 110.472 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.08 124.34 22.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -52.42 165.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.74 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 13.0 p -115.73 -158.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 34.2 t80 -80.41 -71.64 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.978 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.9 mttt -47.42 -37.35 11.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.79 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -67.21 -54.96 16.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.261 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.92 -21.14 27.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.754 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.1 tp10 -69.82 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.268 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.646 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.54 -19.87 11.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.787 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.29 -29.11 17.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 109.613 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.634 ' HE ' HG13 ' T' ' 62' ' ' VAL . 4.2 ttt180 -70.61 -34.31 71.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.001 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 27.2 mtmt -73.52 -17.49 61.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.219 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.646 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -88.35 -6.94 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.73 5.9 8.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.25 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.0 OUTLIER -76.0 117.36 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.702 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.14 125.82 19.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -153.21 101.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.959 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.67 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -72.09 85.75 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.335 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.42 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -177.38 115.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -39.21 108.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.774 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -107.84 122.48 6.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.668 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.623 ' HA ' ' HB ' ' T' ' 57' ' ' VAL . 71.2 m95 -52.68 171.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.701 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -166.58 162.13 16.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.512 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -45.17 159.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.631 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.8 -24.79 0.21 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.425 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.39 22.82 6.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.504 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HG3' HG13 ' T' ' 80' ' ' ILE . 37.6 mtm180 -94.91 165.82 12.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -163.12 108.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -116.64 -171.01 15.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.224 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.545 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.89 82.72 55.3 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.1 Cg_exo -59.89 119.98 7.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.765 2.31 . . . . 0.0 112.3 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.702 HG23 ' CE1' ' T' ' 45' ' ' HIS . 14.5 mm -138.9 132.56 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 74' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 72.73 -175.09 44.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.799 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.631 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 5.4 mt -73.38 117.46 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.5 mm -88.98 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.525 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 5.3 t70 -110.13 135.17 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.77 25.28 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.1 -178.49 26.2 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.862 HG22 ' H ' ' T' ' 82' ' ' LEU . 50.8 mt -61.85 119.83 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.71 6.92 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.862 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.54 33.09 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.82 78.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.688 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtt85 -62.86 -8.62 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 17.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.509 ' O ' HG22 ' T' ' 15' ' ' THR . 1.7 mm-40 -79.46 -176.21 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -134.85 115.8 14.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.054 0.454 . . . . 0.0 111.274 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 28.4 m95 -150.7 -135.05 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.083 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.42 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.8 OUTLIER -118.14 -171.83 2.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.35 179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.576 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.79 130.16 17.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.774 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.13 109.63 22.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.253 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.8 131.78 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.114 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.91 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.1 OUTLIER -131.04 113.98 14.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.541 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.816 HG22 ' CD2' ' T' ' 93' ' ' TYR . 1.6 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.721 0.296 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.3 OUTLIER -147.74 160.26 42.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.085 0.469 . . . . 0.0 111.271 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.779 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.1 t-80 -106.13 158.57 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.099 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -164.26 166.0 21.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.041 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.825 ' HG2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -123.18 -167.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.971 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -170.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.93 -34.15 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.1 t -177.29 19.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.27 160.74 23.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.825 ' HA ' ' HG2' ' T' ' 6' ' ' GLU . 1.2 tttt -98.43 158.47 15.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 111.503 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 23.7 m-85 42.46 60.2 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.494 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' T' ' 12' ' ' TYR . 1.7 mmtm -149.7 10.1 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.43 HD11 ' C ' ' T' ' 6' ' ' GLU . 17.8 mt -106.29 125.24 50.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.0 OUTLIER -99.57 145.42 27.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.008 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.6 t80 -33.56 -41.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.98 70.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.567 ' OE1' HG23 ' T' ' 15' ' ' THR . 83.8 mt-10 -72.96 -52.2 15.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.006 0.432 . . . . 0.0 110.195 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -45.82 -49.59 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.926 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -65.78 -56.99 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.0 -42.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.425 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.0 t -68.23 -50.37 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.4 m -63.71 -48.17 78.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 16.9 tt0 -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.736 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.8 OUTLIER -55.72 -51.77 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.899 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.28 58.24 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.152 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.8 27.54 9.75 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.525 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -107.88 -169.9 21.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.514 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.81 133.3 11.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.444 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -64.02 123.52 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 110.381 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.98 162.77 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.348 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.652 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 23.8 p -108.5 -164.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.754 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 20.5 t80 -75.02 -73.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.167 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mttt -48.06 -37.68 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -67.12 -55.11 15.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.56 HD11 ' HG3' ' T' ' 60' ' ' PRO . 1.7 tm? -58.07 -22.77 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.8 tt0 -70.18 -61.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.241 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -13.52 10.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.709 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -93.88 -28.5 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.484 0.659 . . . . 0.0 109.731 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 5.6 tmm_? -69.7 -32.7 71.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.863 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.5 mttm -68.67 -15.22 63.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -93.47 -17.28 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 135.72 12.17 1.21 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.866 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -79.49 100.74 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.53 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.1 t-160 -129.69 131.28 46.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.168 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.82 98.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.811 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -64.7 81.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 174.45 137.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.67 105.33 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.781 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.625 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -102.98 116.77 5.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.661 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 76.3 m95 -48.22 155.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.793 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.77 -179.61 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.593 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 49.93 -165.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.115 0.483 . . . . 0.0 111.488 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.52 0.35 4.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.471 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.509 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 155.48 14.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.672 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.7 ' HB2' ' HB3' ' T' ' 53' ' ' ALA . 5.3 mtp180 -93.37 135.98 34.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.881 0.372 . . . . 0.0 110.996 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -124.38 134.22 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.765 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.13 -174.61 17.53 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.466 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.508 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -131.11 102.39 15.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.8 Cg_endo -61.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.811 HD11 ' HA ' ' T' ' 47' ' ' CYS . 25.9 mm 74.06 105.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.636 HG22 ' HG2' ' T' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.01 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.12 172.62 47.22 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.913 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.771 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 1.6 mt -67.34 104.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.486 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.5 mm -80.16 85.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.23 132.3 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.4 m-85 -98.01 4.58 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.693 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 81.04 173.52 47.69 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.645 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.7 mt -59.38 115.8 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -87.97 21.31 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.645 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.78 36.89 25.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.68 67.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.591 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.9 OUTLIER -65.41 -4.59 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.7 t -91.52 12.82 19.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.544 ' O ' HG22 ' T' ' 15' ' ' THR . 2.3 mm-40 -68.56 -175.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.724 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 8.3 mtt180 -135.46 115.05 12.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HD1' ' T' ' 12' ' ' TYR . 21.0 m95 -151.89 -132.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.234 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.545 ' HB3' ' OE1' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -121.04 -172.88 2.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.329 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.732 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -145.3 135.13 23.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.193 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 41.1 m-85 -97.91 107.52 20.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.066 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.432 ' HB3' ' CE2' ' T' ' 3' ' ' TYR . 5.2 m -87.31 137.23 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.919 0.39 . . . . 0.0 111.077 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.816 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.3 t80 -140.91 135.51 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.73 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.8 179.882 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.947 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.479 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 25.5 p90 -155.39 170.34 22.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 111.638 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.2 t60 -90.97 153.71 19.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.962 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.454 ' N ' ' CD2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -155.78 148.32 23.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.012 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.08 -168.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.49 153.54 18.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.21 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 8' ' ' ARG . 4.0 mmt180 -61.13 -19.35 61.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -94.46 -24.53 17.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.69 167.41 11.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.555 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 8.3 ttpt -60.07 158.85 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.444 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 8.6 m-30 53.45 61.56 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.102 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -156.33 2.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.687 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -105.21 127.58 52.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.556 HG22 ' O ' ' T' ' 86' ' ' GLU . 1.1 p -99.49 149.94 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.61 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 92.0 t80 -36.18 -41.04 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -42.95 69.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' T' ' 15' ' ' THR . 85.1 mt-10 -74.15 -53.9 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.999 0.428 . . . . 0.0 110.301 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -44.96 -51.49 9.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.99 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -63.92 -55.7 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.644 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.48 -39.03 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.4 t -68.23 -51.73 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.219 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.25 -50.61 67.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.474 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 31.3 tt0 -67.07 -16.48 64.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.429 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.03 -47.87 77.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.754 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.19 53.89 0.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.53 41.78 42.37 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.426 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -121.95 168.22 14.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.432 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.22 137.49 51.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.773 0.321 . . . . 0.0 110.622 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -73.81 122.0 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -49.76 158.79 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.43 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 11.5 p -110.69 -159.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.29 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.844 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 25.7 t80 -77.02 -72.97 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.052 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 1.9 mttp -46.92 -37.23 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.556 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.45 -51.77 57.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.626 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -56.66 -23.89 44.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 110.058 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 8.4 tt0 -72.15 -61.94 1.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.473 ' HA ' ' HE3' ' T' ' 41' ' ' LYS . . . -56.02 -16.23 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.7 -29.64 15.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.396 0.617 . . . . 0.0 109.718 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -72.17 -33.1 67.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.925 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.8 OUTLIER -69.66 -16.98 63.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.574 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.61 -12.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.93 13.01 3.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.973 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.531 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.0 OUTLIER -79.9 126.48 31.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.59 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.8 t-160 -150.21 126.39 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.5 102.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.95 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.94 86.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.332 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 177.31 119.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.004 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.01 118.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.752 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.39 123.14 5.83 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.803 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.61 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.6 m95 -53.03 171.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.107 0.479 . . . . 0.0 111.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.583 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.4 ptp -168.9 173.11 7.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.49 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.33 159.6 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.652 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.5 mmtp 67.23 16.28 10.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.254 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 64.07 33.28 86.82 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.515 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.667 ' HD3' ' HA2' ' T' ' 79' ' ' GLY . 4.7 mtt180 -101.12 157.35 16.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.804 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.4 OUTLIER -154.09 115.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.126 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.97 -168.44 12.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.3 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -135.58 103.24 10.27 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.749 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 24.6 Cg_exo -61.01 -93.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.706 2.27 . . . . 0.0 112.017 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' T' ' 47' ' ' CYS . 40.0 mm 75.24 110.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.797 0.332 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.47 175.96 41.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.938 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -75.04 95.44 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 111.01 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.569 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 18.9 mm -68.06 81.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -108.1 120.42 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.805 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.497 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.9 m-85 -84.83 13.99 5.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 72.86 179.17 35.61 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.179 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.697 HG22 ' H ' ' T' ' 82' ' ' LEU . 40.6 mt -62.05 119.81 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -95.85 14.26 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.697 ' H ' HG22 ' T' ' 80' ' ' ILE . 2.9 mm? 53.73 34.32 18.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.44 ' HB3' ' CG ' ' T' ' 86' ' ' GLU . 0.5 OUTLIER -137.65 67.13 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.989 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -63.94 -3.18 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.03 8.17 43.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.556 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -60.59 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.1 113.05 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 111.305 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.47 ' CD1' HG21 ' T' ' 57' ' ' VAL . 27.9 m95 -151.62 -133.52 0.05 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.555 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -121.91 -170.84 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -146.86 130.69 17.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.752 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.82 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.316 . . . . 0.0 110.457 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.406 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.2 m -83.8 130.24 34.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 110.952 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.947 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -130.44 121.55 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.925 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 179.735 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.807 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -144.62 -179.94 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.853 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.668 ' CG ' HG11 ' T' ' 46' ' ' VAL . 20.3 t-80 -92.88 154.72 18.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.181 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.438 ' HD2' HH11 ' T' ' 5' ' ' ARG . 0.4 OUTLIER -147.33 147.98 30.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.986 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.654 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.5 tt0 -120.14 173.36 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -75.4 168.52 19.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -21.88 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -47.99 4.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 177.17 176.57 45.39 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.559 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.552 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.2 ttpm? -59.08 151.72 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.5 m-30 52.34 75.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -158.04 -5.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' T' ' 7' ' ' ALA . 0.7 OUTLIER -115.01 164.93 13.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.07 0.462 . . . . 0.0 111.275 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.852 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 6.6 p -116.56 -166.19 1.13 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.347 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.597 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.9 t80 -66.44 -40.45 89.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.062 0.458 . . . . 0.0 109.767 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.75 65.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.72 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.852 ' HB2' ' H ' ' T' ' 15' ' ' THR . 54.6 mt-10 -69.16 -42.83 75.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.278 0.561 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -58.42 -40.81 83.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.925 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -31.41 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -63.93 -46.58 84.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.26 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.84 -48.02 83.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 55.4 m -64.63 -51.19 63.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.771 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -70.88 -11.98 61.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.81 -50.03 73.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.841 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -104.2 57.4 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.27 38.37 26.18 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.247 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.636 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -106.66 178.33 22.32 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.655 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -144.52 133.37 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.917 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.5 OUTLIER -47.77 141.63 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.406 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -85.99 143.37 28.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 32.2 p -98.35 -170.68 2.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 111.576 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 37.9 t80 -70.98 -70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.884 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 12.0 mttt -45.62 -38.38 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.494 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.425 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 84.5 mt-30 -66.62 -55.45 15.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.063 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.563 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.78 -19.86 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.696 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.771 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.7 tt0 -74.74 -62.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.254 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.665 ' HA ' ' HD2' ' T' ' 41' ' ' LYS . . . -55.68 -15.44 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.91 -28.45 15.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.621 . . . . 0.0 109.656 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.588 ' HG3' HG22 ' T' ' 62' ' ' VAL . 50.8 ttp85 -72.33 -36.13 68.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.215 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -67.3 -19.36 65.46 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.636 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.597 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -85.79 -16.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.32 14.18 2.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.965 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.09 117.63 22.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.828 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.9 t-160 -138.42 128.36 25.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.668 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -148.43 102.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.773 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.35 67.24 1.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.599 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . -165.06 121.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.556 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.18 112.7 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.172 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.721 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.18 121.89 5.95 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.778 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 80.6 m95 -57.0 165.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.139 0.495 . . . . 0.0 111.831 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.917 ' HA ' HD22 ' T' ' 30' ' ' LEU . 1.0 OUTLIER -159.15 165.34 33.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.324 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.16 158.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.5 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 79.53 -25.22 0.19 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.501 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.582 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.35 20.74 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.507 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.717 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 0.2 OUTLIER -94.4 160.94 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.902 0.382 . . . . 0.0 111.006 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -158.22 109.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.17 -168.25 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.315 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.556 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -132.84 86.38 43.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 111.144 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.821 ' HB3' HG12 ' T' ' 75' ' ' ILE . 32.9 Cg_endo -67.0 118.42 5.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.666 2.244 . . . . 0.0 111.955 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.773 HD11 ' HA ' ' T' ' 47' ' ' CYS . 31.6 mm -134.17 119.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.828 0.347 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.31 -171.0 54.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.866 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.821 HG12 ' HB3' ' T' ' 60' ' ' PRO . 10.0 mt -82.63 121.78 36.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.6 mm -95.1 82.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.44 114.18 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 3.4 m-85 -78.91 -27.25 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 115.35 169.9 16.01 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.472 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.5 mt -53.48 105.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.293 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -90.34 20.29 4.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.956 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' T' ' 82' ' ' LEU . 0.5 OUTLIER 49.45 39.99 17.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.872 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 83' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -126.37 53.84 1.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtm180 -68.13 10.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 85' ' ' SER . . . . . 0.509 ' H ' ' C ' ' T' ' 83' ' ' ASN . 68.0 m -115.66 8.72 15.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.632 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.781 ' O ' HG22 ' T' ' 15' ' ' THR . 3.1 mm-40 -74.43 -170.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.55 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.402 ' HG3' ' C ' ' T' ' 86' ' ' GLU . 0.0 OUTLIER -136.53 115.95 12.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 111.592 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.772 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 4.4 m95 -154.44 -155.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.106 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.631 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -100.12 -172.39 2.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.184 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -143.01 131.18 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.74 0.305 . . . . 0.0 111.452 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.721 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 40.4 m-85 -96.02 113.91 25.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.123 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.402 ' O ' HG23 ' T' ' 2' ' ' VAL . 18.9 m -89.68 153.18 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.807 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 11.2 t80 -141.37 133.02 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.636 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 4.4 m-20 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.634 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.69 0.281 . . . . 0.0 111.317 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 3' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -142.75 151.02 40.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.488 . . . . 0.0 111.378 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.495 ' CD2' HG21 ' T' ' 46' ' ' VAL . 15.0 t-80 -90.88 145.16 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' T' ' 4' ' ' HIS . 5.1 mmm180 -153.82 151.08 29.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.215 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.37 -169.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.792 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -83.44 151.38 25.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 8' ' ' ARG . . . . . 0.439 HH12 HH22 ' T' ' 5' ' ' ARG . 6.6 mmt-85 -54.07 -26.39 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -91.72 -49.66 6.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -179.66 176.69 47.77 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 3.2 ttpm? -68.56 162.03 26.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.794 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.6 m-30 52.07 44.12 29.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.72 5.95 2.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.792 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.7 mt -108.98 142.67 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.076 0.465 . . . . 0.0 111.514 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.2 p -114.7 152.13 32.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.947 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.649 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.0 t80 -38.41 -39.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.82 -40.48 72.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' T' ' 15' ' ' THR . 84.3 mt-10 -75.24 -51.48 13.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.18 -48.96 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.057 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.526 ' HD2' HD23 ' T' ' 30' ' ' LEU . 5.5 tttt -64.91 -52.84 54.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.21 -36.59 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.309 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 7.1 t -70.74 -54.84 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.81 -47.63 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 37.7 tt0 -70.66 -17.43 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.602 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.2 -48.22 68.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.75 54.21 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.943 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.15 42.95 24.88 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.261 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -123.28 174.63 16.56 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -127.75 141.52 51.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.633 0.254 . . . . 0.0 110.605 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.64 125.18 28.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.451 . . . . 0.0 110.071 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 1.058 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.2 152.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.714 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.563 HG23 ' OE1' ' T' ' 35' ' ' GLN . 9.7 p -109.72 -157.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.645 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 22.9 t80 -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.166 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.6 mttm -47.76 -35.96 10.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 35' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.5 mt-30 -67.33 -56.1 11.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.359 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.614 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.6 tm? -56.45 -24.01 42.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 14.1 tp10 -66.49 -62.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.75 -13.99 12.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.639 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.06 -28.2 15.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.448 0.642 . . . . 0.0 109.613 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.563 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -71.06 -32.92 69.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.896 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -67.14 -17.83 65.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.187 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.639 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.82 -18.52 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.499 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 133.89 15.78 1.17 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.865 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.3 OUTLIER -83.46 79.69 9.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.991 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.601 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.5 t-160 -111.93 128.39 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.634 HG22 ' OH ' ' T' ' 91' ' ' TYR . 2.0 m -147.02 111.65 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.081 0.467 . . . . 0.0 110.991 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.722 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -76.12 77.41 2.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.926 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.81 126.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.25 121.29 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.694 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -117.36 120.77 4.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.4 m95 -53.93 166.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.427 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.669 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -162.32 171.36 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.528 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.32 166.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.381 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 77.02 -28.8 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 106.68 18.74 10.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.65 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.786 ' HB3' HG13 ' T' ' 80' ' ' ILE . 3.5 ptp85 -105.34 158.76 16.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 110.547 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.3 OUTLIER -146.25 122.01 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -117.9 -168.41 14.45 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.489 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -131.01 88.08 46.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 111.038 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.925 ' HB3' HG12 ' T' ' 75' ' ' ILE . 56.3 Cg_endo -73.55 123.3 8.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.822 2.348 . . . . 0.0 112.193 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.722 HD11 ' HA ' ' T' ' 47' ' ' CYS . 17.6 mm -136.32 97.66 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.425 HG12 ' ND1' ' T' ' 45' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.95 -169.51 54.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.766 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' T' ' 60' ' ' PRO . 22.6 mt -80.45 122.09 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.489 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.2 mm -96.18 80.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.876 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.507 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 4.1 t70 -110.64 131.12 55.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.8 m-85 -100.33 25.22 7.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.982 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.16 178.58 8.75 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.786 HG13 ' HB3' ' T' ' 56' ' ' ARG . 3.6 mt -65.17 126.67 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 111.194 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -106.62 19.64 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.789 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.67 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 56.12 32.23 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.8 54.95 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' T' ' 15' ' ' THR . 1.4 mtt85 -65.21 -1.93 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.97 11.51 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.515 ' O ' HG22 ' T' ' 15' ' ' THR . 3.0 mm-40 -72.96 -171.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -137.01 115.97 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.387 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.583 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.2 m95 -150.75 -138.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.141 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -112.24 -170.71 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.08 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.472 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.5 126.56 15.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.415 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 1.058 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 30.5 m-85 -97.36 126.81 42.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.898 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.488 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -100.23 162.84 12.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.872 0.368 . . . . 0.0 110.932 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.619 ' CD2' HG22 ' T' ' 2' ' ' VAL . 21.2 t80 -156.11 118.8 4.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.797 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.698 179.735 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.911 ' HB ' ' HD1' ' T' ' 93' ' ' TYR . 2.3 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -160.32 178.98 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.993 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.406 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.1 t-80 -89.11 155.88 19.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.3 OUTLIER -148.81 152.02 35.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.647 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.6 tt0 -122.53 172.79 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.23 158.76 26.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -61.27 -26.99 68.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.9 t -91.81 -50.53 5.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 178.39 172.8 43.17 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.421 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.9 ttpt -66.22 161.94 21.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.737 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.642 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.2 m-30 55.7 53.89 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 8.3 mtmt -154.68 3.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.0 mt -102.43 132.41 48.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 30.3 p -103.47 148.85 25.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.538 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 84.2 t80 -35.66 -38.1 0.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.46 -44.97 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.457 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' T' ' 15' ' ' THR . 64.2 mt-10 -73.05 -47.69 42.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.17 0.51 . . . . 0.0 110.348 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.98 -45.3 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.077 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.91 -47.13 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.58 -47.59 19.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 22' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.7 t -68.19 -53.27 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 87.7 m -59.89 -38.39 82.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.1 tt0 -90.08 -2.64 58.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 1.2 t80 -59.41 -48.13 82.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.95 60.59 2.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.24 22.41 10.14 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.509 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.771 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.96 -158.27 12.56 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 3.7 p80 -155.04 -178.46 7.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.756 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -103.29 124.95 49.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.642 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.84 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -46.02 157.57 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.543 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -111.29 -162.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.894 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 50.0 t80 -75.25 -68.17 0.58 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.945 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 2.2 mtpm? -47.21 -45.28 23.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.28 -49.35 76.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.881 0.372 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -54.92 -29.44 56.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.106 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.0 tt0 -65.05 -61.84 1.91 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.473 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.58 -12.1 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.578 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.73 -29.86 14.58 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.423 0.63 . . . . 0.0 109.892 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.632 ' HE ' HG12 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -72.98 -33.99 66.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.07 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.9 mttt -69.85 -17.49 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.408 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.578 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.5 -17.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.8 11.51 1.43 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.7 129.63 34.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.3 t-160 -146.24 125.56 13.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.711 HG21 ' HE1' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -142.99 98.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.122 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.716 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.47 -0.13 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.566 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -102.64 141.77 34.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.676 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -58.79 114.23 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.87 117.43 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.707 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.3 m95 -52.38 166.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 111.435 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.773 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.9 ptp -164.55 173.24 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.484 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.58 ' HB2' HG22 ' T' ' 32' ' ' THR . . . -51.11 167.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.424 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.13 -28.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.266 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 104.8 18.6 12.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.571 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.564 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.8 ptt180 -105.03 158.67 16.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.701 0.286 . . . . 0.0 110.581 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -142.07 122.86 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.72 -168.43 12.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.676 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -145.51 90.84 5.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.162 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.574 ' HG3' HD12 ' T' ' 36' ' ' LEU . 58.4 Cg_endo -74.9 134.95 18.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.659 2.24 . . . . 0.0 112.179 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm -126.67 145.13 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.632 HG12 ' HE ' ' T' ' 40' ' ' ARG . 4.1 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.087 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.67 -169.91 33.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.057 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.894 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -72.79 101.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.667 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.3 mm -72.05 81.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.07 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.72 137.32 49.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.727 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.451 ' HE1' HG22 ' T' ' 76' ' ' ILE . 0.8 OUTLIER -105.05 28.44 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.59 171.28 3.36 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.8 mt -69.84 119.01 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.9 15.4 2.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.689 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.09 43.66 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -164.76 82.26 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.24 -1.15 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.0 13.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.591 ' O ' HG22 ' T' ' 15' ' ' THR . 3.8 mm-40 -76.84 -177.15 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.7 OUTLIER -134.55 113.29 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.503 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.642 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.7 m95 -153.32 -160.34 1.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.168 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.566 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -92.42 -170.91 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.556 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -141.04 128.62 21.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 23.4 m-85 -91.07 107.86 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.92 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 92' ' ' CYS . . . . . 0.486 ' O ' HG23 ' T' ' 2' ' ' VAL . 3.7 m -88.28 149.32 23.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 111.213 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.911 ' HD1' ' HB ' ' T' ' 2' ' ' VAL . 61.8 t80 -136.47 132.1 34.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.666 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.955 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -156.41 176.21 13.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.021 0.439 . . . . 0.0 111.405 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.775 ' CG ' HG11 ' T' ' 46' ' ' VAL . 39.3 t-80 -98.65 163.79 12.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.447 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.88 146.38 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 0.4 OUTLIER -109.23 -168.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 110.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -95.48 150.67 20.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.08 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -25.66 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -92.13 -48.94 6.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 170.66 172.7 37.23 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 1.4 tttt -58.97 151.02 22.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.618 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 9.3 m-30 61.77 58.67 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.04 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -155.17 5.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.634 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 5.7 mt -109.0 133.1 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.289 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.4 p -104.8 149.32 25.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.286 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 78.3 t80 -35.44 -40.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.982 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.15 -45.25 67.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.525 ' OE1' HG23 ' T' ' 15' ' ' THR . 74.5 mt-10 -72.48 -47.62 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.03 -45.44 52.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -71.08 -50.77 30.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -48.7 -38.69 22.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.24 -53.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.487 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 66.4 m -64.34 -27.18 68.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 23.5 tt0 -98.9 -9.03 24.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.155 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.5 t80 -53.73 -42.96 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.081 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.71 60.23 0.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.268 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.79 26.2 10.52 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.538 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -106.57 -169.29 22.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.561 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -155.71 134.05 11.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.418 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -65.04 125.34 24.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.079 0.466 . . . . 0.0 110.387 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -53.02 161.4 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 26.3 p -109.34 -164.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.207 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.638 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 28.4 t80 -74.91 -72.59 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.143 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mtpt -48.23 -40.21 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.913 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.95 -51.19 63.17 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.601 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 6.5 tp10 -54.71 -60.37 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.232 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.51 14.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.862 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.611 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -90.62 -27.93 18.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 109.723 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.2 OUTLIER -72.23 -33.27 67.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.053 179.339 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.601 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 8.4 mttp -68.99 -17.78 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.396 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.611 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.46 -15.9 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.433 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.22 14.9 2.13 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.068 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.581 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -81.95 99.25 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.669 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.3 OUTLIER -121.73 119.78 32.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -141.3 94.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' T' ' 48' ' ' ALA . 6.5 t -64.37 89.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 171.91 127.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -46.46 101.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -101.66 111.11 4.0 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.676 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 74.2 m95 -44.65 157.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.983 0.42 . . . . 0.0 111.294 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.792 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -174.83 178.13 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.14 -166.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.12 0.4 3.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.305 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.435 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 156.81 13.15 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.739 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.846 ' HG3' HG13 ' T' ' 80' ' ' ILE . 4.4 mtt-85 -90.45 130.76 36.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.443 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -125.08 129.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.961 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 58' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -135.17 -175.74 14.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.329 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.43 78.93 14.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.756 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.7 Cg_exo -63.12 124.59 14.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.758 2.305 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.5 HG23 ' CE1' ' T' ' 45' ' ' HIS . 38.6 mm -130.51 153.3 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 15.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.347 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.62 179.55 50.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.872 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.638 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.7 mt -73.42 111.56 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.542 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.3 mm -91.05 80.15 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 77' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.4 t70 -103.29 129.18 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -94.41 15.84 16.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 79' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 71.22 169.6 9.81 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.846 HG13 ' HG3' ' T' ' 56' ' ' ARG . 10.6 mt -59.36 112.68 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.983 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 81' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' T' ' 81' ' ' ARG . 2.2 mmp_? -91.57 21.05 4.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.576 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 51.66 50.82 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.61 66.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.654 ' O ' ' HB ' ' T' ' 15' ' ' THR . 19.3 mtm105 -66.67 -3.58 6.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m -98.19 18.62 15.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.532 ' O ' HG22 ' T' ' 15' ' ' THR . 3.3 mm-40 -74.87 -171.25 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.5 114.48 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.56 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 22.8 m95 -151.68 -134.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.378 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -121.64 -172.12 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.379 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.531 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.15 137.23 25.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 28.9 m-85 -101.67 107.65 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -85.85 133.83 33.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 111.327 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.955 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.9 OUTLIER -132.57 124.55 28.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.676 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' T' T ' 2' ' ' VAL . . . . . 0.811 HG22 ' HE2' ' T' ' 44' ' ' PHE . 1.3 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.93 169.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 4' ' ' HIS . . . . . 0.522 ' HB2' HG11 ' T' ' 46' ' ' VAL . 9.7 t-80 -96.76 145.7 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.764 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 5' ' ' ARG . . . . . 0.435 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -152.47 166.4 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 6' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.6 OUTLIER -123.3 -170.15 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.66 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 7' ' ' ALA . . . . . 0.667 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.31 150.69 24.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -19.26 61.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 9' ' ' SER . . . . . 0.461 ' HB3' ' CE ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -97.33 -25.89 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 10' ' ' GLY . . . . . 0.658 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 152.51 168.12 16.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -61.85 153.89 27.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.702 0.287 . . . . 0.0 110.855 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 12' ' ' TYR . . . . . 0.766 ' HB3' ' HD2' ' T' ' 87' ' ' ARG . 10.2 m-30 55.52 51.55 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 1.0 OUTLIER -142.28 2.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.636 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 14' ' ' LEU . . . . . 0.667 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.8 mt -105.78 141.23 37.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 15' ' ' THR . . . . . 0.625 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 49.4 p -110.51 149.71 29.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.4 t80 -34.91 -40.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.07 61.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.409 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 18' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.0 mt-10 -68.61 -44.04 75.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 109.966 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.06 -39.22 74.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.972 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 20' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' T' ' 24' ' ' GLU . 10.5 tttm -75.51 -38.22 59.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.106 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 21' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -56.06 -50.01 72.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.81 -53.76 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.42 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 23' ' ' CYS . . . . . 0.635 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 88.3 m -63.31 -26.96 69.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 24' ' ' GLU . . . . . 0.789 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 22.3 tt0 -103.39 1.59 32.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.232 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 25' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -63.71 -43.33 96.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.203 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -100.53 61.26 1.02 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.39 19.97 6.68 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.619 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 28' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.26 -159.97 13.9 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 29' ' ' HIS . . . . . 0.635 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 5.7 p80 -152.88 -177.56 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.996 0.427 . . . . 0.0 110.657 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -101.6 124.06 46.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.6 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 31' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -44.92 154.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.571 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 32' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 6.9 p -108.31 -158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 33' ' ' TYR . . . . . 0.921 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 35.2 t80 -80.99 -73.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.112 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 34' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 20.8 mtmt -44.83 -36.85 3.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.82 -53.1 36.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 36' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.89 -21.13 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.138 0.494 . . . . 0.0 109.984 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 9.3 tt0 -72.63 -61.97 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 38' ' ' ALA . . . . . 0.554 ' HA ' ' HE2' ' T' ' 41' ' ' LYS . . . -58.43 -15.58 11.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 39' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' T' ' 44' ' ' PHE . . . -94.02 -29.73 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.537 0.684 . . . . 0.0 109.578 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 40' ' ' ARG . . . . . 0.658 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -69.06 -32.56 72.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.863 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 41' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' T' ' 38' ' ' ALA . 28.7 mtmt -66.61 -17.85 65.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 42' ' ' ILE . . . . . 0.658 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -92.1 -22.47 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 43' ' ' GLY . . . . . 0.577 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 138.61 17.88 0.56 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.96 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 44' ' ' PHE . . . . . 0.811 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.5 OUTLIER -74.75 86.76 2.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.778 0.323 . . . . 0.0 110.876 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 45' ' ' HIS . . . . . 0.626 ' NE2' HG23 ' T' ' 61' ' ' ILE . 3.5 t-160 -115.36 122.84 47.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.97 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 46' ' ' VAL . . . . . 0.671 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.7 OUTLIER -148.54 112.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 47' ' ' CYS . . . . . 0.926 ' HA ' HD11 ' T' ' 61' ' ' ILE . 1.8 t -82.76 74.38 9.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 48' ' ' ALA . . . . . 0.657 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -176.54 123.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 49' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -42.85 116.68 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 50' ' ' GLY . . . . . 0.665 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.17 117.42 3.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 51' ' ' TRP . . . . . 0.584 ' C ' HD11 ' T' ' 30' ' ' LEU . 75.3 m95 -50.66 166.47 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 52' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 2.0 ptp -162.18 168.61 22.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.362 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 53' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.67 165.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.541 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 54' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mmtp 78.76 -33.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.375 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 111.45 17.22 8.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.695 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 56' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.8 OUTLIER -105.23 157.25 17.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.579 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 57' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -139.39 125.75 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.312 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.23 -168.01 12.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.149 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 59' ' ' TYR . . . . . 0.538 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -144.59 98.32 4.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 60' ' ' PRO . . . . . 0.689 ' HB3' HD13 ' T' ' 75' ' ' ILE . 78.5 Cg_endo -83.41 129.45 5.08 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.814 2.343 . . . . 0.0 112.183 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 61' ' ' ILE . . . . . 0.926 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.4 mm -141.13 111.61 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 62' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.4 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.5 -173.1 33.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 75' ' ' ILE . . . . . 0.921 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -79.78 98.39 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 76' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' T' ' 78' ' ' TYR . 16.0 mm -70.9 79.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.69 117.62 34.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.874 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 78' ' ' TYR . . . . . 0.541 ' CE1' HG22 ' T' ' 76' ' ' ILE . 0.6 OUTLIER -81.14 11.86 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.64 169.41 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 80' ' ' ILE . . . . . 0.606 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.8 mt -52.87 136.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.027 0.441 . . . . 0.0 111.251 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.31 17.08 14.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.018 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 82' ' ' LEU . . . . . 0.606 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 49.54 50.27 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.33 55.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 84' ' ' ARG . . . . . 0.543 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -56.09 -12.52 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.4 15.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 86' ' ' GLU . . . . . 0.565 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.7 mm-40 -78.82 -171.68 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 87' ' ' ARG . . . . . 0.766 ' HD2' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -136.18 113.2 10.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 88' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 3.4 m95 -156.26 179.49 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.056 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 89' ' ' ASP . . . . . 0.657 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -73.83 -170.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.323 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' T' T ' 90' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.08 132.23 19.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.598 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 91' ' ' TYR . . . . . 0.875 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 45.5 m-85 -94.08 115.57 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.63 151.67 21.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 111.331 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' T' T ' 93' ' ' TYR . . . . . 0.665 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 12.0 t80 -148.3 118.88 7.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' T' T ' 94' ' ' ASN . . . . . 0.408 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 59.3 m-20 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 1' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' T' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.64 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -109.98 134.85 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 137.01 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.734 ' CG ' HG11 ' T' ' 46' ' ' VAL . 17.6 t-80 -69.22 150.35 47.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.518 ' HG3' ' SG ' ' T' ' 92' ' ' CYS . 11.0 mmt180 -144.21 144.86 31.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.402 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -115.88 -168.97 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.877 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.13 153.55 18.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -17.45 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.758 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -101.22 -25.2 14.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 142.3 166.29 10.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.465 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.4 ttpm? -56.72 151.97 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 18.8 m-30 63.16 55.39 1.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.589 ' HA ' ' HD2' ' T' ' 87' ' ' ARG . 9.8 mttt -154.5 1.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.669 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.08 134.88 46.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 4.6 p -105.1 148.06 27.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.117 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -35.34 -38.68 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.46 -44.13 65.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' T' ' 15' ' ' THR . 72.0 mt-10 -73.13 -48.24 37.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 110.39 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.608 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.83 -45.59 50.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.036 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.15 -55.7 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -42.18 -38.17 1.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.48 -49.91 49.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 46.2 m -64.0 -51.66 63.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.1 tt0 -69.83 -15.81 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -52.52 -50.94 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.51 53.75 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.25 34.15 32.33 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.235 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -103.71 -178.49 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.614 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -147.07 135.52 21.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.014 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.39 143.73 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.228 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.77 142.25 30.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.421 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 33.5 p -98.84 -170.97 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.501 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.776 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 58.1 t80 -70.63 -68.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.104 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 5.2 mmtp -49.42 -37.75 26.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.764 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.2 mt-30 -67.69 -57.08 6.99 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.258 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.643 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.2 tm? -58.59 -21.36 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 10.3 tt0 -70.26 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.581 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.25 -22.52 18.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.57 -29.33 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.478 0.656 . . . . 0.0 109.442 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.657 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 3.1 tmm_? -69.62 -35.3 75.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.641 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 3.1 mtmp? -71.73 -13.27 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.581 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.4 pt -97.26 -16.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.491 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.417 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.92 9.17 1.14 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.421 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.679 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.4 OUTLIER -75.87 91.13 2.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.986 0.393 . . . . 0.0 110.825 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HB2' HG23 ' T' ' 62' ' ' VAL . 1.5 t-80 -123.24 129.07 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.734 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.21 98.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.283 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.703 ' HA ' HD11 ' T' ' 61' ' ' ILE . 6.1 t -66.27 80.68 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.435 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.66 136.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.695 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.29 112.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.66 118.64 5.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.668 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.531 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.9 m95 -52.36 150.1 5.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.444 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.827 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.85 176.17 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.643 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.0 -165.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.619 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -8.85 9.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.533 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 159.93 18.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.047 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.643 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 6.2 ptp180 -95.07 132.53 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.616 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -121.42 121.0 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.94 -168.93 14.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.2 OUTLIER -133.94 76.99 63.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.864 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_exo -59.39 122.35 11.37 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.792 2.328 . . . . 0.0 112.379 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.703 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.8 mm -139.87 110.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -88.87 -14.88 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -126.73 98.14 31.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.604 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 70.7 Cg_exo -48.73 105.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.555 2.17 . . . . 0.0 112.368 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.16 161.92 53.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.76 -39.8 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.933 2.422 . . . . 0.0 111.954 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.19 -22.43 7.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.819 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -83.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 -1.82 88.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.903 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 64.75 2.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 111.12 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 110.46 44.62 0.97 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.819 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.776 ' HD2' HG13 ' T' ' 76' ' ' ILE . 8.5 mmtm -87.14 157.18 19.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.772 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 130.64 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.11 -168.03 30.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.893 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 33.5 mt -75.39 125.98 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.359 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.776 HG13 ' HD2' ' T' ' 72' ' ' LYS . 5.1 mm -95.95 81.34 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.43 133.51 54.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' T' ' 76' ' ' ILE . 16.8 m-85 -110.76 -6.8 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.79 174.01 25.69 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.8 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.5 mt -55.56 157.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.405 ' N ' HG22 ' T' ' 80' ' ' ILE . 6.5 mtm180 -120.75 11.01 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.8 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.0 44.34 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -168.55 75.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.821 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -66.88 -5.87 14.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.038 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 77.3 p -73.67 10.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.575 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 4.4 mm-40 -75.3 177.42 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.718 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.589 ' HD2' ' HA ' ' T' ' 13' ' ' LYS . 2.8 mtm180 -131.69 113.53 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 111.315 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.672 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.5 m95 -151.87 -153.46 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.203 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.435 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.82 -171.79 2.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.424 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.84 119.22 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.481 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.837 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 33.6 m-85 -86.77 116.2 24.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' T' ' 5' ' ' ARG . 1.3 m -93.48 155.31 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 111.205 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.9 t80 -153.6 99.31 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.587 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.992 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 0.7 OUTLIER -126.14 135.91 27.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.515 ' HD3' ' NE2' ' T' ' 29' ' ' HIS . 52.2 Cg_exo -51.63 -33.29 48.21 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.427 2.084 . . . . 0.0 111.848 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -131.31 -27.34 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.966 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.992 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 37.07 58.24 1.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.307 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.855 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.4 p -89.09 147.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.872 0.368 . . . . 0.0 111.269 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 24.8 p90 -151.91 -176.53 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.783 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.821 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.2 t-80 -109.21 157.68 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 2.1 mmt180 -156.33 148.97 23.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' T' ' 6' ' ' GLU . 2.9 pm0 -112.54 -173.21 2.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.772 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -91.38 158.4 16.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.179 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -61.09 -20.51 62.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' T' ' 13' ' ' LYS . 32.9 m -95.28 -28.54 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.65 167.11 12.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.44 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.454 ' HD2' ' CB ' ' T' ' 48' ' ' ALA . 1.6 ttpm? -56.65 152.13 12.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 19.3 m-30 63.79 54.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' T' ' 9' ' ' SER . 53.7 mttt -152.76 5.77 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.678 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.2 mt -109.19 130.23 55.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.048 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.641 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.2 p -103.09 150.47 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.257 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.528 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 85.9 t80 -35.29 -43.14 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.724 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.641 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 13.8 mt-10 -68.07 -56.29 9.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -44.2 -39.04 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -70.24 -38.36 75.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -60.94 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.52 -48.11 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -66.19 -54.87 20.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.349 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -71.66 -1.58 14.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.701 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -65.1 -48.67 72.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -115.62 63.96 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.242 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.68 45.53 54.59 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.335 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.643 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -115.88 177.53 17.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.535 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -149.65 133.9 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 110.958 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.03 141.22 6.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.328 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.92 146.25 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.463 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 43.6 p -100.93 -172.29 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.92 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 69.8 t80 -70.93 -64.9 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -49.12 -39.33 28.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.536 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.435 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.5 mt-30 -65.64 -53.06 46.62 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.488 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.36 -27.23 62.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.001 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.13 -59.67 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.426 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.422 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.37 -19.45 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.633 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.39 -32.94 15.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.457 0.646 . . . . 0.0 109.681 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.853 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -70.53 -33.35 71.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.871 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -66.09 -21.13 66.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.98 -23.19 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 110.391 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.591 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 141.33 16.26 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.126 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.683 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -75.91 132.41 40.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.904 0.352 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.54 ' CE1' ' HG3' ' T' ' 63' ' ' LYS . 2.6 t-160 -156.11 124.22 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.821 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.78 89.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.82 74.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.675 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.454 ' CB ' ' HD2' ' T' ' 11' ' ' LYS . . . -175.77 119.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.785 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -37.42 114.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.295 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -114.25 121.3 5.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.545 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.528 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.5 m95 -54.68 148.58 12.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.113 0.482 . . . . 0.0 111.634 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.808 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.94 178.81 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.636 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.22 -165.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.468 . . . . 0.0 111.509 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -7.86 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 160.22 18.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.811 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.5 mtp180 -92.78 134.79 34.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -129.92 111.8 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -113.89 -172.26 17.89 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.271 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -122.91 81.45 50.13 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 0.0 111.016 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.0 Cg_exo -59.77 126.2 19.84 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.686 2.258 . . . . 0.0 112.164 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.497 HG23 ' CE1' ' T' ' 45' ' ' HIS . 25.3 mm -131.59 134.31 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.225 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.853 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -102.53 -38.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.54 ' HG3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -126.03 105.94 25.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.733 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.489 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 73.8 Cg_exo -46.69 129.61 14.34 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.829 2.353 . . . . 0.0 112.519 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.28 -171.68 16.78 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.455 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -86.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.76 2.306 . . . . 0.0 112.471 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.78 10.33 7.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.46 23.03 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.855 ' HA3' ' HD2' ' T' ' 72' ' ' LYS . . . 112.02 36.67 1.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.933 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 t80 44.12 44.02 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.019 0.437 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 68.79 71.23 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.709 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.855 ' HD2' ' HA3' ' T' ' 69' ' ' GLY . 6.0 mttp -88.05 155.1 19.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.87 132.09 54.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.218 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.44 168.69 7.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.093 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.92 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.5 mp -62.37 105.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.734 HG13 ' HD3' ' T' ' 72' ' ' LYS . 7.0 mm -73.96 82.29 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.09 120.12 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.417 ' CE1' HG22 ' T' ' 76' ' ' ILE . 7.9 m-85 -87.36 -35.42 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.23 169.66 12.55 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.724 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.0 mt -61.22 115.42 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.0 mmt85 -84.31 11.13 8.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.688 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.25 46.24 16.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.786 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.74 77.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.665 HH21 ' HA ' ' T' ' 82' ' ' LEU . 0.3 OUTLIER -72.4 7.34 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.822 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.43 7.16 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.585 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -66.36 -173.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.93 113.07 11.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.446 . . . . 0.0 111.517 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.597 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.7 m95 -154.47 -166.69 2.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.118 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.451 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -84.34 -173.55 4.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.448 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.26 118.92 10.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.397 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.717 ' CD1' HD21 ' T' ' 36' ' ' LEU . 39.1 m-85 -88.4 113.95 24.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.403 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.431 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 2.0 t -93.89 159.8 15.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.855 0.36 . . . . 0.0 111.05 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.855 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 14.3 t80 -145.11 134.15 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 6.9 m-20 -152.76 141.33 13.99 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.34 -33.26 36.45 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.481 2.121 . . . . 0.0 111.847 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' T' ' 97' ' ' ALA . 11.9 m-70 -119.49 -34.29 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.574 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 33.59 64.66 0.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.325 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.9 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.952 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.55 148.87 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.534 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 17.3 p90 -157.53 177.42 11.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.203 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.79 ' CG ' HG11 ' T' ' 46' ' ' VAL . 37.9 t-80 -97.66 160.09 14.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.501 ' HE ' ' HB2' ' T' ' 5' ' ' ARG . 0.0 OUTLIER -157.11 147.26 20.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.3 OUTLIER -112.52 -168.43 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.731 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -102.6 155.92 17.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.14 -17.72 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 p -98.47 -25.59 14.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.53 166.94 10.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.1 ttpm? -57.41 152.03 15.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 17.7 m-30 61.41 56.28 2.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.142 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -155.12 8.53 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.573 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.731 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.3 mt -110.63 132.32 54.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.291 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.728 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.7 p -103.0 146.54 28.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.141 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.608 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.5 t80 -33.93 -39.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.31 -45.2 70.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' T' ' 15' ' ' THR . 73.4 mt-10 -73.8 -49.9 23.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.39 -41.1 27.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.989 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -50.1 22.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.931 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.71 -40.99 30.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.409 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 6.8 t -70.49 -54.31 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.452 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 63.4 m -60.77 -42.04 96.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.923 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 10.0 tt0 -81.8 -10.25 59.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 0.9 OUTLIER -54.23 -50.89 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.003 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -96.62 61.37 1.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.92 30.72 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.418 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -111.56 -169.31 18.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.502 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.15 135.26 13.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.592 0.234 . . . . 0.0 110.441 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.19 125.43 26.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.463 . . . . 0.0 110.235 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.21 163.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.546 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 5.9 p -111.21 -158.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.752 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 30.9 t80 -79.89 -74.19 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.2 mttt -47.19 -36.35 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.73 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.31 -53.95 30.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.39 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.49 -24.47 31.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.932 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 15.0 tt0 -69.0 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.266 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.486 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.02 -12.01 4.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.585 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.1 -29.88 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.328 0.585 . . . . 0.0 109.872 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -73.42 -33.86 65.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.139 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.3 mtmt -69.97 -17.17 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.36 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.95 -17.63 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.443 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.51 11.53 1.49 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.014 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -82.63 124.48 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.921 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.636 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.9 t-80 -148.6 126.63 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.79 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -146.94 100.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.24 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.834 ' HA ' HD11 ' T' ' 61' ' ' ILE . 5.9 t -66.83 80.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.578 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 175.99 126.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -45.13 113.17 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.279 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.4 114.96 3.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.596 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.608 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 77.6 m95 -48.68 168.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 111.757 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.844 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -161.86 173.77 14.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.504 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.93 166.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 111.52 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 76.84 -31.64 0.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.34 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.58 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.14 20.12 8.1 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.592 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.702 ' HB3' HG13 ' T' ' 80' ' ' ILE . 0.4 OUTLIER -108.99 156.28 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.594 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -137.03 133.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.052 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -137.53 -172.59 12.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.312 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.654 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -133.03 102.59 13.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.849 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.5 Cg_endo -60.33 -88.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.196 . . . . 0.0 112.291 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.834 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm 71.42 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' T' ' 45' ' ' HIS . 14.8 t -60.45 -70.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -101.69 155.02 36.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.86 144.12 36.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.643 2.229 . . . . 0.0 112.353 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.73 ' H ' ' H ' ' T' ' 71' ' ' GLY . . . -97.26 140.85 15.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.43 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 46.1 Cg_endo -68.83 -78.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.43 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.2 OUTLIER -99.8 -1.95 36.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -19.47 65.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.47 36.14 2.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.936 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 58.44 95.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.814 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.799 ' HA3' HG21 ' T' ' 61' ' ' ILE . . . -74.91 4.51 37.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.657 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' T' ' 76' ' ' ILE . 0.0 OUTLIER 41.26 -165.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.015 0.436 . . . . 0.0 111.58 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.06 56.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.169 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.28 176.9 51.66 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.849 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 2.5 mt -76.81 108.67 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 111.258 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.0 mm -79.13 82.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.975 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.1 t70 -110.42 121.65 45.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 1.6 m-85 -83.71 11.96 6.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 69.62 170.74 7.83 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' T' ' 54' ' ' LYS . 9.4 mt -60.33 117.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.18 19.42 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.533 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.71 35.24 20.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.91 53.11 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.728 ' O ' ' HB ' ' T' ' 15' ' ' THR . 21.4 mtt180 -60.95 -5.55 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.64 20.74 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.76 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.56 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.4 mm-40 -83.72 -172.05 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.641 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.56 114.15 10.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.1 m95 -153.98 -164.74 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.97 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.578 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -89.56 -173.96 4.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.55 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.06 135.16 25.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 35.8 m-85 -96.88 111.91 23.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.276 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 9.1 m -90.49 137.2 32.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 111.09 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.952 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.4 OUTLIER -136.83 126.26 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.731 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.0 m-20 -133.24 151.05 76.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.16 -33.64 21.89 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.476 2.117 . . . . 0.0 111.92 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' T' ' 97' ' ' ALA . 21.2 t-160 -123.2 -32.18 3.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 31.45 68.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.334 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.938 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 2.1 p -101.96 146.29 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.424 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 16.1 p90 -151.79 -176.99 5.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.569 ' CD2' HG11 ' T' ' 46' ' ' VAL . 16.4 t-80 -95.38 153.85 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.32 150.97 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.044 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.588 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 26.0 tt0 -120.02 173.19 7.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.735 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.29 159.92 25.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.084 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -61.25 -28.54 69.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' T' ' 13' ' ' LYS . 0.9 OUTLIER -91.55 -50.05 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 176.39 174.21 42.69 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.497 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 20.1 ttpt -62.96 168.14 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 46.3 47.79 13.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.7 OUTLIER -143.41 2.34 1.26 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.785 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.735 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -104.2 139.06 39.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.487 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.672 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 19.8 p -107.8 149.67 27.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.94 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 61.9 t80 -34.07 -42.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 111.054 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.69 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.672 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.7 mt-10 -69.34 -44.66 71.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 110.032 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -56.09 -38.65 70.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.815 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -76.42 -37.13 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -59.56 -38.47 81.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.084 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -53.16 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.355 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -63.89 -28.39 69.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 30.9 tt0 -99.31 -9.28 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 110.307 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -51.34 -42.6 61.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.92 59.0 0.66 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.88 33.34 20.24 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.28 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.27 -168.2 19.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.585 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.67 136.4 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.583 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -70.58 126.89 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 0.0 110.358 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -51.3 161.23 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.575 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.639 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 28.2 p -111.84 -164.94 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.893 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 32.5 t80 -74.76 -70.75 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.991 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 30.0 mttm -45.28 -41.85 9.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.667 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.71 -51.21 63.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.673 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.69 -27.33 49.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.949 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.7 tp10 -65.9 -61.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.087 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.478 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -58.88 -13.27 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.936 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.568 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.92 -30.16 14.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.348 0.594 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 53.0 ttt-85 -73.6 -33.35 64.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.009 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 13.0 mttt -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.568 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.74 -15.73 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.422 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 131.15 12.12 2.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.091 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.47 120.0 23.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.772 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.1 t-80 -136.4 129.32 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.716 HG21 ' HE1' ' T' ' 91' ' ' TYR . 1.3 t -143.24 103.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.447 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.729 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.71 66.32 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -175.26 138.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.671 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -55.09 111.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -108.6 113.85 3.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.6 m95 -47.12 152.06 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' T' ' 50' ' ' GLY . 0.0 OUTLIER -171.5 174.54 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.688 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 53.44 -166.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.543 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 0.34 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.537 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.74 16.16 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.786 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' T' ' 52' ' ' MET . 1.9 mtt180 -92.05 125.52 36.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -116.3 126.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -130.23 -169.2 12.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.318 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.1 OUTLIER -139.45 91.92 10.67 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.855 0.36 . . . . 0.0 111.143 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' T' ' 75' ' ' ILE . 68.4 Cg_endo -78.49 125.06 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.67 2.247 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' T' ' 45' ' ' HIS . 20.0 mm -136.82 101.21 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -73.64 -17.94 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' T' ' 45' ' ' HIS . 0.9 OUTLIER -122.03 91.13 48.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.701 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 50.2 Cg_exo -51.87 128.96 28.45 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.59 -171.84 16.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.414 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.416 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 43.4 Cg_endo -68.31 -78.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.763 2.308 . . . . 0.0 112.322 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -100.76 -21.38 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.956 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' T' ' 69' ' ' GLY . 0.8 OUTLIER -59.81 -82.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.916 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' T' ' 68' ' ' CYS . . . -80.87 -9.92 85.71 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.894 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.8 32.07 21.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.701 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 64.79 24.0 69.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.681 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.668 ' HB3' HD11 ' T' ' 76' ' ' ILE . 29.5 mttm -89.38 151.59 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.26 131.28 53.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.01 -175.93 34.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.834 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.893 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -80.31 89.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.987 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.668 HD11 ' HB3' ' T' ' 72' ' ' LYS . 18.3 mm -62.42 84.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.43 138.21 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.0 m-85 -112.82 27.72 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 68.49 168.2 4.83 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.652 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mt -57.43 147.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.947 0.403 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.676 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 4.7 mmm-85 -115.14 22.52 13.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.02 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.652 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 44.46 53.4 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' T' ' 81' ' ' ARG . 27.5 p-10 -165.81 61.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -58.3 -3.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.467 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -81.93 17.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.571 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -78.01 -172.46 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.63 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -139.04 113.38 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.283 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.748 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 16.2 m95 -153.13 -156.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.105 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -97.33 -171.23 2.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.374 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.17 137.92 29.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.221 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 32.5 m-85 -101.02 120.38 40.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 5.7 m -96.1 147.51 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.431 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 26.5 t80 -137.6 133.95 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.796 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 12.7 m-20 -154.74 137.46 10.17 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.589 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.56 -32.75 28.53 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.496 2.131 . . . . 0.0 111.698 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' T' ' 97' ' ' ALA . 4.0 m-70 -118.35 -34.14 4.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.618 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.36 69.4 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.335 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 1' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.687 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.2 p -88.64 138.35 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.126 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.03 -177.97 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.729 ' CG ' HG11 ' T' ' 46' ' ' VAL . 21.1 t-80 -101.7 161.56 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.467 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.83 144.81 23.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.616 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.8 tt0 -115.62 173.28 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.692 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.799 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -87.25 157.19 19.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.194 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -65.93 -21.5 66.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -91.41 -23.75 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.85 167.79 11.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.463 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 7.6 ttpt -58.59 158.15 8.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.482 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 11.0 m-30 57.2 55.98 5.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -153.25 2.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.8 mt -103.05 136.81 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.072 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.713 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.5 p -107.73 152.91 23.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.243 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 71.5 t80 -36.66 -43.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.03 -39.86 68.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.713 ' HB2' ' H ' ' T' ' 15' ' ' THR . 76.4 mt-10 -70.55 -47.69 59.08 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 109.806 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.464 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -55.89 -46.47 78.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.561 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.636 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -65.67 -39.54 91.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.142 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.8 t -67.89 -52.31 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 92.1 m -64.13 -48.98 73.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.541 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 42.9 tt0 -69.9 -16.4 63.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.532 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.95 -49.09 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.803 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -103.71 51.6 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.28 38.97 34.51 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.356 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -117.98 172.83 14.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.569 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -124.79 139.47 53.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.71 0.291 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -74.64 126.12 30.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.215 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.3 155.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.461 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 27.1 p -110.39 -164.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 27.6 t80 -74.88 -72.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.107 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -47.59 -41.59 21.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.921 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.45 -47.79 80.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.6 OUTLIER -54.81 -40.72 69.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 3.6 tp10 -54.26 -60.66 3.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.188 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.85 -18.48 8.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.607 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.27 -29.75 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.76 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.886 ' HG2' HG23 ' T' ' 62' ' ' VAL . 3.1 tmm_? -71.17 -33.62 70.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.011 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtpt -69.45 -17.03 63.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.314 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.607 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.53 -12.33 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.683 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.24 14.9 3.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.012 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -83.01 124.6 30.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 0.0 110.981 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.536 ' ND1' HG12 ' T' ' 62' ' ' VAL . 2.2 t-160 -147.15 127.25 13.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.75 94.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.564 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 1.3 m -61.75 83.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 170.32 125.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -46.28 113.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -110.43 121.37 5.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.633 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.4 m95 -49.68 152.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.97 0.414 . . . . 0.0 111.318 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.664 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.41 177.82 3.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.73 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.97 -165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.469 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 2.78 2.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.372 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.02 15.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.791 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 28.6 mtt180 -94.72 127.48 40.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.428 HG12 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -115.93 131.37 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -141.38 -178.28 17.45 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.393 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.497 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.95 98.3 39.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.745 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 37.9 Cg_exo -55.35 -84.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.786 2.324 . . . . 0.0 112.689 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.2 mm 73.57 102.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.948 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.886 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -76.06 -41.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.545 ' HG2' HG12 ' T' ' 62' ' ' VAL . 6.9 ptpt -124.43 95.48 43.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.71 141.97 42.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.589 2.193 . . . . 0.0 112.294 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.47 -117.73 2.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.272 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.455 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 73.7 Cg_endo -83.89 -79.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.455 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.4 OUTLIER -104.27 -19.82 13.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.84 -34.21 72.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.31 -14.03 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.837 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 59.4 29.52 19.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.97 17.89 72.12 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.734 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.725 ' HD3' HG13 ' T' ' 76' ' ' ILE . 17.6 mttt -89.67 151.01 22.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.39 129.23 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 74' ' ' GLY . . . . . 0.577 ' HA2' ' NH2' ' T' ' 40' ' ' ARG . . . 86.21 175.39 49.78 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.749 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.3 mt -68.49 107.41 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.046 0.45 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.725 HG13 ' HD3' ' T' ' 72' ' ' LYS . 9.8 mm -81.39 83.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.1 t70 -109.47 132.12 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.604 ' CE1' HG22 ' T' ' 76' ' ' ILE . 10.6 m-85 -105.15 23.01 14.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.69 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 70.05 170.97 8.75 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.729 HG22 ' H ' ' T' ' 82' ' ' LEU . 9.6 mt -51.37 152.29 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.282 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.05 18.65 17.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.729 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 54.76 31.66 15.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -148.92 77.44 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' T' ' 15' ' ' THR . 69.2 mtt180 -65.79 2.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.438 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -102.14 12.67 36.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.537 ' O ' HG22 ' T' ' 15' ' ' THR . 2.4 mm-40 -65.17 -178.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -132.35 114.27 14.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 111.341 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 23.2 m95 -151.43 -136.6 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.274 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.463 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.7 OUTLIER -115.4 -167.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.378 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.464 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.6 132.53 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.276 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.904 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 31.1 m-85 -105.1 127.28 52.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.561 ' O ' HG23 ' T' ' 2' ' ' VAL . 1.2 m -100.76 159.67 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.304 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.687 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 24.2 t80 -150.67 119.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.962 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.8 m120 -139.03 133.73 16.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.484 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.28 -33.52 28.75 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.507 2.138 . . . . 0.0 111.905 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.495 ' O ' ' C ' ' T' ' 97' ' ' ALA . 2.2 p80 -115.25 -31.75 5.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.711 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.962 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 25.74 74.51 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.47 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.705 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.1 p -86.61 142.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.151 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -147.23 -176.69 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.771 ' CG ' HG11 ' T' ' 46' ' ' VAL . 40.7 t-80 -98.93 163.95 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 154.77 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.549 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 24.7 tt0 -121.91 172.91 7.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -78.33 161.23 27.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -20.16 65.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.757 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.539 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.5 m -102.82 -47.49 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 173.91 172.53 39.3 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 150.25 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.692 0.282 . . . . 0.0 110.969 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 61.81 57.36 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 9.0 mttm -153.55 1.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.515 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.66 139.54 39.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.737 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.6 p -108.55 151.8 25.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 67.6 t80 -36.52 -41.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 0.0 110.791 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.79 -39.03 64.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.304 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' T' ' 15' ' ' THR . 82.6 mt-10 -71.02 -45.38 64.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.179 0.514 . . . . 0.0 109.958 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -58.56 -45.26 89.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.565 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 30.3 tttt -68.47 -26.86 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.563 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.71 -41.53 83.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.194 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.78 -51.73 47.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.259 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -63.84 -47.71 79.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.592 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 4.1 tt0 -73.55 -13.45 61.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -54.43 -48.83 71.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -102.9 50.98 0.81 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.758 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.15 39.62 50.53 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.313 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -118.17 177.41 16.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.733 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -130.12 141.83 50.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.564 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.63 125.44 29.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.068 0.461 . . . . 0.0 110.23 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.947 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.22 154.32 0.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.533 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -109.99 -162.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.222 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.637 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 31.6 t80 -77.23 -72.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 14.1 mttm -46.89 -38.49 10.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.732 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.28 -53.55 35.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 110.39 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.63 -23.86 44.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 12.1 tp10 -68.45 -61.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.205 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.409 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.52 -16.09 8.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.798 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.49 -29.48 15.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.491 0.662 . . . . 0.0 109.684 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.58 HH11 ' HA2' ' T' ' 74' ' ' GLY . 0.0 OUTLIER -72.61 -33.25 66.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.112 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.0 mttt -69.52 -17.88 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.286 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.567 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.39 -14.35 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.81 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.406 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 11.35 2.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -81.48 118.6 22.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.75 ' CE1' HG23 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -141.55 127.2 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.771 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -145.43 102.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.28 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.807 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -72.72 80.5 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.701 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 178.55 123.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.835 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -41.73 111.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.31 114.97 3.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.667 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 71.7 m95 -48.95 156.83 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.432 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.686 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -177.61 178.33 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.896 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.671 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 50.77 -165.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -7.52 7.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.498 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 158.49 19.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.858 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.671 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 0.9 OUTLIER -97.53 135.66 39.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.73 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -126.61 122.42 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -170.65 13.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -124.99 82.97 60.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.961 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' T' ' 75' ' ' ILE . 26.7 Cg_exo -60.37 104.95 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.761 2.307 . . . . 0.0 112.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.4 mm -130.74 112.28 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.028 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER -70.01 -16.69 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.897 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.428 ' HD3' ' HD2' ' T' ' 64' ' ' PRO . 0.2 OUTLIER -104.6 164.04 16.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.893 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' HD3' ' T' ' 63' ' ' LYS . 43.8 Cg_exo -54.47 -8.42 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.564 2.176 . . . . 0.0 112.402 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 65' ' ' GLY . . . . . 0.458 ' HA3' ' HA3' ' T' ' 69' ' ' GLY . . . 79.89 135.99 1.42 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.39 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.551 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 98.6 Cg_endo -92.1 -67.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.073 2.516 . . . . 0.0 112.226 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.551 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.2 OUTLIER -122.25 -22.91 5.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 10.3 41.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.458 ' HA3' ' HA3' ' T' ' 65' ' ' GLY . . . -124.49 -38.41 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.008 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 64.06 41.87 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.55 17.82 78.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.74 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.571 ' HD2' HG13 ' T' ' 76' ' ' ILE . 9.9 mttm -92.53 154.8 18.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.98 131.96 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 74' ' ' GLY . . . . . 0.58 ' HA2' HH11 ' T' ' 40' ' ' ARG . . . 90.03 -176.24 42.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.85 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.637 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -70.36 110.85 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 111.058 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.571 HG13 ' HD2' ' T' ' 72' ' ' LYS . 5.2 mm -89.36 79.86 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -101.92 122.83 44.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.41 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.1 m-85 -84.01 3.36 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.011 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.09 172.44 44.37 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.488 HG12 ' C ' ' T' ' 55' ' ' GLY . 6.3 mt -65.4 119.92 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.315 . . . . 0.0 111.027 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -112.03 28.35 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.424 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 52.96 27.89 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -114.38 51.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.618 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -70.65 4.34 2.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -106.62 6.97 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.562 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -72.15 -171.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 23.5 mtp85 -132.63 113.48 13.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.139 0.495 . . . . 0.0 111.56 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.8 m95 -153.99 -171.24 3.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.038 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.596 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -81.99 -171.21 3.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.424 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.77 136.87 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.947 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 38.8 m-85 -103.24 127.91 50.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.583 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.7 OUTLIER -99.56 161.35 13.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 111.284 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.705 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 25.2 t80 -151.62 119.88 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.757 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.847 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 27.6 m-20 -143.43 147.07 38.41 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.58 -51.13 9.82 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.54 2.16 . . . . 0.0 111.498 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.488 ' O ' ' C ' ' T' ' 97' ' ' ALA . 18.9 p-80 -101.48 -28.45 12.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.58 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 27.11 66.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.371 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.895 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.715 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.6 p -92.32 141.91 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 111.273 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -145.59 -176.91 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.797 ' CG ' HG11 ' T' ' 46' ' ' VAL . 16.1 t-80 -113.56 155.26 25.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.96 164.43 38.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 -170.0 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -90.7 149.55 22.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -60.12 -16.47 32.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.774 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -98.77 -25.35 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 149.19 167.65 14.13 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.492 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 8.1 tttm -62.38 153.84 29.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.345 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.9 m-30 57.06 51.92 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.774 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 3.7 mttm -142.69 1.05 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.9 mt -104.33 146.77 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.755 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 22.3 p -114.36 153.31 30.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.012 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 72.2 t80 -37.76 -40.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.849 0.357 . . . . 0.0 110.751 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.99 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.359 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.755 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.7 mt-10 -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.173 0.511 . . . . 0.0 109.936 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.09 -46.2 85.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -67.69 -26.5 66.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.489 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -69.41 -40.98 77.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.86 -50.41 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -52.27 50.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.148 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 6.5 tt0 -71.62 -3.04 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.644 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -65.71 -45.11 83.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.574 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.81 59.61 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.047 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 55.82 21.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.262 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -138.96 166.96 25.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.784 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.47 139.07 51.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.612 0.244 . . . . 0.0 110.57 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -74.22 124.65 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.0 110.316 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.69 153.13 1.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.483 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 28.3 p -106.17 -164.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.977 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.88 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 53.0 t80 -75.61 -69.79 0.47 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.021 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -46.68 -42.7 16.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.17 -46.25 84.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.647 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.73 -38.01 71.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.226 0.536 . . . . 0.0 109.661 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 12.0 tt0 -57.02 -60.68 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.428 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.67 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.48 -21.59 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.058 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -90.91 -28.85 17.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 0.0 109.633 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' T' ' 62' ' ' VAL . 19.2 ttp85 -71.59 -34.21 69.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.001 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtmp? -73.24 -18.05 61.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.221 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.67 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -87.88 -7.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.92 7.07 7.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.331 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -78.17 130.64 36.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.534 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.6 t-160 -153.07 130.8 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.763 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.797 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.37 99.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.261 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.587 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.731 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 179.67 122.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -41.45 110.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.71 115.94 4.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.838 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.3 m95 -48.19 156.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 111.367 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.725 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.1 OUTLIER -178.28 177.37 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.055 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.04 -165.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.754 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -14.03 10.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.476 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 160.85 23.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.926 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 10.7 ptp180 -99.71 136.41 39.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.538 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.584 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -127.88 119.57 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -118.68 -173.67 15.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.257 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.434 ' O ' HG12 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -120.56 82.32 33.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.7 Cg_exo -59.97 120.9 8.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.689 2.259 . . . . 0.0 112.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' T' ' 47' ' ' CYS . 10.4 mm -138.69 100.56 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.589 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.4 OUTLIER -71.52 -41.85 72.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' T' ' 62' ' ' VAL . 0.0 OUTLIER -113.36 96.86 41.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 9.9 Cg_endo -53.0 144.03 47.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.774 2.316 . . . . 0.0 112.285 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.04 15.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.312 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 39.3 Cg_endo -68.15 -77.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 0.0 112.181 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.401 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -97.41 -12.69 22.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.755 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 48.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.47 -31.21 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 62.71 32.53 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 111.013 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.92 16.77 70.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.675 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.915 ' HD3' HG13 ' T' ' 76' ' ' ILE . 15.7 mttp -95.09 149.87 20.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.805 0.336 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.12 128.55 53.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 168.4 44.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.88 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.0 mp -63.49 97.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.757 0.313 . . . . 0.0 111.301 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.915 HG13 ' HD3' ' T' ' 72' ' ' LYS . 16.1 mm -70.8 80.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.464 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.4 t70 -105.12 123.17 47.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 2.2 m-85 -86.31 -3.16 58.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.967 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.57 169.69 40.32 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.745 HG22 ' H ' ' T' ' 82' ' ' LEU . 16.2 mt -60.67 127.83 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 111.082 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.88 16.99 21.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.745 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.99 45.75 26.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.897 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -163.93 77.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -69.89 -4.94 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 17.26 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.582 ' O ' HG22 ' T' ' 15' ' ' THR . 2.6 mm-40 -80.32 -171.81 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.599 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.645 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 2.7 ppt_? -137.53 111.75 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.094 0.473 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.65 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.2 m95 -153.71 -172.11 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.171 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.543 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -82.54 -170.62 3.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.32 137.79 27.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.799 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 36.2 m-85 -103.45 121.14 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.523 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.1 OUTLIER -96.13 154.17 17.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.014 0.435 . . . . 0.0 111.3 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.715 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 28.8 t80 -143.7 126.27 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.849 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 26.6 m-20 -149.56 134.04 9.16 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.525 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -50.28 -32.43 33.03 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 111.705 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' T' ' 97' ' ' ALA . 37.1 t60 -116.3 -34.74 4.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.566 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.13 71.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.362 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.939 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.962 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -83.01 146.44 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 2.0 p90 -151.22 177.46 10.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.163 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.603 ' CG ' HG11 ' T' ' 46' ' ' VAL . 8.3 t-80 -112.86 160.74 17.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.154 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 6.0 tpp180 -158.89 159.81 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 -169.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.868 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -96.17 149.86 21.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -20.49 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.485 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -95.72 -22.74 17.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.833 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 144.47 166.97 11.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -65.02 162.74 16.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.7 m-30 53.69 38.75 29.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.4 OUTLIER -134.54 4.9 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.876 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 7.7 mt -107.51 139.04 42.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.982 0.42 . . . . 0.0 111.427 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.8 p -109.86 149.12 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.011 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -34.48 -41.16 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.786 0.326 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.39 -43.85 69.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.319 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.8 mt-10 -70.38 -46.78 63.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.7 -43.95 47.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.95 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -65.63 -54.45 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -50.01 -36.8 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 t -75.18 -54.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.524 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' T' ' 28' ' ' GLY . 58.8 m -64.19 -30.32 71.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 24.4 tt0 -92.59 -12.14 32.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 110.104 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.4 t80 -54.33 -41.62 69.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.044 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -107.69 59.09 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.218 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.53 20.46 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.415 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -94.54 -174.3 38.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.92 136.26 14.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -48.14 137.17 10.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.475 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.54 166.94 22.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.134 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 47.0 p -117.99 -175.15 2.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 0.0 111.373 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.95 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 48.0 t80 -69.54 -68.99 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.955 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.2 mttp -45.89 -42.09 12.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.583 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.2 mt-30 -65.03 -51.04 63.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -60.17 -22.17 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.5 tt0 -73.98 -61.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.286 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.44 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.28 -13.45 7.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.826 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.598 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.2 -29.11 14.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 8.4 ttt-85 -72.73 -34.38 67.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.035 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.7 mtpt -69.67 -15.79 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.598 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.0 -19.16 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.741 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.48 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.11 11.77 1.02 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.103 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.65 115.74 20.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.566 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.4 t-160 -135.53 127.99 30.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.603 HG11 ' CG ' ' T' ' 4' ' ' HIS . 1.3 t -144.64 102.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.249 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.674 ' HA ' HD11 ' T' ' 61' ' ' ILE . 52.8 t -77.56 63.85 2.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.74 125.59 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.894 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.523 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -42.5 115.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.05 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.59 119.31 4.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.632 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.1 m95 -53.48 148.52 9.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.47 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.763 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -167.5 175.31 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.344 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.62 -165.99 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -2.17 4.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.441 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.9 14.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.868 ' HG3' HG13 ' T' ' 80' ' ' ILE . 6.8 mtt180 -88.41 125.94 34.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.88 117.81 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.73 -169.72 13.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.261 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -141.48 95.06 7.34 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 111.219 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HB3' HD13 ' T' ' 75' ' ' ILE . 71.8 Cg_endo -81.58 131.25 7.26 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' T' ' 47' ' ' CYS . 15.2 mm -134.77 107.22 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.184 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.01 -45.7 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.465 ' H ' ' HG2' ' T' ' 63' ' ' LYS . 0.0 OUTLIER -118.59 94.27 47.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 140.73 90.96 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.571 2.181 . . . . 0.0 112.305 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.3 -135.3 5.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.436 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 73.2 Cg_endo -85.77 -80.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.855 2.37 . . . . 0.0 112.447 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.4 OUTLIER -104.73 -16.3 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.783 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.77 74.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.44 -22.48 8.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 70' ' ' PHE . . . . . 0.434 ' HB3' ' HG3' ' T' ' 72' ' ' LYS . 3.1 t80 61.06 22.5 12.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.59 14.58 75.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.703 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.914 ' HD3' HG13 ' T' ' 76' ' ' ILE . 27.5 mttm -83.58 150.83 25.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.97 129.08 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.47 -174.78 35.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.907 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.95 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -79.88 95.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.163 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.914 HG13 ' HD3' ' T' ' 72' ' ' LYS . 11.6 mm -68.18 83.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -110.38 122.05 46.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.53 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.0 OUTLIER -87.69 -5.94 58.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.072 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.715 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 91.22 169.11 41.99 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.868 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.7 mt -59.36 122.4 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -102.37 13.84 33.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.949 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.6 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.48 48.93 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.32 58.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.656 HH11 ' HB2' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -60.39 -9.71 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -79.69 12.59 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.487 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -79.37 -178.68 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.688 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -134.85 116.36 14.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.585 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 20.8 m95 -150.18 -134.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.339 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -115.83 -166.83 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.357 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -148.0 119.54 7.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.369 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 28.4 m-85 -87.63 103.8 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.498 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.6 m -82.26 151.84 26.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.962 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -148.91 125.75 11.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.769 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.893 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.7 m120 -137.03 162.03 58.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.679 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 15.7 Cg_endo -57.8 -52.9 5.15 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.621 2.214 . . . . 0.0 111.622 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.508 ' O ' ' C ' ' T' ' 97' ' ' ALA . 18.1 p80 -102.31 -29.46 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.531 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 23.83 66.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.425 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.831 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.7 p -92.5 143.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.805 0.336 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.47 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 21.0 p90 -143.21 178.41 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.818 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.855 ' CG ' HG11 ' T' ' 46' ' ' VAL . 46.9 t-80 -96.1 159.05 15.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.205 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.827 ' HG2' HG11 ' T' ' 22' ' ' VAL . 0.0 OUTLIER -151.31 151.4 31.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.031 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.0 tt0 -122.91 173.09 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -88.64 157.72 18.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.191 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.665 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -93.8 -24.82 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.38 166.86 10.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.55 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 17.4 ttpt -58.41 155.66 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 110.97 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.497 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 10.5 m-30 58.5 54.2 5.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.989 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -152.5 3.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.828 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -104.32 134.9 46.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 28.0 p -105.56 150.93 24.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 78.8 t80 -34.86 -42.28 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.956 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -42.25 65.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.373 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' T' ' 15' ' ' THR . 67.5 mt-10 -69.72 -46.58 65.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.017 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.83 -42.12 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.738 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -68.0 -34.9 77.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.605 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.96 -36.37 83.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.972 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.827 HG11 ' HG2' ' T' ' 5' ' ' ARG . 3.0 t -69.16 -50.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.178 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -64.57 -54.31 34.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.029 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 44.0 tt0 -62.26 -19.26 63.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -54.06 -48.41 70.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.81 54.45 0.66 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.37 31.5 35.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.241 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -100.95 167.56 19.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.646 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.575 ' NE2' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -133.91 138.14 45.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.004 0.431 . . . . 0.0 111.412 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.672 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.87 139.17 22.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -81.17 166.27 20.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.438 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 38.9 p -120.82 -175.01 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.0 111.684 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.846 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 36.0 t80 -68.32 -70.34 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.781 ' HA ' ' HG3' ' T' ' 37' ' ' GLU . 3.0 mttp -46.69 -40.99 14.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.865 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.5 mt-30 -63.65 -47.13 82.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.743 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -55.72 -30.81 61.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.384 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.781 ' HG3' ' HA ' ' T' ' 34' ' ' LYS . 0.0 OUTLIER -66.51 -60.86 2.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.451 0.643 . . . . 0.0 110.118 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.474 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -53.44 -18.52 2.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.913 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.569 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.17 -30.72 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.398 0.618 . . . . 0.0 109.678 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' T' ' 62' ' ' VAL . 0.1 OUTLIER -72.65 -32.95 66.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.044 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.4 mtmp? -69.69 -18.21 63.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.569 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.61 -10.95 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.41 14.03 4.57 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.515 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.2 t80 -82.15 125.66 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.59 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.5 t-160 -147.61 126.1 12.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.855 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -145.66 101.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.222 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.891 ' HA ' HD11 ' T' ' 61' ' ' ILE . 4.4 t -72.15 78.99 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.62 116.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.594 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -38.61 117.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.072 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.27 122.73 5.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.692 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.5 m95 -53.99 146.56 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.672 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -164.64 178.41 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.471 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.04 -166.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.475 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.77 3.88 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.448 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.04 13.7 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.856 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.842 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 11.4 mtt180 -91.47 127.09 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.55 125.38 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.02 -175.67 14.16 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.594 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -134.7 103.68 11.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.815 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.3 Cg_exo -58.5 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.623 2.216 . . . . 0.0 112.199 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' T' ' 47' ' ' CYS . 30.0 mm 75.42 108.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER -81.23 -38.41 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -113.68 96.9 42.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.92 139.68 91.21 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.535 2.156 . . . . 0.0 112.243 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.54 -151.47 10.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.398 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.658 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 74.1 Cg_endo -87.79 -64.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.996 2.464 . . . . 0.0 111.982 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.658 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.5 OUTLIER -104.72 -22.53 13.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.771 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -80.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.48 -6.04 83.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.926 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.12 27.69 17.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.019 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.35 12.49 63.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.677 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.989 ' HD3' HG13 ' T' ' 76' ' ' ILE . 21.6 mttp -81.72 159.5 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.761 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.25 130.5 52.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.47 176.21 49.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.846 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -68.47 112.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 111.021 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.989 HG13 ' HD3' ' T' ' 72' ' ' LYS . 6.6 mm -87.23 88.7 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.117 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -112.87 112.89 24.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.556 ' CE1' HG22 ' T' ' 76' ' ' ILE . 3.2 m-85 -79.38 4.35 15.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.842 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 76.65 170.11 31.32 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.803 HG22 ' H ' ' T' ' 82' ' ' LEU . 11.9 mt -48.21 142.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 3.9 mmm-85 -108.26 16.09 23.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.803 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.75 35.37 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -169.07 86.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -70.42 -1.15 9.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -76.87 15.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.564 ' O ' HG22 ' T' ' 15' ' ' THR . 3.5 mm-40 -75.11 -173.57 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -138.22 113.7 9.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 111.1 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.529 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 15.7 m95 -151.22 -137.79 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.507 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.55 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -116.01 -165.35 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.449 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.34 126.89 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 111.559 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 29.9 m-85 -97.47 107.59 20.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.51 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.5 t -84.89 154.93 21.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.831 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 13.9 t80 -144.02 123.05 12.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.999 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.851 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 5.3 m120 -139.11 141.2 28.97 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.322 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.575 ' HD3' ' NE2' ' T' ' 29' ' ' HIS . 73.7 Cg_exo -49.22 -33.22 27.35 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.36 2.04 . . . . 0.0 111.87 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' T' ' 97' ' ' ALA . 81.7 t60 -119.6 -33.26 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.543 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 31.83 75.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.416 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.873 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' T' T ' 1' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' T' ' 94' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.771 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p -96.95 148.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.0 111.516 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.402 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 31.0 p90 -156.98 -176.52 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.71 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.8 t-80 -101.38 159.33 15.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.049 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 8.1 mmt180 -153.04 148.49 27.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.7 tt0 -116.4 173.34 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.859 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.43 156.07 20.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -20.7 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.444 ' HB3' ' NZ ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -93.88 -28.01 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.8 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 147.65 168.27 13.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.345 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.446 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 4.1 ttpm? -63.68 165.23 8.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 16.2 m-30 50.8 43.95 28.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 3.8 mttt -138.63 -2.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.859 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.4 mt -102.18 139.56 37.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.336 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.649 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 2.8 p -110.46 151.58 27.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.108 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.53 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 79.5 t80 -34.01 -42.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.99 68.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.223 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.0 mt-10 -68.63 -45.27 72.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.93 -40.4 63.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.896 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 15.1 tttt -70.11 -34.89 73.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -64.53 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.53 -50.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.21 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.68 -53.26 50.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.4 tt0 -63.8 -21.07 66.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.413 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.4 OUTLIER -51.38 -49.81 60.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.844 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -106.03 53.47 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.58 42.23 43.66 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.231 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -115.07 165.86 12.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.728 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' CE1' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -129.46 139.45 51.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.891 0.377 . . . . 0.0 111.312 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.45 149.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.983 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -90.7 149.28 22.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.401 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 62.8 p -105.93 -175.57 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.915 0.388 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.944 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 51.8 t80 -67.29 -68.57 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.042 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -48.29 -42.86 32.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.947 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.12 -50.19 69.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.809 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -60.45 -31.69 70.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.336 0.588 . . . . 0.0 109.646 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' HG2' ' HE2' ' T' ' 41' ' ' LYS . 8.8 tt0 -65.28 -58.39 6.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.236 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.4 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -52.14 -23.91 6.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.648 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -87.51 -30.53 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.516 0.674 . . . . 0.0 109.78 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.771 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.4 OUTLIER -70.45 -33.71 71.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.093 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HE2' ' HG2' ' T' ' 37' ' ' GLU . 11.4 mttm -67.48 -19.22 65.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.197 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.648 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.1 -21.83 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.567 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 139.7 15.19 0.56 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.211 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.771 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -70.75 137.64 49.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.737 0.303 . . . . 0.0 110.683 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.2 t-160 -161.09 124.45 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.67 103.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.846 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.48 72.79 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -178.72 139.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -56.28 116.64 3.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -113.39 121.39 5.48 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.725 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 77.0 m95 -55.16 144.44 24.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.503 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -163.26 176.06 10.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.664 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.95 -165.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.584 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -6.41 9.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.563 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.11 16.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.954 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.7 ptp180 -93.69 130.36 39.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.712 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.495 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.01 121.26 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.967 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.21 -169.07 13.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.289 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.691 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -143.77 93.02 6.28 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.128 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.795 ' HB3' HD13 ' T' ' 75' ' ' ILE . 73.5 Cg_endo -80.93 130.54 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.739 2.293 . . . . 0.0 112.259 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.846 HD11 ' HA ' ' T' ' 47' ' ' CYS . 22.6 mm -142.98 107.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.7 m -67.75 -39.72 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.57 95.02 11.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.835 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' T' ' 62' ' ' VAL . 54.1 Cg_exo -50.04 104.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.576 2.184 . . . . 0.0 112.523 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.57 161.43 52.65 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.226 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.06 -49.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.848 2.365 . . . . 0.0 111.804 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 -16.83 16.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.418 ' HB3' ' H ' ' T' ' 69' ' ' GLY . 0.7 OUTLIER -83.99 -89.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.126 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' T' ' 68' ' ' CYS . . . -75.11 0.25 59.35 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.05 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 66.45 -2.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.31 4.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.779 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.508 ' HB3' HD11 ' T' ' 76' ' ' ILE . 15.9 mmtm -81.28 153.74 26.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.874 0.369 . . . . 0.0 110.959 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 131.06 53.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.174 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.34 179.36 52.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.966 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -74.85 98.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.05 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.691 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 8.8 mm -70.21 85.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.94 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.584 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.5 m-85 -111.6 22.05 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.38 170.86 7.5 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.749 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.2 mt -53.94 152.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.433 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.1 mmm180 -130.63 16.24 5.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.749 ' H ' HG22 ' T' ' 80' ' ' ILE . 4.3 mm? 56.28 27.26 11.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.89 57.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.576 ' O ' ' HB ' ' T' ' 15' ' ' THR . 11.4 mtm180 -66.45 -1.67 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 9.6 t -97.47 6.19 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.59 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -68.21 -176.47 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.33 113.35 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.438 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.711 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 12.7 m95 -152.87 -155.99 0.66 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.204 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.12 -169.76 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.227 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.453 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.9 121.87 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 0.0 111.437 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.809 ' CD1' HD21 ' T' ' 36' ' ' LEU . 34.4 m-85 -90.26 107.47 19.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.496 ' O ' HG23 ' T' ' 2' ' ' VAL . 8.0 m -82.29 164.58 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.337 . . . . 0.0 111.023 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.771 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 7.9 t80 -153.04 118.1 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.825 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.8 m-20 -134.85 142.08 40.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.437 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 53.3 Cg_exo -51.25 -33.91 46.95 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.488 2.125 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' T' ' 97' ' ' ALA . 30.5 m80 -117.81 -35.3 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.532 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 33.77 70.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.902 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.876 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.5 OUTLIER -78.97 143.72 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -145.5 -179.97 7.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.774 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.1 t-80 -112.31 161.91 16.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.517 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 10.9 mmt180 -155.9 161.53 40.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.672 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -126.29 -174.31 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.615 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -86.36 153.61 21.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -58.77 -20.77 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.806 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -27.58 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.44 167.74 12.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.519 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.574 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 1.6 ttpt -55.37 153.52 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.2 m-30 55.37 69.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.1 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -158.74 -7.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.778 HD11 ' C ' ' T' ' 89' ' ' ASP . 1.1 pp -111.94 161.62 16.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.106 0.479 . . . . 0.0 111.27 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.804 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 3.4 p -114.58 -166.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.1 t80 -67.5 -41.39 84.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.34 -38.63 74.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.541 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.804 ' HB2' ' H ' ' T' ' 15' ' ' THR . 53.7 mt-10 -71.76 -43.3 66.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.194 0.521 . . . . 0.0 110.182 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.403 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -54.03 -41.78 68.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.986 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -55.93 10.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.118 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.5 -36.65 3.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.285 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.54 -56.04 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.437 ' O ' ' CA ' ' T' ' 28' ' ' GLY . 82.9 m -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 18.5 tt0 -88.21 -12.72 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 109.614 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.2 t80 -57.31 -39.5 75.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.86 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -113.4 56.64 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.163 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.63 34.75 28.74 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.584 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.96 171.1 14.23 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.427 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.61 ' CE1' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -135.18 143.56 46.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.284 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.818 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -52.74 136.52 33.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.292 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.87 153.51 32.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 35.4 p -106.5 -172.29 2.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 111.673 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.928 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 65.3 t80 -71.63 -67.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.07 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -46.56 -40.89 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.413 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 93.9 mt-30 -64.75 -49.38 71.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.668 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -59.19 -23.66 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.071 0.462 . . . . 0.0 110.118 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 2.9 tp10 -74.04 -62.08 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.98 -13.73 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.995 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -95.06 -29.99 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.362 0.601 . . . . 0.0 109.671 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.827 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -71.6 -33.04 68.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.954 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.5 OUTLIER -69.76 -16.67 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.374 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.05 -14.98 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.599 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.416 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.21 17.58 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.988 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.615 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -80.15 112.63 17.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 111.006 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.887 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.3 t-160 -135.13 124.11 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.71 89.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.511 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 13.9 t -63.87 85.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.581 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . 172.57 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.871 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -38.29 113.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.656 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.84 126.39 7.64 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.563 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 75.0 m95 -58.03 149.73 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.92 0.39 . . . . 0.0 111.426 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.818 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.44 179.27 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.591 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.08 -166.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.437 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -7.22 5.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.382 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 157.58 20.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.624 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.807 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.1 mtm180 -94.68 130.61 41.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.908 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.449 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -120.8 121.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.8 -173.75 13.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.443 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -132.63 101.82 14.11 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.77 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.9 Cg_endo -61.01 -81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.804 2.336 . . . . 0.0 112.517 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 8.2 mm 75.04 106.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.887 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -77.41 -32.47 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.53 ' H ' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -122.36 97.34 45.19 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.847 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.37 101.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.93 -168.21 34.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.322 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.49 -89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 112.297 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -13.88 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.11 52.06 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 160.76 -25.34 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.997 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 t80 49.08 33.43 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.46 40.99 98.43 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.708 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.636 ' HB3' HD11 ' T' ' 76' ' ' ILE . 33.5 mttt -103.69 150.13 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.62 130.1 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.209 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.82 167.56 43.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.928 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.2 mp -64.1 100.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.387 . . . . 0.0 111.42 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' T' ' 72' ' ' LYS . 10.7 mm -69.68 87.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -108.45 120.12 41.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.531 ' CE1' HG22 ' T' ' 76' ' ' ILE . 12.9 m-85 -91.06 -11.33 39.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 103.66 173.76 25.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.807 HG13 ' HG3' ' T' ' 56' ' ' ARG . 19.4 mt -61.41 122.71 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -91.71 9.54 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.764 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 59.58 38.81 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.4 OUTLIER -145.13 75.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.7 mpt_? -74.61 16.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.927 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.447 ' H ' ' C ' ' T' ' 83' ' ' ASN . 5.5 m -114.33 6.75 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.789 ' O ' HG22 ' T' ' 15' ' ' THR . 2.9 mm-40 -63.67 -171.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.73 113.61 11.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.685 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 7.8 m95 -153.55 -147.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.778 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.5 OUTLIER -106.78 -171.23 1.85 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.36 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' T' ' 14' ' ' LEU . . . -141.3 121.53 13.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.644 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.668 ' CD1' HD21 ' T' ' 36' ' ' LEU . 23.4 m-85 -90.59 110.37 21.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.443 ' O ' HG23 ' T' ' 2' ' ' VAL . 86.4 m -86.47 167.97 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.188 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.876 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 2.5 t80 -158.46 124.34 4.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.742 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.8 m120 -139.73 143.58 35.55 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.552 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 76.7 Cg_exo -49.18 -33.41 27.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.52 2.147 . . . . 0.0 112.035 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -125.13 -30.55 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.638 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 37.67 75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 1' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.775 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 2.3 p -97.82 139.68 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 111.202 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.538 ' HE1' ' HB1' ' T' ' 97' ' ' ALA . 25.5 p90 -147.93 178.35 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.999 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 3.9 t60 -92.07 155.56 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' T' ' 5' ' ' ARG . 2.6 tpp85 -149.02 153.88 38.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.612 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.1 tt0 -125.77 173.91 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.594 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -82.65 151.68 26.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -62.33 -18.29 61.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.693 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 17.0 m -98.84 -27.74 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.654 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 151.09 167.51 14.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.43 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.508 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 14.3 tttt -60.23 153.89 21.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.8 m-30 57.37 49.61 12.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.693 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 4.2 mttm -142.28 1.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.693 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.4 mt -105.82 134.14 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.258 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.668 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.4 p -104.0 151.62 22.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.138 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.536 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.8 t80 -34.25 -44.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.99 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.668 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 15.0 mt-10 -66.38 -54.9 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.274 0.559 . . . . 0.0 109.842 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -43.51 -43.51 5.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.946 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -67.17 -37.75 84.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.69 -34.58 77.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.5 t -69.64 -53.2 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.285 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -64.31 -52.61 57.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.2 tt0 -62.52 -21.05 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.38 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -52.2 -48.86 64.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.694 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -106.0 52.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.42 38.1 56.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.235 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.84 169.82 13.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.763 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.559 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.61 140.01 44.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.952 0.405 . . . . 0.0 111.236 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.891 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.03 139.02 18.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.376 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.81 152.23 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 37.7 p -107.54 -171.38 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.557 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.762 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 55.3 t80 -70.85 -67.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.029 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.1 OUTLIER -46.79 -40.55 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.564 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.16 -54.24 27.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.279 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -58.63 -19.86 42.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.774 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 2.5 tp10 -72.34 -62.19 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.16 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.445 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.82 -15.66 9.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.757 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.573 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.22 -29.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.463 0.649 . . . . 0.0 109.753 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.748 ' HG3' HG22 ' T' ' 62' ' ' VAL . 9.8 ttt-85 -73.03 -33.47 65.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.187 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.545 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 45.5 mttt -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.427 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.573 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -86.34 -17.27 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 15.1 1.9 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.021 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.49 94.65 7.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.979 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.597 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.6 t-80 -115.17 125.99 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.745 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -147.89 100.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' HD11 ' T' ' 61' ' ' ILE . 40.5 t -75.79 65.83 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.6 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -161.91 118.61 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -39.87 121.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -123.39 121.24 4.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.731 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.536 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 84.1 m95 -54.18 162.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.798 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.891 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -155.63 174.39 15.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.392 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -53.53 160.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.286 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mtpp 78.66 -30.66 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.508 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 112.44 23.93 5.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.531 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.706 ' HG3' HG13 ' T' ' 80' ' ' ILE . 19.1 mtt180 -100.18 160.22 14.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.932 0.396 . . . . 0.0 110.809 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -149.1 107.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -108.82 -167.65 20.79 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.291 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.567 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -137.44 85.07 21.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.125 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.822 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 23.1 Cg_exo -62.76 129.04 24.9 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.887 2.391 . . . . 0.0 112.238 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.645 HD11 ' HA ' ' T' ' 47' ' ' CYS . 8.5 mm -141.39 116.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.232 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' T' ' 40' ' ' ARG . 0.2 OUTLIER -90.07 -16.03 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 2.8 tttp -140.99 93.9 8.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.537 ' HB2' ' HA2' ' T' ' 71' ' ' GLY . 17.8 Cg_endo -61.31 129.44 28.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.643 2.229 . . . . 0.0 112.401 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.65 -145.7 10.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.424 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.7 -81.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.747 2.298 . . . . 0.0 112.317 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.18 -26.02 11.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.59 -45.0 94.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.797 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.92 -25.38 14.87 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.867 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 58.81 26.03 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' T' ' 64' ' ' PRO . . . 64.06 16.8 60.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.549 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.452 ' HB3' HD11 ' T' ' 76' ' ' ILE . 4.0 mmmt -76.16 164.63 25.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 130.69 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 74' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' T' ' 40' ' ' ARG . . . 71.34 -168.21 51.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.822 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 12.7 mt -76.06 124.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.897 0.379 . . . . 0.0 111.212 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.8 mm -93.29 81.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.8 120.99 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.47 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.5 m-85 -86.33 -74.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.41 169.79 36.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.232 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.706 HG13 ' HG3' ' T' ' 56' ' ' ARG . 51.8 mt -57.7 108.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.041 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 81' ' ' ARG . 7.4 mmt85 -87.09 15.46 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.545 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.77 27.95 7.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -121.97 62.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.994 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' T' ' 15' ' ' THR . 3.2 mpt_? -69.99 -0.92 8.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.81 3.24 47.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.674 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.586 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -64.79 -170.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -135.79 112.44 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.123 0.487 . . . . 0.0 111.648 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 5.2 m95 -155.44 -177.13 6.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.837 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -77.65 -173.24 2.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -140.38 133.56 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 42.1 m-85 -97.82 117.04 31.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.428 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.446 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.7 t -92.68 154.29 18.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.0 110.836 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 8.1 t80 -149.41 114.05 5.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 1.021 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.0 m-20 -129.72 166.57 25.04 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.764 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.745 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 57.0 Cg_endo -73.31 -53.59 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.627 2.218 . . . . 0.0 111.595 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -100.94 25.97 7.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 1.021 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . -72.47 51.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.271 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.91 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p -79.53 148.27 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 111.315 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.604 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 26.7 p90 -162.17 173.5 14.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 111.705 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.645 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.7 t60 -93.27 150.43 20.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 4.2 tpp85 -152.25 154.83 36.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.9 OUTLIER -116.13 -169.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -90.64 152.3 20.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.405 HH22 HH12 ' T' ' 5' ' ' ARG . 3.6 mmp_? -52.86 -24.35 8.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.726 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -93.27 -47.74 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 174.75 177.98 44.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -65.42 146.75 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.852 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.544 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 7.9 m-30 63.67 61.83 0.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.053 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -155.89 6.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.0 mt -109.03 138.69 44.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.4 p -107.67 148.05 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 83.0 t80 -34.99 -39.53 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.93 61.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.373 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.583 ' OE1' HG23 ' T' ' 15' ' ' THR . 77.8 mt-10 -71.36 -46.3 60.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.226 0.536 . . . . 0.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.576 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -57.39 -37.11 72.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -75.56 -32.21 60.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.023 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.5 -45.64 75.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.361 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 2.9 t -66.83 -50.31 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.306 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 56.6 m -64.44 -45.25 88.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.7 tt0 -78.57 -6.94 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -59.07 -50.76 72.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.842 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.55 58.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.175 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.54 34.08 13.32 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.458 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.46 -172.42 18.2 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.2 134.17 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 0.258 . . . . 0.0 110.472 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.08 124.34 22.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -52.42 165.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.74 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 13.0 p -115.73 -158.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 34.2 t80 -80.41 -71.64 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.978 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.9 mttt -47.42 -37.35 11.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.79 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -67.21 -54.96 16.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.261 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.92 -21.14 27.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.754 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.1 tp10 -69.82 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.268 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.646 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.54 -19.87 11.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.787 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.29 -29.11 17.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 109.613 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.634 ' HE ' HG13 ' T' ' 62' ' ' VAL . 4.2 ttt180 -70.61 -34.31 71.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.001 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 27.2 mtmt -73.52 -17.49 61.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.219 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.646 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -88.35 -6.94 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.73 5.9 8.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.25 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.0 OUTLIER -76.0 117.36 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.702 ' CE1' HG23 ' T' ' 61' ' ' ILE . 1.0 OUTLIER -140.14 125.82 19.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -153.21 101.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.959 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.67 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -72.09 85.75 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.335 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.42 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -177.38 115.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -39.21 108.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.774 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -107.84 122.48 6.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.668 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.623 ' HA ' ' HB ' ' T' ' 57' ' ' VAL . 71.2 m95 -52.68 171.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.701 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -166.58 162.13 16.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.512 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -45.17 159.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.631 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.8 -24.79 0.21 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.425 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.39 22.82 6.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.504 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HG3' HG13 ' T' ' 80' ' ' ILE . 37.6 mtm180 -94.91 165.82 12.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -163.12 108.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -116.64 -171.01 15.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.224 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.545 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.89 82.72 55.3 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.1 Cg_exo -59.89 119.98 7.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.765 2.31 . . . . 0.0 112.3 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.702 HG23 ' CE1' ' T' ' 45' ' ' HIS . 14.5 mm -138.9 132.56 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -110.09 -29.05 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.493 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 1.8 ttmt -123.76 83.76 54.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.62 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 20.8 Cg_endo -62.63 137.52 64.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.597 2.198 . . . . 0.0 112.191 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.69 -130.89 2.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.442 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.61 -80.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.278 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.22 -23.5 11.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.19 44.93 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . 169.7 -44.13 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.943 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 70' ' ' PHE . . . . . 0.408 ' HB2' ' HD2' ' T' ' 72' ' ' LYS . 23.9 m-85 58.88 29.76 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' T' ' 64' ' ' PRO . . . 66.81 25.1 73.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.463 ' HD3' HG13 ' T' ' 76' ' ' ILE . 11.8 mttp -91.12 152.5 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.21 130.47 53.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 74' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 72.73 -175.09 44.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.799 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.631 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 5.4 mt -73.38 117.46 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.5 mm -88.98 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.525 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 5.3 t70 -110.13 135.17 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.77 25.28 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.1 -178.49 26.2 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.862 HG22 ' H ' ' T' ' 82' ' ' LEU . 50.8 mt -61.85 119.83 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.71 6.92 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.862 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.54 33.09 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.82 78.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.688 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtt85 -62.86 -8.62 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 17.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.509 ' O ' HG22 ' T' ' 15' ' ' THR . 1.7 mm-40 -79.46 -176.21 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -134.85 115.8 14.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.054 0.454 . . . . 0.0 111.274 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 28.4 m95 -150.7 -135.05 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.083 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.42 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.8 OUTLIER -118.14 -171.83 2.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.35 179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.576 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.79 130.16 17.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.774 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.13 109.63 22.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.253 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.8 131.78 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.114 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.91 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.1 OUTLIER -131.04 113.98 14.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.745 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.2 m-20 -131.82 158.75 74.57 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.541 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -54.92 -51.41 10.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.574 2.183 . . . . 0.0 111.493 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.484 ' O ' ' C ' ' T' ' 97' ' ' ALA . 10.4 t-160 -104.55 -27.74 11.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 27.54 70.9 0.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.438 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.816 HG22 ' CD2' ' T' ' 93' ' ' TYR . 1.6 t -111.35 138.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.227 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.3 OUTLIER -147.74 160.26 42.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.085 0.469 . . . . 0.0 111.271 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.779 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.1 t-80 -106.13 158.57 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.099 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -164.26 166.0 21.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.041 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.825 ' HG2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -123.18 -167.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.971 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -170.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.93 -34.15 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.1 t -177.29 19.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.27 160.74 23.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.825 ' HA ' ' HG2' ' T' ' 6' ' ' GLU . 1.2 tttt -98.43 158.47 15.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 111.503 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 23.7 m-85 42.46 60.2 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.494 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' T' ' 12' ' ' TYR . 1.7 mmtm -149.7 10.1 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.43 HD11 ' C ' ' T' ' 6' ' ' GLU . 17.8 mt -106.29 125.24 50.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.0 OUTLIER -99.57 145.42 27.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.008 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.6 t80 -33.56 -41.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.98 70.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.567 ' OE1' HG23 ' T' ' 15' ' ' THR . 83.8 mt-10 -72.96 -52.2 15.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.006 0.432 . . . . 0.0 110.195 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -45.82 -49.59 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.926 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -65.78 -56.99 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.0 -42.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.425 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.0 t -68.23 -50.37 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.4 m -63.71 -48.17 78.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 16.9 tt0 -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.736 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.8 OUTLIER -55.72 -51.77 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.899 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.28 58.24 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.152 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.8 27.54 9.75 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.525 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -107.88 -169.9 21.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.514 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.81 133.3 11.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.444 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -64.02 123.52 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 110.381 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.98 162.77 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.348 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.652 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 23.8 p -108.5 -164.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.754 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 20.5 t80 -75.02 -73.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.167 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mttt -48.06 -37.68 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -67.12 -55.11 15.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.56 HD11 ' HG3' ' T' ' 60' ' ' PRO . 1.7 tm? -58.07 -22.77 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.8 tt0 -70.18 -61.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.241 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -13.52 10.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.709 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -93.88 -28.5 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.484 0.659 . . . . 0.0 109.731 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 5.6 tmm_? -69.7 -32.7 71.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.863 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.5 mttm -68.67 -15.22 63.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -93.47 -17.28 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 135.72 12.17 1.21 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.866 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -79.49 100.74 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.53 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.1 t-160 -129.69 131.28 46.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.168 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.82 98.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.811 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -64.7 81.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 174.45 137.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.67 105.33 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.781 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.625 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -102.98 116.77 5.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.661 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 76.3 m95 -48.22 155.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.793 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.77 -179.61 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.593 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 49.93 -165.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.115 0.483 . . . . 0.0 111.488 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.52 0.35 4.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.471 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.509 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 155.48 14.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.672 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.7 ' HB2' ' HB3' ' T' ' 53' ' ' ALA . 5.3 mtp180 -93.37 135.98 34.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.881 0.372 . . . . 0.0 110.996 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -124.38 134.22 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.765 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.13 -174.61 17.53 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.466 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.508 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -131.11 102.39 15.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.8 Cg_endo -61.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.811 HD11 ' HA ' ' T' ' 47' ' ' CYS . 25.9 mm 74.06 105.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.636 HG22 ' HG2' ' T' ' 40' ' ' ARG . 0.2 OUTLIER -81.68 -29.77 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.01 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -116.97 85.19 17.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.15 154.62 32.94 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.653 2.236 . . . . 0.0 112.274 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.48 -139.72 3.08 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.405 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.479 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 71.1 Cg_endo -79.85 -74.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.666 2.244 . . . . 0.0 112.416 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.479 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.4 OUTLIER -103.72 -11.77 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.9 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 42.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' T' ' 72' ' ' LYS . . . 144.57 -9.93 1.9 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.922 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 60.6 28.69 18.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 111.001 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.72 70.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.793 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.888 ' HD3' HG13 ' T' ' 76' ' ' ILE . 14.4 mttp -82.85 158.05 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.62 132.38 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.262 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.12 172.62 47.22 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.913 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.771 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 1.6 mt -67.34 104.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.888 HG13 ' HD3' ' T' ' 72' ' ' LYS . 9.5 mm -80.16 85.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.23 132.3 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.4 m-85 -98.01 4.58 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.693 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 81.04 173.52 47.69 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.645 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.7 mt -59.38 115.8 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -87.97 21.31 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.645 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.78 36.89 25.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.68 67.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.591 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.9 OUTLIER -65.41 -4.59 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.7 t -91.52 12.82 19.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.544 ' O ' HG22 ' T' ' 15' ' ' THR . 2.3 mm-40 -68.56 -175.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.724 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 8.3 mtt180 -135.46 115.05 12.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HD1' ' T' ' 12' ' ' TYR . 21.0 m95 -151.89 -132.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.234 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.545 ' HB3' ' OE1' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -121.04 -172.88 2.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.329 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.732 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -145.3 135.13 23.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.193 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 41.1 m-85 -97.91 107.52 20.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.066 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.432 ' HB3' ' CE2' ' T' ' 3' ' ' TYR . 5.2 m -87.31 137.23 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.919 0.39 . . . . 0.0 111.077 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.816 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.3 t80 -140.91 135.51 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.73 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.426 ' H ' ' HB2' ' T' ' 97' ' ' ALA . 5.9 m-20 -132.74 153.42 81.06 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.8 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.93 -32.8 13.28 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.485 2.123 . . . . 0.0 111.803 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' T' ' 97' ' ' ALA . 7.9 m-70 -121.35 -32.06 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.315 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' T' ' 96' ' ' HIS . . . 31.92 62.5 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.373 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 41.2 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.87 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.947 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.5 p -90.69 138.72 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.239 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.598 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 25.5 p90 -155.39 170.34 22.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 111.638 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.2 t60 -90.97 153.71 19.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.962 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.454 ' N ' ' CD2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -155.78 148.32 23.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.012 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.08 -168.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.49 153.54 18.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.21 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 8' ' ' ARG . 4.0 mmt180 -61.13 -19.35 61.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -94.46 -24.53 17.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.69 167.41 11.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.555 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 8.3 ttpt -60.07 158.85 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.444 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 8.6 m-30 53.45 61.56 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.102 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -156.33 2.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.687 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -105.21 127.58 52.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.556 HG22 ' O ' ' T' ' 86' ' ' GLU . 1.1 p -99.49 149.94 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.61 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 92.0 t80 -36.18 -41.04 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -42.95 69.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' T' ' 15' ' ' THR . 85.1 mt-10 -74.15 -53.9 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.999 0.428 . . . . 0.0 110.301 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -44.96 -51.49 9.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.99 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -63.92 -55.7 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.644 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.48 -39.03 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.4 t -68.23 -51.73 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.219 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.25 -50.61 67.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.474 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 31.3 tt0 -67.07 -16.48 64.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.429 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.03 -47.87 77.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.754 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.19 53.89 0.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.53 41.78 42.37 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.426 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -121.95 168.22 14.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.432 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.22 137.49 51.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.773 0.321 . . . . 0.0 110.622 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -73.81 122.0 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -49.76 158.79 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.43 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 11.5 p -110.69 -159.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.29 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.844 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 25.7 t80 -77.02 -72.97 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.052 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 1.9 mttp -46.92 -37.23 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.556 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.45 -51.77 57.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.626 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -56.66 -23.89 44.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 110.058 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 8.4 tt0 -72.15 -61.94 1.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.473 ' HA ' ' HE3' ' T' ' 41' ' ' LYS . . . -56.02 -16.23 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.7 -29.64 15.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.396 0.617 . . . . 0.0 109.718 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -72.17 -33.1 67.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.925 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.8 OUTLIER -69.66 -16.98 63.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.574 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.61 -12.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.93 13.01 3.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.973 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.531 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.0 OUTLIER -79.9 126.48 31.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.59 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.8 t-160 -150.21 126.39 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.5 102.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.95 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.94 86.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.332 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 177.31 119.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.004 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.01 118.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.752 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.39 123.14 5.83 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.803 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.61 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.6 m95 -53.03 171.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.107 0.479 . . . . 0.0 111.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.583 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.4 ptp -168.9 173.11 7.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.49 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.33 159.6 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.652 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.5 mmtp 67.23 16.28 10.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.254 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 64.07 33.28 86.82 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.515 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.667 ' HD3' ' HA2' ' T' ' 79' ' ' GLY . 4.7 mtt180 -101.12 157.35 16.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.804 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.4 OUTLIER -154.09 115.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.126 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.97 -168.44 12.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.3 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -135.58 103.24 10.27 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.749 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 24.6 Cg_exo -61.01 -93.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.706 2.27 . . . . 0.0 112.017 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' T' ' 47' ' ' CYS . 40.0 mm 75.24 110.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -82.23 -38.18 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.9 OUTLIER -110.87 106.58 57.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.728 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.543 ' HB2' ' HA2' ' T' ' 71' ' ' GLY . 20.3 Cg_endo -62.5 123.21 12.0 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.618 2.212 . . . . 0.0 112.282 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.78 -174.0 13.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.369 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.85 -60.16 0.1 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.603 2.202 . . . . 0.0 112.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -3.18 13.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 38.31 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.47 -24.37 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.98 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 61.11 24.32 14.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' T' ' 64' ' ' PRO . . . 65.89 15.51 62.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.614 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.912 ' HD3' HG13 ' T' ' 76' ' ' ILE . 3.7 mttp -88.77 151.91 22.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.85 128.55 54.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.47 175.96 41.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.938 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -75.04 95.44 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 111.01 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.912 HG13 ' HD3' ' T' ' 72' ' ' LYS . 18.9 mm -68.06 81.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -108.1 120.42 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.805 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.497 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.9 m-85 -84.83 13.99 5.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 72.86 179.17 35.61 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.179 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.697 HG22 ' H ' ' T' ' 82' ' ' LEU . 40.6 mt -62.05 119.81 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -95.85 14.26 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.697 ' H ' HG22 ' T' ' 80' ' ' ILE . 2.9 mm? 53.73 34.32 18.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.44 ' HB3' ' CG ' ' T' ' 86' ' ' GLU . 0.5 OUTLIER -137.65 67.13 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.989 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -63.94 -3.18 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.03 8.17 43.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.556 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -60.59 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.1 113.05 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 111.305 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.47 ' CD1' HG21 ' T' ' 57' ' ' VAL . 27.9 m95 -151.62 -133.52 0.05 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.555 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -121.91 -170.84 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -146.86 130.69 17.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.752 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.82 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.316 . . . . 0.0 110.457 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.406 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.2 m -83.8 130.24 34.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 110.952 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.947 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -130.44 121.55 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.925 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.714 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 6.6 m-20 -128.86 150.06 74.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.478 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 72.3 Cg_exo -47.84 -33.36 19.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.515 2.143 . . . . 0.0 111.831 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' T' ' 97' ' ' ALA . 36.2 m80 -122.55 -32.24 3.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.285 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.714 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.22 77.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.401 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.894 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.807 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.7 p -87.55 142.67 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.487 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 18.0 p90 -144.62 -179.94 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.668 ' CG ' HG11 ' T' ' 46' ' ' VAL . 20.3 t-80 -92.88 154.72 18.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.181 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.438 ' HD2' HH11 ' T' ' 5' ' ' ARG . 0.4 OUTLIER -147.33 147.98 30.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.986 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.654 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.5 tt0 -120.14 173.36 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -75.4 168.52 19.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -21.88 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -47.99 4.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 177.17 176.57 45.39 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.559 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.552 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.2 ttpm? -59.08 151.72 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.5 m-30 52.34 75.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -158.04 -5.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' T' ' 7' ' ' ALA . 0.7 OUTLIER -115.01 164.93 13.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.07 0.462 . . . . 0.0 111.275 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.852 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 6.6 p -116.56 -166.19 1.13 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.347 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.597 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.9 t80 -66.44 -40.45 89.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.062 0.458 . . . . 0.0 109.767 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.75 65.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.72 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.852 ' HB2' ' H ' ' T' ' 15' ' ' THR . 54.6 mt-10 -69.16 -42.83 75.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.278 0.561 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -58.42 -40.81 83.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.925 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -31.41 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -63.93 -46.58 84.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.26 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.84 -48.02 83.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 55.4 m -64.63 -51.19 63.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.771 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -70.88 -11.98 61.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.81 -50.03 73.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.841 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -104.2 57.4 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.27 38.37 26.18 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.247 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.636 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -106.66 178.33 22.32 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.655 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -144.52 133.37 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.917 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.5 OUTLIER -47.77 141.63 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.406 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -85.99 143.37 28.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 32.2 p -98.35 -170.68 2.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 111.576 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 37.9 t80 -70.98 -70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.884 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 12.0 mttt -45.62 -38.38 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.494 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.425 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 84.5 mt-30 -66.62 -55.45 15.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.063 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.563 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.78 -19.86 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.696 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.771 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.7 tt0 -74.74 -62.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.254 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.665 ' HA ' ' HD2' ' T' ' 41' ' ' LYS . . . -55.68 -15.44 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.91 -28.45 15.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.621 . . . . 0.0 109.656 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.588 ' HG3' HG22 ' T' ' 62' ' ' VAL . 50.8 ttp85 -72.33 -36.13 68.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.215 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -67.3 -19.36 65.46 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.636 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.597 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -85.79 -16.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.32 14.18 2.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.965 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.09 117.63 22.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.828 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.73 ' CE1' HG23 ' T' ' 61' ' ' ILE . 0.9 OUTLIER -138.42 128.36 25.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.668 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -148.43 102.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.773 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.35 67.24 1.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.599 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . -165.06 121.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.556 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.18 112.7 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.172 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.721 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.18 121.89 5.95 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.778 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 80.6 m95 -57.0 165.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.139 0.495 . . . . 0.0 111.831 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.917 ' HA ' HD22 ' T' ' 30' ' ' LEU . 1.0 OUTLIER -159.15 165.34 33.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.324 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.16 158.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.5 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 79.53 -25.22 0.19 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.501 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.582 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.35 20.74 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.507 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.717 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 0.2 OUTLIER -94.4 160.94 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.902 0.382 . . . . 0.0 111.006 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -158.22 109.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.17 -168.25 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.315 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.556 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -132.84 86.38 43.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 111.144 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.821 ' HB3' HG12 ' T' ' 75' ' ' ILE . 32.9 Cg_endo -67.0 118.42 5.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.666 2.244 . . . . 0.0 111.955 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.773 HD11 ' HA ' ' T' ' 47' ' ' CYS . 31.6 mm -134.17 119.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -97.69 -24.61 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.499 ' H ' ' CD2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -123.58 93.04 48.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.52 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.691 2.261 . . . . 0.0 112.552 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.33 159.01 29.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.381 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 57.0 Cg_endo -71.12 -76.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.744 2.296 . . . . 0.0 112.584 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.469 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -86.38 -6.24 58.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.228 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.17 42.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' T' ' 70' ' ' PHE . . . 168.74 -38.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.927 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 70' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' T' ' 69' ' ' GLY . 0.9 OUTLIER 172.1 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.89 42.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -81.33 178.9 8.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.09 131.31 53.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.31 -171.0 54.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.866 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.821 HG12 ' HB3' ' T' ' 60' ' ' PRO . 10.0 mt -82.63 121.78 36.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.6 mm -95.1 82.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.44 114.18 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 3.4 m-85 -78.91 -27.25 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 115.35 169.9 16.01 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.472 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.5 mt -53.48 105.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.293 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -90.34 20.29 4.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.956 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' T' ' 82' ' ' LEU . 0.5 OUTLIER 49.45 39.99 17.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.872 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 83' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -126.37 53.84 1.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtm180 -68.13 10.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 85' ' ' SER . . . . . 0.509 ' H ' ' C ' ' T' ' 83' ' ' ASN . 68.0 m -115.66 8.72 15.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.632 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.781 ' O ' HG22 ' T' ' 15' ' ' THR . 3.1 mm-40 -74.43 -170.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.55 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.402 ' HG3' ' C ' ' T' ' 86' ' ' GLU . 0.0 OUTLIER -136.53 115.95 12.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 111.592 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.772 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 4.4 m95 -154.44 -155.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.106 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.631 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -100.12 -172.39 2.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.184 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -143.01 131.18 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.74 0.305 . . . . 0.0 111.452 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.721 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 40.4 m-85 -96.02 113.91 25.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.123 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.402 ' O ' HG23 ' T' ' 2' ' ' VAL . 18.9 m -89.68 153.18 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.807 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 11.2 t80 -141.37 133.02 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.686 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.4 m-20 -153.27 141.18 13.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.634 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.8 -33.34 40.46 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.484 2.122 . . . . 0.0 111.858 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' T' ' 97' ' ' ALA . 6.6 m-70 -119.42 -34.77 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.532 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 32.89 57.82 0.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.397 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -105.04 137.44 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.69 0.281 . . . . 0.0 111.317 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -142.75 151.02 40.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.488 . . . . 0.0 111.378 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.495 ' CD2' HG21 ' T' ' 46' ' ' VAL . 15.0 t-80 -90.88 145.16 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' T' ' 4' ' ' HIS . 5.1 mmm180 -153.82 151.08 29.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.215 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.37 -169.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.792 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -83.44 151.38 25.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 8' ' ' ARG . . . . . 0.439 HH12 HH22 ' T' ' 5' ' ' ARG . 6.6 mmt-85 -54.07 -26.39 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -91.72 -49.66 6.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -179.66 176.69 47.77 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 3.2 ttpm? -68.56 162.03 26.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.794 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.6 m-30 52.07 44.12 29.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.72 5.95 2.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.792 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.7 mt -108.98 142.67 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.076 0.465 . . . . 0.0 111.514 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.2 p -114.7 152.13 32.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.947 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.649 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.0 t80 -38.41 -39.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.82 -40.48 72.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' T' ' 15' ' ' THR . 84.3 mt-10 -75.24 -51.48 13.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.18 -48.96 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.057 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.526 ' HD2' HD23 ' T' ' 30' ' ' LEU . 5.5 tttt -64.91 -52.84 54.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.21 -36.59 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.309 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 7.1 t -70.74 -54.84 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.81 -47.63 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 37.7 tt0 -70.66 -17.43 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.602 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.2 -48.22 68.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.75 54.21 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.943 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.15 42.95 24.88 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.261 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -123.28 174.63 16.56 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -127.75 141.52 51.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.633 0.254 . . . . 0.0 110.605 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.64 125.18 28.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.451 . . . . 0.0 110.071 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 1.058 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.2 152.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.714 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.563 HG23 ' OE1' ' T' ' 35' ' ' GLN . 9.7 p -109.72 -157.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.645 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 22.9 t80 -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.166 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.6 mttm -47.76 -35.96 10.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 35' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.5 mt-30 -67.33 -56.1 11.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.359 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.614 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.6 tm? -56.45 -24.01 42.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 14.1 tp10 -66.49 -62.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.75 -13.99 12.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.639 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.06 -28.2 15.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.448 0.642 . . . . 0.0 109.613 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.563 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -71.06 -32.92 69.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.896 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -67.14 -17.83 65.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.187 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.639 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.82 -18.52 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.499 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 133.89 15.78 1.17 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.865 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.3 OUTLIER -83.46 79.69 9.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.991 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.601 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.5 t-160 -111.93 128.39 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.634 HG22 ' OH ' ' T' ' 91' ' ' TYR . 2.0 m -147.02 111.65 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.081 0.467 . . . . 0.0 110.991 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.722 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -76.12 77.41 2.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.926 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.81 126.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.25 121.29 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.694 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -117.36 120.77 4.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.4 m95 -53.93 166.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.427 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.669 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -162.32 171.36 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.528 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.32 166.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.381 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 77.02 -28.8 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 106.68 18.74 10.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.65 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.786 ' HB3' HG13 ' T' ' 80' ' ' ILE . 3.5 ptp85 -105.34 158.76 16.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 110.547 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.3 OUTLIER -146.25 122.01 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -117.9 -168.41 14.45 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.489 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -131.01 88.08 46.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 111.038 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.925 ' HB3' HG12 ' T' ' 75' ' ' ILE . 56.3 Cg_endo -73.55 123.3 8.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.822 2.348 . . . . 0.0 112.193 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.722 HD11 ' HA ' ' T' ' 47' ' ' CYS . 17.6 mm -136.32 97.66 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.506 ' CG1' ' N ' ' T' ' 63' ' ' LYS . 0.6 OUTLIER -62.82 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.529 ' O ' ' HE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -115.27 92.26 31.3 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.452 ' HG3' ' O ' ' T' ' 72' ' ' LYS . 78.3 Cg_exo -45.38 121.96 4.27 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.63 2.22 . . . . 0.0 112.435 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.59 166.23 21.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.489 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 57.8 Cg_endo -71.69 -78.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.669 2.246 . . . . 0.0 112.395 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 67' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -76.52 -0.36 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -7.32 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.37 55.59 2.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.94 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 t80 39.6 76.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.97 6.65 6.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.55 ' HB3' HD11 ' T' ' 76' ' ' ILE . 0.0 OUTLIER 41.53 -164.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.401 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 128.07 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.914 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.95 -169.51 54.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.766 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' T' ' 60' ' ' PRO . 22.6 mt -80.45 122.09 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' T' ' 72' ' ' LYS . 5.2 mm -96.18 80.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.876 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.507 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 4.1 t70 -110.64 131.12 55.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.8 m-85 -100.33 25.22 7.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.982 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.16 178.58 8.75 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.786 HG13 ' HB3' ' T' ' 56' ' ' ARG . 3.6 mt -65.17 126.67 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 111.194 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -106.62 19.64 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.789 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.67 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 56.12 32.23 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.8 54.95 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' T' ' 15' ' ' THR . 1.4 mtt85 -65.21 -1.93 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.97 11.51 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.515 ' O ' HG22 ' T' ' 15' ' ' THR . 3.0 mm-40 -72.96 -171.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -137.01 115.97 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.387 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.583 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.2 m95 -150.75 -138.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.141 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -112.24 -170.71 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.08 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.472 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.5 126.56 15.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.415 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 1.058 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 30.5 m-85 -97.36 126.81 42.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.898 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.488 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -100.23 162.84 12.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.872 0.368 . . . . 0.0 110.932 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.619 ' CD2' HG22 ' T' ' 2' ' ' VAL . 21.2 t80 -156.11 118.8 4.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.797 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.862 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 3.0 m120 -139.34 146.79 50.14 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.698 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.1 -52.08 8.07 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.552 2.168 . . . . 0.0 111.617 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.527 ' O ' ' C ' ' T' ' 97' ' ' ALA . 14.2 m-70 -97.26 -27.52 14.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.305 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 23.09 71.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.461 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 tttt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.877 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.911 ' HB ' ' HD1' ' T' ' 93' ' ' TYR . 2.3 p -102.48 152.52 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -160.32 178.98 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.993 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.406 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.1 t-80 -89.11 155.88 19.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.3 OUTLIER -148.81 152.02 35.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.647 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.6 tt0 -122.53 172.79 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.23 158.76 26.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -61.27 -26.99 68.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.9 t -91.81 -50.53 5.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 178.39 172.8 43.17 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.421 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.9 ttpt -66.22 161.94 21.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.737 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.642 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.2 m-30 55.7 53.89 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 8.3 mtmt -154.68 3.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.0 mt -102.43 132.41 48.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 30.3 p -103.47 148.85 25.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.538 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 84.2 t80 -35.66 -38.1 0.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.46 -44.97 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.457 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' T' ' 15' ' ' THR . 64.2 mt-10 -73.05 -47.69 42.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.17 0.51 . . . . 0.0 110.348 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.98 -45.3 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.077 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.91 -47.13 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.58 -47.59 19.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 22' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.7 t -68.19 -53.27 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 87.7 m -59.89 -38.39 82.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.1 tt0 -90.08 -2.64 58.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 1.2 t80 -59.41 -48.13 82.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.95 60.59 2.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.24 22.41 10.14 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.509 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.771 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.96 -158.27 12.56 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 3.7 p80 -155.04 -178.46 7.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.756 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -103.29 124.95 49.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.642 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.84 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -46.02 157.57 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.543 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -111.29 -162.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.894 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 50.0 t80 -75.25 -68.17 0.58 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.945 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 2.2 mtpm? -47.21 -45.28 23.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.28 -49.35 76.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.881 0.372 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -54.92 -29.44 56.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.106 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.0 tt0 -65.05 -61.84 1.91 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.473 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.58 -12.1 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.578 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.73 -29.86 14.58 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.423 0.63 . . . . 0.0 109.892 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.632 ' HE ' HG12 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -72.98 -33.99 66.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.07 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.9 mttt -69.85 -17.49 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.408 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.578 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.5 -17.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.8 11.51 1.43 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.7 129.63 34.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.3 t-160 -146.24 125.56 13.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.711 HG21 ' HE1' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -142.99 98.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.122 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.716 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.47 -0.13 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.566 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -102.64 141.77 34.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.676 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -58.79 114.23 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.87 117.43 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.707 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.3 m95 -52.38 166.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 111.435 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.773 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.9 ptp -164.55 173.24 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.484 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.58 ' HB2' HG22 ' T' ' 32' ' ' THR . . . -51.11 167.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.424 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.13 -28.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.266 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 104.8 18.6 12.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.571 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.564 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.8 ptt180 -105.03 158.67 16.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.701 0.286 . . . . 0.0 110.581 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -142.07 122.86 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.72 -168.43 12.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.676 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -145.51 90.84 5.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.162 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.574 ' HG3' HD12 ' T' ' 36' ' ' LEU . 58.4 Cg_endo -74.9 134.95 18.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.659 2.24 . . . . 0.0 112.179 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm -126.67 145.13 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.632 HG12 ' HE ' ' T' ' 40' ' ' ARG . 4.1 m -98.08 -44.57 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.087 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 63' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.0 OUTLIER -118.46 94.12 46.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 64' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 30.9 Cg_endo -65.37 131.1 27.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.499 2.133 . . . . 0.0 112.288 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.71 -133.69 3.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.75 -83.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 0.0 112.379 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -17.69 24.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.859 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -4.71 57.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.18 64.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.955 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -46.95 -29.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.815 0.341 . . . . 0.0 111.023 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.2 23.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.696 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' T' ' 76' ' ' ILE . 7.8 mttt -92.17 149.94 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 128.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.67 -169.91 33.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.057 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.894 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -72.79 101.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.667 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.3 mm -72.05 81.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.07 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.72 137.32 49.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.727 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.451 ' HE1' HG22 ' T' ' 76' ' ' ILE . 0.8 OUTLIER -105.05 28.44 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.59 171.28 3.36 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.8 mt -69.84 119.01 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.9 15.4 2.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.689 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.09 43.66 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -164.76 82.26 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.24 -1.15 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.0 13.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.591 ' O ' HG22 ' T' ' 15' ' ' THR . 3.8 mm-40 -76.84 -177.15 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.7 OUTLIER -134.55 113.29 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.503 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.642 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.7 m95 -153.32 -160.34 1.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.168 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.566 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -92.42 -170.91 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.556 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -141.04 128.62 21.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 23.4 m-85 -91.07 107.86 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.92 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 92' ' ' CYS . . . . . 0.486 ' O ' HG23 ' T' ' 2' ' ' VAL . 3.7 m -88.28 149.32 23.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 111.213 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.911 ' HD1' ' HB ' ' T' ' 2' ' ' VAL . 61.8 t80 -136.47 132.1 34.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' T' ' 97' ' ' ALA . 69.1 m-20 -116.91 81.21 11.9 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 95' ' ' PRO . . . . . 0.73 ' HB3' ' HE2' ' T' ' 93' ' ' TYR . 64.4 Cg_endo -75.79 -56.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.469 2.112 . . . . 0.0 110.116 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.459 ' H ' ' HG2' ' T' ' 95' ' ' PRO . 20.0 t-160 -126.06 10.14 7.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.958 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.583 ' HB2' ' CA ' ' T' ' 28' ' ' GLY . . . -77.72 54.49 1.24 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.224 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.955 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -86.57 147.07 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.591 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 12.5 p90 -156.41 176.21 13.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.021 0.439 . . . . 0.0 111.405 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.775 ' CG ' HG11 ' T' ' 46' ' ' VAL . 39.3 t-80 -98.65 163.79 12.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.447 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.88 146.38 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 0.4 OUTLIER -109.23 -168.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 110.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -95.48 150.67 20.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.08 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -25.66 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -92.13 -48.94 6.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 170.66 172.7 37.23 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 1.4 tttt -58.97 151.02 22.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.618 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 9.3 m-30 61.77 58.67 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.04 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -155.17 5.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.634 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 5.7 mt -109.0 133.1 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.289 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.4 p -104.8 149.32 25.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.286 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 78.3 t80 -35.44 -40.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.982 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.15 -45.25 67.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.525 ' OE1' HG23 ' T' ' 15' ' ' THR . 74.5 mt-10 -72.48 -47.62 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.03 -45.44 52.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -71.08 -50.77 30.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -48.7 -38.69 22.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.24 -53.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.487 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 66.4 m -64.34 -27.18 68.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 23.5 tt0 -98.9 -9.03 24.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.155 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.5 t80 -53.73 -42.96 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.081 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.71 60.23 0.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.268 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.79 26.2 10.52 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.538 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -106.57 -169.29 22.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.561 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -155.71 134.05 11.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.418 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -65.04 125.34 24.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.079 0.466 . . . . 0.0 110.387 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -53.02 161.4 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 26.3 p -109.34 -164.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.207 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.638 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 28.4 t80 -74.91 -72.59 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.143 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mtpt -48.23 -40.21 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.913 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.95 -51.19 63.17 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.601 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 6.5 tp10 -54.71 -60.37 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.232 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.51 14.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.862 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.611 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -90.62 -27.93 18.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 109.723 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.2 OUTLIER -72.23 -33.27 67.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.053 179.339 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.601 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 8.4 mttp -68.99 -17.78 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.396 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.611 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.46 -15.9 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.433 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.22 14.9 2.13 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.068 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.581 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -81.95 99.25 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.669 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 0.3 OUTLIER -121.73 119.78 32.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -141.3 94.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' T' ' 48' ' ' ALA . 6.5 t -64.37 89.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 171.91 127.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -46.46 101.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -101.66 111.11 4.0 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.676 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 74.2 m95 -44.65 157.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.983 0.42 . . . . 0.0 111.294 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.792 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -174.83 178.13 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.14 -166.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.12 0.4 3.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.305 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.435 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 156.81 13.15 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.739 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.846 ' HG3' HG13 ' T' ' 80' ' ' ILE . 4.4 mtt-85 -90.45 130.76 36.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.443 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -125.08 129.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.961 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 58' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -135.17 -175.74 14.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.329 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.43 78.93 14.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.756 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.7 Cg_exo -63.12 124.59 14.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.758 2.305 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.5 HG23 ' CE1' ' T' ' 45' ' ' HIS . 38.6 mm -130.51 153.3 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 15.5 t -102.93 -64.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.347 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.05 155.63 45.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.056 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.08 -169.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.588 2.192 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.49 81.34 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.289 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 66' ' ' PRO . . . . . 0.862 ' HG3' ' HA ' ' T' ' 70' ' ' PHE . 72.8 Cg_endo -85.82 -27.61 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.952 2.434 . . . . 0.0 112.379 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 21.1 t30 44.43 16.23 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.398 0.618 . . . . 0.0 109.858 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 68' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -113.85 -41.17 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.102 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.6 14.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 70' ' ' PHE . . . . . 0.862 ' HA ' ' HG3' ' T' ' 66' ' ' PRO . 0.6 OUTLIER 73.65 81.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 71' ' ' GLY . . . . . 0.447 ' O ' HG13 ' T' ' 61' ' ' ILE . . . -91.3 17.27 56.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.604 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.05 -166.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.04 0.447 . . . . 0.0 111.558 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.23 124.96 46.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.093 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.62 179.55 50.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.872 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.638 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.7 mt -73.42 111.56 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.542 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.3 mm -91.05 80.15 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 77' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.4 t70 -103.29 129.18 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -94.41 15.84 16.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 79' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 71.22 169.6 9.81 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.846 HG13 ' HG3' ' T' ' 56' ' ' ARG . 10.6 mt -59.36 112.68 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.983 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 81' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' T' ' 81' ' ' ARG . 2.2 mmp_? -91.57 21.05 4.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.576 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 51.66 50.82 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.61 66.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.654 ' O ' ' HB ' ' T' ' 15' ' ' THR . 19.3 mtm105 -66.67 -3.58 6.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m -98.19 18.62 15.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.532 ' O ' HG22 ' T' ' 15' ' ' THR . 3.3 mm-40 -74.87 -171.25 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.5 114.48 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.56 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 22.8 m95 -151.68 -134.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.378 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -121.64 -172.12 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.379 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.531 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.15 137.23 25.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 28.9 m-85 -101.67 107.65 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -85.85 133.83 33.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 111.327 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.955 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.9 OUTLIER -132.57 124.55 28.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.662 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.9 m120 -134.14 148.5 68.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.75 -33.28 18.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.512 2.141 . . . . 0.0 111.849 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.456 ' O ' ' C ' ' T' ' 97' ' ' ALA . 38.7 m80 -122.77 -32.03 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.439 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.66 71.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.338 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.863 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' T' T ' 2' ' ' VAL . . . . . 0.811 HG22 ' HE2' ' T' ' 44' ' ' PHE . 1.3 p -86.07 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 3' ' ' TYR . . . . . 0.719 ' HE1' ' HB1' ' T' ' 97' ' ' ALA . 13.8 p90 -141.93 169.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 4' ' ' HIS . . . . . 0.522 ' HB2' HG11 ' T' ' 46' ' ' VAL . 9.7 t-80 -96.76 145.7 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.764 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 5' ' ' ARG . . . . . 0.435 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -152.47 166.4 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 6' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.6 OUTLIER -123.3 -170.15 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.66 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 7' ' ' ALA . . . . . 0.667 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.31 150.69 24.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -19.26 61.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 9' ' ' SER . . . . . 0.461 ' HB3' ' CE ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -97.33 -25.89 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 10' ' ' GLY . . . . . 0.658 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 152.51 168.12 16.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -61.85 153.89 27.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.702 0.287 . . . . 0.0 110.855 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 12' ' ' TYR . . . . . 0.766 ' HB3' ' HD2' ' T' ' 87' ' ' ARG . 10.2 m-30 55.52 51.55 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 1.0 OUTLIER -142.28 2.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.636 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 14' ' ' LEU . . . . . 0.667 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.8 mt -105.78 141.23 37.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 15' ' ' THR . . . . . 0.625 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 49.4 p -110.51 149.71 29.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.4 t80 -34.91 -40.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.07 61.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.409 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 18' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.0 mt-10 -68.61 -44.04 75.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 109.966 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.06 -39.22 74.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.972 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 20' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' T' ' 24' ' ' GLU . 10.5 tttm -75.51 -38.22 59.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.106 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 21' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -56.06 -50.01 72.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.81 -53.76 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.42 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 23' ' ' CYS . . . . . 0.635 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 88.3 m -63.31 -26.96 69.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 24' ' ' GLU . . . . . 0.789 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 22.3 tt0 -103.39 1.59 32.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.232 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 25' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -63.71 -43.33 96.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.203 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -100.53 61.26 1.02 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.39 19.97 6.68 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.619 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 28' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.26 -159.97 13.9 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 29' ' ' HIS . . . . . 0.635 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 5.7 p80 -152.88 -177.56 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.996 0.427 . . . . 0.0 110.657 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -101.6 124.06 46.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.6 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 31' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -44.92 154.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.571 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 32' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 6.9 p -108.31 -158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 33' ' ' TYR . . . . . 0.921 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 35.2 t80 -80.99 -73.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.112 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 34' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 20.8 mtmt -44.83 -36.85 3.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.82 -53.1 36.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 36' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.89 -21.13 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.138 0.494 . . . . 0.0 109.984 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 9.3 tt0 -72.63 -61.97 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 38' ' ' ALA . . . . . 0.554 ' HA ' ' HE2' ' T' ' 41' ' ' LYS . . . -58.43 -15.58 11.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 39' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' T' ' 44' ' ' PHE . . . -94.02 -29.73 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.537 0.684 . . . . 0.0 109.578 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 40' ' ' ARG . . . . . 0.658 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -69.06 -32.56 72.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.863 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 41' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' T' ' 38' ' ' ALA . 28.7 mtmt -66.61 -17.85 65.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 42' ' ' ILE . . . . . 0.658 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -92.1 -22.47 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 43' ' ' GLY . . . . . 0.577 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 138.61 17.88 0.56 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.96 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 44' ' ' PHE . . . . . 0.811 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.5 OUTLIER -74.75 86.76 2.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.778 0.323 . . . . 0.0 110.876 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 45' ' ' HIS . . . . . 0.626 ' NE2' HG23 ' T' ' 61' ' ' ILE . 3.5 t-160 -115.36 122.84 47.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.97 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 46' ' ' VAL . . . . . 0.671 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.7 OUTLIER -148.54 112.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 47' ' ' CYS . . . . . 0.926 ' HA ' HD11 ' T' ' 61' ' ' ILE . 1.8 t -82.76 74.38 9.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 48' ' ' ALA . . . . . 0.657 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -176.54 123.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 49' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -42.85 116.68 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 50' ' ' GLY . . . . . 0.665 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.17 117.42 3.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 51' ' ' TRP . . . . . 0.584 ' C ' HD11 ' T' ' 30' ' ' LEU . 75.3 m95 -50.66 166.47 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 52' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 2.0 ptp -162.18 168.61 22.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.362 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 53' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.67 165.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.541 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 54' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mmtp 78.76 -33.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.375 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 111.45 17.22 8.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.695 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 56' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.8 OUTLIER -105.23 157.25 17.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.579 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 57' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -139.39 125.75 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.312 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.23 -168.01 12.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.149 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 59' ' ' TYR . . . . . 0.538 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -144.59 98.32 4.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 60' ' ' PRO . . . . . 0.689 ' HB3' HD13 ' T' ' 75' ' ' ILE . 78.5 Cg_endo -83.41 129.45 5.08 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.814 2.343 . . . . 0.0 112.183 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 61' ' ' ILE . . . . . 0.926 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.4 mm -141.13 111.61 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 62' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.4 m -66.48 -41.39 88.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -114.54 88.06 15.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.56 148.16 92.59 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.622 2.215 . . . . 0.0 112.27 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.89 -137.67 3.95 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.4 -77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.264 . . . . 0.0 112.392 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.57 -3.93 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -23.62 66.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.28 -5.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.963 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 62.36 33.65 16.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.964 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.99 22.72 65.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.672 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 72' ' ' LYS . . . . . 0.732 ' HD3' HG13 ' T' ' 76' ' ' ILE . 23.7 mttp -85.46 155.12 21.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 132.78 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.5 -173.1 33.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 75' ' ' ILE . . . . . 0.921 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -79.78 98.39 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 76' ' ' ILE . . . . . 0.732 HG13 ' HD3' ' T' ' 72' ' ' LYS . 16.0 mm -70.9 79.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.69 117.62 34.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.874 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 78' ' ' TYR . . . . . 0.541 ' CE1' HG22 ' T' ' 76' ' ' ILE . 0.6 OUTLIER -81.14 11.86 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.64 169.41 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 80' ' ' ILE . . . . . 0.606 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.8 mt -52.87 136.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.027 0.441 . . . . 0.0 111.251 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.31 17.08 14.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.018 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 82' ' ' LEU . . . . . 0.606 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 49.54 50.27 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.33 55.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 84' ' ' ARG . . . . . 0.543 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -56.09 -12.52 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.4 15.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 86' ' ' GLU . . . . . 0.565 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.7 mm-40 -78.82 -171.68 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 87' ' ' ARG . . . . . 0.766 ' HD2' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -136.18 113.2 10.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 88' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 3.4 m95 -156.26 179.49 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.056 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 89' ' ' ASP . . . . . 0.657 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -73.83 -170.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.323 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' T' T ' 90' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.08 132.23 19.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.598 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 91' ' ' TYR . . . . . 0.875 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 45.5 m-85 -94.08 115.57 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.63 151.67 21.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 111.331 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 93' ' ' TYR . . . . . 0.665 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 12.0 t80 -148.3 118.88 7.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 94' ' ' ASN . . . . . 0.865 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 59.3 m-20 -132.34 141.38 41.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.93 -32.76 23.91 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.505 2.137 . . . . 0.0 111.738 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' T' T ' 96' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' T' ' 97' ' ' ALA . 15.1 m-70 -121.75 -32.75 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 97' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 31.12 53.38 0.18 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.354 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.64 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.872 0.368 . . . . 0.0 111.161 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 137.01 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.734 ' CG ' HG11 ' T' ' 46' ' ' VAL . 17.6 t-80 -69.22 150.35 47.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.518 ' HG3' ' SG ' ' T' ' 92' ' ' CYS . 11.0 mmt180 -144.21 144.86 31.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.402 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -115.88 -168.97 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.877 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.13 153.55 18.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -17.45 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.758 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -101.22 -25.2 14.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 142.3 166.29 10.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.465 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.4 ttpm? -56.72 151.97 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 18.8 m-30 63.16 55.39 1.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.589 ' HA ' ' HD2' ' T' ' 87' ' ' ARG . 9.8 mttt -154.5 1.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.669 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.08 134.88 46.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 4.6 p -105.1 148.06 27.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.117 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -35.34 -38.68 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.46 -44.13 65.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' T' ' 15' ' ' THR . 72.0 mt-10 -73.13 -48.24 37.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 110.39 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.608 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.83 -45.59 50.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.036 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.15 -55.7 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -42.18 -38.17 1.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.48 -49.91 49.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 46.2 m -64.0 -51.66 63.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.1 tt0 -69.83 -15.81 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -52.52 -50.94 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.51 53.75 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.25 34.15 32.33 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.235 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -103.71 -178.49 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.614 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -147.07 135.52 21.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.014 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.39 143.73 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.228 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.77 142.25 30.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.421 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 33.5 p -98.84 -170.97 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.501 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.776 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 58.1 t80 -70.63 -68.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.104 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 5.2 mmtp -49.42 -37.75 26.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.764 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.2 mt-30 -67.69 -57.08 6.99 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.258 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.643 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.2 tm? -58.59 -21.36 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 10.3 tt0 -70.26 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.581 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.25 -22.52 18.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.57 -29.33 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.478 0.656 . . . . 0.0 109.442 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.657 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 3.1 tmm_? -69.62 -35.3 75.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.641 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 3.1 mtmp? -71.73 -13.27 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.581 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.4 pt -97.26 -16.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.491 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.417 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.92 9.17 1.14 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.421 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.679 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.4 OUTLIER -75.87 91.13 2.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.986 0.393 . . . . 0.0 110.825 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.8 t-160 -123.24 129.07 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.734 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.21 98.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.283 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.703 ' HA ' HD11 ' T' ' 61' ' ' ILE . 6.1 t -66.27 80.68 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.435 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.66 136.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.695 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.29 112.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.66 118.64 5.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.668 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.531 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.9 m95 -52.36 150.1 5.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.444 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.827 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.85 176.17 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.643 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.0 -165.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.619 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -8.85 9.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.533 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 159.93 18.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.047 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.643 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 6.2 ptp180 -95.07 132.53 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.616 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -121.42 121.0 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.94 -168.93 14.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.2 OUTLIER -133.94 76.99 63.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.864 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_exo -59.39 122.35 11.37 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.792 2.328 . . . . 0.0 112.379 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.703 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.8 mm -139.87 110.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.11 -168.03 30.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.893 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 33.5 mt -75.39 125.98 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.359 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.592 HG22 ' CE1' ' T' ' 78' ' ' TYR . 5.1 mm -95.95 81.34 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.43 133.51 54.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' T' ' 76' ' ' ILE . 16.8 m-85 -110.76 -6.8 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.79 174.01 25.69 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.8 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.5 mt -55.56 157.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.405 ' N ' HG22 ' T' ' 80' ' ' ILE . 6.5 mtm180 -120.75 11.01 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.8 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.0 44.34 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -168.55 75.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.821 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -66.88 -5.87 14.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.038 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 77.3 p -73.67 10.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.575 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 4.4 mm-40 -75.3 177.42 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.718 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.589 ' HD2' ' HA ' ' T' ' 13' ' ' LYS . 2.8 mtm180 -131.69 113.53 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 111.315 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.672 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.5 m95 -151.87 -153.46 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.203 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.435 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.82 -171.79 2.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.424 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.84 119.22 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.481 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.837 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 33.6 m-85 -86.77 116.2 24.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' T' ' 5' ' ' ARG . 1.3 m -93.48 155.31 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 111.205 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.9 t80 -153.6 99.31 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.587 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' T' ' 94' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.855 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.4 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.872 0.368 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 24.8 p90 -151.91 -176.53 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.783 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.821 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.2 t-80 -109.21 157.68 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 2.1 mmt180 -156.33 148.97 23.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' T' ' 6' ' ' GLU . 2.9 pm0 -112.54 -173.21 2.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.772 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -91.38 158.4 16.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.179 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -61.09 -20.51 62.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' T' ' 13' ' ' LYS . 32.9 m -95.28 -28.54 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.65 167.11 12.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.44 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.454 ' HD2' ' CB ' ' T' ' 48' ' ' ALA . 1.6 ttpm? -56.65 152.13 12.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 19.3 m-30 63.79 54.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' T' ' 9' ' ' SER . 53.7 mttt -152.76 5.77 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.678 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.2 mt -109.19 130.23 55.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.048 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.641 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.2 p -103.09 150.47 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.257 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.528 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 85.9 t80 -35.29 -43.14 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.724 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.641 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 13.8 mt-10 -68.07 -56.29 9.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -44.2 -39.04 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -70.24 -38.36 75.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -60.94 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.52 -48.11 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -66.19 -54.87 20.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.349 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -71.66 -1.58 14.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.701 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -65.1 -48.67 72.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -115.62 63.96 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.242 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.68 45.53 54.59 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.335 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.643 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -115.88 177.53 17.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.535 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -149.65 133.9 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 110.958 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.03 141.22 6.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.328 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.92 146.25 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.463 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 43.6 p -100.93 -172.29 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.92 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 69.8 t80 -70.93 -64.9 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -49.12 -39.33 28.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.536 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.435 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.5 mt-30 -65.64 -53.06 46.62 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.488 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.36 -27.23 62.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.001 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.13 -59.67 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.426 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.422 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.37 -19.45 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.633 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.39 -32.94 15.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.457 0.646 . . . . 0.0 109.681 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.853 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -70.53 -33.35 71.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.871 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -66.09 -21.13 66.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.98 -23.19 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 110.391 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.591 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 141.33 16.26 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.126 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.683 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -75.91 132.41 40.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.904 0.352 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.538 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.6 t-160 -156.11 124.22 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.821 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.78 89.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.82 74.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.675 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.454 ' CB ' ' HD2' ' T' ' 11' ' ' LYS . . . -175.77 119.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.785 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -37.42 114.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.295 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -114.25 121.3 5.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.545 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.528 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.5 m95 -54.68 148.58 12.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.113 0.482 . . . . 0.0 111.634 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.808 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.94 178.81 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.636 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.22 -165.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.468 . . . . 0.0 111.509 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -7.86 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 160.22 18.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.811 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.5 mtp180 -92.78 134.79 34.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -129.92 111.8 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -113.89 -172.26 17.89 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.271 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -122.91 81.45 50.13 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 0.0 111.016 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.0 Cg_exo -59.77 126.2 19.84 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.686 2.258 . . . . 0.0 112.164 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.497 HG23 ' CE1' ' T' ' 45' ' ' HIS . 25.3 mm -131.59 134.31 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.225 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.853 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.798 0.332 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.44 168.69 7.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.093 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.92 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.5 mp -62.37 105.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.461 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 7.0 mm -73.96 82.29 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.09 120.12 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.417 ' CE1' HG22 ' T' ' 76' ' ' ILE . 7.9 m-85 -87.36 -35.42 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.23 169.66 12.55 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.724 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.0 mt -61.22 115.42 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.0 mmt85 -84.31 11.13 8.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.688 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.25 46.24 16.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.786 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.74 77.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.665 HH21 ' HA ' ' T' ' 82' ' ' LEU . 0.3 OUTLIER -72.4 7.34 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.822 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.43 7.16 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.585 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -66.36 -173.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.93 113.07 11.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.446 . . . . 0.0 111.517 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.597 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.7 m95 -154.47 -166.69 2.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.118 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.451 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -84.34 -173.55 4.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.448 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.26 118.92 10.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.397 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.717 ' CD1' HD21 ' T' ' 36' ' ' LEU . 39.1 m-85 -88.4 113.95 24.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.403 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.431 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 2.0 t -93.89 159.8 15.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.855 0.36 . . . . 0.0 111.05 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.855 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 14.3 t80 -145.11 134.15 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.643 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 6.9 m-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.952 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -157.53 177.42 11.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.203 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.79 ' CG ' HG11 ' T' ' 46' ' ' VAL . 37.9 t-80 -97.66 160.09 14.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.501 ' HE ' ' HB2' ' T' ' 5' ' ' ARG . 0.0 OUTLIER -157.11 147.26 20.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.3 OUTLIER -112.52 -168.43 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.731 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -102.6 155.92 17.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.14 -17.72 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 p -98.47 -25.59 14.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.53 166.94 10.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.1 ttpm? -57.41 152.03 15.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 17.7 m-30 61.41 56.28 2.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.142 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -155.12 8.53 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.573 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.731 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.3 mt -110.63 132.32 54.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.291 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.728 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.7 p -103.0 146.54 28.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.141 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.608 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.5 t80 -33.93 -39.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.31 -45.2 70.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' T' ' 15' ' ' THR . 73.4 mt-10 -73.8 -49.9 23.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.39 -41.1 27.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.989 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -50.1 22.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.931 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.71 -40.99 30.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.409 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 6.8 t -70.49 -54.31 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.452 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 63.4 m -60.77 -42.04 96.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.923 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 10.0 tt0 -81.8 -10.25 59.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 0.9 OUTLIER -54.23 -50.89 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.003 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -96.62 61.37 1.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.92 30.72 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.418 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -111.56 -169.31 18.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.502 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.15 135.26 13.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.592 0.234 . . . . 0.0 110.441 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.19 125.43 26.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.463 . . . . 0.0 110.235 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.21 163.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.546 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 5.9 p -111.21 -158.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.752 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 30.9 t80 -79.89 -74.19 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.2 mttt -47.19 -36.35 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.73 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.31 -53.95 30.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.39 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.49 -24.47 31.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.932 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 15.0 tt0 -69.0 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.266 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.486 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.02 -12.01 4.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.585 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.1 -29.88 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.328 0.585 . . . . 0.0 109.872 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -73.42 -33.86 65.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.139 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.3 mtmt -69.97 -17.17 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.36 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.95 -17.63 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.443 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.51 11.53 1.49 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.014 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -82.63 124.48 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.921 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.583 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.4 t-160 -148.6 126.63 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.79 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -146.94 100.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.24 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.834 ' HA ' HD11 ' T' ' 61' ' ' ILE . 5.9 t -66.83 80.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.578 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 175.99 126.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -45.13 113.17 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.279 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.4 114.96 3.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.596 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.608 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 77.6 m95 -48.68 168.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 111.757 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.844 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -161.86 173.77 14.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.504 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.93 166.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 111.52 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 76.84 -31.64 0.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.34 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.58 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.14 20.12 8.1 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.592 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.702 ' HB3' HG13 ' T' ' 80' ' ' ILE . 0.4 OUTLIER -108.99 156.28 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.594 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -137.03 133.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.052 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -137.53 -172.59 12.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.312 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.654 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -133.03 102.59 13.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.849 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.5 Cg_endo -60.33 -88.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.196 . . . . 0.0 112.291 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.834 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm 71.42 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' T' ' 45' ' ' HIS . 14.8 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.28 176.9 51.66 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.849 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 2.5 mt -76.81 108.67 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 111.258 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.0 mm -79.13 82.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.975 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.1 t70 -110.42 121.65 45.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 1.6 m-85 -83.71 11.96 6.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 69.62 170.74 7.83 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' T' ' 54' ' ' LYS . 9.4 mt -60.33 117.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.18 19.42 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.533 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.71 35.24 20.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.91 53.11 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.728 ' O ' ' HB ' ' T' ' 15' ' ' THR . 21.4 mtt180 -60.95 -5.55 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.64 20.74 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.76 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.56 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.4 mm-40 -83.72 -172.05 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.641 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.56 114.15 10.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.1 m95 -153.98 -164.74 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.97 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.578 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -89.56 -173.96 4.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.55 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.06 135.16 25.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 35.8 m-85 -96.88 111.91 23.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.276 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 9.1 m -90.49 137.2 32.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 111.09 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.952 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.4 OUTLIER -136.83 126.26 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 2.1 p . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.79 -176.99 5.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.881 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.569 ' CD2' HG11 ' T' ' 46' ' ' VAL . 16.4 t-80 -95.38 153.85 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.32 150.97 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.044 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.588 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 26.0 tt0 -120.02 173.19 7.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.735 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.29 159.92 25.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.084 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -61.25 -28.54 69.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' T' ' 13' ' ' LYS . 0.9 OUTLIER -91.55 -50.05 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 176.39 174.21 42.69 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.497 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 20.1 ttpt -62.96 168.14 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 46.3 47.79 13.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.7 OUTLIER -143.41 2.34 1.26 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.785 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.735 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -104.2 139.06 39.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.487 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.672 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 19.8 p -107.8 149.67 27.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.94 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 61.9 t80 -34.07 -42.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 111.054 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.69 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.672 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.7 mt-10 -69.34 -44.66 71.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 110.032 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -56.09 -38.65 70.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.815 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -76.42 -37.13 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -59.56 -38.47 81.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.084 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -53.16 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.355 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -63.89 -28.39 69.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 30.9 tt0 -99.31 -9.28 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 110.307 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -51.34 -42.6 61.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.92 59.0 0.66 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.88 33.34 20.24 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.28 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.27 -168.2 19.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.585 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.67 136.4 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.583 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -70.58 126.89 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 0.0 110.358 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -51.3 161.23 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.575 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.639 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 28.2 p -111.84 -164.94 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.893 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 32.5 t80 -74.76 -70.75 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.991 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 30.0 mttm -45.28 -41.85 9.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.667 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.71 -51.21 63.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.673 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.69 -27.33 49.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.949 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.7 tp10 -65.9 -61.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.087 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.478 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -58.88 -13.27 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.936 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.568 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.92 -30.16 14.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.348 0.594 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 53.0 ttt-85 -73.6 -33.35 64.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.009 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 13.0 mttt -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.568 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.74 -15.73 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.422 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 131.15 12.12 2.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.091 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.47 120.0 23.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.628 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.5 t-160 -136.4 129.32 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.716 HG21 ' HE1' ' T' ' 91' ' ' TYR . 1.3 t -143.24 103.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.447 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.729 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.71 66.32 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -175.26 138.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.671 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -55.09 111.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -108.6 113.85 3.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.6 m95 -47.12 152.06 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' T' ' 50' ' ' GLY . 0.0 OUTLIER -171.5 174.54 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.688 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 53.44 -166.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.543 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 0.34 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.537 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.74 16.16 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.786 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' T' ' 52' ' ' MET . 1.9 mtt180 -92.05 125.52 36.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -116.3 126.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -130.23 -169.2 12.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.318 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.1 OUTLIER -139.45 91.92 10.67 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.855 0.36 . . . . 0.0 111.143 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' T' ' 75' ' ' ILE . 68.4 Cg_endo -78.49 125.06 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.67 2.247 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.729 HD11 ' HA ' ' T' ' 47' ' ' CYS . 20.0 mm -136.82 101.21 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.01 -175.93 34.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.834 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.893 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -80.31 89.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.987 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.567 HG22 ' CE1' ' T' ' 78' ' ' TYR . 18.3 mm -62.42 84.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.43 138.21 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.0 m-85 -112.82 27.72 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 68.49 168.2 4.83 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.652 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mt -57.43 147.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.947 0.403 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.676 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 4.7 mmm-85 -115.14 22.52 13.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.02 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.652 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 44.46 53.4 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' T' ' 81' ' ' ARG . 27.5 p-10 -165.81 61.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -58.3 -3.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.467 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -81.93 17.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.571 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -78.01 -172.46 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.63 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -139.04 113.38 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.283 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.748 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 16.2 m95 -153.13 -156.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.105 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -97.33 -171.23 2.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.374 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.17 137.92 29.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.221 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 32.5 m-85 -101.02 120.38 40.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 5.7 m -96.1 147.51 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.431 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 26.5 t80 -137.6 133.95 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.589 179.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.687 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.03 -177.97 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.729 ' CG ' HG11 ' T' ' 46' ' ' VAL . 21.1 t-80 -101.7 161.56 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.467 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.83 144.81 23.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.616 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.8 tt0 -115.62 173.28 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.692 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.799 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -87.25 157.19 19.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.194 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -65.93 -21.5 66.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -91.41 -23.75 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.85 167.79 11.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.463 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 7.6 ttpt -58.59 158.15 8.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.482 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 11.0 m-30 57.2 55.98 5.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -153.25 2.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.8 mt -103.05 136.81 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.072 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.713 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.5 p -107.73 152.91 23.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.243 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 71.5 t80 -36.66 -43.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.03 -39.86 68.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.713 ' HB2' ' H ' ' T' ' 15' ' ' THR . 76.4 mt-10 -70.55 -47.69 59.08 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 109.806 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.464 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -55.89 -46.47 78.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.561 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.636 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -65.67 -39.54 91.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.142 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.8 t -67.89 -52.31 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 92.1 m -64.13 -48.98 73.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.541 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 42.9 tt0 -69.9 -16.4 63.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.532 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.95 -49.09 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.803 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -103.71 51.6 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.28 38.97 34.51 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.356 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -117.98 172.83 14.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.569 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -124.79 139.47 53.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.71 0.291 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -74.64 126.12 30.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.215 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.3 155.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.461 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 27.1 p -110.39 -164.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 27.6 t80 -74.88 -72.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.107 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -47.59 -41.59 21.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.921 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.45 -47.79 80.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.6 OUTLIER -54.81 -40.72 69.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 3.6 tp10 -54.26 -60.66 3.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.188 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.85 -18.48 8.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.607 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.27 -29.75 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.76 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.886 ' HG2' HG23 ' T' ' 62' ' ' VAL . 3.1 tmm_? -71.17 -33.62 70.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.011 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtpt -69.45 -17.03 63.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.314 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.607 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.53 -12.33 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.683 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.24 14.9 3.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.012 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -83.01 124.6 30.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 0.0 110.981 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.536 ' ND1' HG12 ' T' ' 62' ' ' VAL . 2.2 t-160 -147.15 127.25 13.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.75 94.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.564 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 1.3 m -61.75 83.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 170.32 125.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -46.28 113.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -110.43 121.37 5.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.633 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.4 m95 -49.68 152.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.97 0.414 . . . . 0.0 111.318 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.664 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.41 177.82 3.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.73 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.97 -165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.469 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 2.78 2.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.372 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.02 15.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.791 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 28.6 mtt180 -94.72 127.48 40.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.428 HG12 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -115.93 131.37 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -141.38 -178.28 17.45 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.393 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.497 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.95 98.3 39.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.745 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 37.9 Cg_exo -55.35 -84.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.786 2.324 . . . . 0.0 112.689 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.2 mm 73.57 102.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.948 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.886 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.861 0.363 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . 0.577 ' HA2' ' NH2' ' T' ' 40' ' ' ARG . . . 86.21 175.39 49.78 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.749 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.3 mt -68.49 107.41 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.046 0.45 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' T' ' 78' ' ' TYR . 9.8 mm -81.39 83.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.1 t70 -109.47 132.12 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.604 ' CE1' HG22 ' T' ' 76' ' ' ILE . 10.6 m-85 -105.15 23.01 14.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.69 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 70.05 170.97 8.75 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.729 HG22 ' H ' ' T' ' 82' ' ' LEU . 9.6 mt -51.37 152.29 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.282 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.05 18.65 17.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.729 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 54.76 31.66 15.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -148.92 77.44 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' T' ' 15' ' ' THR . 69.2 mtt180 -65.79 2.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.438 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -102.14 12.67 36.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.537 ' O ' HG22 ' T' ' 15' ' ' THR . 2.4 mm-40 -65.17 -178.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -132.35 114.27 14.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 111.341 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 23.2 m95 -151.43 -136.6 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.274 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.463 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.7 OUTLIER -115.4 -167.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.378 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.464 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.6 132.53 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.276 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.904 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 31.1 m-85 -105.1 127.28 52.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.561 ' O ' HG23 ' T' ' 2' ' ' VAL . 1.2 m -100.76 159.67 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.304 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.687 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 24.2 t80 -150.67 119.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.484 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.705 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.1 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.792 0.33 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -147.23 -176.69 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.771 ' CG ' HG11 ' T' ' 46' ' ' VAL . 40.7 t-80 -98.93 163.95 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 154.77 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.549 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 24.7 tt0 -121.91 172.91 7.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -78.33 161.23 27.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -20.16 65.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.757 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.539 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.5 m -102.82 -47.49 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 173.91 172.53 39.3 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 150.25 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.692 0.282 . . . . 0.0 110.969 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 61.81 57.36 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 9.0 mttm -153.55 1.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.515 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.66 139.54 39.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.737 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.6 p -108.55 151.8 25.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 67.6 t80 -36.52 -41.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 0.0 110.791 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.79 -39.03 64.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.304 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' T' ' 15' ' ' THR . 82.6 mt-10 -71.02 -45.38 64.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.179 0.514 . . . . 0.0 109.958 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -58.56 -45.26 89.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.565 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 30.3 tttt -68.47 -26.86 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.563 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.71 -41.53 83.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.194 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.78 -51.73 47.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.259 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -63.84 -47.71 79.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.592 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 4.1 tt0 -73.55 -13.45 61.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -54.43 -48.83 71.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -102.9 50.98 0.81 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.758 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.15 39.62 50.53 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.313 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -118.17 177.41 16.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.733 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -130.12 141.83 50.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.564 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.63 125.44 29.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.068 0.461 . . . . 0.0 110.23 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.947 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.22 154.32 0.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.533 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -109.99 -162.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.222 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.637 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 31.6 t80 -77.23 -72.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 14.1 mttm -46.89 -38.49 10.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.732 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.28 -53.55 35.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 110.39 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.63 -23.86 44.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 12.1 tp10 -68.45 -61.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.205 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.409 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.52 -16.09 8.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.798 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.49 -29.48 15.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.491 0.662 . . . . 0.0 109.684 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.58 HH11 ' HA2' ' T' ' 74' ' ' GLY . 0.0 OUTLIER -72.61 -33.25 66.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.112 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.0 mttt -69.52 -17.88 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.286 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.567 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.39 -14.35 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.81 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.406 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 11.35 2.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -81.48 118.6 22.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.632 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.9 t-160 -141.55 127.2 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.771 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -145.43 102.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.28 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.807 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -72.72 80.5 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.701 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 178.55 123.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.835 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -41.73 111.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.31 114.97 3.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.667 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 71.7 m95 -48.95 156.83 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.432 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.686 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -177.61 178.33 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.896 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.671 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 50.77 -165.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -7.52 7.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.498 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 158.49 19.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.858 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.671 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 0.9 OUTLIER -97.53 135.66 39.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.73 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -126.61 122.42 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -170.65 13.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -124.99 82.97 60.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.961 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' T' ' 75' ' ' ILE . 26.7 Cg_exo -60.37 104.95 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.761 2.307 . . . . 0.0 112.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.4 mm -130.74 112.28 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.028 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.897 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.821 0.344 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . 0.58 ' HA2' HH11 ' T' ' 40' ' ' ARG . . . 90.03 -176.24 42.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.85 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.637 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -70.36 110.85 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 111.058 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.2 mm -89.36 79.86 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -101.92 122.83 44.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.41 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.1 m-85 -84.01 3.36 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.011 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.09 172.44 44.37 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.488 HG12 ' C ' ' T' ' 55' ' ' GLY . 6.3 mt -65.4 119.92 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.315 . . . . 0.0 111.027 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -112.03 28.35 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.424 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 52.96 27.89 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -114.38 51.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.618 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -70.65 4.34 2.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -106.62 6.97 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.562 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -72.15 -171.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 23.5 mtp85 -132.63 113.48 13.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.139 0.495 . . . . 0.0 111.56 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.8 m95 -153.99 -171.24 3.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.038 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.596 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -81.99 -171.21 3.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.424 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.77 136.87 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.947 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 38.8 m-85 -103.24 127.91 50.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.583 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.7 OUTLIER -99.56 161.35 13.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 111.284 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.705 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 25.2 t80 -151.62 119.88 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.757 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.715 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.6 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.804 0.335 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -145.59 -176.91 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.797 ' CG ' HG11 ' T' ' 46' ' ' VAL . 16.1 t-80 -113.56 155.26 25.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.96 164.43 38.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 -170.0 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -90.7 149.55 22.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -60.12 -16.47 32.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.774 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -98.77 -25.35 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 149.19 167.65 14.13 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.492 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 8.1 tttm -62.38 153.84 29.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.345 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.9 m-30 57.06 51.92 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.774 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 3.7 mttm -142.69 1.05 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.9 mt -104.33 146.77 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.755 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 22.3 p -114.36 153.31 30.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.012 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 72.2 t80 -37.76 -40.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.849 0.357 . . . . 0.0 110.751 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.99 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.359 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.755 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.7 mt-10 -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.173 0.511 . . . . 0.0 109.936 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.09 -46.2 85.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -67.69 -26.5 66.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.489 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -69.41 -40.98 77.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.86 -50.41 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -52.27 50.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.148 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 6.5 tt0 -71.62 -3.04 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.644 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -65.71 -45.11 83.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.574 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.81 59.61 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.047 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 55.82 21.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.262 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -138.96 166.96 25.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.784 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.47 139.07 51.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.612 0.244 . . . . 0.0 110.57 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -74.22 124.65 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.0 110.316 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.69 153.13 1.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.483 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 28.3 p -106.17 -164.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.977 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.88 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 53.0 t80 -75.61 -69.79 0.47 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.021 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -46.68 -42.7 16.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.17 -46.25 84.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.647 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.73 -38.01 71.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.226 0.536 . . . . 0.0 109.661 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 12.0 tt0 -57.02 -60.68 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.428 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.67 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.48 -21.59 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.058 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -90.91 -28.85 17.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 0.0 109.633 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' T' ' 62' ' ' VAL . 19.2 ttp85 -71.59 -34.21 69.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.001 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtmp? -73.24 -18.05 61.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.221 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.67 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -87.88 -7.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.92 7.07 7.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.331 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -78.17 130.64 36.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.702 ' HD1' HG12 ' T' ' 62' ' ' VAL . 2.6 t-160 -153.07 130.8 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.763 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.797 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.37 99.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.261 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.587 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.731 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 179.67 122.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -41.45 110.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.71 115.94 4.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.838 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.3 m95 -48.19 156.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 111.367 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.725 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.1 OUTLIER -178.28 177.37 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.055 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.04 -165.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.754 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -14.03 10.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.476 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 160.85 23.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.926 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 10.7 ptp180 -99.71 136.41 39.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.538 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.584 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -127.88 119.57 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -118.68 -173.67 15.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.257 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.434 ' O ' HG12 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -120.56 82.32 33.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.7 Cg_exo -59.97 120.9 8.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.689 2.259 . . . . 0.0 112.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' T' ' 47' ' ' CYS . 10.4 mm -138.69 100.56 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.702 HG12 ' HD1' ' T' ' 45' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.899 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 168.4 44.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.88 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.0 mp -63.49 97.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.757 0.313 . . . . 0.0 111.301 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.8 80.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.464 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.4 t70 -105.12 123.17 47.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 2.2 m-85 -86.31 -3.16 58.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.967 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.57 169.69 40.32 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.745 HG22 ' H ' ' T' ' 82' ' ' LEU . 16.2 mt -60.67 127.83 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 111.082 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.88 16.99 21.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.745 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.99 45.75 26.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.897 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.488 HD22 ' HG2' ' T' ' 86' ' ' GLU . 18.9 t30 -163.93 77.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -69.89 -4.94 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 17.26 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.582 ' O ' HG22 ' T' ' 15' ' ' THR . 2.6 mm-40 -80.32 -171.81 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.599 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.645 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 2.7 ppt_? -137.53 111.75 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.094 0.473 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.65 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.2 m95 -153.71 -172.11 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.171 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.543 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -82.54 -170.62 3.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.32 137.79 27.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.799 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 36.2 m-85 -103.45 121.14 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.523 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.1 OUTLIER -96.13 154.17 17.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.014 0.435 . . . . 0.0 111.3 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.715 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 28.8 t80 -143.7 126.27 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.503 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 26.6 m-20 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.525 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.962 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 2.0 p90 -151.22 177.46 10.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.163 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.603 ' CG ' HG11 ' T' ' 46' ' ' VAL . 8.3 t-80 -112.86 160.74 17.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.154 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 6.0 tpp180 -158.89 159.81 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 -169.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.868 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -96.17 149.86 21.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -20.49 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.485 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -95.72 -22.74 17.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.833 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 144.47 166.97 11.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -65.02 162.74 16.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.7 m-30 53.69 38.75 29.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.4 OUTLIER -134.54 4.9 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.876 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 7.7 mt -107.51 139.04 42.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.982 0.42 . . . . 0.0 111.427 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.8 p -109.86 149.12 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.011 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -34.48 -41.16 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.786 0.326 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.39 -43.85 69.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.319 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.8 mt-10 -70.38 -46.78 63.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.7 -43.95 47.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.95 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -65.63 -54.45 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -50.01 -36.8 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 t -75.18 -54.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.524 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' T' ' 28' ' ' GLY . 58.8 m -64.19 -30.32 71.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 24.4 tt0 -92.59 -12.14 32.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 110.104 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.4 t80 -54.33 -41.62 69.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.044 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -107.69 59.09 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.218 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.53 20.46 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.415 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -94.54 -174.3 38.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.92 136.26 14.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -48.14 137.17 10.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.475 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.54 166.94 22.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.134 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 47.0 p -117.99 -175.15 2.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 0.0 111.373 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.95 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 48.0 t80 -69.54 -68.99 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.955 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.2 mttp -45.89 -42.09 12.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.583 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.2 mt-30 -65.03 -51.04 63.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -60.17 -22.17 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.5 tt0 -73.98 -61.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.286 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.44 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.28 -13.45 7.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.826 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.598 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.2 -29.11 14.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 8.4 ttt-85 -72.73 -34.38 67.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.035 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.7 mtpt -69.67 -15.79 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.598 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.0 -19.16 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.741 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.48 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.11 11.77 1.02 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.103 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.65 115.74 20.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.566 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.4 t-160 -135.53 127.99 30.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.603 HG11 ' CG ' ' T' ' 4' ' ' HIS . 1.3 t -144.64 102.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.249 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.674 ' HA ' HD11 ' T' ' 61' ' ' ILE . 52.8 t -77.56 63.85 2.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.74 125.59 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.894 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.523 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -42.5 115.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.05 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.59 119.31 4.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.632 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.1 m95 -53.48 148.52 9.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.47 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.763 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -167.5 175.31 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.344 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.62 -165.99 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -2.17 4.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.441 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.9 14.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.868 ' HG3' HG13 ' T' ' 80' ' ' ILE . 6.8 mtt180 -88.41 125.94 34.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.88 117.81 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.73 -169.72 13.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.261 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -141.48 95.06 7.34 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 111.219 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HB3' HD13 ' T' ' 75' ' ' ILE . 71.8 Cg_endo -81.58 131.25 7.26 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' T' ' 47' ' ' CYS . 15.2 mm -134.77 107.22 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.184 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.47 -174.78 35.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.907 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.95 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -79.88 95.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.163 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.53 HG22 ' CE1' ' T' ' 78' ' ' TYR . 11.6 mm -68.18 83.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -110.38 122.05 46.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.53 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.0 OUTLIER -87.69 -5.94 58.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.072 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.715 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 91.22 169.11 41.99 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.868 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.7 mt -59.36 122.4 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -102.37 13.84 33.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.949 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.6 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.48 48.93 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.32 58.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.656 HH11 ' HB2' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -60.39 -9.71 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -79.69 12.59 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.487 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -79.37 -178.68 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.688 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -134.85 116.36 14.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.585 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 20.8 m95 -150.18 -134.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.339 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -115.83 -166.83 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.357 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -148.0 119.54 7.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.369 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 28.4 m-85 -87.63 103.8 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.498 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.6 m -82.26 151.84 26.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.962 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -148.91 125.75 11.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.769 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.679 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.831 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.7 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.805 0.336 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 21.0 p90 -143.21 178.41 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.818 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.855 ' CG ' HG11 ' T' ' 46' ' ' VAL . 46.9 t-80 -96.1 159.05 15.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.205 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.827 ' HG2' HG11 ' T' ' 22' ' ' VAL . 0.0 OUTLIER -151.31 151.4 31.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.031 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.0 tt0 -122.91 173.09 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -88.64 157.72 18.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.191 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.665 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -93.8 -24.82 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.38 166.86 10.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.55 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 17.4 ttpt -58.41 155.66 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 110.97 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.497 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 10.5 m-30 58.5 54.2 5.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.989 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -152.5 3.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.828 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -104.32 134.9 46.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 28.0 p -105.56 150.93 24.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 78.8 t80 -34.86 -42.28 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.956 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -42.25 65.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.373 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' T' ' 15' ' ' THR . 67.5 mt-10 -69.72 -46.58 65.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.017 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.83 -42.12 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.738 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -68.0 -34.9 77.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.605 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.96 -36.37 83.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.972 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.827 HG11 ' HG2' ' T' ' 5' ' ' ARG . 3.0 t -69.16 -50.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.178 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -64.57 -54.31 34.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.029 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 44.0 tt0 -62.26 -19.26 63.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -54.06 -48.41 70.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.81 54.45 0.66 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.37 31.5 35.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.241 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -100.95 167.56 19.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.646 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.556 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -133.91 138.14 45.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.004 0.431 . . . . 0.0 111.412 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.672 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.87 139.17 22.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -81.17 166.27 20.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.438 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 38.9 p -120.82 -175.01 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.0 111.684 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.846 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 36.0 t80 -68.32 -70.34 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.781 ' HA ' ' HG3' ' T' ' 37' ' ' GLU . 3.0 mttp -46.69 -40.99 14.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.865 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.5 mt-30 -63.65 -47.13 82.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.743 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -55.72 -30.81 61.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.384 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.781 ' HG3' ' HA ' ' T' ' 34' ' ' LYS . 0.0 OUTLIER -66.51 -60.86 2.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.451 0.643 . . . . 0.0 110.118 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.474 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -53.44 -18.52 2.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.913 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.569 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.17 -30.72 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.398 0.618 . . . . 0.0 109.678 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' T' ' 62' ' ' VAL . 0.1 OUTLIER -72.65 -32.95 66.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.044 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.4 mtmp? -69.69 -18.21 63.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.569 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.61 -10.95 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.41 14.03 4.57 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.515 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.2 t80 -82.15 125.66 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.59 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.5 t-160 -147.61 126.1 12.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.855 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -145.66 101.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.222 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.891 ' HA ' HD11 ' T' ' 61' ' ' ILE . 4.4 t -72.15 78.99 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.62 116.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.594 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -38.61 117.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.072 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.27 122.73 5.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.692 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.5 m95 -53.99 146.56 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.672 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -164.64 178.41 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.471 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.04 -166.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.475 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.77 3.88 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.448 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.04 13.7 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.856 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.842 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 11.4 mtt180 -91.47 127.09 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.55 125.38 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.02 -175.67 14.16 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.594 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -134.7 103.68 11.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.815 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.3 Cg_exo -58.5 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.623 2.216 . . . . 0.0 112.199 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' T' ' 47' ' ' CYS . 30.0 mm 75.42 108.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.903 0.383 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.47 176.21 49.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.846 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -68.47 112.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 111.021 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.573 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.6 mm -87.23 88.7 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.117 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -112.87 112.89 24.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.556 ' CE1' HG22 ' T' ' 76' ' ' ILE . 3.2 m-85 -79.38 4.35 15.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.842 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 76.65 170.11 31.32 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.803 HG22 ' H ' ' T' ' 82' ' ' LEU . 11.9 mt -48.21 142.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 3.9 mmm-85 -108.26 16.09 23.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.803 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.75 35.37 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -169.07 86.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -70.42 -1.15 9.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -76.87 15.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.564 ' O ' HG22 ' T' ' 15' ' ' THR . 3.5 mm-40 -75.11 -173.57 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -138.22 113.7 9.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 111.1 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.529 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 15.7 m95 -151.22 -137.79 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.507 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.55 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -116.01 -165.35 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.449 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.34 126.89 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 111.559 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 29.9 m-85 -97.47 107.59 20.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.51 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.5 t -84.89 154.93 21.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.831 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 13.9 t80 -144.02 123.05 12.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.999 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.322 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.771 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.826 0.346 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -156.98 -176.52 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.71 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.8 t-80 -101.38 159.33 15.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.049 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 8.1 mmt180 -153.04 148.49 27.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.7 tt0 -116.4 173.34 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.859 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.43 156.07 20.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -20.7 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.444 ' HB3' ' NZ ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -93.88 -28.01 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.8 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 147.65 168.27 13.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.345 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.446 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 4.1 ttpm? -63.68 165.23 8.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 16.2 m-30 50.8 43.95 28.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 3.8 mttt -138.63 -2.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.859 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.4 mt -102.18 139.56 37.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.336 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.649 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 2.8 p -110.46 151.58 27.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.108 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.53 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 79.5 t80 -34.01 -42.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.99 68.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.223 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.0 mt-10 -68.63 -45.27 72.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.93 -40.4 63.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.896 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 15.1 tttt -70.11 -34.89 73.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -64.53 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.53 -50.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.21 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.68 -53.26 50.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.4 tt0 -63.8 -21.07 66.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.413 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.4 OUTLIER -51.38 -49.81 60.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.844 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -106.03 53.47 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.58 42.23 43.66 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.231 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -115.07 165.86 12.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.728 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.555 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.46 139.45 51.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.891 0.377 . . . . 0.0 111.312 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.45 149.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.983 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -90.7 149.28 22.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.401 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 62.8 p -105.93 -175.57 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.915 0.388 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.944 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 51.8 t80 -67.29 -68.57 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.042 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -48.29 -42.86 32.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.947 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.12 -50.19 69.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.809 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -60.45 -31.69 70.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.336 0.588 . . . . 0.0 109.646 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' HG2' ' HE2' ' T' ' 41' ' ' LYS . 8.8 tt0 -65.28 -58.39 6.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.236 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.4 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -52.14 -23.91 6.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.648 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -87.51 -30.53 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.516 0.674 . . . . 0.0 109.78 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.771 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.4 OUTLIER -70.45 -33.71 71.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.093 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HE2' ' HG2' ' T' ' 37' ' ' GLU . 11.4 mttm -67.48 -19.22 65.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.197 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.648 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.1 -21.83 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.567 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 139.7 15.19 0.56 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.211 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.771 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -70.75 137.64 49.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.737 0.303 . . . . 0.0 110.683 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.2 t-160 -161.09 124.45 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.67 103.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.846 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.48 72.79 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -178.72 139.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -56.28 116.64 3.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -113.39 121.39 5.48 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.725 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 77.0 m95 -55.16 144.44 24.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.503 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -163.26 176.06 10.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.664 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.95 -165.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.584 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -6.41 9.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.563 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.11 16.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.954 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.7 ptp180 -93.69 130.36 39.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.712 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.495 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.01 121.26 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.967 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.21 -169.07 13.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.289 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.691 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -143.77 93.02 6.28 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.128 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.795 ' HB3' HD13 ' T' ' 75' ' ' ILE . 73.5 Cg_endo -80.93 130.54 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.739 2.293 . . . . 0.0 112.259 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.846 HD11 ' HA ' ' T' ' 47' ' ' CYS . 22.6 mm -142.98 107.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.7 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.913 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.838 0.352 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.34 179.36 52.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.966 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -74.85 98.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.05 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.691 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 8.8 mm -70.21 85.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.94 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.584 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.5 m-85 -111.6 22.05 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.38 170.86 7.5 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.749 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.2 mt -53.94 152.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.433 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.1 mmm180 -130.63 16.24 5.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.749 ' H ' HG22 ' T' ' 80' ' ' ILE . 4.3 mm? 56.28 27.26 11.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.89 57.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.576 ' O ' ' HB ' ' T' ' 15' ' ' THR . 11.4 mtm180 -66.45 -1.67 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 9.6 t -97.47 6.19 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.59 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -68.21 -176.47 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.33 113.35 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.438 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.711 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 12.7 m95 -152.87 -155.99 0.66 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.204 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.12 -169.76 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.227 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.453 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.9 121.87 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 0.0 111.437 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.809 ' CD1' HD21 ' T' ' 36' ' ' LEU . 34.4 m-85 -90.26 107.47 19.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.496 ' O ' HG23 ' T' ' 2' ' ' VAL . 8.0 m -82.29 164.58 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.337 . . . . 0.0 111.023 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.771 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 7.9 t80 -153.04 118.1 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.437 179.536 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.876 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -145.5 -179.97 7.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.774 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.1 t-80 -112.31 161.91 16.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.517 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 10.9 mmt180 -155.9 161.53 40.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.672 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -126.29 -174.31 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.615 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -86.36 153.61 21.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -58.77 -20.77 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.806 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -27.58 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.44 167.74 12.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.519 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.574 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 1.6 ttpt -55.37 153.52 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.2 m-30 55.37 69.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.1 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -158.74 -7.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.778 HD11 ' C ' ' T' ' 89' ' ' ASP . 1.1 pp -111.94 161.62 16.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.106 0.479 . . . . 0.0 111.27 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.804 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 3.4 p -114.58 -166.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.1 t80 -67.5 -41.39 84.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.34 -38.63 74.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.541 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.804 ' HB2' ' H ' ' T' ' 15' ' ' THR . 53.7 mt-10 -71.76 -43.3 66.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.194 0.521 . . . . 0.0 110.182 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.403 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -54.03 -41.78 68.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.986 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -55.93 10.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.118 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.5 -36.65 3.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.285 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.54 -56.04 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.437 ' O ' ' CA ' ' T' ' 28' ' ' GLY . 82.9 m -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 18.5 tt0 -88.21 -12.72 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 109.614 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.2 t80 -57.31 -39.5 75.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.86 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -113.4 56.64 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.163 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.63 34.75 28.74 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.584 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.96 171.1 14.23 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.427 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.593 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.18 143.56 46.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.284 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.818 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -52.74 136.52 33.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.292 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.87 153.51 32.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 35.4 p -106.5 -172.29 2.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 111.673 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.928 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 65.3 t80 -71.63 -67.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.07 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -46.56 -40.89 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.413 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 93.9 mt-30 -64.75 -49.38 71.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.668 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -59.19 -23.66 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.071 0.462 . . . . 0.0 110.118 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 2.9 tp10 -74.04 -62.08 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.98 -13.73 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.995 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -95.06 -29.99 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.362 0.601 . . . . 0.0 109.671 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.827 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -71.6 -33.04 68.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.954 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.5 OUTLIER -69.76 -16.67 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.374 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.05 -14.98 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.599 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.416 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.21 17.58 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.988 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.615 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -80.15 112.63 17.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 111.006 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.887 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.3 t-160 -135.13 124.11 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.71 89.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.511 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 13.9 t -63.87 85.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.581 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . 172.57 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.871 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -38.29 113.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.656 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.84 126.39 7.64 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.563 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 75.0 m95 -58.03 149.73 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.92 0.39 . . . . 0.0 111.426 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.818 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.44 179.27 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.591 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.08 -166.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.437 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -7.22 5.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.382 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 157.58 20.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.624 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.807 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.1 mtm180 -94.68 130.61 41.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.908 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.449 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -120.8 121.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.8 -173.75 13.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.443 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -132.63 101.82 14.11 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.77 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.9 Cg_endo -61.01 -81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.804 2.336 . . . . 0.0 112.517 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 8.2 mm 75.04 106.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.887 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.82 167.56 43.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.928 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.2 mp -64.1 100.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.387 . . . . 0.0 111.42 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.635 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 10.7 mm -69.68 87.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -108.45 120.12 41.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.531 ' CE1' HG22 ' T' ' 76' ' ' ILE . 12.9 m-85 -91.06 -11.33 39.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 103.66 173.76 25.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.807 HG13 ' HG3' ' T' ' 56' ' ' ARG . 19.4 mt -61.41 122.71 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -91.71 9.54 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.764 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 59.58 38.81 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.4 OUTLIER -145.13 75.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.7 mpt_? -74.61 16.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.927 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.447 ' H ' ' C ' ' T' ' 83' ' ' ASN . 5.5 m -114.33 6.75 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.789 ' O ' HG22 ' T' ' 15' ' ' THR . 2.9 mm-40 -63.67 -171.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.73 113.61 11.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.685 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 7.8 m95 -153.55 -147.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.778 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.5 OUTLIER -106.78 -171.23 1.85 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.36 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' T' ' 14' ' ' LEU . . . -141.3 121.53 13.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.644 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.668 ' CD1' HD21 ' T' ' 36' ' ' LEU . 23.4 m-85 -90.59 110.37 21.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.443 ' O ' HG23 ' T' ' 2' ' ' VAL . 86.4 m -86.47 167.97 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.188 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.876 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 2.5 t80 -158.46 124.34 4.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.552 179.772 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.775 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 2.3 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.762 0.315 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -147.93 178.35 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.999 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -92.07 155.56 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' T' ' 5' ' ' ARG . 2.6 tpp85 -149.02 153.88 38.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.612 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.1 tt0 -125.77 173.91 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.594 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -82.65 151.68 26.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -62.33 -18.29 61.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.693 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 17.0 m -98.84 -27.74 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.654 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 151.09 167.51 14.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.43 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.508 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 14.3 tttt -60.23 153.89 21.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.8 m-30 57.37 49.61 12.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.693 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 4.2 mttm -142.28 1.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.693 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.4 mt -105.82 134.14 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.258 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.668 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.4 p -104.0 151.62 22.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.138 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.536 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.8 t80 -34.25 -44.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.99 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.668 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 15.0 mt-10 -66.38 -54.9 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.274 0.559 . . . . 0.0 109.842 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -43.51 -43.51 5.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.946 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -67.17 -37.75 84.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.69 -34.58 77.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.5 t -69.64 -53.2 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.285 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -64.31 -52.61 57.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.2 tt0 -62.52 -21.05 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.38 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -52.2 -48.86 64.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.694 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -106.0 52.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.42 38.1 56.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.235 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.84 169.82 13.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.763 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.559 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.61 140.01 44.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.952 0.405 . . . . 0.0 111.236 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.891 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.03 139.02 18.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.376 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.81 152.23 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 37.7 p -107.54 -171.38 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.557 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.762 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 55.3 t80 -70.85 -67.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.029 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.1 OUTLIER -46.79 -40.55 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.564 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.16 -54.24 27.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.279 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -58.63 -19.86 42.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.774 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 2.5 tp10 -72.34 -62.19 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.16 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.445 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.82 -15.66 9.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.757 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.573 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.22 -29.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.463 0.649 . . . . 0.0 109.753 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.748 ' HG3' HG22 ' T' ' 62' ' ' VAL . 9.8 ttt-85 -73.03 -33.47 65.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.187 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.545 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 45.5 mttt -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.427 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.573 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -86.34 -17.27 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 15.1 1.9 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.021 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.49 94.65 7.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.979 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.48 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.7 t-160 -115.17 125.99 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.745 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -147.89 100.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' HD11 ' T' ' 61' ' ' ILE . 40.5 t -75.79 65.83 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.6 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -161.91 118.61 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -39.87 121.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -123.39 121.24 4.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.731 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.536 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 84.1 m95 -54.18 162.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.798 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.891 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -155.63 174.39 15.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.392 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -53.53 160.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.286 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mtpp 78.66 -30.66 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.508 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 112.44 23.93 5.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.531 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.706 ' HG3' HG13 ' T' ' 80' ' ' ILE . 19.1 mtt180 -100.18 160.22 14.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.932 0.396 . . . . 0.0 110.809 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -149.1 107.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -108.82 -167.65 20.79 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.291 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.567 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -137.44 85.07 21.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.125 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.822 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 23.1 Cg_exo -62.76 129.04 24.9 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.887 2.391 . . . . 0.0 112.238 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.645 HD11 ' HA ' ' T' ' 47' ' ' CYS . 8.5 mm -141.39 116.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.232 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' T' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.802 0.334 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' T' ' 40' ' ' ARG . . . 71.34 -168.21 51.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.822 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 12.7 mt -76.06 124.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.897 0.379 . . . . 0.0 111.212 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.8 mm -93.29 81.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.8 120.99 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.47 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.5 m-85 -86.33 -74.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.41 169.79 36.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.232 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.706 HG13 ' HG3' ' T' ' 56' ' ' ARG . 51.8 mt -57.7 108.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.041 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 81' ' ' ARG . 7.4 mmt85 -87.09 15.46 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.545 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.77 27.95 7.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.402 ' HA ' HD22 ' T' ' 83' ' ' ASN . 0.5 OUTLIER -121.97 62.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.994 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' T' ' 15' ' ' THR . 3.2 mpt_? -69.99 -0.92 8.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.81 3.24 47.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.674 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.586 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -64.79 -170.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -135.79 112.44 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.123 0.487 . . . . 0.0 111.648 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 5.2 m95 -155.44 -177.13 6.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.837 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -77.65 -173.24 2.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -140.38 133.56 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 42.1 m-85 -97.82 117.04 31.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.428 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.446 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.7 t -92.68 154.29 18.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.0 110.836 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 8.1 t80 -149.41 114.05 5.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.764 179.747 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.91 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.854 0.359 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.459 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 26.7 p90 -162.17 173.5 14.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 111.705 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.645 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.7 t60 -93.27 150.43 20.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 4.2 tpp85 -152.25 154.83 36.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.9 OUTLIER -116.13 -169.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -90.64 152.3 20.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . 0.405 HH22 HH12 ' T' ' 5' ' ' ARG . 3.6 mmp_? -52.86 -24.35 8.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.726 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -93.27 -47.74 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 174.75 177.98 44.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -65.42 146.75 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.852 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.544 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 7.9 m-30 63.67 61.83 0.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.053 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -155.89 6.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.0 mt -109.03 138.69 44.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.4 p -107.67 148.05 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 83.0 t80 -34.99 -39.53 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.93 61.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.373 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.583 ' OE1' HG23 ' T' ' 15' ' ' THR . 77.8 mt-10 -71.36 -46.3 60.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.226 0.536 . . . . 0.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.576 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -57.39 -37.11 72.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -75.56 -32.21 60.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.023 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.5 -45.64 75.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.361 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 2.9 t -66.83 -50.31 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.306 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 56.6 m -64.44 -45.25 88.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.7 tt0 -78.57 -6.94 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -59.07 -50.76 72.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.842 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.55 58.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.175 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.54 34.08 13.32 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.458 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.46 -172.42 18.2 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.2 134.17 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 0.258 . . . . 0.0 110.472 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.08 124.34 22.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -52.42 165.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.74 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 13.0 p -115.73 -158.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 34.2 t80 -80.41 -71.64 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.978 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.9 mttt -47.42 -37.35 11.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.79 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -67.21 -54.96 16.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.261 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.92 -21.14 27.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.754 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.1 tp10 -69.82 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.268 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.646 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.54 -19.87 11.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.787 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.29 -29.11 17.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 109.613 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.634 ' HE ' HG13 ' T' ' 62' ' ' VAL . 4.2 ttt180 -70.61 -34.31 71.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.001 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 27.2 mtmt -73.52 -17.49 61.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.219 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.646 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -88.35 -6.94 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.73 5.9 8.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.25 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.0 OUTLIER -76.0 117.36 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HB2' HG23 ' T' ' 62' ' ' VAL . 3.4 t-160 -140.14 125.82 19.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -153.21 101.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.959 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.67 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -72.09 85.75 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.335 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.42 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -177.38 115.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -39.21 108.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.774 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -107.84 122.48 6.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.668 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.623 ' HA ' ' HB ' ' T' ' 57' ' ' VAL . 71.2 m95 -52.68 171.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.701 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -166.58 162.13 16.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.512 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -45.17 159.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.631 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.8 -24.79 0.21 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.425 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.39 22.82 6.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.504 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HG3' HG13 ' T' ' 80' ' ' ILE . 37.6 mtm180 -94.91 165.82 12.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -163.12 108.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -116.64 -171.01 15.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.224 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.545 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.89 82.72 55.3 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.1 Cg_exo -59.89 119.98 7.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.765 2.31 . . . . 0.0 112.3 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' T' ' 47' ' ' CYS . 14.5 mm -138.9 132.56 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 72.73 -175.09 44.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.799 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.631 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 5.4 mt -73.38 117.46 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.5 mm -88.98 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.525 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 5.3 t70 -110.13 135.17 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.77 25.28 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.1 -178.49 26.2 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.862 HG22 ' H ' ' T' ' 82' ' ' LEU . 50.8 mt -61.85 119.83 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.71 6.92 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.862 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.54 33.09 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.82 78.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.688 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtt85 -62.86 -8.62 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 17.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.509 ' O ' HG22 ' T' ' 15' ' ' THR . 1.7 mm-40 -79.46 -176.21 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -134.85 115.8 14.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.054 0.454 . . . . 0.0 111.274 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 28.4 m95 -150.7 -135.05 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.083 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.42 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.8 OUTLIER -118.14 -171.83 2.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.35 179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.576 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.79 130.16 17.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.774 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.13 109.63 22.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.253 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.8 131.78 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.114 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.91 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.1 OUTLIER -131.04 113.98 14.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.541 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.816 HG22 ' CD2' ' T' ' 93' ' ' TYR . 1.6 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.721 0.296 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.3 OUTLIER -147.74 160.26 42.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.085 0.469 . . . . 0.0 111.271 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.779 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.1 t-80 -106.13 158.57 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.099 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -164.26 166.0 21.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.041 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.825 ' HG2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -123.18 -167.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.971 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -170.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.93 -34.15 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.1 t -177.29 19.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.27 160.74 23.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.825 ' HA ' ' HG2' ' T' ' 6' ' ' GLU . 1.2 tttt -98.43 158.47 15.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 111.503 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 23.7 m-85 42.46 60.2 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.494 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' T' ' 12' ' ' TYR . 1.7 mmtm -149.7 10.1 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.43 HD11 ' C ' ' T' ' 6' ' ' GLU . 17.8 mt -106.29 125.24 50.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.0 OUTLIER -99.57 145.42 27.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.008 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.6 t80 -33.56 -41.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.98 70.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.567 ' OE1' HG23 ' T' ' 15' ' ' THR . 83.8 mt-10 -72.96 -52.2 15.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.006 0.432 . . . . 0.0 110.195 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -45.82 -49.59 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.926 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -65.78 -56.99 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.0 -42.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.425 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.0 t -68.23 -50.37 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.4 m -63.71 -48.17 78.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 16.9 tt0 -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.736 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.8 OUTLIER -55.72 -51.77 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.899 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.28 58.24 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.152 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.8 27.54 9.75 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.525 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -107.88 -169.9 21.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.514 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.81 133.3 11.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.444 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -64.02 123.52 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 110.381 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.98 162.77 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.348 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.652 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 23.8 p -108.5 -164.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.754 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 20.5 t80 -75.02 -73.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.167 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mttt -48.06 -37.68 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -67.12 -55.11 15.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.56 HD11 ' HG3' ' T' ' 60' ' ' PRO . 1.7 tm? -58.07 -22.77 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.8 tt0 -70.18 -61.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.241 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -13.52 10.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.709 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -93.88 -28.5 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.484 0.659 . . . . 0.0 109.731 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 5.6 tmm_? -69.7 -32.7 71.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.863 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.5 mttm -68.67 -15.22 63.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -93.47 -17.28 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 135.72 12.17 1.21 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.866 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -79.49 100.74 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.53 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.1 t-160 -129.69 131.28 46.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.168 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.82 98.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.811 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -64.7 81.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 174.45 137.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.67 105.33 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.781 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.625 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -102.98 116.77 5.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.661 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 76.3 m95 -48.22 155.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.793 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.77 -179.61 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.593 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 49.93 -165.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.115 0.483 . . . . 0.0 111.488 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.52 0.35 4.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.471 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.509 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 155.48 14.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.672 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.7 ' HB2' ' HB3' ' T' ' 53' ' ' ALA . 5.3 mtp180 -93.37 135.98 34.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.881 0.372 . . . . 0.0 110.996 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -124.38 134.22 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.765 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.13 -174.61 17.53 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.466 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.508 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -131.11 102.39 15.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.8 Cg_endo -61.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.811 HD11 ' HA ' ' T' ' 47' ' ' CYS . 25.9 mm 74.06 105.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.636 HG22 ' HG2' ' T' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.01 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.12 172.62 47.22 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.913 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.771 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 1.6 mt -67.34 104.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.486 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.5 mm -80.16 85.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.23 132.3 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.4 m-85 -98.01 4.58 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.693 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 81.04 173.52 47.69 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.645 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.7 mt -59.38 115.8 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -87.97 21.31 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.645 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.78 36.89 25.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.68 67.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.591 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.9 OUTLIER -65.41 -4.59 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.7 t -91.52 12.82 19.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.544 ' O ' HG22 ' T' ' 15' ' ' THR . 2.3 mm-40 -68.56 -175.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.724 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 8.3 mtt180 -135.46 115.05 12.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HD1' ' T' ' 12' ' ' TYR . 21.0 m95 -151.89 -132.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.234 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.545 ' HB3' ' OE1' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -121.04 -172.88 2.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.329 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.732 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -145.3 135.13 23.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.193 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 41.1 m-85 -97.91 107.52 20.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.066 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.432 ' HB3' ' CE2' ' T' ' 3' ' ' TYR . 5.2 m -87.31 137.23 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.919 0.39 . . . . 0.0 111.077 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.816 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.3 t80 -140.91 135.51 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.73 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.8 179.882 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.947 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.5 p . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.479 ' HA ' ' CZ ' ' T' ' 44' ' ' PHE . 25.5 p90 -155.39 170.34 22.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 111.638 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.2 t60 -90.97 153.71 19.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.962 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.454 ' N ' ' CD2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -155.78 148.32 23.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.012 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.08 -168.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.49 153.54 18.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.21 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 8' ' ' ARG . 4.0 mmt180 -61.13 -19.35 61.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -94.46 -24.53 17.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.69 167.41 11.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.555 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 8.3 ttpt -60.07 158.85 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.444 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 8.6 m-30 53.45 61.56 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.102 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -156.33 2.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.687 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -105.21 127.58 52.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.556 HG22 ' O ' ' T' ' 86' ' ' GLU . 1.1 p -99.49 149.94 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.61 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 92.0 t80 -36.18 -41.04 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -42.95 69.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' T' ' 15' ' ' THR . 85.1 mt-10 -74.15 -53.9 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.999 0.428 . . . . 0.0 110.301 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -44.96 -51.49 9.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.99 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -63.92 -55.7 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.644 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.48 -39.03 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.4 t -68.23 -51.73 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.219 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.25 -50.61 67.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.474 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 31.3 tt0 -67.07 -16.48 64.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.429 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.03 -47.87 77.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.754 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.19 53.89 0.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.53 41.78 42.37 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.426 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -121.95 168.22 14.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.432 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.22 137.49 51.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.773 0.321 . . . . 0.0 110.622 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -73.81 122.0 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -49.76 158.79 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.43 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 11.5 p -110.69 -159.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.29 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.844 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 25.7 t80 -77.02 -72.97 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.052 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 1.9 mttp -46.92 -37.23 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.556 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.45 -51.77 57.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.626 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -56.66 -23.89 44.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 110.058 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 8.4 tt0 -72.15 -61.94 1.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.473 ' HA ' ' HE3' ' T' ' 41' ' ' LYS . . . -56.02 -16.23 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.7 -29.64 15.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.396 0.617 . . . . 0.0 109.718 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -72.17 -33.1 67.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.925 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.8 OUTLIER -69.66 -16.98 63.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.574 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.61 -12.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.93 13.01 3.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.973 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.531 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.0 OUTLIER -79.9 126.48 31.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.59 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.8 t-160 -150.21 126.39 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.5 102.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.95 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.94 86.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.332 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 177.31 119.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.004 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.01 118.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.752 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.39 123.14 5.83 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.803 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.61 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.6 m95 -53.03 171.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.107 0.479 . . . . 0.0 111.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.583 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.4 ptp -168.9 173.11 7.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.49 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.33 159.6 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.652 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.5 mmtp 67.23 16.28 10.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.254 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 64.07 33.28 86.82 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.515 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.667 ' HD3' ' HA2' ' T' ' 79' ' ' GLY . 4.7 mtt180 -101.12 157.35 16.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.804 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.4 OUTLIER -154.09 115.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.126 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.97 -168.44 12.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.3 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -135.58 103.24 10.27 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.749 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 24.6 Cg_exo -61.01 -93.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.706 2.27 . . . . 0.0 112.017 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' T' ' 47' ' ' CYS . 40.0 mm 75.24 110.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.797 0.332 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.47 175.96 41.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.938 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -75.04 95.44 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 111.01 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.569 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 18.9 mm -68.06 81.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -108.1 120.42 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.805 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.497 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.9 m-85 -84.83 13.99 5.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 72.86 179.17 35.61 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.179 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.697 HG22 ' H ' ' T' ' 82' ' ' LEU . 40.6 mt -62.05 119.81 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -95.85 14.26 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.697 ' H ' HG22 ' T' ' 80' ' ' ILE . 2.9 mm? 53.73 34.32 18.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.44 ' HB3' ' CG ' ' T' ' 86' ' ' GLU . 0.5 OUTLIER -137.65 67.13 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.989 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -63.94 -3.18 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.03 8.17 43.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.556 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -60.59 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.1 113.05 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 111.305 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.47 ' CD1' HG21 ' T' ' 57' ' ' VAL . 27.9 m95 -151.62 -133.52 0.05 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.555 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -121.91 -170.84 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -146.86 130.69 17.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.752 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.82 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.316 . . . . 0.0 110.457 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.406 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.2 m -83.8 130.24 34.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 110.952 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.947 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -130.44 121.55 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.925 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 179.735 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.807 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -144.62 -179.94 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.853 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.668 ' CG ' HG11 ' T' ' 46' ' ' VAL . 20.3 t-80 -92.88 154.72 18.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.181 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.438 ' HD2' HH11 ' T' ' 5' ' ' ARG . 0.4 OUTLIER -147.33 147.98 30.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.986 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.654 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.5 tt0 -120.14 173.36 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -75.4 168.52 19.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -21.88 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -47.99 4.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 177.17 176.57 45.39 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.559 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.552 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.2 ttpm? -59.08 151.72 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.5 m-30 52.34 75.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -158.04 -5.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' T' ' 7' ' ' ALA . 0.7 OUTLIER -115.01 164.93 13.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.07 0.462 . . . . 0.0 111.275 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.852 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 6.6 p -116.56 -166.19 1.13 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.347 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.597 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.9 t80 -66.44 -40.45 89.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.062 0.458 . . . . 0.0 109.767 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.75 65.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.72 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.852 ' HB2' ' H ' ' T' ' 15' ' ' THR . 54.6 mt-10 -69.16 -42.83 75.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.278 0.561 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -58.42 -40.81 83.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.925 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -31.41 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -63.93 -46.58 84.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.26 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.84 -48.02 83.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 55.4 m -64.63 -51.19 63.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.771 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -70.88 -11.98 61.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.81 -50.03 73.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.841 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -104.2 57.4 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.27 38.37 26.18 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.247 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.636 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -106.66 178.33 22.32 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.655 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -144.52 133.37 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.917 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.5 OUTLIER -47.77 141.63 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.406 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -85.99 143.37 28.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 32.2 p -98.35 -170.68 2.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 111.576 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 37.9 t80 -70.98 -70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.884 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 12.0 mttt -45.62 -38.38 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.494 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.425 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 84.5 mt-30 -66.62 -55.45 15.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.063 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.563 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.78 -19.86 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.696 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.771 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.7 tt0 -74.74 -62.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.254 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.665 ' HA ' ' HD2' ' T' ' 41' ' ' LYS . . . -55.68 -15.44 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.91 -28.45 15.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.621 . . . . 0.0 109.656 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.588 ' HG3' HG22 ' T' ' 62' ' ' VAL . 50.8 ttp85 -72.33 -36.13 68.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.215 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -67.3 -19.36 65.46 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.636 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.597 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -85.79 -16.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.32 14.18 2.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.965 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.09 117.63 22.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.828 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.9 t-160 -138.42 128.36 25.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.668 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -148.43 102.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.773 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.35 67.24 1.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.599 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . -165.06 121.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.556 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.18 112.7 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.172 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.721 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.18 121.89 5.95 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.778 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 80.6 m95 -57.0 165.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.139 0.495 . . . . 0.0 111.831 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.917 ' HA ' HD22 ' T' ' 30' ' ' LEU . 1.0 OUTLIER -159.15 165.34 33.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.324 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.16 158.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.5 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 79.53 -25.22 0.19 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.501 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.582 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.35 20.74 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.507 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.717 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 0.2 OUTLIER -94.4 160.94 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.902 0.382 . . . . 0.0 111.006 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -158.22 109.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.17 -168.25 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.315 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.556 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -132.84 86.38 43.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 111.144 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.821 ' HB3' HG12 ' T' ' 75' ' ' ILE . 32.9 Cg_endo -67.0 118.42 5.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.666 2.244 . . . . 0.0 111.955 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.773 HD11 ' HA ' ' T' ' 47' ' ' CYS . 31.6 mm -134.17 119.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.828 0.347 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.31 -171.0 54.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.866 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.821 HG12 ' HB3' ' T' ' 60' ' ' PRO . 10.0 mt -82.63 121.78 36.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.6 mm -95.1 82.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.44 114.18 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 3.4 m-85 -78.91 -27.25 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 115.35 169.9 16.01 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.472 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.5 mt -53.48 105.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.293 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -90.34 20.29 4.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.956 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' T' ' 82' ' ' LEU . 0.5 OUTLIER 49.45 39.99 17.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.872 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -126.37 53.84 1.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtm180 -68.13 10.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . 0.509 ' H ' ' C ' ' T' ' 83' ' ' ASN . 68.0 m -115.66 8.72 15.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.632 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.781 ' O ' HG22 ' T' ' 15' ' ' THR . 3.1 mm-40 -74.43 -170.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.55 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.402 ' HG3' ' C ' ' T' ' 86' ' ' GLU . 0.0 OUTLIER -136.53 115.95 12.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 111.592 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.772 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 4.4 m95 -154.44 -155.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.106 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.631 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -100.12 -172.39 2.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.184 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -143.01 131.18 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.74 0.305 . . . . 0.0 111.452 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.721 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 40.4 m-85 -96.02 113.91 25.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.123 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.402 ' O ' HG23 ' T' ' 2' ' ' VAL . 18.9 m -89.68 153.18 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.807 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 11.2 t80 -141.37 133.02 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.636 ' OD1' ' HA2' ' T' ' 28' ' ' GLY . 4.4 m-20 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.634 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.69 0.281 . . . . 0.0 111.317 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -142.75 151.02 40.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.488 . . . . 0.0 111.378 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.495 ' CD2' HG21 ' T' ' 46' ' ' VAL . 15.0 t-80 -90.88 145.16 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' T' ' 4' ' ' HIS . 5.1 mmm180 -153.82 151.08 29.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.215 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.37 -169.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.792 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -83.44 151.38 25.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . 0.439 HH12 HH22 ' T' ' 5' ' ' ARG . 6.6 mmt-85 -54.07 -26.39 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -91.72 -49.66 6.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -179.66 176.69 47.77 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 3.2 ttpm? -68.56 162.03 26.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.794 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.6 m-30 52.07 44.12 29.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.72 5.95 2.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.792 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.7 mt -108.98 142.67 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.076 0.465 . . . . 0.0 111.514 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.2 p -114.7 152.13 32.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.947 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.649 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.0 t80 -38.41 -39.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.82 -40.48 72.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' T' ' 15' ' ' THR . 84.3 mt-10 -75.24 -51.48 13.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.18 -48.96 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.057 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.526 ' HD2' HD23 ' T' ' 30' ' ' LEU . 5.5 tttt -64.91 -52.84 54.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.21 -36.59 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.309 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 7.1 t -70.74 -54.84 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.81 -47.63 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 37.7 tt0 -70.66 -17.43 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.602 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.2 -48.22 68.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.75 54.21 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.943 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.15 42.95 24.88 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.261 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -123.28 174.63 16.56 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -127.75 141.52 51.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.633 0.254 . . . . 0.0 110.605 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.64 125.18 28.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.451 . . . . 0.0 110.071 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 1.058 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.2 152.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.714 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.563 HG23 ' OE1' ' T' ' 35' ' ' GLN . 9.7 p -109.72 -157.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.645 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 22.9 t80 -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.166 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.6 mttm -47.76 -35.96 10.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.5 mt-30 -67.33 -56.1 11.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.359 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.614 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.6 tm? -56.45 -24.01 42.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 14.1 tp10 -66.49 -62.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.75 -13.99 12.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.639 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.06 -28.2 15.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.448 0.642 . . . . 0.0 109.613 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.563 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -71.06 -32.92 69.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.896 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -67.14 -17.83 65.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.187 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.639 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.82 -18.52 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.499 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 133.89 15.78 1.17 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.865 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.3 OUTLIER -83.46 79.69 9.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.991 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.601 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.5 t-160 -111.93 128.39 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.634 HG22 ' OH ' ' T' ' 91' ' ' TYR . 2.0 m -147.02 111.65 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.081 0.467 . . . . 0.0 110.991 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.722 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -76.12 77.41 2.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.926 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.81 126.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.25 121.29 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.694 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -117.36 120.77 4.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.4 m95 -53.93 166.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.427 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.669 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -162.32 171.36 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.528 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.32 166.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.381 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 77.02 -28.8 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 106.68 18.74 10.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.65 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.786 ' HB3' HG13 ' T' ' 80' ' ' ILE . 3.5 ptp85 -105.34 158.76 16.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 110.547 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.3 OUTLIER -146.25 122.01 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -117.9 -168.41 14.45 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.489 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -131.01 88.08 46.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 111.038 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.925 ' HB3' HG12 ' T' ' 75' ' ' ILE . 56.3 Cg_endo -73.55 123.3 8.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.822 2.348 . . . . 0.0 112.193 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.722 HD11 ' HA ' ' T' ' 47' ' ' CYS . 17.6 mm -136.32 97.66 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.425 HG12 ' ND1' ' T' ' 45' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.95 -169.51 54.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.766 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' T' ' 60' ' ' PRO . 22.6 mt -80.45 122.09 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.489 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.2 mm -96.18 80.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.876 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.507 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 4.1 t70 -110.64 131.12 55.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.8 m-85 -100.33 25.22 7.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.982 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.16 178.58 8.75 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.786 HG13 ' HB3' ' T' ' 56' ' ' ARG . 3.6 mt -65.17 126.67 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 111.194 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -106.62 19.64 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.789 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.67 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 56.12 32.23 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.8 54.95 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' T' ' 15' ' ' THR . 1.4 mtt85 -65.21 -1.93 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.97 11.51 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.515 ' O ' HG22 ' T' ' 15' ' ' THR . 3.0 mm-40 -72.96 -171.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -137.01 115.97 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.387 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.583 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.2 m95 -150.75 -138.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.141 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -112.24 -170.71 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.08 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.472 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.5 126.56 15.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.415 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 1.058 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 30.5 m-85 -97.36 126.81 42.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.898 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.488 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -100.23 162.84 12.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.872 0.368 . . . . 0.0 110.932 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.619 ' CD2' HG22 ' T' ' 2' ' ' VAL . 21.2 t80 -156.11 118.8 4.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.797 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.698 179.735 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.911 ' HB ' ' HD1' ' T' ' 93' ' ' TYR . 2.3 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -160.32 178.98 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.993 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.406 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.1 t-80 -89.11 155.88 19.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.3 OUTLIER -148.81 152.02 35.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.647 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.6 tt0 -122.53 172.79 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.23 158.76 26.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -61.27 -26.99 68.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.9 t -91.81 -50.53 5.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 178.39 172.8 43.17 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.421 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.9 ttpt -66.22 161.94 21.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.737 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.642 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.2 m-30 55.7 53.89 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 8.3 mtmt -154.68 3.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.0 mt -102.43 132.41 48.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 30.3 p -103.47 148.85 25.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.538 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 84.2 t80 -35.66 -38.1 0.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.46 -44.97 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.457 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' T' ' 15' ' ' THR . 64.2 mt-10 -73.05 -47.69 42.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.17 0.51 . . . . 0.0 110.348 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.98 -45.3 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.077 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.91 -47.13 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.58 -47.59 19.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.7 t -68.19 -53.27 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 87.7 m -59.89 -38.39 82.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.1 tt0 -90.08 -2.64 58.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 1.2 t80 -59.41 -48.13 82.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.95 60.59 2.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.24 22.41 10.14 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.509 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.771 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.96 -158.27 12.56 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 3.7 p80 -155.04 -178.46 7.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.756 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -103.29 124.95 49.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.642 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.84 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -46.02 157.57 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.543 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -111.29 -162.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.894 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 50.0 t80 -75.25 -68.17 0.58 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.945 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 2.2 mtpm? -47.21 -45.28 23.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.28 -49.35 76.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.881 0.372 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -54.92 -29.44 56.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.106 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.0 tt0 -65.05 -61.84 1.91 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.473 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.58 -12.1 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.578 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.73 -29.86 14.58 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.423 0.63 . . . . 0.0 109.892 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.632 ' HE ' HG12 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -72.98 -33.99 66.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.07 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.9 mttt -69.85 -17.49 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.408 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.578 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.5 -17.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.8 11.51 1.43 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.7 129.63 34.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.3 t-160 -146.24 125.56 13.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.711 HG21 ' HE1' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -142.99 98.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.122 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.716 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.47 -0.13 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.566 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -102.64 141.77 34.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.676 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -58.79 114.23 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.87 117.43 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.707 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.3 m95 -52.38 166.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 111.435 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.773 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.9 ptp -164.55 173.24 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.484 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.58 ' HB2' HG22 ' T' ' 32' ' ' THR . . . -51.11 167.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.424 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.13 -28.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.266 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 104.8 18.6 12.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.571 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.564 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.8 ptt180 -105.03 158.67 16.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.701 0.286 . . . . 0.0 110.581 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -142.07 122.86 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.72 -168.43 12.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.676 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -145.51 90.84 5.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.162 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.574 ' HG3' HD12 ' T' ' 36' ' ' LEU . 58.4 Cg_endo -74.9 134.95 18.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.659 2.24 . . . . 0.0 112.179 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm -126.67 145.13 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.632 HG12 ' HE ' ' T' ' 40' ' ' ARG . 4.1 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.087 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.67 -169.91 33.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.057 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.894 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -72.79 101.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.667 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.3 mm -72.05 81.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.07 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.72 137.32 49.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.727 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.451 ' HE1' HG22 ' T' ' 76' ' ' ILE . 0.8 OUTLIER -105.05 28.44 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.59 171.28 3.36 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.8 mt -69.84 119.01 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.9 15.4 2.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.689 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.09 43.66 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.76 82.26 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.24 -1.15 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.0 13.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.591 ' O ' HG22 ' T' ' 15' ' ' THR . 3.8 mm-40 -76.84 -177.15 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.7 OUTLIER -134.55 113.29 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.503 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.642 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.7 m95 -153.32 -160.34 1.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.168 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.566 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -92.42 -170.91 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.556 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -141.04 128.62 21.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 23.4 m-85 -91.07 107.86 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.92 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . 0.486 ' O ' HG23 ' T' ' 2' ' ' VAL . 3.7 m -88.28 149.32 23.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 111.213 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.911 ' HD1' ' HB ' ' T' ' 2' ' ' VAL . 61.8 t80 -136.47 132.1 34.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' T' ' 94' ' ' ASN . 3.6 m120 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.955 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -156.41 176.21 13.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.021 0.439 . . . . 0.0 111.405 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.775 ' CG ' HG11 ' T' ' 46' ' ' VAL . 39.3 t-80 -98.65 163.79 12.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.447 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.88 146.38 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 0.4 OUTLIER -109.23 -168.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 110.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -95.48 150.67 20.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.08 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -25.66 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -92.13 -48.94 6.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 170.66 172.7 37.23 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 1.4 tttt -58.97 151.02 22.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.618 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 9.3 m-30 61.77 58.67 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.04 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -155.17 5.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.634 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 5.7 mt -109.0 133.1 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.289 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.4 p -104.8 149.32 25.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.286 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 78.3 t80 -35.44 -40.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.982 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.15 -45.25 67.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.525 ' OE1' HG23 ' T' ' 15' ' ' THR . 74.5 mt-10 -72.48 -47.62 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.03 -45.44 52.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -71.08 -50.77 30.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -48.7 -38.69 22.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.24 -53.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.487 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 66.4 m -64.34 -27.18 68.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 23.5 tt0 -98.9 -9.03 24.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.155 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.5 t80 -53.73 -42.96 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.081 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.71 60.23 0.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.268 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.79 26.2 10.52 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.538 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -106.57 -169.29 22.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.561 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -155.71 134.05 11.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.418 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -65.04 125.34 24.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.079 0.466 . . . . 0.0 110.387 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -53.02 161.4 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 26.3 p -109.34 -164.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.207 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.638 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 28.4 t80 -74.91 -72.59 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.143 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mtpt -48.23 -40.21 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.913 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.95 -51.19 63.17 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.601 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 6.5 tp10 -54.71 -60.37 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.232 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.51 14.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.862 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.611 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -90.62 -27.93 18.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 109.723 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.2 OUTLIER -72.23 -33.27 67.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.053 179.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.601 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 8.4 mttp -68.99 -17.78 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.396 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.611 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.46 -15.9 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.433 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.22 14.9 2.13 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.068 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.581 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -81.95 99.25 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.669 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.7 t-160 -121.73 119.78 32.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -141.3 94.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' T' ' 48' ' ' ALA . 6.5 t -64.37 89.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 171.91 127.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -46.46 101.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -101.66 111.11 4.0 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.676 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 74.2 m95 -44.65 157.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.983 0.42 . . . . 0.0 111.294 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.792 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -174.83 178.13 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.14 -166.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.12 0.4 3.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.305 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.435 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 156.81 13.15 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.739 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.846 ' HG3' HG13 ' T' ' 80' ' ' ILE . 4.4 mtt-85 -90.45 130.76 36.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.443 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -125.08 129.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.961 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -135.17 -175.74 14.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.329 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.43 78.93 14.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.756 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.7 Cg_exo -63.12 124.59 14.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.758 2.305 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' T' ' 45' ' ' HIS . 38.6 mm -130.51 153.3 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 15.5 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.347 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.62 179.55 50.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.872 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.638 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.7 mt -73.42 111.56 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.542 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.3 mm -91.05 80.15 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.4 t70 -103.29 129.18 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -94.41 15.84 16.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 71.22 169.6 9.81 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.846 HG13 ' HG3' ' T' ' 56' ' ' ARG . 10.6 mt -59.36 112.68 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.983 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' T' ' 81' ' ' ARG . 2.2 mmp_? -91.57 21.05 4.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.576 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 51.66 50.82 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.61 66.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.654 ' O ' ' HB ' ' T' ' 15' ' ' THR . 19.3 mtm105 -66.67 -3.58 6.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m -98.19 18.62 15.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.532 ' O ' HG22 ' T' ' 15' ' ' THR . 3.3 mm-40 -74.87 -171.25 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.5 114.48 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.56 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 22.8 m95 -151.68 -134.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.378 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -121.64 -172.12 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.379 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.531 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.15 137.23 25.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 28.9 m-85 -101.67 107.65 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -85.85 133.83 33.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 111.327 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.955 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.9 OUTLIER -132.57 124.55 28.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.676 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' T' T ' 2' ' ' VAL . . . . . 0.811 HG22 ' HE2' ' T' ' 44' ' ' PHE . 1.3 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.93 169.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 4' ' ' HIS . . . . . 0.522 ' HB2' HG11 ' T' ' 46' ' ' VAL . 9.7 t-80 -96.76 145.7 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.764 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 5' ' ' ARG . . . . . 0.435 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -152.47 166.4 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 6' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.6 OUTLIER -123.3 -170.15 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.66 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 7' ' ' ALA . . . . . 0.667 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.31 150.69 24.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -19.26 61.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 9' ' ' SER . . . . . 0.461 ' HB3' ' CE ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -97.33 -25.89 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 10' ' ' GLY . . . . . 0.658 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 152.51 168.12 16.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -61.85 153.89 27.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.702 0.287 . . . . 0.0 110.855 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 12' ' ' TYR . . . . . 0.766 ' HB3' ' HD2' ' T' ' 87' ' ' ARG . 10.2 m-30 55.52 51.55 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 1.0 OUTLIER -142.28 2.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.636 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 14' ' ' LEU . . . . . 0.667 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.8 mt -105.78 141.23 37.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 15' ' ' THR . . . . . 0.625 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 49.4 p -110.51 149.71 29.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.4 t80 -34.91 -40.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.07 61.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.409 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 18' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.0 mt-10 -68.61 -44.04 75.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 109.966 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.06 -39.22 74.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.972 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 20' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' T' ' 24' ' ' GLU . 10.5 tttm -75.51 -38.22 59.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.106 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 21' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -56.06 -50.01 72.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.81 -53.76 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.42 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 23' ' ' CYS . . . . . 0.635 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 88.3 m -63.31 -26.96 69.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 24' ' ' GLU . . . . . 0.789 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 22.3 tt0 -103.39 1.59 32.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.232 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 25' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -63.71 -43.33 96.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.203 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -100.53 61.26 1.02 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.39 19.97 6.68 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.619 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 28' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.26 -159.97 13.9 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 29' ' ' HIS . . . . . 0.635 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 5.7 p80 -152.88 -177.56 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.996 0.427 . . . . 0.0 110.657 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -101.6 124.06 46.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.6 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 31' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -44.92 154.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.571 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 32' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 6.9 p -108.31 -158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 33' ' ' TYR . . . . . 0.921 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 35.2 t80 -80.99 -73.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.112 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 34' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 20.8 mtmt -44.83 -36.85 3.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.82 -53.1 36.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 36' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.89 -21.13 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.138 0.494 . . . . 0.0 109.984 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 9.3 tt0 -72.63 -61.97 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 38' ' ' ALA . . . . . 0.554 ' HA ' ' HE2' ' T' ' 41' ' ' LYS . . . -58.43 -15.58 11.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 39' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' T' ' 44' ' ' PHE . . . -94.02 -29.73 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.537 0.684 . . . . 0.0 109.578 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 40' ' ' ARG . . . . . 0.658 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -69.06 -32.56 72.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.863 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 41' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' T' ' 38' ' ' ALA . 28.7 mtmt -66.61 -17.85 65.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 42' ' ' ILE . . . . . 0.658 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -92.1 -22.47 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 43' ' ' GLY . . . . . 0.577 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 138.61 17.88 0.56 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.96 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 44' ' ' PHE . . . . . 0.811 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.5 OUTLIER -74.75 86.76 2.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.778 0.323 . . . . 0.0 110.876 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 45' ' ' HIS . . . . . 0.626 ' NE2' HG23 ' T' ' 61' ' ' ILE . 3.5 t-160 -115.36 122.84 47.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.97 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 46' ' ' VAL . . . . . 0.671 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.7 OUTLIER -148.54 112.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 47' ' ' CYS . . . . . 0.926 ' HA ' HD11 ' T' ' 61' ' ' ILE . 1.8 t -82.76 74.38 9.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 48' ' ' ALA . . . . . 0.657 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -176.54 123.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 49' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -42.85 116.68 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 50' ' ' GLY . . . . . 0.665 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.17 117.42 3.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 51' ' ' TRP . . . . . 0.584 ' C ' HD11 ' T' ' 30' ' ' LEU . 75.3 m95 -50.66 166.47 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 52' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 2.0 ptp -162.18 168.61 22.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.362 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 53' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.67 165.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.541 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 54' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mmtp 78.76 -33.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.375 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 111.45 17.22 8.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.695 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 56' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.8 OUTLIER -105.23 157.25 17.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.579 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 57' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -139.39 125.75 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.312 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.23 -168.01 12.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.149 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 59' ' ' TYR . . . . . 0.538 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -144.59 98.32 4.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 60' ' ' PRO . . . . . 0.689 ' HB3' HD13 ' T' ' 75' ' ' ILE . 78.5 Cg_endo -83.41 129.45 5.08 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.814 2.343 . . . . 0.0 112.183 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 61' ' ' ILE . . . . . 0.926 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.4 mm -141.13 111.61 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 62' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.4 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.5 -173.1 33.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 75' ' ' ILE . . . . . 0.921 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -79.78 98.39 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 76' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' T' ' 78' ' ' TYR . 16.0 mm -70.9 79.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.69 117.62 34.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.874 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 78' ' ' TYR . . . . . 0.541 ' CE1' HG22 ' T' ' 76' ' ' ILE . 0.6 OUTLIER -81.14 11.86 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.64 169.41 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 80' ' ' ILE . . . . . 0.606 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.8 mt -52.87 136.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.027 0.441 . . . . 0.0 111.251 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.31 17.08 14.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.018 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 82' ' ' LEU . . . . . 0.606 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 49.54 50.27 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.33 55.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 84' ' ' ARG . . . . . 0.543 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -56.09 -12.52 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.4 15.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 86' ' ' GLU . . . . . 0.565 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.7 mm-40 -78.82 -171.68 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 87' ' ' ARG . . . . . 0.766 ' HD2' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -136.18 113.2 10.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 88' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 3.4 m95 -156.26 179.49 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.056 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 89' ' ' ASP . . . . . 0.657 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -73.83 -170.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.323 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' T' T ' 90' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.08 132.23 19.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.598 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 91' ' ' TYR . . . . . 0.875 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 45.5 m-85 -94.08 115.57 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.63 151.67 21.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 111.331 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' T' T ' 93' ' ' TYR . . . . . 0.665 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 12.0 t80 -148.3 118.88 7.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' T' T ' 94' ' ' ASN . . . . . 0.408 ' OD1' ' HA3' ' T' ' 28' ' ' GLY . 59.3 m-20 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' T' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.64 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.9 OUTLIER -109.98 134.85 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 137.01 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.734 ' CG ' HG11 ' T' ' 46' ' ' VAL . 17.6 t-80 -69.22 150.35 47.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.518 ' HG3' ' SG ' ' T' ' 92' ' ' CYS . 11.0 mmt180 -144.21 144.86 31.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.402 ' O ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -115.88 -168.97 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.877 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.13 153.55 18.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -17.45 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.758 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -101.22 -25.2 14.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 142.3 166.29 10.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.465 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.4 ttpm? -56.72 151.97 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 18.8 m-30 63.16 55.39 1.91 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.589 ' HA ' ' HD2' ' T' ' 87' ' ' ARG . 9.8 mttt -154.5 1.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.669 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.08 134.88 46.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 4.6 p -105.1 148.06 27.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.117 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -35.34 -38.68 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.46 -44.13 65.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' T' ' 15' ' ' THR . 72.0 mt-10 -73.13 -48.24 37.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 110.39 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.608 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.83 -45.59 50.3 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.036 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -66.15 -55.7 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -42.18 -38.17 1.66 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.48 -49.91 49.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 46.2 m -64.0 -51.66 63.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.1 tt0 -69.83 -15.81 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -52.52 -50.94 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -100.51 53.75 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.866 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.25 34.15 32.33 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.235 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -103.71 -178.49 25.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.614 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -147.07 135.52 21.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 111.014 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.39 143.73 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.228 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.77 142.25 30.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.421 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 33.5 p -98.84 -170.97 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.032 0.444 . . . . 0.0 111.501 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.776 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 58.1 t80 -70.63 -68.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.104 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 5.2 mmtp -49.42 -37.75 26.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.764 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.421 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.2 mt-30 -67.69 -57.08 6.99 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.258 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.643 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.2 tm? -58.59 -21.36 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 10.3 tt0 -70.26 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.581 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.25 -22.52 18.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.935 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.57 -29.33 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.478 0.656 . . . . 0.0 109.442 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.657 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 3.1 tmm_? -69.62 -35.3 75.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.641 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 3.1 mtmp? -71.73 -13.27 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.581 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.4 pt -97.26 -16.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.491 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.417 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.92 9.17 1.14 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.421 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.679 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.4 OUTLIER -75.87 91.13 2.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.986 0.393 . . . . 0.0 110.825 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.8 t-160 -123.24 129.07 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.734 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.21 98.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.283 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.703 ' HA ' HD11 ' T' ' 61' ' ' ILE . 6.1 t -66.27 80.68 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.435 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.66 136.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.695 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.29 112.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.66 118.64 5.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.668 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.531 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.9 m95 -52.36 150.1 5.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.444 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.827 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.85 176.17 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.725 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.643 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.0 -165.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.619 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -8.85 9.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.533 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 159.93 18.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.047 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.643 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 6.2 ptp180 -95.07 132.53 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.643 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.616 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -121.42 121.0 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.94 -168.93 14.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.2 OUTLIER -133.94 76.99 63.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.864 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.844 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 36.3 Cg_exo -59.39 122.35 11.37 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.792 2.328 . . . . 0.0 112.379 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.703 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.8 mm -139.87 110.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.983 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -88.87 -14.88 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.405 ' H ' ' CE1' ' T' ' 45' ' ' HIS . 35.7 tttp -126.73 98.14 31.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.604 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 70.7 Cg_exo -48.73 105.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.555 2.17 . . . . 0.0 112.368 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.16 161.92 53.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.76 -39.8 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.933 2.422 . . . . 0.0 111.954 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.19 -22.43 7.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.819 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -83.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 -1.82 88.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.903 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 64.75 2.35 1.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.73 0.3 . . . . 0.0 111.12 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 110.46 44.62 0.97 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.819 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.776 ' HD2' HG13 ' T' ' 76' ' ' ILE . 8.5 mmtm -87.14 157.18 19.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.772 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 130.64 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.11 -168.03 30.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.893 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 33.5 mt -75.39 125.98 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.359 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.776 HG13 ' HD2' ' T' ' 72' ' ' LYS . 5.1 mm -95.95 81.34 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.43 133.51 54.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' T' ' 76' ' ' ILE . 16.8 m-85 -110.76 -6.8 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.79 174.01 25.69 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.8 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.5 mt -55.56 157.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.915 0.388 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.405 ' N ' HG22 ' T' ' 80' ' ' ILE . 6.5 mtm180 -120.75 11.01 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.8 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.0 44.34 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -168.55 75.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.821 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -66.88 -5.87 14.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.038 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 77.3 p -73.67 10.95 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.575 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 4.4 mm-40 -75.3 177.42 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.718 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.589 ' HD2' ' HA ' ' T' ' 13' ' ' LYS . 2.8 mtm180 -131.69 113.53 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 111.315 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.672 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.5 m95 -151.87 -153.46 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.203 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.435 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.82 -171.79 2.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.424 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.84 119.22 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.481 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.837 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 33.6 m-85 -86.77 116.2 24.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.283 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' T' ' 5' ' ' ARG . 1.3 m -93.48 155.31 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.936 0.398 . . . . 0.0 111.205 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.9 t80 -153.6 99.31 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.587 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.992 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 0.7 OUTLIER -126.14 135.91 27.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.515 ' HD3' ' NE2' ' T' ' 29' ' ' HIS . 52.2 Cg_exo -51.63 -33.29 48.21 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.427 2.084 . . . . 0.0 111.848 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -131.31 -27.34 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.966 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.992 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 37.07 58.24 1.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.307 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.855 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.4 p -89.09 147.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.872 0.368 . . . . 0.0 111.269 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' T' ' 92' ' ' CYS . 24.8 p90 -151.91 -176.53 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.783 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.821 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.2 t-80 -109.21 157.68 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.226 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.45 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 2.1 mmt180 -156.33 148.97 23.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' T' ' 6' ' ' GLU . 2.9 pm0 -112.54 -173.21 2.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.772 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -91.38 158.4 16.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.179 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -61.09 -20.51 62.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.704 ' HB2' ' HD2' ' T' ' 13' ' ' LYS . 32.9 m -95.28 -28.54 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.65 167.11 12.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.44 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.454 ' HD2' ' CB ' ' T' ' 48' ' ' ALA . 1.6 ttpm? -56.65 152.13 12.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 19.3 m-30 63.79 54.25 1.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.704 ' HD2' ' HB2' ' T' ' 9' ' ' SER . 53.7 mttt -152.76 5.77 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.678 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.772 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.2 mt -109.19 130.23 55.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.048 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.641 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.2 p -103.09 150.47 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.257 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.528 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 85.9 t80 -35.29 -43.14 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.724 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.641 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 13.8 mt-10 -68.07 -56.29 9.41 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.188 0.518 . . . . 0.0 109.88 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -44.2 -39.04 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -70.24 -38.36 75.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -60.94 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.52 -48.11 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -66.19 -54.87 20.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.349 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -71.66 -1.58 14.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.701 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -65.1 -48.67 72.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -115.62 63.96 0.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.242 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.68 45.53 54.59 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.335 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.643 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -115.88 177.53 17.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.535 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -149.65 133.9 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.379 . . . . 0.0 110.958 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.03 141.22 6.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.328 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.92 146.25 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.463 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 43.6 p -100.93 -172.29 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.92 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 69.8 t80 -70.93 -64.9 0.81 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -49.12 -39.33 28.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.536 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.435 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 89.5 mt-30 -65.64 -53.06 46.62 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.488 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.36 -27.23 62.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.001 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.13 -59.67 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.426 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.422 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.37 -19.45 5.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.633 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.39 -32.94 15.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.457 0.646 . . . . 0.0 109.681 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.853 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -70.53 -33.35 71.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.871 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -66.09 -21.13 66.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.98 -23.19 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 110.391 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.591 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 141.33 16.26 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.126 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.683 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -75.91 132.41 40.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.904 0.352 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.54 ' CE1' ' HG3' ' T' ' 63' ' ' LYS . 2.6 t-160 -156.11 124.22 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.821 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.78 89.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -64.82 74.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.675 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.454 ' CB ' ' HD2' ' T' ' 11' ' ' LYS . . . -175.77 119.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.785 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -37.42 114.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.295 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.677 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -114.25 121.3 5.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.545 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.528 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 75.5 m95 -54.68 148.58 12.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.113 0.482 . . . . 0.0 111.634 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.808 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.94 178.81 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.636 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.22 -165.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.468 . . . . 0.0 111.509 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -7.86 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 160.22 18.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.811 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.5 mtp180 -92.78 134.79 34.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -129.92 111.8 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -113.89 -172.26 17.89 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.271 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -122.91 81.45 50.13 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 0.0 111.016 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.0 Cg_exo -59.77 126.2 19.84 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.686 2.258 . . . . 0.0 112.164 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.497 HG23 ' CE1' ' T' ' 45' ' ' HIS . 25.3 mm -131.59 134.31 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.225 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.853 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -102.53 -38.59 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.54 ' HG3' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -126.03 105.94 25.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.733 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.489 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 73.8 Cg_exo -46.69 129.61 14.34 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.829 2.353 . . . . 0.0 112.519 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.28 -171.68 16.78 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.455 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.02 -86.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.76 2.306 . . . . 0.0 112.471 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.78 10.33 7.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.46 23.03 0.97 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.855 ' HA3' ' HD2' ' T' ' 72' ' ' LYS . . . 112.02 36.67 1.63 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.933 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 35.5 t80 44.12 44.02 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.019 0.437 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 68.79 71.23 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.709 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.855 ' HD2' ' HA3' ' T' ' 69' ' ' GLY . 6.0 mttp -88.05 155.1 19.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.836 0.35 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.87 132.09 54.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.218 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.44 168.69 7.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.093 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.92 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.5 mp -62.37 105.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.734 HG13 ' HD3' ' T' ' 72' ' ' LYS . 7.0 mm -73.96 82.29 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.09 120.12 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.417 ' CE1' HG22 ' T' ' 76' ' ' ILE . 7.9 m-85 -87.36 -35.42 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.23 169.66 12.55 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.724 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.0 mt -61.22 115.42 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.0 mmt85 -84.31 11.13 8.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.688 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.25 46.24 16.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.786 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.74 77.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.665 HH21 ' HA ' ' T' ' 82' ' ' LEU . 0.3 OUTLIER -72.4 7.34 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.822 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.43 7.16 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.585 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -66.36 -173.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.93 113.07 11.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.038 0.446 . . . . 0.0 111.517 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.597 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.7 m95 -154.47 -166.69 2.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.118 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.451 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.4 OUTLIER -84.34 -173.55 4.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.448 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.26 118.92 10.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.397 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.717 ' CD1' HD21 ' T' ' 36' ' ' LEU . 39.1 m-85 -88.4 113.95 24.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.403 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.431 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 2.0 t -93.89 159.8 15.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.855 0.36 . . . . 0.0 111.05 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.855 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 14.3 t80 -145.11 134.15 22.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 6.9 m-20 -152.76 141.33 13.99 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.34 -33.26 36.45 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.481 2.121 . . . . 0.0 111.847 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' T' ' 97' ' ' ALA . 11.9 m-70 -119.49 -34.29 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.574 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.644 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 33.59 64.66 0.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.325 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.9 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.952 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.3 p -91.55 148.87 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.534 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 17.3 p90 -157.53 177.42 11.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.203 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.79 ' CG ' HG11 ' T' ' 46' ' ' VAL . 37.9 t-80 -97.66 160.09 14.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.501 ' HE ' ' HB2' ' T' ' 5' ' ' ARG . 0.0 OUTLIER -157.11 147.26 20.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.849 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.3 OUTLIER -112.52 -168.43 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.731 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -102.6 155.92 17.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.14 -17.72 58.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.8 p -98.47 -25.59 14.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.53 166.94 10.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HE2' ' CE2' ' T' ' 12' ' ' TYR . 2.1 ttpm? -57.41 152.03 15.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 111.058 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 17.7 m-30 61.41 56.28 2.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.142 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -155.12 8.53 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.573 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.731 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.3 mt -110.63 132.32 54.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.291 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.728 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.7 p -103.0 146.54 28.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.141 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.608 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.5 t80 -33.93 -39.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.31 -45.2 70.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' T' ' 15' ' ' THR . 73.4 mt-10 -73.8 -49.9 23.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.345 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.39 -41.1 27.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.989 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -50.1 22.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.931 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.71 -40.99 30.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.409 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 6.8 t -70.49 -54.31 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.452 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 63.4 m -60.77 -42.04 96.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.923 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 10.0 tt0 -81.8 -10.25 59.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 0.9 OUTLIER -54.23 -50.89 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.003 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -96.62 61.37 1.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.224 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.92 30.72 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.418 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -111.56 -169.31 18.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.502 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.15 135.26 13.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.592 0.234 . . . . 0.0 110.441 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.19 125.43 26.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.463 . . . . 0.0 110.235 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.21 163.92 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.546 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.566 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 5.9 p -111.21 -158.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.752 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 30.9 t80 -79.89 -74.19 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.2 mttt -47.19 -36.35 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.73 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.31 -53.95 30.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.39 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.49 -24.47 31.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.932 179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 15.0 tt0 -69.0 -62.64 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.266 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.486 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.02 -12.01 4.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.585 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.1 -29.88 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.328 0.585 . . . . 0.0 109.872 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -73.42 -33.86 65.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.139 179.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.3 mtmt -69.97 -17.17 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.36 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.585 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.95 -17.63 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.443 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.51 11.53 1.49 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.014 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.7 OUTLIER -82.63 124.48 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.921 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.583 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.4 t-160 -148.6 126.63 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.79 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -146.94 100.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.24 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.834 ' HA ' HD11 ' T' ' 61' ' ' ILE . 5.9 t -66.83 80.75 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.578 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 175.99 126.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -45.13 113.17 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.279 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.4 114.96 3.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.596 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.608 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 77.6 m95 -48.68 168.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 111.757 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.844 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -161.86 173.77 14.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.504 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -51.93 166.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 111.52 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.776 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.0 OUTLIER 76.84 -31.64 0.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.34 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.58 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.14 20.12 8.1 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.592 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.702 ' HB3' HG13 ' T' ' 80' ' ' ILE . 0.4 OUTLIER -108.99 156.28 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 0.0 110.594 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -137.03 133.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.052 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -137.53 -172.59 12.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.312 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.654 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -133.03 102.59 13.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.849 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 19.5 Cg_endo -60.33 -88.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.595 2.196 . . . . 0.0 112.291 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.834 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm 71.42 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' T' ' 45' ' ' HIS . 14.8 t -60.45 -70.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -101.69 155.02 36.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.86 144.12 36.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.643 2.229 . . . . 0.0 112.353 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.73 ' H ' ' H ' ' T' ' 71' ' ' GLY . . . -97.26 140.85 15.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.377 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.43 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 46.1 Cg_endo -68.83 -78.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.43 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -99.8 -1.95 36.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.874 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -19.47 65.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.47 36.14 2.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.936 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 58.44 95.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.814 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.799 ' HA3' HG21 ' T' ' 61' ' ' ILE . . . -74.91 4.51 37.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.657 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' T' ' 76' ' ' ILE . 0.0 OUTLIER 41.26 -165.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.015 0.436 . . . . 0.0 111.58 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.06 56.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.169 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.28 176.9 51.66 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.849 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 2.5 mt -76.81 108.67 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 111.258 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.0 mm -79.13 82.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.975 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.1 t70 -110.42 121.65 45.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 1.6 m-85 -83.71 11.96 6.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' T' ' 77' ' ' ASP . . . 69.62 170.74 7.83 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' T' ' 54' ' ' LYS . 9.4 mt -60.33 117.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.082 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.18 19.42 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.533 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.71 35.24 20.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.91 53.11 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.728 ' O ' ' HB ' ' T' ' 15' ' ' THR . 21.4 mtt180 -60.95 -5.55 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.64 20.74 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.76 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.56 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.4 mm-40 -83.72 -172.05 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.641 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.56 114.15 10.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.1 m95 -153.98 -164.74 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.97 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.578 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -89.56 -173.96 4.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.55 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.06 135.16 25.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 35.8 m-85 -96.88 111.91 23.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.276 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 9.1 m -90.49 137.2 32.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 111.09 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.952 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.4 OUTLIER -136.83 126.26 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.715 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.731 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.0 m-20 -133.24 151.05 76.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.16 -33.64 21.89 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.476 2.117 . . . . 0.0 111.92 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' T' ' 97' ' ' ALA . 21.2 t-160 -123.2 -32.18 3.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 31.45 68.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.334 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.938 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.745 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 2.1 p -101.96 146.29 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 111.414 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.424 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 16.1 p90 -151.79 -176.99 5.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.569 ' CD2' HG11 ' T' ' 46' ' ' VAL . 16.4 t-80 -95.38 153.85 17.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.32 150.97 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.044 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.588 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 26.0 tt0 -120.02 173.19 7.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.735 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.29 159.92 25.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.084 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -61.25 -28.54 69.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' T' ' 13' ' ' LYS . 0.9 OUTLIER -91.55 -50.05 5.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.612 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 176.39 174.21 42.69 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.497 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.491 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 20.1 ttpt -62.96 168.14 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 46.3 47.79 13.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.86 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.7 OUTLIER -143.41 2.34 1.26 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.785 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.735 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -104.2 139.06 39.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.487 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.672 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 19.8 p -107.8 149.67 27.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.94 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 61.9 t80 -34.07 -42.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.866 0.365 . . . . 0.0 111.054 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.38 -41.69 66.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.672 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.7 mt-10 -69.34 -44.66 71.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.188 0.518 . . . . 0.0 110.032 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -56.09 -38.65 70.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.815 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -76.42 -37.13 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -59.56 -38.47 81.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.084 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -53.16 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.355 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -63.89 -28.39 69.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 30.9 tt0 -99.31 -9.28 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 110.307 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.8 t80 -51.34 -42.6 61.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.92 59.0 0.66 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.88 33.34 20.24 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.28 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.27 -168.2 19.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.585 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.67 136.4 17.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.583 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.647 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -70.58 126.89 30.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.991 0.424 . . . . 0.0 110.358 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -51.3 161.23 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.575 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.639 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 28.2 p -111.84 -164.94 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.893 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 32.5 t80 -74.76 -70.75 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.991 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 30.0 mttm -45.28 -41.85 9.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.667 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.71 -51.21 63.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.673 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -55.69 -27.33 49.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.949 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.7 tp10 -65.9 -61.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.087 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.478 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -58.88 -13.27 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.936 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.568 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.92 -30.16 14.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.348 0.594 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 53.0 ttt-85 -73.6 -33.35 64.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.009 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 13.0 mttt -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.568 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.74 -15.73 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.422 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 131.15 12.12 2.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.091 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.47 120.0 23.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 0.0 110.797 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.628 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.5 t-160 -136.4 129.32 31.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.784 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.716 HG21 ' HE1' ' T' ' 91' ' ' TYR . 1.3 t -143.24 103.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.447 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.729 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.71 66.32 1.45 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -175.26 138.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.671 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -55.09 111.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -108.6 113.85 3.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.6 m95 -47.12 152.06 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' T' ' 50' ' ' GLY . 0.0 OUTLIER -171.5 174.54 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.688 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' T' ' 32' ' ' THR . . . 53.44 -166.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.543 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 0.34 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.537 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.433 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.74 16.16 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.786 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.623 ' O ' ' HG3' ' T' ' 52' ' ' MET . 1.9 mtt180 -92.05 125.52 36.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.871 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -116.3 126.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.997 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -130.23 -169.2 12.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.318 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.499 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.1 OUTLIER -139.45 91.92 10.67 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.855 0.36 . . . . 0.0 111.143 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' T' ' 75' ' ' ILE . 68.4 Cg_endo -78.49 125.06 6.71 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.67 2.247 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.729 HD11 ' HA ' ' T' ' 47' ' ' CYS . 20.0 mm -136.82 101.21 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -73.64 -17.94 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.03 91.13 48.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.701 ' HB3' ' HA2' ' T' ' 71' ' ' GLY . 50.2 Cg_exo -51.87 128.96 28.45 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.59 -171.84 16.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.414 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.416 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 43.4 Cg_endo -68.31 -78.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.763 2.308 . . . . 0.0 112.322 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -100.76 -21.38 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.956 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' T' ' 69' ' ' GLY . 0.8 OUTLIER -59.81 -82.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.916 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' T' ' 68' ' ' CYS . . . -80.87 -9.92 85.71 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.894 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.8 32.07 21.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.701 ' HA2' ' HB3' ' T' ' 64' ' ' PRO . . . 64.79 24.0 69.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.681 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.668 ' HB3' HD11 ' T' ' 76' ' ' ILE . 29.5 mttm -89.38 151.59 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.26 131.28 53.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.01 -175.93 34.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.834 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.893 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -80.31 89.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.987 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.668 HD11 ' HB3' ' T' ' 72' ' ' LYS . 18.3 mm -62.42 84.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.43 138.21 51.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.0 m-85 -112.82 27.72 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 68.49 168.2 4.83 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.652 HG22 ' H ' ' T' ' 82' ' ' LEU . 7.2 mt -57.43 147.84 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.947 0.403 . . . . 0.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.676 ' HB2' ' OD1' ' T' ' 83' ' ' ASN . 4.7 mmm-85 -115.14 22.52 13.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.02 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.652 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 44.46 53.4 6.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.285 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' T' ' 81' ' ' ARG . 27.5 p-10 -165.81 61.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -58.3 -3.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.467 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.3 OUTLIER -81.93 17.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.571 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -78.01 -172.46 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.63 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -139.04 113.38 8.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.283 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.748 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 16.2 m95 -153.13 -156.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.105 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -97.33 -171.23 2.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.374 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.17 137.92 29.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.221 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 32.5 m-85 -101.02 120.38 40.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 5.7 m -96.1 147.51 23.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.015 0.436 . . . . 0.0 111.431 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.745 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 26.5 t80 -137.6 133.95 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.796 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 12.7 m-20 -154.74 137.46 10.17 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.589 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.56 -32.75 28.53 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.496 2.131 . . . . 0.0 111.698 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.466 ' O ' ' C ' ' T' ' 97' ' ' ALA . 4.0 m-70 -118.35 -34.14 4.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.618 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.36 69.4 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.335 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.827 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.687 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.2 p -88.64 138.35 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.126 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.03 -177.97 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.729 ' CG ' HG11 ' T' ' 46' ' ' VAL . 21.1 t-80 -101.7 161.56 13.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.467 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.83 144.81 23.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.616 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.8 tt0 -115.62 173.28 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.692 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.799 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -87.25 157.19 19.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.194 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -65.93 -21.5 66.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 21.2 m -91.41 -23.75 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.798 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.85 167.79 11.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.463 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 7.6 ttpt -58.59 158.15 8.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.482 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 11.0 m-30 57.2 55.98 5.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -153.25 2.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.8 mt -103.05 136.81 42.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.072 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.713 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.5 p -107.73 152.91 23.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.243 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 71.5 t80 -36.66 -43.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.904 0.383 . . . . 0.0 110.757 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.03 -39.86 68.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.327 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.713 ' HB2' ' H ' ' T' ' 15' ' ' THR . 76.4 mt-10 -70.55 -47.69 59.08 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 109.806 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.464 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -55.89 -46.47 78.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.561 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -29.54 69.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.636 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -65.67 -39.54 91.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.142 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.8 t -67.89 -52.31 40.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 92.1 m -64.13 -48.98 73.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.541 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 42.9 tt0 -69.9 -16.4 63.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.532 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.95 -49.09 69.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.803 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -103.71 51.6 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.28 38.97 34.51 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.356 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -117.98 172.83 14.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.569 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -124.79 139.47 53.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.71 0.291 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -74.64 126.12 30.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.215 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.3 155.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.461 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 27.1 p -110.39 -164.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 27.6 t80 -74.88 -72.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.107 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -47.59 -41.59 21.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.921 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.45 -47.79 80.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.6 OUTLIER -54.81 -40.72 69.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 3.6 tp10 -54.26 -60.66 3.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.188 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.85 -18.48 8.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.607 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -91.27 -29.75 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.76 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.886 ' HG2' HG23 ' T' ' 62' ' ' VAL . 3.1 tmm_? -71.17 -33.62 70.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.011 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtpt -69.45 -17.03 63.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.314 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.607 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.53 -12.33 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 110.683 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.24 14.9 3.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.012 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -83.01 124.6 30.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.353 . . . . 0.0 110.981 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.536 ' ND1' HG12 ' T' ' 62' ' ' VAL . 2.2 t-160 -147.15 127.25 13.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.75 94.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.564 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 1.3 m -61.75 83.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 170.32 125.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -46.28 113.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' T' ' 52' ' ' MET . . . -110.43 121.37 5.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.633 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 74.4 m95 -49.68 152.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.97 0.414 . . . . 0.0 111.318 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.664 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -170.41 177.82 3.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.73 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.97 -165.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.469 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 2.78 2.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.372 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.02 15.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.791 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.69 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 28.6 mtt180 -94.72 127.48 40.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.428 HG12 ' CZ3' ' T' ' 51' ' ' TRP . 0.2 OUTLIER -115.93 131.37 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -141.38 -178.28 17.45 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.393 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.497 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.95 98.3 39.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.745 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 37.9 Cg_exo -55.35 -84.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.786 2.324 . . . . 0.0 112.689 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 17.2 mm 73.57 102.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.948 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.886 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -76.06 -41.36 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.21 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.545 ' HG2' HG12 ' T' ' 62' ' ' VAL . 6.9 ptpt -124.43 95.48 43.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.71 141.97 42.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.589 2.193 . . . . 0.0 112.294 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.47 -117.73 2.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.272 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.455 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 73.7 Cg_endo -83.89 -79.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.455 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -104.27 -19.82 13.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.84 -34.21 72.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.31 -14.03 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.837 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 59.4 29.52 19.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.97 17.89 72.12 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.734 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.725 ' HD3' HG13 ' T' ' 76' ' ' ILE . 17.6 mttt -89.67 151.01 22.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.39 129.23 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . 0.577 ' HA2' ' NH2' ' T' ' 40' ' ' ARG . . . 86.21 175.39 49.78 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.84 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.749 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 1.3 mt -68.49 107.41 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.046 0.45 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.725 HG13 ' HD3' ' T' ' 72' ' ' LYS . 9.8 mm -81.39 83.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.1 t70 -109.47 132.12 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.868 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.604 ' CE1' HG22 ' T' ' 76' ' ' ILE . 10.6 m-85 -105.15 23.01 14.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.69 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 70.05 170.97 8.75 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.729 HG22 ' H ' ' T' ' 82' ' ' LEU . 9.6 mt -51.37 152.29 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 111.282 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.05 18.65 17.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.729 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 54.76 31.66 15.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.2 OUTLIER -148.92 77.44 1.37 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' T' ' 15' ' ' THR . 69.2 mtt180 -65.79 2.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.438 ' H ' ' C ' ' T' ' 83' ' ' ASN . 0.4 OUTLIER -102.14 12.67 36.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.537 ' O ' HG22 ' T' ' 15' ' ' THR . 2.4 mm-40 -65.17 -178.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.609 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.1 OUTLIER -132.35 114.27 14.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.401 . . . . 0.0 111.341 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.574 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 23.2 m95 -151.43 -136.6 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.274 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.463 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.7 OUTLIER -115.4 -167.57 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.378 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.464 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.6 132.53 18.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.276 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.904 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 31.1 m-85 -105.1 127.28 52.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.561 ' O ' HG23 ' T' ' 2' ' ' VAL . 1.2 m -100.76 159.67 14.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 111.304 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.687 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 24.2 t80 -150.67 119.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.962 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.8 m120 -139.03 133.73 16.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.484 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.28 -33.52 28.75 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.507 2.138 . . . . 0.0 111.905 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.495 ' O ' ' C ' ' T' ' 97' ' ' ALA . 2.2 p80 -115.25 -31.75 5.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.711 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.962 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 25.74 74.51 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.47 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.705 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.1 p -86.61 142.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.151 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -147.23 -176.69 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.771 ' CG ' HG11 ' T' ' 46' ' ' VAL . 40.7 t-80 -98.93 163.95 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 154.77 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.549 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 24.7 tt0 -121.91 172.91 7.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -78.33 161.23 27.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -20.16 65.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.757 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.539 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.5 m -102.82 -47.49 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 173.91 172.53 39.3 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.515 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 150.25 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.692 0.282 . . . . 0.0 110.969 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.2 m-30 61.81 57.36 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 9.0 mttm -153.55 1.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.515 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.602 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 12.3 mt -104.66 139.54 39.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.023 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.737 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 1.6 p -108.55 151.8 25.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 67.6 t80 -36.52 -41.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.81 0.338 . . . . 0.0 110.791 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.79 -39.03 64.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.304 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' T' ' 15' ' ' THR . 82.6 mt-10 -71.02 -45.38 64.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.179 0.514 . . . . 0.0 109.958 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -58.56 -45.26 89.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.565 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 30.3 tttt -68.47 -26.86 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.563 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.71 -41.53 83.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.194 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 3.5 t -67.78 -51.73 47.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.259 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -63.84 -47.71 79.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.592 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 4.1 tt0 -73.55 -13.45 61.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -54.43 -48.83 71.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -102.9 50.98 0.81 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.758 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.15 39.62 50.53 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.313 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -118.17 177.41 16.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.733 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -130.12 141.83 50.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.564 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.63 125.44 29.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.068 0.461 . . . . 0.0 110.23 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.947 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.22 154.32 0.6 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.533 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -109.99 -162.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.222 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.637 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 31.6 t80 -77.23 -72.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.105 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 14.1 mttm -46.89 -38.49 10.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.732 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.28 -53.55 35.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 110.39 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.63 -23.86 44.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 12.1 tp10 -68.45 -61.78 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.205 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.409 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.52 -16.09 8.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.798 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.49 -29.48 15.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.491 0.662 . . . . 0.0 109.684 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.58 HH11 ' HA2' ' T' ' 74' ' ' GLY . 0.0 OUTLIER -72.61 -33.25 66.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.112 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.0 mttt -69.52 -17.88 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.286 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.567 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.39 -14.35 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 110.81 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.406 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 11.35 2.53 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.045 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -81.48 118.6 22.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.632 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.9 t-160 -141.55 127.2 19.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.771 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -145.43 102.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.28 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.807 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -72.72 80.5 1.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.701 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 178.55 123.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.835 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.571 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -41.73 111.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.31 114.97 3.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.667 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 71.7 m95 -48.95 156.83 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.977 0.418 . . . . 0.0 111.432 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.686 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -177.61 178.33 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.896 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.671 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 50.77 -165.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -7.52 7.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.498 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 158.49 19.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.858 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.671 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 0.9 OUTLIER -97.53 135.66 39.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.73 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.1 OUTLIER -126.61 122.42 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.61 -170.65 13.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.215 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.571 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.4 OUTLIER -124.99 82.97 60.76 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.961 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.62 ' HG3' HD13 ' T' ' 75' ' ' ILE . 26.7 Cg_exo -60.37 104.95 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.761 2.307 . . . . 0.0 112.138 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.4 mm -130.74 112.28 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.028 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER -70.01 -16.69 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.897 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.428 ' HD3' ' HD2' ' T' ' 64' ' ' PRO . 0.2 OUTLIER -104.6 164.04 16.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.893 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' HD3' ' T' ' 63' ' ' LYS . 43.8 Cg_exo -54.47 -8.42 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.564 2.176 . . . . 0.0 112.402 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . 0.458 ' HA3' ' HA3' ' T' ' 69' ' ' GLY . . . 79.89 135.99 1.42 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.39 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.551 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 98.6 Cg_endo -92.1 -67.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.073 2.516 . . . . 0.0 112.226 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.551 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -122.25 -22.91 5.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 10.3 41.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.458 ' HA3' ' HA3' ' T' ' 65' ' ' GLY . . . -124.49 -38.41 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.008 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 64.06 41.87 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.55 17.82 78.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.74 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.571 ' HD2' HG13 ' T' ' 76' ' ' ILE . 9.9 mttm -92.53 154.8 18.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.98 131.96 50.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . 0.58 ' HA2' HH11 ' T' ' 40' ' ' ARG . . . 90.03 -176.24 42.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.85 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.637 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -70.36 110.85 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 0.0 111.058 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.571 HG13 ' HD2' ' T' ' 72' ' ' LYS . 5.2 mm -89.36 79.86 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -101.92 122.83 44.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.41 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.1 m-85 -84.01 3.36 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.011 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.09 172.44 44.37 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.488 HG12 ' C ' ' T' ' 55' ' ' GLY . 6.3 mt -65.4 119.92 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.315 . . . . 0.0 111.027 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -112.03 28.35 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.424 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 52.96 27.89 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -114.38 51.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.958 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.618 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -70.65 4.34 2.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -106.62 6.97 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.562 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 3.1 mm-40 -72.15 -171.42 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 23.5 mtp85 -132.63 113.48 13.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.139 0.495 . . . . 0.0 111.56 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 6.8 m95 -153.99 -171.24 3.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.038 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.596 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -81.99 -171.21 3.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.424 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.77 136.87 24.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.947 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 38.8 m-85 -103.24 127.91 50.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.583 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.7 OUTLIER -99.56 161.35 13.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.956 0.408 . . . . 0.0 111.284 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.705 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 25.2 t80 -151.62 119.88 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.757 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.847 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 27.6 m-20 -143.43 147.07 38.41 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.623 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.58 -51.13 9.82 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.54 2.16 . . . . 0.0 111.498 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.488 ' O ' ' C ' ' T' ' 97' ' ' ALA . 18.9 p-80 -101.48 -28.45 12.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.58 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 27.11 66.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.371 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.895 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.715 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.6 p -92.32 141.91 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 111.273 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -145.59 -176.91 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.797 ' CG ' HG11 ' T' ' 46' ' ' VAL . 16.1 t-80 -113.56 155.26 25.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.96 164.43 38.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.82 -170.0 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -90.7 149.55 22.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -60.12 -16.47 32.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.774 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -98.77 -25.35 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 149.19 167.65 14.13 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.492 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 8.1 tttm -62.38 153.84 29.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.345 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.9 m-30 57.06 51.92 9.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.774 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 3.7 mttm -142.69 1.05 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.9 mt -104.33 146.77 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.755 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 22.3 p -114.36 153.31 30.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.012 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 72.2 t80 -37.76 -40.44 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.849 0.357 . . . . 0.0 110.751 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.47 -38.99 62.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.359 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.755 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.7 mt-10 -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.173 0.511 . . . . 0.0 109.936 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -58.09 -46.2 85.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -67.69 -26.5 66.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.489 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -69.41 -40.98 77.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.908 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.86 -50.41 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -52.27 50.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.148 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 6.5 tt0 -71.62 -3.04 19.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.644 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -65.71 -45.11 83.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.574 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.81 59.61 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.047 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 55.82 21.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.262 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.503 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -138.96 166.96 25.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.784 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.47 139.07 51.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.612 0.244 . . . . 0.0 110.57 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -74.22 124.65 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.09 0.471 . . . . 0.0 110.316 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -49.69 153.13 1.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.483 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 28.3 p -106.17 -164.02 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.977 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.88 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 53.0 t80 -75.61 -69.79 0.47 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.021 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -46.68 -42.7 16.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.17 -46.25 84.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.647 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.73 -38.01 71.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.226 0.536 . . . . 0.0 109.661 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 12.0 tt0 -57.02 -60.68 3.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.428 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.67 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -54.48 -21.59 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.058 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -90.91 -28.85 17.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.394 0.616 . . . . 0.0 109.633 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.589 ' HG2' HG23 ' T' ' 62' ' ' VAL . 19.2 ttp85 -71.59 -34.21 69.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.001 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.9 mtmp? -73.24 -18.05 61.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.221 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.67 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -87.88 -7.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.92 7.07 7.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.331 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -78.17 130.64 36.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.534 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.6 t-160 -153.07 130.8 11.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.763 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.797 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -152.37 99.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.261 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.587 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.731 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 179.67 122.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' T' ' 57' ' ' VAL . . . -41.45 110.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.71 115.94 4.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.838 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.3 m95 -48.19 156.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.929 0.395 . . . . 0.0 111.367 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.725 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.1 OUTLIER -178.28 177.37 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.055 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.04 -165.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.754 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -14.03 10.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.476 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 160.85 23.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.926 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.724 ' HG2' ' HB3' ' T' ' 53' ' ' ALA . 10.7 ptp180 -99.71 136.41 39.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.538 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.584 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -127.88 119.57 51.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -118.68 -173.67 15.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.257 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.434 ' O ' HG12 ' T' ' 61' ' ' ILE . 0.3 OUTLIER -120.56 82.32 33.04 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 27.7 Cg_exo -59.97 120.9 8.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.689 2.259 . . . . 0.0 112.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.587 HD11 ' HA ' ' T' ' 47' ' ' CYS . 10.4 mm -138.69 100.56 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.589 HG23 ' HG2' ' T' ' 40' ' ' ARG . 0.4 OUTLIER -71.52 -41.85 72.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' T' ' 62' ' ' VAL . 0.0 OUTLIER -113.36 96.86 41.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 9.9 Cg_endo -53.0 144.03 47.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.774 2.316 . . . . 0.0 112.285 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.04 15.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.312 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 39.3 Cg_endo -68.15 -77.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 0.0 112.181 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.401 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -97.41 -12.69 22.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.755 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 48.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.47 -31.21 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 62.71 32.53 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 111.013 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.92 16.77 70.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.675 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.915 ' HD3' HG13 ' T' ' 76' ' ' ILE . 15.7 mttp -95.09 149.87 20.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.805 0.336 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.12 128.55 53.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 168.4 44.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.88 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.0 mp -63.49 97.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.757 0.313 . . . . 0.0 111.301 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.915 HG13 ' HD3' ' T' ' 72' ' ' LYS . 16.1 mm -70.8 80.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.464 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 3.4 t70 -105.12 123.17 47.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' T' ' 78' ' ' TYR . 2.2 m-85 -86.31 -3.16 58.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.967 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.57 169.69 40.32 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.745 HG22 ' H ' ' T' ' 82' ' ' LEU . 16.2 mt -60.67 127.83 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.786 0.327 . . . . 0.0 111.082 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.88 16.99 21.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.745 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.99 45.75 26.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.897 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.488 HD22 ' HG2' ' T' ' 86' ' ' GLU . 18.9 t30 -163.93 77.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.1 OUTLIER -69.89 -4.94 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 17.26 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.582 ' O ' HG22 ' T' ' 15' ' ' THR . 2.6 mm-40 -80.32 -171.81 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.599 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.645 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 2.7 ppt_? -137.53 111.75 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.094 0.473 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.65 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.2 m95 -153.71 -172.11 4.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.171 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.543 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.2 OUTLIER -82.54 -170.62 3.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -144.32 137.79 27.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.799 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 36.2 m-85 -103.45 121.14 42.21 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.523 ' O ' HG23 ' T' ' 2' ' ' VAL . 0.1 OUTLIER -96.13 154.17 17.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.014 0.435 . . . . 0.0 111.3 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.715 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 28.8 t80 -143.7 126.27 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.789 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.849 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 26.6 m-20 -149.56 134.04 9.16 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.525 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -50.28 -32.43 33.03 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.493 2.129 . . . . 0.0 111.705 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' T' ' 97' ' ' ALA . 37.1 t60 -116.3 -34.74 4.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.566 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.13 71.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.362 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.939 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.962 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -83.01 146.44 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' T' ' 3' ' ' TYR . 2.0 p90 -151.22 177.46 10.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.163 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.603 ' CG ' HG11 ' T' ' 46' ' ' VAL . 8.3 t-80 -112.86 160.74 17.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.154 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.503 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 6.0 tpp180 -158.89 159.81 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.8 -169.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.868 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -96.17 149.86 21.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.164 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -20.49 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.485 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 0.3 OUTLIER -95.72 -22.74 17.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.833 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 144.47 166.97 11.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.43 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.1 ttpm? -65.02 162.74 16.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.341 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.7 m-30 53.69 38.75 29.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.755 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 0.4 OUTLIER -134.54 4.9 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.876 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 7.7 mt -107.51 139.04 42.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.982 0.42 . . . . 0.0 111.427 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.8 p -109.86 149.12 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.011 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 79.4 t80 -34.48 -41.16 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.786 0.326 . . . . 0.0 110.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.39 -43.85 69.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.319 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.8 mt-10 -70.38 -46.78 63.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.126 0.488 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -49.7 -43.95 47.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.95 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -65.63 -54.45 27.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -50.01 -36.8 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 t -75.18 -54.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.524 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' T' ' 28' ' ' GLY . 58.8 m -64.19 -30.32 71.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 24.4 tt0 -92.59 -12.14 32.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.292 0.568 . . . . 0.0 110.104 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.4 t80 -54.33 -41.62 69.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.044 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -107.69 59.09 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.218 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.53 20.46 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.415 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -94.54 -174.3 38.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.465 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.92 136.26 14.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -48.14 137.17 10.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.475 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.54 166.94 22.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.134 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 47.0 p -117.99 -175.15 2.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 0.0 111.373 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.95 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 48.0 t80 -69.54 -68.99 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.955 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.2 mttp -45.89 -42.09 12.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.583 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.412 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.2 mt-30 -65.03 -51.04 63.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.512 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.758 HD12 ' HG3' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -60.17 -22.17 62.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.896 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.5 tt0 -73.98 -61.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.286 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.44 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.28 -13.45 7.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.826 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.598 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.2 -29.11 14.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.769 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.67 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 8.4 ttt-85 -72.73 -34.38 67.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.035 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 10.7 mtpt -69.67 -15.79 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.598 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.0 -19.16 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.741 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.48 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 137.11 11.77 1.02 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.103 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.67 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.65 115.74 20.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.954 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.566 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.4 t-160 -135.53 127.99 30.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.603 HG11 ' CG ' ' T' ' 4' ' ' HIS . 1.3 t -144.64 102.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.249 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.674 ' HA ' HD11 ' T' ' 61' ' ' ILE . 52.8 t -77.56 63.85 2.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.74 125.59 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.894 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.523 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -42.5 115.71 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.05 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.59 119.31 4.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.632 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.1 m95 -53.48 148.52 9.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.47 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.763 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -167.5 175.31 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.344 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.688 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.62 -165.99 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -2.17 4.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.441 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.9 14.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.868 ' HG3' HG13 ' T' ' 80' ' ' ILE . 6.8 mtt180 -88.41 125.94 34.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.88 117.81 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.96 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.73 -169.72 13.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.261 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -141.48 95.06 7.34 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 111.219 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.81 ' HB3' HD13 ' T' ' 75' ' ' ILE . 71.8 Cg_endo -81.58 131.25 7.26 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' T' ' 47' ' ' CYS . 15.2 mm -134.77 107.22 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.184 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.01 -45.7 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.465 ' H ' ' HG2' ' T' ' 63' ' ' LYS . 0.0 OUTLIER -118.59 94.27 47.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.65 140.73 90.96 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.571 2.181 . . . . 0.0 112.305 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.3 -135.3 5.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.436 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 73.2 Cg_endo -85.77 -80.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.855 2.37 . . . . 0.0 112.447 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -104.73 -16.3 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.783 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.36 -42.77 74.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.44 -22.48 8.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . 0.434 ' HB3' ' HG3' ' T' ' 72' ' ' LYS . 3.1 t80 61.06 22.5 12.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.59 14.58 75.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.703 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.914 ' HD3' HG13 ' T' ' 76' ' ' ILE . 27.5 mttm -83.58 150.83 25.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.97 129.08 48.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.47 -174.78 35.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.907 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.95 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.6 OUTLIER -79.88 95.75 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.884 0.373 . . . . 0.0 111.163 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.914 HG13 ' HD3' ' T' ' 72' ' ' LYS . 11.6 mm -68.18 83.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -110.38 122.05 46.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.53 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.0 OUTLIER -87.69 -5.94 58.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.072 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.715 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 91.22 169.11 41.99 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.868 HG13 ' HG3' ' T' ' 56' ' ' ARG . 6.7 mt -59.36 122.4 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -102.37 13.84 33.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.949 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.6 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 54.48 48.93 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.841 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.32 58.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.656 HH11 ' HB2' ' T' ' 84' ' ' ARG . 0.0 OUTLIER -60.39 -9.71 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.961 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -79.69 12.59 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.487 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.4 mm-40 -79.37 -178.68 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.688 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -134.85 116.36 14.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.585 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 20.8 m95 -150.18 -134.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.339 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.43 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.4 OUTLIER -115.83 -166.83 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.357 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -148.0 119.54 7.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.369 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 28.4 m-85 -87.63 103.8 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.498 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 87.6 m -82.26 151.84 26.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.877 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.962 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 1.2 t80 -148.91 125.75 11.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.769 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.893 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.7 m120 -137.03 162.03 58.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.679 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 15.7 Cg_endo -57.8 -52.9 5.15 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.621 2.214 . . . . 0.0 111.622 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.508 ' O ' ' C ' ' T' ' 97' ' ' ALA . 18.1 p80 -102.31 -29.46 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.531 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 23.83 66.02 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.425 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.831 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.7 p -92.5 143.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.805 0.336 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.47 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 21.0 p90 -143.21 178.41 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.818 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.855 ' CG ' HG11 ' T' ' 46' ' ' VAL . 46.9 t-80 -96.1 159.05 15.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.205 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.827 ' HG2' HG11 ' T' ' 22' ' ' VAL . 0.0 OUTLIER -151.31 151.4 31.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.031 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' T' ' 7' ' ' ALA . 28.0 tt0 -122.91 173.09 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.754 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.828 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -88.64 157.72 18.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.191 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.665 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 74.1 m -93.8 -24.82 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.38 166.86 10.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.55 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 17.4 ttpt -58.41 155.66 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 110.97 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.497 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 10.5 m-30 58.5 54.2 5.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.989 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -152.5 3.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.796 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.828 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.6 mt -104.32 134.9 46.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 28.0 p -105.56 150.93 24.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.77 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 78.8 t80 -34.86 -42.28 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.956 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -42.25 65.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.373 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' T' ' 15' ' ' THR . 67.5 mt-10 -69.72 -46.58 65.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.017 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.83 -42.12 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.738 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -68.0 -34.9 77.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.605 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.96 -36.37 83.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.972 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.827 HG11 ' HG2' ' T' ' 5' ' ' ARG . 3.0 t -69.16 -50.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.178 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -64.57 -54.31 34.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.029 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 44.0 tt0 -62.26 -19.26 63.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -54.06 -48.41 70.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.81 54.45 0.66 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.37 31.5 35.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.241 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -100.95 167.56 19.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.646 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.575 ' NE2' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -133.91 138.14 45.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.004 0.431 . . . . 0.0 111.412 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.672 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.87 139.17 22.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.5 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -81.17 166.27 20.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.438 ' OG1' ' HG3' ' T' ' 35' ' ' GLN . 38.9 p -120.82 -175.01 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.0 111.684 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.846 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 36.0 t80 -68.32 -70.34 0.27 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.781 ' HA ' ' HG3' ' T' ' 37' ' ' GLU . 3.0 mttp -46.69 -40.99 14.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.865 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 94.5 mt-30 -63.65 -47.13 82.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.743 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.631 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.4 OUTLIER -55.72 -30.81 61.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.384 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.781 ' HG3' ' HA ' ' T' ' 34' ' ' LYS . 0.0 OUTLIER -66.51 -60.86 2.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.451 0.643 . . . . 0.0 110.118 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.474 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -53.44 -18.52 2.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.913 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.569 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.17 -30.72 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.398 0.618 . . . . 0.0 109.678 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' T' ' 62' ' ' VAL . 0.1 OUTLIER -72.65 -32.95 66.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.044 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.4 mtmp? -69.69 -18.21 63.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.569 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.61 -10.95 10.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.941 0.401 . . . . 0.0 110.682 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.41 14.03 4.57 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.515 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.2 t80 -82.15 125.66 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.59 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.5 t-160 -147.61 126.1 12.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.855 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -145.66 101.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.222 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.891 ' HA ' HD11 ' T' ' 61' ' ' ILE . 4.4 t -72.15 78.99 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.62 116.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.594 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -38.61 117.73 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.072 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.27 122.73 5.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.692 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 79.5 m95 -53.99 146.56 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 111.551 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.672 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -164.64 178.41 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.471 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 51.04 -166.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.475 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.77 3.88 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.448 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.456 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 151.04 13.7 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.856 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.842 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 11.4 mtt180 -91.47 127.09 36.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.55 125.38 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.04 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.02 -175.67 14.16 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.467 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.594 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -134.7 103.68 11.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.815 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 38.3 Cg_exo -58.5 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.623 2.216 . . . . 0.0 112.199 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' T' ' 47' ' ' CYS . 30.0 mm 75.42 108.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.224 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.2 OUTLIER -81.23 -38.41 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -113.68 96.9 42.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.92 139.68 91.21 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.535 2.156 . . . . 0.0 112.243 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.54 -151.47 10.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.398 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.729 ' HG2' ' ND2' ' T' ' 67' ' ' ASN . 74.1 Cg_endo -87.79 -64.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.996 2.464 . . . . 0.0 111.982 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.729 ' ND2' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -104.72 -22.53 13.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.771 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -80.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.48 -6.04 83.47 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.926 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.12 27.69 17.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.019 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.35 12.49 63.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.677 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.989 ' HD3' HG13 ' T' ' 76' ' ' ILE . 21.6 mttp -81.72 159.5 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.761 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.25 130.5 52.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.47 176.21 49.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.846 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.0 mt -68.47 112.58 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 0.0 111.021 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.989 HG13 ' HD3' ' T' ' 72' ' ' LYS . 6.6 mm -87.23 88.7 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.117 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -112.87 112.89 24.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.556 ' CE1' HG22 ' T' ' 76' ' ' ILE . 3.2 m-85 -79.38 4.35 15.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.842 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 76.65 170.11 31.32 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.803 HG22 ' H ' ' T' ' 82' ' ' LEU . 11.9 mt -48.21 142.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 3.9 mmm-85 -108.26 16.09 23.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.803 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.75 35.37 21.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -169.07 86.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -70.42 -1.15 9.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -76.87 15.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.564 ' O ' HG22 ' T' ' 15' ' ' THR . 3.5 mm-40 -75.11 -173.57 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -138.22 113.7 9.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.962 0.41 . . . . 0.0 111.1 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.529 ' NE1' ' HB3' ' T' ' 86' ' ' GLU . 15.7 m95 -151.22 -137.79 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.507 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.55 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -116.01 -165.35 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.449 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.479 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -147.34 126.89 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.787 0.327 . . . . 0.0 111.559 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 29.9 m-85 -97.47 107.59 20.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.51 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.5 t -84.89 154.93 21.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.831 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 13.9 t80 -144.02 123.05 12.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.999 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.851 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 5.3 m120 -139.11 141.2 28.97 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.322 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.575 ' HD3' ' NE2' ' T' ' 29' ' ' HIS . 73.7 Cg_exo -49.22 -33.22 27.35 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.36 2.04 . . . . 0.0 111.87 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' T' ' 97' ' ' ALA . 81.7 t60 -119.6 -33.26 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.543 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 31.83 75.12 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.416 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.873 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' T' ' 94' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.771 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p -96.95 148.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.0 111.516 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.402 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 31.0 p90 -156.98 -176.52 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.71 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.8 t-80 -101.38 159.33 15.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.049 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 8.1 mmt180 -153.04 148.49 27.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.925 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.7 tt0 -116.4 173.34 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.859 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.43 156.07 20.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.149 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -20.7 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.444 ' HB3' ' NZ ' ' T' ' 13' ' ' LYS . 0.4 OUTLIER -93.88 -28.01 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.8 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' T' ' 13' ' ' LYS . . . 147.65 168.27 13.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.345 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.446 ' HE2' ' CE1' ' T' ' 12' ' ' TYR . 4.1 ttpm? -63.68 165.23 8.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.896 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 16.2 m-30 50.8 43.95 28.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 3.8 mttt -138.63 -2.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.859 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.4 mt -102.18 139.56 37.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.336 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.649 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 2.8 p -110.46 151.58 27.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.108 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.53 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 79.5 t80 -34.01 -42.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.99 68.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.223 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' T' ' 15' ' ' THR . 72.0 mt-10 -68.63 -45.27 72.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -52.93 -40.4 63.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.896 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' T' ' 24' ' ' GLU . 15.1 tttt -70.11 -34.89 73.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.715 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -64.53 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.53 -50.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.21 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -64.68 -53.26 50.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.362 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 2.4 tt0 -63.8 -21.07 66.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.413 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.4 OUTLIER -51.38 -49.81 60.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.844 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -106.03 53.47 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.58 42.23 43.66 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.231 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -115.07 165.86 12.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.728 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' CE1' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -129.46 139.45 51.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.891 0.377 . . . . 0.0 111.312 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -48.45 149.31 1.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.983 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -90.7 149.28 22.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.401 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 62.8 p -105.93 -175.57 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.915 0.388 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.944 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 51.8 t80 -67.29 -68.57 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.042 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -48.29 -42.86 32.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.947 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -64.12 -50.19 69.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 110.699 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.809 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -60.45 -31.69 70.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.336 0.588 . . . . 0.0 109.646 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' HG2' ' HE2' ' T' ' 41' ' ' LYS . 8.8 tt0 -65.28 -58.39 6.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.236 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.4 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -52.14 -23.91 6.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.786 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.648 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -87.51 -30.53 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.516 0.674 . . . . 0.0 109.78 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.771 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.4 OUTLIER -70.45 -33.71 71.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.093 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.489 ' HE2' ' HG2' ' T' ' 37' ' ' GLU . 11.4 mttm -67.48 -19.22 65.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.197 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.648 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.1 -21.83 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.567 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 139.7 15.19 0.56 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.211 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.771 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.6 OUTLIER -70.75 137.64 49.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.737 0.303 . . . . 0.0 110.683 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' T' ' 62' ' ' VAL . 3.2 t-160 -161.09 124.45 3.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.98 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.71 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -146.67 103.96 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.846 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -72.48 72.79 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.442 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -178.72 139.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.774 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -56.28 116.64 3.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.886 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -113.39 121.39 5.48 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.725 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 77.0 m95 -55.16 144.44 24.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.503 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 0.0 OUTLIER -163.26 176.06 10.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.664 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' T' ' 56' ' ' ARG . . . 51.95 -165.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.584 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -6.41 9.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.563 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.11 16.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.954 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.7 ptp180 -93.69 130.36 39.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.39 . . . . 0.0 110.712 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.495 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.01 121.26 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.967 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.21 -169.07 13.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.289 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.691 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -143.77 93.02 6.28 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.128 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.795 ' HB3' HD13 ' T' ' 75' ' ' ILE . 73.5 Cg_endo -80.93 130.54 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.739 2.293 . . . . 0.0 112.259 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.846 HD11 ' HA ' ' T' ' 47' ' ' CYS . 22.6 mm -142.98 107.9 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.7 m -67.75 -39.72 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.913 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.57 95.02 11.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.835 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' T' ' 62' ' ' VAL . 54.1 Cg_exo -50.04 104.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.576 2.184 . . . . 0.0 112.523 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.57 161.43 52.65 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.226 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.06 -49.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.848 2.365 . . . . 0.0 111.804 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 -16.83 16.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.418 ' HB3' ' H ' ' T' ' 69' ' ' GLY . 0.7 OUTLIER -83.99 -89.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.126 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' T' ' 68' ' ' CYS . . . -75.11 0.25 59.35 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.05 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 66.45 -2.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.12 29.31 4.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.779 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.508 ' HB3' HD11 ' T' ' 76' ' ' ILE . 15.9 mmtm -81.28 153.74 26.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.874 0.369 . . . . 0.0 110.959 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 131.06 53.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.174 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.34 179.36 52.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.966 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -74.85 98.04 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.05 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.691 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 8.8 mm -70.21 85.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.94 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.584 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.5 m-85 -111.6 22.05 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.38 170.86 7.5 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.749 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.2 mt -53.94 152.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.433 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' T' ' 81' ' ' ARG . 4.1 mmm180 -130.63 16.24 5.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.749 ' H ' HG22 ' T' ' 80' ' ' ILE . 4.3 mm? 56.28 27.26 11.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.89 57.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.576 ' O ' ' HB ' ' T' ' 15' ' ' THR . 11.4 mtm180 -66.45 -1.67 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 9.6 t -97.47 6.19 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.59 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.9 mm-40 -68.21 -176.47 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -134.33 113.35 11.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.438 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.711 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 12.7 m95 -152.87 -155.99 0.66 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.204 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.442 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -96.12 -169.76 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.227 179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.453 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -143.9 121.87 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.808 0.337 . . . . 0.0 111.437 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.809 ' CD1' HD21 ' T' ' 36' ' ' LEU . 34.4 m-85 -90.26 107.47 19.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.496 ' O ' HG23 ' T' ' 2' ' ' VAL . 8.0 m -82.29 164.58 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.337 . . . . 0.0 111.023 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.771 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 7.9 t80 -153.04 118.1 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.825 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.8 m-20 -134.85 142.08 40.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.437 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 53.3 Cg_exo -51.25 -33.91 46.95 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.488 2.125 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' T' ' 97' ' ' ALA . 30.5 m80 -117.81 -35.3 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.532 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 33.77 70.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.902 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.876 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 0.5 OUTLIER -78.97 143.72 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 0.0 111.101 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -145.5 -179.97 7.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.774 ' CG ' HG11 ' T' ' 46' ' ' VAL . 9.1 t-80 -112.31 161.91 16.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.517 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 10.9 mmt180 -155.9 161.53 40.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.672 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -126.29 -174.31 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.892 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.615 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -86.36 153.61 21.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.099 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' T' ' 8' ' ' ARG . 0.0 OUTLIER -58.77 -20.77 52.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.806 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -27.58 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.44 167.74 12.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.519 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.574 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 1.6 ttpt -55.37 153.52 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.101 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.2 m-30 55.37 69.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.1 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -158.74 -7.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.692 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.778 HD11 ' C ' ' T' ' 89' ' ' ASP . 1.1 pp -111.94 161.62 16.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.106 0.479 . . . . 0.0 111.27 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.804 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 3.4 p -114.58 -166.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.342 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.1 t80 -67.5 -41.39 84.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.34 -38.63 74.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.541 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.804 ' HB2' ' H ' ' T' ' 15' ' ' THR . 53.7 mt-10 -71.76 -43.3 66.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.194 0.521 . . . . 0.0 110.182 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.403 ' HA ' HD13 ' T' ' 14' ' ' LEU . . . -54.03 -41.78 68.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.986 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -55.93 10.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.118 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.5 -36.65 3.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.285 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 13.9 t -73.54 -56.04 10.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.437 ' O ' ' CA ' ' T' ' 28' ' ' GLY . 82.9 m -65.03 -31.41 72.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 18.5 tt0 -88.21 -12.72 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 109.614 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.2 t80 -57.31 -39.5 75.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.86 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -113.4 56.64 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.163 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.63 34.75 28.74 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.584 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.96 171.1 14.23 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.427 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.61 ' CE1' ' HD3' ' T' ' 95' ' ' PRO . 0.0 OUTLIER -135.18 143.56 46.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.284 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.818 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.3 OUTLIER -52.74 136.52 33.33 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.292 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -77.87 153.51 32.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 35.4 p -106.5 -172.29 2.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 111.673 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.928 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 65.3 t80 -71.63 -67.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.07 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -46.56 -40.89 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.413 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 93.9 mt-30 -64.75 -49.38 71.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.668 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -59.19 -23.66 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.071 0.462 . . . . 0.0 110.118 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 2.9 tp10 -74.04 -62.08 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.98 -13.73 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.995 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -95.06 -29.99 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.362 0.601 . . . . 0.0 109.671 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.827 ' HG2' HG23 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -71.6 -33.04 68.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.954 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.5 OUTLIER -69.76 -16.67 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.374 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.609 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.05 -14.98 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.599 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.416 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 126.21 17.58 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.988 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.615 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.8 OUTLIER -80.15 112.63 17.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 111.006 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.887 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.3 t-160 -135.13 124.11 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.2 OUTLIER -143.71 89.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.511 ' HA ' ' CD1' ' T' ' 61' ' ' ILE . 13.9 t -63.87 85.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.581 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . 172.57 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.871 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -38.29 113.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.656 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.84 126.39 7.64 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.563 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 75.0 m95 -58.03 149.73 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.92 0.39 . . . . 0.0 111.426 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.818 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -169.44 179.27 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.591 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.08 -166.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.437 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -7.22 5.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.382 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 157.58 20.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.624 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.807 ' HG3' HG13 ' T' ' 80' ' ' ILE . 3.1 mtm180 -94.68 130.61 41.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.908 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.449 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -120.8 121.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.8 -173.75 13.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.443 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.635 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -132.63 101.82 14.11 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.865 0.364 . . . . 0.0 110.77 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.9 Cg_endo -61.01 -81.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.804 2.336 . . . . 0.0 112.517 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' T' ' 47' ' ' CYS . 8.2 mm 75.04 106.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.887 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 0.5 OUTLIER -77.41 -32.47 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.53 ' H ' ' CE1' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -122.36 97.34 45.19 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.847 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.37 101.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.93 -168.21 34.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.322 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.49 -89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.613 2.209 . . . . 0.0 112.297 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -13.88 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.11 52.06 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 160.76 -25.34 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.997 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 t80 49.08 33.43 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.46 40.99 98.43 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.708 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.636 ' HB3' HD11 ' T' ' 76' ' ' ILE . 33.5 mttt -103.69 150.13 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.62 130.1 52.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.209 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.82 167.56 43.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.011 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.928 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 3.2 mp -64.1 100.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.387 . . . . 0.0 111.42 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' T' ' 72' ' ' LYS . 10.7 mm -69.68 87.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.133 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -108.45 120.12 41.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.531 ' CE1' HG22 ' T' ' 76' ' ' ILE . 12.9 m-85 -91.06 -11.33 39.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 103.66 173.76 25.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.807 HG13 ' HG3' ' T' ' 56' ' ' ARG . 19.4 mt -61.41 122.71 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -91.71 9.54 32.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.764 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 59.58 38.81 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.4 OUTLIER -145.13 75.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.43 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.7 mpt_? -74.61 16.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.927 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.447 ' H ' ' C ' ' T' ' 83' ' ' ASN . 5.5 m -114.33 6.75 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.789 ' O ' HG22 ' T' ' 15' ' ' THR . 2.9 mm-40 -63.67 -171.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.73 113.61 11.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.685 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 7.8 m95 -153.55 -147.38 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.778 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.5 OUTLIER -106.78 -171.23 1.85 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.36 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' T' ' 14' ' ' LEU . . . -141.3 121.53 13.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.644 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.668 ' CD1' HD21 ' T' ' 36' ' ' LEU . 23.4 m-85 -90.59 110.37 21.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.443 ' O ' HG23 ' T' ' 2' ' ' VAL . 86.4 m -86.47 167.97 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.188 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.876 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 2.5 t80 -158.46 124.34 4.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.742 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.8 m120 -139.73 143.58 35.55 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.552 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 76.7 Cg_exo -49.18 -33.41 27.6 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.52 2.147 . . . . 0.0 112.035 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -125.13 -30.55 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.638 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 37.67 75.74 0.06 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.956 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' T' ' 97' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.775 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 2.3 p -97.82 139.68 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 111.202 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.538 ' HE1' ' HB1' ' T' ' 97' ' ' ALA . 25.5 p90 -147.93 178.35 8.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.999 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.409 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 0.7 OUTLIER -92.07 155.56 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' T' ' 5' ' ' ARG . 2.6 tpp85 -149.02 153.88 38.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.612 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.1 tt0 -125.77 173.91 8.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.594 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -82.65 151.68 26.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.253 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -62.33 -18.29 61.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.693 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 17.0 m -98.84 -27.74 13.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.857 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.654 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 151.09 167.51 14.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.43 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.508 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 14.3 tttt -60.23 153.89 21.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 8.8 m-30 57.37 49.61 12.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.693 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 4.2 mttm -142.28 1.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.546 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.693 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 9.4 mt -105.82 134.14 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.258 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.668 ' OG1' ' HG3' ' T' ' 18' ' ' GLU . 1.4 p -104.0 151.62 22.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.138 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.536 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.8 t80 -34.25 -44.38 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.847 0.356 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.99 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.668 ' HG3' ' OG1' ' T' ' 15' ' ' THR . 15.0 mt-10 -66.38 -54.9 19.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.274 0.559 . . . . 0.0 109.842 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -43.51 -43.51 5.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.946 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -67.17 -37.75 84.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -62.69 -34.58 77.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.5 t -69.64 -53.2 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.285 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -64.31 -52.61 57.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.2 tt0 -62.52 -21.05 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.38 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -52.2 -48.86 64.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.694 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -106.0 52.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.42 38.1 56.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.235 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -110.84 169.82 13.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.763 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.559 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -135.61 140.01 44.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.952 0.405 . . . . 0.0 111.236 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.891 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.4 OUTLIER -51.03 139.02 18.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.376 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -83.81 152.23 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 37.7 p -107.54 -171.38 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.098 0.475 . . . . 0.0 111.557 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.762 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 55.3 t80 -70.85 -67.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.029 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 0.1 OUTLIER -46.79 -40.55 13.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.564 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.16 -54.24 27.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.95 0.405 . . . . 0.0 110.279 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -58.63 -19.86 42.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.774 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 2.5 tp10 -72.34 -62.19 1.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.16 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.445 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -57.82 -15.66 9.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.757 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.573 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.22 -29.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.463 0.649 . . . . 0.0 109.753 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.748 ' HG3' HG22 ' T' ' 62' ' ' VAL . 9.8 ttt-85 -73.03 -33.47 65.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.187 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.545 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 45.5 mttt -70.17 -18.74 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.427 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.573 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -86.34 -17.27 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.22 15.1 1.9 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.021 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.49 94.65 7.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 110.979 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.48 ' HD2' ' N ' ' T' ' 46' ' ' VAL . 2.7 t-160 -115.17 125.99 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.594 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.745 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.1 OUTLIER -147.89 100.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.645 ' HA ' HD11 ' T' ' 61' ' ' ILE . 40.5 t -75.79 65.83 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.6 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -161.91 118.61 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -39.87 121.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -123.39 121.24 4.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.731 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.536 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 84.1 m95 -54.18 162.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.798 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.891 ' HA ' HD22 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -155.63 174.39 15.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.392 179.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -53.53 160.46 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.286 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mtpp 78.66 -30.66 0.15 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.508 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 112.44 23.93 5.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.531 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.706 ' HG3' HG13 ' T' ' 80' ' ' ILE . 19.1 mtt180 -100.18 160.22 14.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.932 0.396 . . . . 0.0 110.809 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -149.1 107.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -108.82 -167.65 20.79 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.291 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.567 ' HD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -137.44 85.07 21.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.125 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.822 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 23.1 Cg_exo -62.76 129.04 24.9 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.887 2.391 . . . . 0.0 112.238 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.645 HD11 ' HA ' ' T' ' 47' ' ' CYS . 8.5 mm -141.39 116.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.232 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' T' ' 40' ' ' ARG . 0.2 OUTLIER -90.07 -16.03 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 2.8 tttp -140.99 93.9 8.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.537 ' HB2' ' HA2' ' T' ' 71' ' ' GLY . 17.8 Cg_endo -61.31 129.44 28.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.643 2.229 . . . . 0.0 112.401 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.65 -145.7 10.52 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.424 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.7 -81.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.747 2.298 . . . . 0.0 112.317 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.18 -26.02 11.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.59 -45.0 94.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.797 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.92 -25.38 14.87 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.867 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 58.81 26.03 14.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' T' ' 64' ' ' PRO . . . 64.06 16.8 60.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.549 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.452 ' HB3' HD11 ' T' ' 76' ' ' ILE . 4.0 mmmt -76.16 164.63 25.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.843 0.354 . . . . 0.0 110.901 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 130.69 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . 0.407 ' HA2' ' NE ' ' T' ' 40' ' ' ARG . . . 71.34 -168.21 51.09 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.822 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 12.7 mt -76.06 124.52 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.897 0.379 . . . . 0.0 111.212 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' T' ' 59' ' ' TYR . 5.8 mm -93.29 81.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.8 120.99 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.47 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.5 m-85 -86.33 -74.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.41 169.79 36.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.232 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.706 HG13 ' HG3' ' T' ' 56' ' ' ARG . 51.8 mt -57.7 108.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.041 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 81' ' ' ARG . 7.4 mmt85 -87.09 15.46 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.545 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 53.77 27.95 7.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.897 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.402 ' HA ' HD22 ' T' ' 83' ' ' ASN . 0.5 OUTLIER -121.97 62.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.994 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' T' ' 15' ' ' THR . 3.2 mpt_? -69.99 -0.92 8.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.81 3.24 47.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.674 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.586 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.6 mm-40 -64.79 -170.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.672 ' HD3' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -135.79 112.44 10.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.123 0.487 . . . . 0.0 111.648 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 5.2 m95 -155.44 -177.13 6.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.837 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.3 OUTLIER -77.65 -173.24 2.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.253 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.511 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -140.38 133.56 29.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 42.1 m-85 -97.82 117.04 31.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.428 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.446 ' O ' HG23 ' T' ' 2' ' ' VAL . 4.7 t -92.68 154.29 18.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.0 110.836 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 8.1 t80 -149.41 114.05 5.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 1.021 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 2.0 m-20 -129.72 166.57 25.04 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.764 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.745 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 57.0 Cg_endo -73.31 -53.59 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.627 2.218 . . . . 0.0 111.595 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -100.94 25.97 7.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 1.021 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . -72.47 51.1 0.25 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.271 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.91 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.5 p -79.53 148.27 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 111.315 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.604 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 26.7 p90 -162.17 173.5 14.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 111.705 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.645 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.7 t60 -93.27 150.43 20.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' T' ' 6' ' ' GLU . 4.2 tpp85 -152.25 154.83 36.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.94 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' T' ' 5' ' ' ARG . 0.9 OUTLIER -116.13 -169.07 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' T' ' 10' ' ' GLY . . . -90.64 152.3 20.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.405 HH22 HH12 ' T' ' 5' ' ' ARG . 3.6 mmp_? -52.86 -24.35 8.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.726 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -93.27 -47.74 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 174.75 177.98 44.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.432 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 0.3 OUTLIER -65.42 146.75 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.852 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.544 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 7.9 m-30 63.67 61.83 0.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.053 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -155.89 6.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.0 mt -109.03 138.69 44.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 2.4 p -107.67 148.05 29.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 83.0 t80 -34.99 -39.53 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.807 0.337 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.93 61.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.373 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.583 ' OE1' HG23 ' T' ' 15' ' ' THR . 77.8 mt-10 -71.36 -46.3 60.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.226 0.536 . . . . 0.0 110.147 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.576 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -57.39 -37.11 72.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -75.56 -32.21 60.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.023 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -67.5 -45.64 75.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.361 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 2.9 t -66.83 -50.31 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.306 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 56.6 m -64.44 -45.25 88.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 11.7 tt0 -78.57 -6.94 56.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.7 OUTLIER -59.07 -50.76 72.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.842 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -98.55 58.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.175 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.54 34.08 13.32 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.458 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.46 -172.42 18.2 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -151.2 134.17 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.716 0.258 . . . . 0.0 110.472 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -67.08 124.34 22.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -52.42 165.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.74 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 13.0 p -115.73 -158.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 34.2 t80 -80.41 -71.64 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.978 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 23.9 mttt -47.42 -37.35 11.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.79 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -67.21 -54.96 16.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.261 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -56.92 -21.14 27.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.754 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 2.1 tp10 -69.82 -62.04 1.54 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.268 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.646 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -55.54 -19.87 11.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.787 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -91.29 -29.11 17.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 109.613 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.634 ' HE ' HG13 ' T' ' 62' ' ' VAL . 4.2 ttt180 -70.61 -34.31 71.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.001 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 27.2 mtmt -73.52 -17.49 61.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.219 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.646 HG23 ' O ' ' T' ' 38' ' ' ALA . 1.2 pt -88.35 -6.94 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.73 5.9 8.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.25 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.556 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 1.0 OUTLIER -76.0 117.36 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.658 ' HB2' HG23 ' T' ' 62' ' ' VAL . 3.4 t-160 -140.14 125.82 19.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -153.21 101.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.959 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.67 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.8 OUTLIER -72.09 85.75 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.335 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.42 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -177.38 115.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.785 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -39.21 108.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.124 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.774 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -107.84 122.48 6.78 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.668 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.623 ' HA ' ' HB ' ' T' ' 57' ' ' VAL . 71.2 m95 -52.68 171.56 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.701 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -166.58 162.13 16.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.512 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -45.17 159.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.631 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.8 -24.79 0.21 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.425 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.39 22.82 6.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.504 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.661 ' HG3' HG13 ' T' ' 80' ' ' ILE . 37.6 mtm180 -94.91 165.82 12.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -163.12 108.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -116.64 -171.01 15.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.224 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.545 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -123.89 82.72 55.3 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.952 0.406 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 28.1 Cg_exo -59.89 119.98 7.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.765 2.31 . . . . 0.0 112.3 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' T' ' 47' ' ' CYS . 14.5 mm -138.9 132.56 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.658 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -110.09 -29.05 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -123.76 83.76 54.2 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.763 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.62 ' HA ' ' HA3' ' T' ' 69' ' ' GLY . 20.8 Cg_endo -62.63 137.52 64.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.597 2.198 . . . . 0.0 112.191 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.69 -130.89 2.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.442 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.61 -80.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.278 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' T' ' 67' ' ' ASN . 0.0 OUTLIER -109.22 -23.5 11.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.19 44.93 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' T' ' 64' ' ' PRO . . . 169.7 -44.13 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.943 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . 0.408 ' HB2' ' HD2' ' T' ' 72' ' ' LYS . 23.9 m-85 58.88 29.76 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' T' ' 64' ' ' PRO . . . 66.81 25.1 73.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.463 ' HD3' HG13 ' T' ' 76' ' ' ILE . 11.8 mttp -91.12 152.5 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.21 130.47 53.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' T' ' 40' ' ' ARG . . . 72.73 -175.09 44.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.799 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.631 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 5.4 mt -73.38 117.46 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.5 mm -88.98 81.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.525 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 5.3 t70 -110.13 135.17 51.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.77 25.28 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.1 -178.49 26.2 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.862 HG22 ' H ' ' T' ' 82' ' ' LEU . 50.8 mt -61.85 119.83 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.71 6.92 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.862 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 58.54 33.09 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.82 78.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.688 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtt85 -62.86 -8.62 7.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 17.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.509 ' O ' HG22 ' T' ' 15' ' ' THR . 1.7 mm-40 -79.46 -176.21 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.684 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' T' ' 87' ' ' ARG . 0.0 OUTLIER -134.85 115.8 14.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.054 0.454 . . . . 0.0 111.274 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.512 ' HB3' ' O ' ' T' ' 49' ' ' ALA . 28.4 m95 -150.7 -135.05 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.083 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.42 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.8 OUTLIER -118.14 -171.83 2.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.35 179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.576 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.79 130.16 17.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.058 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.774 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.13 109.63 22.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.312 . . . . 0.0 110.253 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.8 131.78 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.114 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.91 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 0.1 OUTLIER -131.04 113.98 14.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.745 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.2 m-20 -131.82 158.75 74.57 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.541 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' T' ' 94' ' ' ASN . 11.1 Cg_endo -54.92 -51.41 10.37 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.574 2.183 . . . . 0.0 111.493 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.484 ' O ' ' C ' ' T' ' 97' ' ' ALA . 10.4 t-160 -104.55 -27.74 11.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 27.54 70.9 0.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.438 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.816 HG22 ' CD2' ' T' ' 93' ' ' TYR . 1.6 t -111.35 138.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.227 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.3 OUTLIER -147.74 160.26 42.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.085 0.469 . . . . 0.0 111.271 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.779 ' CG ' HG11 ' T' ' 46' ' ' VAL . 10.1 t-80 -106.13 158.57 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.099 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.458 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -164.26 166.0 21.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.041 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.825 ' HG2' ' HA ' ' T' ' 11' ' ' LYS . 0.0 OUTLIER -123.18 -167.44 1.6 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.971 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -170.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.19 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.93 -34.15 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 19.1 t -177.29 19.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.27 160.74 23.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.825 ' HA ' ' HG2' ' T' ' 6' ' ' GLU . 1.2 tttt -98.43 158.47 15.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 111.503 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.695 ' HD1' ' HA ' ' T' ' 88' ' ' TRP . 23.7 m-85 42.46 60.2 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.494 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' T' ' 12' ' ' TYR . 1.7 mmtm -149.7 10.1 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.481 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.43 HD11 ' C ' ' T' ' 6' ' ' GLU . 17.8 mt -106.29 125.24 50.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.571 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.591 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.0 OUTLIER -99.57 145.42 27.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.008 178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 77.6 t80 -33.56 -41.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.98 70.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.567 ' OE1' HG23 ' T' ' 15' ' ' THR . 83.8 mt-10 -72.96 -52.2 15.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.006 0.432 . . . . 0.0 110.195 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -45.82 -49.59 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.926 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -65.78 -56.99 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.0 -42.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.425 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.0 t -68.23 -50.37 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.423 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.4 m -63.71 -48.17 78.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 16.9 tt0 -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.736 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.8 OUTLIER -55.72 -51.77 66.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.899 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.28 58.24 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.152 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.8 27.54 9.75 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.525 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -107.88 -169.9 21.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.514 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -154.81 133.3 11.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.444 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -64.02 123.52 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 110.381 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -50.98 162.77 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.348 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.652 ' HA ' ' H ' ' T' ' 53' ' ' ALA . 23.8 p -108.5 -164.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.754 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 20.5 t80 -75.02 -73.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.167 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mttt -48.06 -37.68 15.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -67.12 -55.11 15.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.56 HD11 ' HG3' ' T' ' 60' ' ' PRO . 1.7 tm? -58.07 -22.77 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.8 tt0 -70.18 -61.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.241 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -13.52 10.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.709 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' T' ' 44' ' ' PHE . . . -93.88 -28.5 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.484 0.659 . . . . 0.0 109.731 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 5.6 tmm_? -69.7 -32.7 71.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.863 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 1.5 mttm -68.67 -15.22 63.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -93.47 -17.28 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 135.72 12.17 1.21 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.866 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.3 OUTLIER -79.49 100.74 7.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.53 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.1 t-160 -129.69 131.28 46.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.168 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.82 98.1 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.148 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.811 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.5 OUTLIER -64.7 81.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 174.45 137.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.8 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' T' ' 88' ' ' TRP . . . -54.67 105.33 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.781 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.625 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -102.98 116.77 5.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.661 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 76.3 m95 -48.22 155.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.35 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.793 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -171.77 -179.61 2.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.593 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 49.93 -165.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.115 0.483 . . . . 0.0 111.488 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.52 0.35 4.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.471 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.509 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 155.48 14.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.672 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.7 ' HB2' ' HB3' ' T' ' 53' ' ' ALA . 5.3 mtp180 -93.37 135.98 34.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.881 0.372 . . . . 0.0 110.996 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -124.38 134.22 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.765 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.13 -174.61 17.53 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.466 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.508 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -131.11 102.39 15.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 18.8 Cg_endo -61.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.292 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.811 HD11 ' HA ' ' T' ' 47' ' ' CYS . 25.9 mm 74.06 105.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.636 HG22 ' HG2' ' T' ' 40' ' ' ARG . 0.2 OUTLIER -81.68 -29.77 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.01 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -116.97 85.19 17.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.15 154.62 32.94 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.653 2.236 . . . . 0.0 112.274 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.48 -139.72 3.08 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.405 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.479 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 71.1 Cg_endo -79.85 -74.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.666 2.244 . . . . 0.0 112.416 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.479 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.1 OUTLIER -103.72 -11.77 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.9 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 42.76 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' T' ' 72' ' ' LYS . . . 144.57 -9.93 1.9 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.922 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 t80 60.6 28.69 18.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 111.001 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.16 15.72 70.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.793 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.888 ' HD3' HG13 ' T' ' 76' ' ' ILE . 14.4 mttp -82.85 158.05 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.62 132.38 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.262 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.12 172.62 47.22 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.913 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.771 ' HA ' ' HA ' ' T' ' 60' ' ' PRO . 1.6 mt -67.34 104.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.888 HG13 ' HD3' ' T' ' 72' ' ' LYS . 9.5 mm -80.16 85.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.23 132.3 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' T' ' 76' ' ' ILE . 2.4 m-85 -98.01 4.58 49.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.693 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 81.04 173.52 47.69 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.645 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.7 mt -59.38 115.8 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.814 0.34 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -87.97 21.31 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.645 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.78 36.89 25.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.791 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.68 67.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.591 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.9 OUTLIER -65.41 -4.59 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 5.7 t -91.52 12.82 19.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.544 ' O ' HG22 ' T' ' 15' ' ' THR . 2.3 mm-40 -68.56 -175.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.724 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' T' ' 13' ' ' LYS . 8.3 mtt180 -135.46 115.05 12.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.695 ' HA ' ' HD1' ' T' ' 12' ' ' TYR . 21.0 m95 -151.89 -132.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.234 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.545 ' HB3' ' OE1' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -121.04 -172.88 2.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.329 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.732 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -145.3 135.13 23.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.193 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' T' ' 30' ' ' LEU . 41.1 m-85 -97.91 107.52 20.02 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.066 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.432 ' HB3' ' CE2' ' T' ' 3' ' ' TYR . 5.2 m -87.31 137.23 32.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.919 0.39 . . . . 0.0 111.077 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.816 ' CD2' HG22 ' T' ' 2' ' ' VAL . 1.3 t80 -140.91 135.51 31.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.73 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.426 ' H ' ' HB2' ' T' ' 97' ' ' ALA . 5.9 m-20 -132.74 153.42 81.06 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.8 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.93 -32.8 13.28 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.485 2.123 . . . . 0.0 111.803 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' T' ' 97' ' ' ALA . 7.9 m-70 -121.35 -32.06 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.315 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' T' ' 96' ' ' HIS . . . 31.92 62.5 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.373 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 41.2 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.87 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.947 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.5 p -90.69 138.72 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.786 0.327 . . . . 0.0 111.239 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.598 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 25.5 p90 -155.39 170.34 22.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 111.638 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' T' ' 46' ' ' VAL . 4.2 t60 -90.97 153.71 19.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.962 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.454 ' N ' ' CD2' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -155.78 148.32 23.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.012 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.08 -168.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -99.49 153.54 18.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.21 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' T' ' 8' ' ' ARG . 4.0 mmt180 -61.13 -19.35 61.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -94.46 -24.53 17.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.69 167.41 11.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.555 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 8.3 ttpt -60.07 158.85 10.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.444 ' HA ' ' CA ' ' T' ' 88' ' ' TRP . 8.6 m-30 53.45 61.56 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.102 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -156.33 2.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.687 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.697 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 6.5 mt -105.21 127.58 52.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.556 HG22 ' O ' ' T' ' 86' ' ' GLU . 1.1 p -99.49 149.94 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.61 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 92.0 t80 -36.18 -41.04 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.846 0.355 . . . . 0.0 111.002 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -42.95 69.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' T' ' 15' ' ' THR . 85.1 mt-10 -74.15 -53.9 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.999 0.428 . . . . 0.0 110.301 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' T' ' 90' ' ' ALA . . . -44.96 -51.49 9.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.99 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -63.92 -55.7 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.644 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -41.48 -39.03 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 3.4 t -68.23 -51.73 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.219 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.25 -50.61 67.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.474 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 31.3 tt0 -67.07 -16.48 64.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.429 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.03 -47.87 77.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.754 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.19 53.89 0.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.53 41.78 42.37 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.426 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -121.95 168.22 14.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.432 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -129.22 137.49 51.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.773 0.321 . . . . 0.0 110.622 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.1 OUTLIER -73.81 122.0 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' T' ' 2' ' ' VAL . . . -49.76 158.79 0.44 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.43 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 11.5 p -110.69 -159.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.29 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.844 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 25.7 t80 -77.02 -72.97 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.052 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 1.9 mttp -46.92 -37.23 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.556 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.45 -51.77 57.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.47 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.626 HD12 ' HG2' ' T' ' 60' ' ' PRO . 0.2 OUTLIER -56.66 -23.89 44.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.097 0.475 . . . . 0.0 110.058 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 8.4 tt0 -72.15 -61.94 1.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.473 ' HA ' ' HE3' ' T' ' 41' ' ' LYS . . . -56.02 -16.23 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.936 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.574 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.7 -29.64 15.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.396 0.617 . . . . 0.0 109.718 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -72.17 -33.1 67.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.925 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.8 OUTLIER -69.66 -16.98 63.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.574 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -89.61 -12.63 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.93 13.01 3.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.973 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.531 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 1.0 OUTLIER -79.9 126.48 31.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.889 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.59 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.8 t-160 -150.21 126.39 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -151.5 102.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.048 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.95 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.94 86.5 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.332 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 177.31 119.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.004 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.01 118.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.752 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -115.39 123.14 5.83 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.803 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.61 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 67.6 m95 -53.03 171.73 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.107 0.479 . . . . 0.0 111.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.583 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.4 ptp -168.9 173.11 7.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.49 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.33 159.6 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.652 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' T' ' 80' ' ' ILE . 1.5 mmtp 67.23 16.28 10.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.254 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 64.07 33.28 86.82 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.515 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.667 ' HD3' ' HA2' ' T' ' 79' ' ' GLY . 4.7 mtt180 -101.12 157.35 16.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.804 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.4 OUTLIER -154.09 115.19 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.126 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -127.97 -168.44 12.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.3 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -135.58 103.24 10.27 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 111.04 -179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.749 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 24.6 Cg_exo -61.01 -93.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.706 2.27 . . . . 0.0 112.017 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' T' ' 47' ' ' CYS . 40.0 mm 75.24 110.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.1 OUTLIER -82.23 -38.18 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.9 OUTLIER -110.87 106.58 57.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.728 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.543 ' HB2' ' HA2' ' T' ' 71' ' ' GLY . 20.3 Cg_endo -62.5 123.21 12.0 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.618 2.212 . . . . 0.0 112.282 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.78 -174.0 13.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.369 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.85 -60.16 0.1 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.603 2.202 . . . . 0.0 112.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -3.18 13.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.25 38.31 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.47 -24.37 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.98 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 61.11 24.32 14.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' T' ' 64' ' ' PRO . . . 65.89 15.51 62.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.614 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.912 ' HD3' HG13 ' T' ' 76' ' ' ILE . 3.7 mttp -88.77 151.91 22.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.83 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.85 128.55 54.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.47 175.96 41.73 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.938 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.844 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -75.04 95.44 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 111.01 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.912 HG13 ' HD3' ' T' ' 72' ' ' LYS . 18.9 mm -68.06 81.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -108.1 120.42 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.805 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.497 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.9 m-85 -84.83 13.99 5.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HD3' ' T' ' 56' ' ' ARG . . . 72.86 179.17 35.61 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.179 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.697 HG22 ' H ' ' T' ' 82' ' ' LEU . 40.6 mt -62.05 119.81 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -95.85 14.26 23.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.697 ' H ' HG22 ' T' ' 80' ' ' ILE . 2.9 mm? 53.73 34.32 18.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.44 ' HB3' ' CG ' ' T' ' 86' ' ' GLU . 0.5 OUTLIER -137.65 67.13 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.989 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -63.94 -3.18 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.03 8.17 43.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.087 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.556 ' O ' HG22 ' T' ' 15' ' ' THR . 1.8 mm-40 -60.59 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.1 113.05 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 111.305 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.47 ' CD1' HG21 ' T' ' 57' ' ' VAL . 27.9 m95 -151.62 -133.52 0.05 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.963 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.555 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -121.91 -170.84 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' T' ' 19' ' ' ALA . . . -146.86 130.69 17.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.752 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 41.8 m-85 -98.82 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.316 . . . . 0.0 110.457 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.406 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 1.2 m -83.8 130.24 34.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.049 0.452 . . . . 0.0 110.952 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.947 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.3 OUTLIER -130.44 121.55 26.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.925 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.714 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 6.6 m-20 -128.86 150.06 74.03 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.478 ' HD3' ' CE1' ' T' ' 29' ' ' HIS . 72.3 Cg_exo -47.84 -33.36 19.37 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.515 2.143 . . . . 0.0 111.831 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' T' ' 97' ' ' ALA . 36.2 m80 -122.55 -32.24 3.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.285 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.714 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.22 77.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.401 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.894 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.807 ' HB ' ' CD2' ' T' ' 93' ' ' TYR . 1.7 p -87.55 142.67 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.487 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 18.0 p90 -144.62 -179.94 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.853 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.668 ' CG ' HG11 ' T' ' 46' ' ' VAL . 20.3 t-80 -92.88 154.72 18.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.181 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.438 ' HD2' HH11 ' T' ' 5' ' ' ARG . 0.4 OUTLIER -147.33 147.98 30.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.986 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.654 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 27.5 tt0 -120.14 173.36 7.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' T' ' 14' ' ' LEU . . . -75.4 168.52 19.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.053 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -21.88 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -47.99 4.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.952 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 177.17 176.57 45.39 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.559 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.552 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 2.2 ttpm? -59.08 151.72 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' T' ' 48' ' ' ALA . 18.5 m-30 52.34 75.39 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -158.04 -5.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' T' ' 7' ' ' ALA . 0.7 OUTLIER -115.01 164.93 13.46 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.07 0.462 . . . . 0.0 111.275 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.852 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 6.6 p -116.56 -166.19 1.13 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.347 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.597 ' HB2' ' CZ3' ' T' ' 51' ' ' TRP . 62.9 t80 -66.44 -40.45 89.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.062 0.458 . . . . 0.0 109.767 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.75 65.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.72 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.852 ' HB2' ' H ' ' T' ' 15' ' ' THR . 54.6 mt-10 -69.16 -42.83 75.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.278 0.561 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -58.42 -40.81 83.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.925 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -31.41 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.21 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -63.93 -46.58 84.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 0.0 111.26 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.84 -48.02 83.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 55.4 m -64.63 -51.19 63.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.771 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -70.88 -11.98 61.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.693 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.5 OUTLIER -56.81 -50.03 73.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.841 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -104.2 57.4 0.72 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.27 38.37 26.18 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.247 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.636 ' HA2' ' OD1' ' T' ' 94' ' ' ASN . . . -106.66 178.33 22.32 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.655 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -144.52 133.37 22.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.028 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.917 HD22 ' HA ' ' T' ' 52' ' ' MET . 0.5 OUTLIER -47.77 141.63 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.406 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -85.99 143.37 28.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 32.2 p -98.35 -170.68 2.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 111.576 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.749 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 37.9 t80 -70.98 -70.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.884 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 12.0 mttt -45.62 -38.38 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.494 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.425 ' HG3' ' OG1' ' T' ' 32' ' ' THR . 84.5 mt-30 -66.62 -55.45 15.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.063 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.563 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.78 -19.86 31.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.696 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.771 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 7.7 tt0 -74.74 -62.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.254 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.665 ' HA ' ' HD2' ' T' ' 41' ' ' LYS . . . -55.68 -15.44 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -93.91 -28.45 15.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.621 . . . . 0.0 109.656 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.588 ' HG3' HG22 ' T' ' 62' ' ' VAL . 50.8 ttp85 -72.33 -36.13 68.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.215 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 0.0 OUTLIER -67.3 -19.36 65.46 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.636 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.597 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -85.79 -16.73 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.983 0.42 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.448 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 130.32 14.18 2.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.965 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.9 OUTLIER -82.09 117.63 22.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.828 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.659 ' HB2' HG23 ' T' ' 62' ' ' VAL . 2.9 t-160 -138.42 128.36 25.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.668 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.1 OUTLIER -148.43 102.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.773 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -74.35 67.24 1.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.599 ' HA ' ' OH ' ' T' ' 12' ' ' TYR . . . -165.06 121.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.954 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.556 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -43.18 112.7 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.172 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.721 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -111.18 121.89 5.95 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.778 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' T' ' 16' ' ' TYR . 80.6 m95 -57.0 165.0 1.38 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.139 0.495 . . . . 0.0 111.831 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.917 ' HA ' HD22 ' T' ' 30' ' ' LEU . 1.0 OUTLIER -159.15 165.34 33.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.324 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.16 158.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.5 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 79.53 -25.22 0.19 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.501 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.582 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 109.35 20.74 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.507 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.717 ' HG2' ' HA2' ' T' ' 79' ' ' GLY . 0.2 OUTLIER -94.4 160.94 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.902 0.382 . . . . 0.0 111.006 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.8 OUTLIER -158.22 109.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' T' ' 49' ' ' ALA . . . -116.17 -168.25 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.315 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.556 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -132.84 86.38 43.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 111.144 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.821 ' HB3' HG12 ' T' ' 75' ' ' ILE . 32.9 Cg_endo -67.0 118.42 5.55 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.666 2.244 . . . . 0.0 111.955 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.773 HD11 ' HA ' ' T' ' 47' ' ' CYS . 31.6 mm -134.17 119.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -97.69 -24.61 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.56 ' O ' ' HE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -123.58 93.04 48.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.52 99.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.691 2.261 . . . . 0.0 112.552 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.33 159.01 29.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.381 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 57.0 Cg_endo -71.12 -76.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.744 2.296 . . . . 0.0 112.584 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.469 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -86.38 -6.24 58.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.228 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -26.17 42.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' T' ' 70' ' ' PHE . . . 168.74 -38.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.927 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' T' ' 69' ' ' GLY . 0.9 OUTLIER 172.1 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.89 42.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.616 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -81.33 178.9 8.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.09 131.31 53.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.31 -171.0 54.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.866 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.821 HG12 ' HB3' ' T' ' 60' ' ' PRO . 10.0 mt -82.63 121.78 36.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 5.6 mm -95.1 82.08 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.44 114.18 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' T' ' 78' ' ' TYR . 3.4 m-85 -78.91 -27.25 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.717 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 115.35 169.9 16.01 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.472 ' CG1' ' HG3' ' T' ' 56' ' ' ARG . 7.5 mt -53.48 105.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.293 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -90.34 20.29 4.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.956 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' T' ' 82' ' ' LEU . 0.5 OUTLIER 49.45 39.99 17.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.872 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' T' ' 85' ' ' SER . 0.1 OUTLIER -126.37 53.84 1.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.484 ' O ' ' HB ' ' T' ' 15' ' ' THR . 2.3 mtm180 -68.13 10.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.816 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . 0.509 ' H ' ' C ' ' T' ' 83' ' ' ASN . 68.0 m -115.66 8.72 15.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.632 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.781 ' O ' HG22 ' T' ' 15' ' ' THR . 3.1 mm-40 -74.43 -170.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.55 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.402 ' HG3' ' C ' ' T' ' 86' ' ' GLU . 0.0 OUTLIER -136.53 115.95 12.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 111.592 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.772 ' O ' ' HG ' ' T' ' 14' ' ' LEU . 4.4 m95 -154.44 -155.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.106 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.631 ' C ' HD11 ' T' ' 14' ' ' LEU . 0.0 OUTLIER -100.12 -172.39 2.21 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.184 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' T' ' 14' ' ' LEU . . . -143.01 131.18 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.74 0.305 . . . . 0.0 111.452 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.721 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 40.4 m-85 -96.02 113.91 25.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.123 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.402 ' O ' HG23 ' T' ' 2' ' ' VAL . 18.9 m -89.68 153.18 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.311 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.807 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 11.2 t80 -141.37 133.02 27.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.77 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.686 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.4 m-20 -153.27 141.18 13.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.634 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.8 -33.34 40.46 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.484 2.122 . . . . 0.0 111.858 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' T' ' 97' ' ' ALA . 6.6 m-70 -119.42 -34.77 3.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.532 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 32.89 57.82 0.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.397 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' T' ' 93' ' ' TYR . 0.8 OUTLIER -105.04 137.44 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.69 0.281 . . . . 0.0 111.317 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -142.75 151.02 40.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.488 . . . . 0.0 111.378 179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.495 ' CD2' HG21 ' T' ' 46' ' ' VAL . 15.0 t-80 -90.88 145.16 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.814 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' T' ' 4' ' ' HIS . 5.1 mmm180 -153.82 151.08 29.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.215 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.37 -169.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.792 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -83.44 151.38 25.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . 0.439 HH12 HH22 ' T' ' 5' ' ' ARG . 6.6 mmt-85 -54.07 -26.39 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -91.72 -49.66 6.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.922 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . -179.66 176.69 47.77 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' OD2' ' T' ' 89' ' ' ASP . 3.2 ttpm? -68.56 162.03 26.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.794 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 9.6 m-30 52.07 44.12 29.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.72 5.95 2.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.794 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.792 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 11.7 mt -108.98 142.67 39.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.076 0.465 . . . . 0.0 111.514 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.2 p -114.7 152.13 32.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.947 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.649 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 84.0 t80 -38.41 -39.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.82 -40.48 72.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' T' ' 15' ' ' THR . 84.3 mt-10 -75.24 -51.48 13.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -48.18 -48.96 34.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.057 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.526 ' HD2' HD23 ' T' ' 30' ' ' LEU . 5.5 tttt -64.91 -52.84 54.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.57 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -44.21 -36.59 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.309 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 7.1 t -70.74 -54.84 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.234 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 64.8 m -61.81 -47.63 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 37.7 tt0 -70.66 -17.43 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.602 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 0.6 OUTLIER -53.2 -48.22 68.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.75 54.21 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.943 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 48.15 42.95 24.88 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.261 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -123.28 174.63 16.56 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.586 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' T' ' 29' ' ' HIS . 0.0 OUTLIER -127.75 141.52 51.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.633 0.254 . . . . 0.0 110.605 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -76.64 125.18 28.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.451 . . . . 0.0 110.071 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 1.058 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -48.2 152.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.714 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.563 HG23 ' OE1' ' T' ' 35' ' ' GLN . 9.7 p -109.72 -157.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.146 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.645 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 22.9 t80 -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.166 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 10.6 mttm -47.76 -35.96 10.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . 0.563 ' OE1' HG23 ' T' ' 32' ' ' THR . 92.5 mt-30 -67.33 -56.1 11.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.876 0.369 . . . . 0.0 110.359 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.614 HD13 ' O ' ' T' ' 36' ' ' LEU . 1.6 tm? -56.45 -24.01 42.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 14.1 tp10 -66.49 -62.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.188 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.75 -13.99 12.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.639 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -95.06 -28.2 15.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.448 0.642 . . . . 0.0 109.613 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.563 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -71.06 -32.92 69.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.896 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -67.14 -17.83 65.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.187 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.639 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -90.82 -18.52 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.723 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.499 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 133.89 15.78 1.17 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.865 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' T' ' 39' ' ' ALA . 0.3 OUTLIER -83.46 79.69 9.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.991 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.601 ' CE1' HG23 ' T' ' 61' ' ' ILE . 2.5 t-160 -111.93 128.39 56.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.634 HG22 ' OH ' ' T' ' 91' ' ' TYR . 2.0 m -147.02 111.65 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.081 0.467 . . . . 0.0 110.991 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.722 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.1 OUTLIER -76.12 77.41 2.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.926 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . 177.81 126.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' T' ' 58' ' ' GLY . . . -44.25 121.29 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.694 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -117.36 120.77 4.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.707 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.4 m95 -53.93 166.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.018 0.437 . . . . 0.0 111.427 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.669 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -162.32 171.36 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.528 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.32 166.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.381 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' T' ' 80' ' ' ILE . 0.0 OUTLIER 77.02 -28.8 0.17 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.334 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 106.68 18.74 10.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.65 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.786 ' HB3' HG13 ' T' ' 80' ' ' ILE . 3.5 ptp85 -105.34 158.76 16.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 110.547 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' T' ' 51' ' ' TRP . 0.3 OUTLIER -146.25 122.01 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -117.9 -168.41 14.45 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.489 ' CD2' ' HB ' ' T' ' 76' ' ' ILE . 0.0 OUTLIER -131.01 88.08 46.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 111.038 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.925 ' HB3' HG12 ' T' ' 75' ' ' ILE . 56.3 Cg_endo -73.55 123.3 8.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.822 2.348 . . . . 0.0 112.193 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.722 HD11 ' HA ' ' T' ' 47' ' ' CYS . 17.6 mm -136.32 97.66 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.506 ' CG1' ' N ' ' T' ' 63' ' ' LYS . 0.6 OUTLIER -62.82 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.529 ' O ' ' HE1' ' T' ' 45' ' ' HIS . 0.0 OUTLIER -115.27 92.26 31.3 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.452 ' HG3' ' O ' ' T' ' 72' ' ' LYS . 78.3 Cg_exo -45.38 121.96 4.27 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.63 2.22 . . . . 0.0 112.435 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.59 166.23 21.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.489 ' HG2' ' H ' ' T' ' 67' ' ' ASN . 57.8 Cg_endo -71.69 -78.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.669 2.246 . . . . 0.0 112.395 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -76.52 -0.36 22.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -7.32 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.37 55.59 2.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.94 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 t80 39.6 76.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.97 6.65 6.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.55 ' HB3' HD11 ' T' ' 76' ' ' ILE . 0.0 OUTLIER 41.53 -164.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.401 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 128.07 54.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.914 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.95 -169.51 54.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.766 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' T' ' 60' ' ' PRO . 22.6 mt -80.45 122.09 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.887 0.375 . . . . 0.0 111.124 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' T' ' 72' ' ' LYS . 5.2 mm -96.18 80.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.876 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.507 ' HB2' ' HA3' ' T' ' 58' ' ' GLY . 4.1 t70 -110.64 131.12 55.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' T' ' 76' ' ' ILE . 1.8 m-85 -100.33 25.22 7.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.982 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.16 178.58 8.75 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.786 HG13 ' HB3' ' T' ' 56' ' ' ARG . 3.6 mt -65.17 126.67 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.86 0.362 . . . . 0.0 111.194 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -106.62 19.64 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.789 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.67 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 56.12 32.23 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -124.8 54.95 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' T' ' 15' ' ' THR . 1.4 mtt85 -65.21 -1.93 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.97 11.51 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.7 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.515 ' O ' HG22 ' T' ' 15' ' ' THR . 3.0 mm-40 -72.96 -171.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -137.01 115.97 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.387 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.583 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 17.2 m95 -150.75 -138.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.141 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.6 OUTLIER -112.24 -170.71 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.08 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.472 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -144.5 126.56 15.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.415 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 1.058 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 30.5 m-85 -97.36 126.81 42.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.898 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.488 ' HB3' ' CZ ' ' T' ' 3' ' ' TYR . 0.1 OUTLIER -100.23 162.84 12.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.872 0.368 . . . . 0.0 110.932 -179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.619 ' CD2' HG22 ' T' ' 2' ' ' VAL . 21.2 t80 -156.11 118.8 4.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.797 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.862 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 3.0 m120 -139.34 146.79 50.14 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.698 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.1 -52.08 8.07 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.552 2.168 . . . . 0.0 111.617 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.527 ' O ' ' C ' ' T' ' 97' ' ' ALA . 14.2 m-70 -97.26 -27.52 14.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.305 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 23.09 71.91 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.461 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 tttt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.877 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.911 ' HB ' ' HD1' ' T' ' 93' ' ' TYR . 2.3 p -102.48 152.52 5.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.864 0.364 . . . . 0.0 111.344 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -160.32 178.98 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.993 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.406 ' CG ' ' N ' ' T' ' 5' ' ' ARG . 8.1 t-80 -89.11 155.88 19.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' T' ' 4' ' ' HIS . 0.3 OUTLIER -148.81 152.02 35.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.969 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.647 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 28.6 tt0 -122.53 172.79 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.741 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -80.23 158.76 26.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -61.27 -26.99 68.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' T' ' 13' ' ' LYS . 1.9 t -91.81 -50.53 5.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 178.39 172.8 43.17 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.421 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' T' ' 6' ' ' GLU . 13.9 ttpt -66.22 161.94 21.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.737 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.642 ' HA ' ' HA ' ' T' ' 88' ' ' TRP . 11.2 m-30 55.7 53.89 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' T' ' 9' ' ' SER . 8.3 mtmt -154.68 3.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.0 mt -102.43 132.41 48.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 30.3 p -103.47 148.85 25.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.538 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' T' ' 84' ' ' ARG . 84.2 t80 -35.66 -38.1 0.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.46 -44.97 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.457 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' T' ' 15' ' ' THR . 64.2 mt-10 -73.05 -47.69 42.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.17 0.51 . . . . 0.0 110.348 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.98 -45.3 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.077 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.91 -47.13 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.58 -47.59 19.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' T' ' 25' ' ' PHE . 4.7 t -68.19 -53.27 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.407 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 87.7 m -59.89 -38.39 82.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 32.1 tt0 -90.08 -2.64 58.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' T' ' 22' ' ' VAL . 1.2 t80 -59.41 -48.13 82.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.95 60.59 2.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.24 22.41 10.14 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.509 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.771 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.96 -158.27 12.56 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 3.7 p80 -155.04 -178.46 7.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.756 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.0 OUTLIER -103.29 124.95 49.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.642 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.84 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -46.02 157.57 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.543 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 21.2 p -111.29 -162.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.894 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 50.0 t80 -75.25 -68.17 0.58 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.945 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 2.2 mtpm? -47.21 -45.28 23.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.28 -49.35 76.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.881 0.372 . . . . 0.0 110.517 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.2 OUTLIER -54.92 -29.44 56.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.106 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' T' ' 34' ' ' LYS . 10.0 tt0 -65.05 -61.84 1.91 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.473 ' O ' HG23 ' T' ' 42' ' ' ILE . . . -59.58 -12.1 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.1 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.578 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -94.73 -29.86 14.58 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.423 0.63 . . . . 0.0 109.892 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.632 ' HE ' HG12 ' T' ' 62' ' ' VAL . 0.0 OUTLIER -72.98 -33.99 66.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.07 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' T' ' 37' ' ' GLU . 21.9 mttt -69.85 -17.49 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.408 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.578 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -87.5 -17.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.466 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 134.8 11.51 1.43 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' T' ' 40' ' ' ARG . 0.8 OUTLIER -80.7 129.63 34.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' T' ' 61' ' ' ILE . 3.3 t-160 -146.24 125.56 13.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.711 HG21 ' HE1' ' T' ' 91' ' ' TYR . 0.9 OUTLIER -142.99 98.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.122 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.716 ' HA ' HD11 ' T' ' 61' ' ' ILE . 0.0 OUTLIER -67.47 -0.13 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.806 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.566 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -102.64 141.77 34.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.676 ' HA ' ' HD1' ' T' ' 59' ' ' TYR . . . -58.79 114.23 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.183 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -109.87 117.43 4.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.707 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 72.3 m95 -52.38 166.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 111.435 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.773 ' HA ' HD11 ' T' ' 30' ' ' LEU . 3.9 ptp -164.55 173.24 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.484 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.58 ' HB2' HG22 ' T' ' 32' ' ' THR . . . -51.11 167.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.424 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 0.0 OUTLIER 76.13 -28.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.266 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 104.8 18.6 12.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.571 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.564 ' O ' ' HG3' ' T' ' 52' ' ' MET . 2.8 ptt180 -105.03 158.67 16.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.701 0.286 . . . . 0.0 110.581 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -142.07 122.86 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.72 -168.43 12.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.172 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.676 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -145.51 90.84 5.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.162 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.574 ' HG3' HD12 ' T' ' 36' ' ' LEU . 58.4 Cg_endo -74.9 134.95 18.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.659 2.24 . . . . 0.0 112.179 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' T' ' 47' ' ' CYS . 29.6 mm -126.67 145.13 34.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.632 HG12 ' HE ' ' T' ' 40' ' ' ARG . 4.1 m -98.08 -44.57 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.087 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' T' ' 64' ' ' PRO . 0.0 OUTLIER -118.46 94.12 46.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' T' ' 63' ' ' LYS . 30.9 Cg_endo -65.37 131.1 27.08 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.499 2.133 . . . . 0.0 112.288 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.71 -133.69 3.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.75 -83.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 0.0 112.379 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -17.69 24.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.859 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -4.71 57.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.984 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.18 64.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.955 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -46.95 -29.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.815 0.341 . . . . 0.0 111.023 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.2 23.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.696 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.432 ' HB3' ' CD1' ' T' ' 76' ' ' ILE . 7.8 mttt -92.17 149.94 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.65 128.3 23.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.67 -169.91 33.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.057 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.894 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -72.79 101.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.667 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 9.3 mm -72.05 81.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.07 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.72 137.32 49.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.727 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.451 ' HE1' HG22 ' T' ' 76' ' ' ILE . 0.8 OUTLIER -105.05 28.44 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.59 171.28 3.36 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' T' ' 82' ' ' LEU . 13.8 mt -69.84 119.01 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -82.9 15.4 2.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.689 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.1 OUTLIER 53.09 43.66 31.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -164.76 82.26 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' T' ' 16' ' ' TYR . 0.0 OUTLIER -69.24 -1.15 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.0 13.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.591 ' O ' HG22 ' T' ' 15' ' ' THR . 3.8 mm-40 -76.84 -177.15 4.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.733 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' T' ' 12' ' ' TYR . 0.7 OUTLIER -134.55 113.29 11.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.503 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.642 ' HA ' ' HA ' ' T' ' 12' ' ' TYR . 9.7 m95 -153.32 -160.34 1.11 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.168 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.566 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.0 OUTLIER -92.42 -170.91 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.556 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -141.04 128.62 21.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.84 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 23.4 m-85 -91.07 107.86 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.92 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . 0.486 ' O ' HG23 ' T' ' 2' ' ' VAL . 3.7 m -88.28 149.32 23.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 111.213 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.911 ' HD1' ' HB ' ' T' ' 2' ' ' VAL . 61.8 t80 -136.47 132.1 34.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.71 ' ND2' ' HB3' ' T' ' 97' ' ' ALA . 3.6 m120 -116.91 81.21 11.9 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . 0.73 ' HB3' ' HE2' ' T' ' 93' ' ' TYR . 64.4 Cg_endo -75.79 -56.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.469 2.112 . . . . 0.0 110.116 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.459 ' H ' ' HG2' ' T' ' 95' ' ' PRO . 20.0 t-160 -126.06 10.14 7.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.958 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.71 ' HB3' ' ND2' ' T' ' 94' ' ' ASN . . . -77.72 54.49 1.24 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.224 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.955 ' HB ' ' HD2' ' T' ' 93' ' ' TYR . 1.0 OUTLIER -86.57 147.07 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.591 ' CE1' ' HB1' ' T' ' 97' ' ' ALA . 12.5 p90 -156.41 176.21 13.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.021 0.439 . . . . 0.0 111.405 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.775 ' CG ' HG11 ' T' ' 46' ' ' VAL . 39.3 t-80 -98.65 163.79 12.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.447 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.88 146.38 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' T' ' 7' ' ' ALA . 0.4 OUTLIER -109.23 -168.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 110.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -95.48 150.67 20.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.08 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -25.66 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -92.13 -48.94 6.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 170.66 172.7 37.23 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.46 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' N ' ' T' ' 12' ' ' TYR . 1.4 tttt -58.97 151.02 22.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.618 ' N ' ' HG2' ' T' ' 11' ' ' LYS . 9.3 m-30 61.77 58.67 1.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.04 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -155.17 5.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.634 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 5.7 mt -109.0 133.1 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.289 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' T' ' 84' ' ' ARG . 1.4 p -104.8 149.32 25.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.286 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CE3' ' T' ' 51' ' ' TRP . 78.3 t80 -35.44 -40.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.982 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.15 -45.25 67.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.525 ' OE1' HG23 ' T' ' 15' ' ' THR . 74.5 mt-10 -72.48 -47.62 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 110.344 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' T' ' 90' ' ' ALA . . . -50.03 -45.44 52.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -71.08 -50.77 30.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -48.7 -38.69 22.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.24 -53.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.487 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . . . . . . . . . 66.4 m -64.34 -27.18 68.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 23.5 tt0 -98.9 -9.03 24.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.155 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.5 t80 -53.73 -42.96 68.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.081 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.71 60.23 0.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.268 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.79 26.2 10.52 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.538 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -106.57 -169.29 22.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.561 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' T' ' 93' ' ' TYR . 0.0 OUTLIER -155.71 134.05 11.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 0.0 110.418 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' T' ' 52' ' ' MET . 0.1 OUTLIER -65.04 125.34 24.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.079 0.466 . . . . 0.0 110.387 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -53.02 161.4 0.81 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 26.3 p -109.34 -164.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.207 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.638 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 28.4 t80 -74.91 -72.59 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.143 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 8.2 mtpt -48.23 -40.21 23.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.913 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.95 -51.19 63.17 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.875 0.369 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' T' ' 32' ' ' THR . 0.7 OUTLIER -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.601 ' HG3' ' HE3' ' T' ' 41' ' ' LYS . 6.5 tp10 -54.71 -60.37 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.232 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.21 -21.51 14.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.862 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.611 ' O ' HG12 ' T' ' 42' ' ' ILE . . . -90.62 -27.93 18.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.0 109.723 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.2 OUTLIER -72.23 -33.27 67.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.053 179.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.601 ' HE3' ' HG3' ' T' ' 37' ' ' GLU . 8.4 mttp -68.99 -17.78 63.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.396 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.611 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -88.46 -15.9 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.0 110.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.433 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 129.22 14.9 2.13 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.068 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.581 ' HZ ' ' N ' ' T' ' 4' ' ' HIS . 0.8 OUTLIER -81.95 99.25 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.669 ' HB2' ' HB ' ' T' ' 62' ' ' VAL . 2.7 t-160 -121.73 119.78 32.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' T' ' 4' ' ' HIS . 0.0 OUTLIER -141.3 94.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' T' ' 48' ' ' ALA . 6.5 t -64.37 89.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' T' ' 47' ' ' CYS . . . 171.91 127.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -46.46 101.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -101.66 111.11 4.0 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.676 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.582 ' CE3' ' HB2' ' T' ' 16' ' ' TYR . 74.2 m95 -44.65 157.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.983 0.42 . . . . 0.0 111.294 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.792 ' HA ' HD11 ' T' ' 30' ' ' LEU . 0.0 OUTLIER -174.83 178.13 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' T' ' 56' ' ' ARG . . . 50.14 -166.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.12 0.4 3.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.305 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.435 ' O ' ' HZ3' ' T' ' 51' ' ' TRP . . . 156.81 13.15 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.659 -0.782 . . . . 0.0 111.739 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.846 ' HG3' HG13 ' T' ' 80' ' ' ILE . 4.4 mtt-85 -90.45 130.76 36.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 110.868 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.443 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.1 OUTLIER -125.08 129.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.961 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' T' ' 77' ' ' ASP . . . -135.17 -175.74 14.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.329 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -118.43 78.93 14.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 110.756 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' T' ' 75' ' ' ILE . 21.7 Cg_exo -63.12 124.59 14.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.758 2.305 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' T' ' 45' ' ' HIS . 38.6 mm -130.51 153.3 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' T' ' 45' ' ' HIS . 15.5 t -102.93 -64.98 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.347 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.05 155.63 45.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.056 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.08 -169.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.588 2.192 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.49 81.34 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.289 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . 0.862 ' HG3' ' HA ' ' T' ' 70' ' ' PHE . 72.8 Cg_endo -85.82 -27.61 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.952 2.434 . . . . 0.0 112.379 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 44.43 16.23 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.398 0.618 . . . . 0.0 109.858 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . 0.55 ' N ' ' O ' ' T' ' 66' ' ' PRO . 0.0 OUTLIER -113.85 -41.17 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.102 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.6 14.17 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . 0.862 ' HA ' ' HG3' ' T' ' 66' ' ' PRO . 0.6 OUTLIER 73.65 81.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . 0.447 ' O ' HG13 ' T' ' 61' ' ' ILE . . . -91.3 17.27 56.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.604 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.05 -166.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.04 0.447 . . . . 0.0 111.558 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.23 124.96 46.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.093 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.62 179.55 50.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.872 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.638 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 2.7 mt -73.42 111.56 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.542 ' HB ' ' CD2' ' T' ' 59' ' ' TYR . 6.3 mm -91.05 80.15 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' T' ' 79' ' ' GLY . 2.4 t70 -103.29 129.18 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.009 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -94.41 15.84 16.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' T' ' 56' ' ' ARG . . . 71.22 169.6 9.81 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.846 HG13 ' HG3' ' T' ' 56' ' ' ARG . 10.6 mt -59.36 112.68 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.983 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' T' ' 81' ' ' ARG . 2.2 mmp_? -91.57 21.05 4.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.973 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.576 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 51.66 50.82 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.61 66.3 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.654 ' O ' ' HB ' ' T' ' 15' ' ' THR . 19.3 mtm105 -66.67 -3.58 6.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m -98.19 18.62 15.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.532 ' O ' HG22 ' T' ' 15' ' ' THR . 3.3 mm-40 -74.87 -171.25 1.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.5 114.48 10.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.56 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 22.8 m95 -151.68 -134.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.378 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' T' ' 11' ' ' LYS . 0.5 OUTLIER -121.64 -172.12 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.379 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.531 ' CB ' ' HB1' ' T' ' 19' ' ' ALA . . . -145.15 137.23 25.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' T' ' 50' ' ' GLY . 28.9 m-85 -101.67 107.65 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -85.85 133.83 33.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 111.327 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.955 ' HD2' ' HB ' ' T' ' 2' ' ' VAL . 0.9 OUTLIER -132.57 124.55 28.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.554 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.662 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 4.9 m120 -134.14 148.5 68.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.75 -33.28 18.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.512 2.141 . . . . 0.0 111.849 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.456 ' O ' ' C ' ' T' ' 97' ' ' ALA . 28.1 m-70 -122.77 -32.03 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.439 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 30.66 71.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.338 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.863 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' T' T ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' T' T ' 2' ' ' VAL . . . . . 0.811 HG22 ' HE2' ' T' ' 44' ' ' PHE . 1.3 p -86.07 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 111.229 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 3' ' ' TYR . . . . . 0.719 ' HE1' ' HB1' ' T' ' 97' ' ' ALA . 13.8 p90 -141.93 169.64 17.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 4' ' ' HIS . . . . . 0.522 ' HB2' HG11 ' T' ' 46' ' ' VAL . 9.7 t-80 -96.76 145.7 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.764 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 5' ' ' ARG . . . . . 0.435 ' HG3' ' H ' ' T' ' 6' ' ' GLU . 0.0 OUTLIER -152.47 166.4 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 6' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' T' ' 5' ' ' ARG . 0.6 OUTLIER -123.3 -170.15 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.66 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 7' ' ' ALA . . . . . 0.667 ' HB2' ' HG ' ' T' ' 14' ' ' LEU . . . -86.31 150.69 24.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -19.26 61.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 9' ' ' SER . . . . . 0.461 ' HB3' ' CE ' ' T' ' 13' ' ' LYS . 0.5 OUTLIER -97.33 -25.89 15.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 10' ' ' GLY . . . . . 0.658 ' O ' ' HB3' ' T' ' 7' ' ' ALA . . . 152.51 168.12 16.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -61.85 153.89 27.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.702 0.287 . . . . 0.0 110.855 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 12' ' ' TYR . . . . . 0.766 ' HB3' ' HD2' ' T' ' 87' ' ' ARG . 10.2 m-30 55.52 51.55 12.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.811 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' T' ' 10' ' ' GLY . 1.0 OUTLIER -142.28 2.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.636 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 14' ' ' LEU . . . . . 0.667 ' HG ' ' HB2' ' T' ' 7' ' ' ALA . 8.8 mt -105.78 141.23 37.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 15' ' ' THR . . . . . 0.625 ' H ' ' HB2' ' T' ' 18' ' ' GLU . 49.4 p -110.51 149.71 29.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.089 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 16' ' ' TYR . . . . . 0.561 ' CD1' ' HA2' ' T' ' 55' ' ' GLY . 81.4 t80 -34.91 -40.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.41 -43.07 61.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.409 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 18' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' T' ' 15' ' ' THR . 71.0 mt-10 -68.61 -44.04 75.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 109.966 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 19' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 90' ' ' ALA . . . -57.06 -39.22 74.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.972 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 20' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' T' ' 24' ' ' GLU . 10.5 tttm -75.51 -38.22 59.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.106 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 21' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' T' ' 25' ' ' PHE . . . -56.06 -50.01 72.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -68.81 -53.76 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.42 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 23' ' ' CYS . . . . . 0.635 ' HB3' ' O ' ' T' ' 29' ' ' HIS . 88.3 m -63.31 -26.96 69.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 24' ' ' GLU . . . . . 0.789 ' HA ' ' O ' ' T' ' 28' ' ' GLY . 22.3 tt0 -103.39 1.59 32.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.232 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 25' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' T' ' 21' ' ' ALA . 1.6 t80 -63.71 -43.33 96.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.203 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -100.53 61.26 1.02 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.64 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.39 19.97 6.68 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.619 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 28' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' T' ' 24' ' ' GLU . . . -113.26 -159.97 13.9 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 29' ' ' HIS . . . . . 0.635 ' O ' ' HB3' ' T' ' 23' ' ' CYS . 5.7 p80 -152.88 -177.56 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.996 0.427 . . . . 0.0 110.657 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' T' ' 30' ' ' LEU . 0.0 OUTLIER -101.6 124.06 46.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.6 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 31' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' T' ' 91' ' ' TYR . . . -44.92 154.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.571 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 32' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' T' ' 36' ' ' LEU . 6.9 p -108.31 -158.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.101 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 33' ' ' TYR . . . . . 0.921 ' HE1' ' HB ' ' T' ' 75' ' ' ILE . 35.2 t80 -80.99 -73.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.112 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 34' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' T' ' 37' ' ' GLU . 20.8 mtmt -44.83 -36.85 3.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.501 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 35' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.82 -53.1 36.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 36' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' T' ' 91' ' ' TYR . 0.2 OUTLIER -57.89 -21.13 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.138 0.494 . . . . 0.0 109.984 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 37' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' T' ' 41' ' ' LYS . 9.3 tt0 -72.63 -61.97 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 38' ' ' ALA . . . . . 0.554 ' HA ' ' HE2' ' T' ' 41' ' ' LYS . . . -58.43 -15.58 11.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 39' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' T' ' 44' ' ' PHE . . . -94.02 -29.73 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.537 0.684 . . . . 0.0 109.578 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 40' ' ' ARG . . . . . 0.658 ' HA ' ' HB3' ' T' ' 44' ' ' PHE . 0.0 OUTLIER -69.06 -32.56 72.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.863 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 41' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' T' ' 38' ' ' ALA . 28.7 mtmt -66.61 -17.85 65.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 42' ' ' ILE . . . . . 0.658 HG12 ' O ' ' T' ' 39' ' ' ALA . 1.1 pt -92.1 -22.47 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 110.444 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 43' ' ' GLY . . . . . 0.577 ' N ' HG13 ' T' ' 42' ' ' ILE . . . 138.61 17.88 0.56 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.96 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 44' ' ' PHE . . . . . 0.811 ' HE2' HG22 ' T' ' 2' ' ' VAL . 0.5 OUTLIER -74.75 86.76 2.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.778 0.323 . . . . 0.0 110.876 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 45' ' ' HIS . . . . . 0.626 ' NE2' HG23 ' T' ' 61' ' ' ILE . 3.5 t-160 -115.36 122.84 47.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.97 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 46' ' ' VAL . . . . . 0.671 HG11 ' HE1' ' T' ' 91' ' ' TYR . 0.7 OUTLIER -148.54 112.21 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 47' ' ' CYS . . . . . 0.926 ' HA ' HD11 ' T' ' 61' ' ' ILE . 1.8 t -82.76 74.38 9.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 48' ' ' ALA . . . . . 0.657 ' HB1' ' OD1' ' T' ' 89' ' ' ASP . . . -176.54 123.23 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.837 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 49' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' T' ' 88' ' ' TRP . . . -42.85 116.68 0.92 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 50' ' ' GLY . . . . . 0.665 ' HA3' ' CE2' ' T' ' 91' ' ' TYR . . . -116.17 117.42 3.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 51' ' ' TRP . . . . . 0.584 ' C ' HD11 ' T' ' 30' ' ' LEU . 75.3 m95 -50.66 166.47 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.01 0.433 . . . . 0.0 111.475 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 52' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' T' ' 56' ' ' ARG . 2.0 ptp -162.18 168.61 22.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.362 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 53' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' T' ' 54' ' ' LYS . . . -48.67 165.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.541 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 54' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' T' ' 53' ' ' ALA . 2.3 mmtp 78.76 -33.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.375 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 55' ' ' GLY . . . . . 0.561 ' HA2' ' CD1' ' T' ' 16' ' ' TYR . . . 111.45 17.22 8.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.695 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 56' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' T' ' 52' ' ' MET . 0.8 OUTLIER -105.23 157.25 17.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.579 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 57' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' T' ' 49' ' ' ALA . 0.2 OUTLIER -139.39 125.75 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.312 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 58' ' ' GLY . . . . . . . . . . . . . . . -126.23 -168.01 12.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.149 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 59' ' ' TYR . . . . . 0.538 ' HD1' ' HA ' ' T' ' 49' ' ' ALA . 0.0 OUTLIER -144.59 98.32 4.94 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 60' ' ' PRO . . . . . 0.689 ' HB3' HD13 ' T' ' 75' ' ' ILE . 78.5 Cg_endo -83.41 129.45 5.08 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.814 2.343 . . . . 0.0 112.183 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 61' ' ' ILE . . . . . 0.926 HD11 ' HA ' ' T' ' 47' ' ' CYS . 16.4 mm -141.13 111.61 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.153 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 62' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' T' ' 45' ' ' HIS . 2.4 m -66.48 -41.39 88.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.049 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -114.54 88.06 15.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 64' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.56 148.16 92.59 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.622 2.215 . . . . 0.0 112.27 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.89 -137.67 3.95 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 66' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.4 -77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.264 . . . . 0.0 112.392 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.57 -3.93 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -23.62 66.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.28 -5.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.963 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 70' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 62.36 33.65 16.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.964 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.99 22.72 65.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.672 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 72' ' ' LYS . . . . . 0.732 ' HD3' HG13 ' T' ' 76' ' ' ILE . 23.7 mttp -85.46 155.12 21.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 132.78 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.5 -173.1 33.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.872 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 75' ' ' ILE . . . . . 0.921 ' HB ' ' HE1' ' T' ' 33' ' ' TYR . 0.7 OUTLIER -79.78 98.39 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 76' ' ' ILE . . . . . 0.732 HG13 ' HD3' ' T' ' 72' ' ' LYS . 16.0 mm -70.9 79.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.69 117.62 34.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.874 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 78' ' ' TYR . . . . . 0.541 ' CE1' HG22 ' T' ' 76' ' ' ILE . 0.6 OUTLIER -81.14 11.86 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.64 169.41 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 80' ' ' ILE . . . . . 0.606 HG22 ' H ' ' T' ' 82' ' ' LEU . 8.8 mt -52.87 136.19 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.027 0.441 . . . . 0.0 111.251 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 81' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.31 17.08 14.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.018 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 82' ' ' LEU . . . . . 0.606 ' H ' HG22 ' T' ' 80' ' ' ILE . 0.2 OUTLIER 49.54 50.27 18.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.33 55.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 84' ' ' ARG . . . . . 0.543 ' O ' ' HB ' ' T' ' 15' ' ' THR . 0.0 OUTLIER -56.09 -12.52 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.4 15.56 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 86' ' ' GLU . . . . . 0.565 ' HB3' ' NE1' ' T' ' 88' ' ' TRP . 2.7 mm-40 -78.82 -171.68 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 87' ' ' ARG . . . . . 0.766 ' HD2' ' HB3' ' T' ' 12' ' ' TYR . 0.0 OUTLIER -136.18 113.2 10.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 88' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' T' ' 49' ' ' ALA . 3.4 m95 -156.26 179.49 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.056 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 89' ' ' ASP . . . . . 0.657 ' OD1' ' HB1' ' T' ' 48' ' ' ALA . 0.5 OUTLIER -73.83 -170.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.323 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' T' T ' 90' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' T' ' 19' ' ' ALA . . . -146.08 132.23 19.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.598 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 91' ' ' TYR . . . . . 0.875 ' HB3' ' HB3' ' T' ' 31' ' ' ALA . 45.5 m-85 -94.08 115.57 27.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 92' ' ' CYS . . . . . . . . . . . . . 3.4 m -89.63 151.67 21.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 111.331 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 93' ' ' TYR . . . . . 0.665 ' CD2' ' HB ' ' T' ' 2' ' ' VAL . 12.0 t80 -148.3 118.88 7.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 94' ' ' ASN . . . . . 0.865 ' HB2' ' HB2' ' T' ' 97' ' ' ALA . 59.3 m-20 -132.34 141.38 41.1 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 95' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -48.93 -32.76 23.91 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.505 2.137 . . . . 0.0 111.738 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' T' T ' 96' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' T' ' 97' ' ' ALA . 15.1 m-70 -121.75 -32.75 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.599 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 97' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' T' ' 94' ' ' ASN . . . 31.12 53.38 0.18 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.354 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' T' T ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 stop_ save_